Publications

Publications – 2022

Khan S, Shi W, Kaneko T, Baron SJ The Evolving Role of the Multidisciplinary Heart Team in Aortic Stenosis. US Cardiol. 2022 Jul 25;16:e19. doi: 10.15420/usc.2022.04. eCollection 2022.
Kaur G, Chand S, Rai D, Baibhav B, Blankstein R, Mukherjee D, Levy P, Gulati M Contemporary Risk Stratification of Acute Coronary Syndrome. US Cardiol. 2022 Oct 14;16:e23. doi: 10.15420/usc.2022.10. eCollection 2022.
Zhang L, Smyth D, Al-Khalaf M, Blet A, Du Q, Bernick J, Gong M, Chi X, Oh Y, Roba-Oshin M, Coletta E, Feletou M, Gramolini AO, Kim KH, Coutinho T, Januzzi JL Jr, Tyl B, Ziegler A, Liu PP Insulin-like growth factor-binding protein-7 (IGFBP7) links senescence to heart failure. Nat Cardiovasc Res. 2022 Dec;1(12):1195-1214. doi: 10.1038/s44161-022-00181-y. Epub 2022 Dec 22.
Lansky A, Baron SJ, Grines CL, Tremmel JA, Al-Lamee R, Angiolillo DJ, Chieffo A, Croce K, Jacobs AK, Madan M, Maehara A, Mehilli J, Mehran R, Ng V, Parikh PB, Saw J, Abbott JD SCAI Expert Consensus Statement on Sex-Specific Considerations in Myocardial Revascularization. J Soc Cardiovasc Angiogr Interv. 2022 Feb 3;1(2):100016. doi: 10.1016/j.jscai.2021.100016. eCollection 2022 Mar-Apr.
Marinacci LX, Gavin MC, Laham RJ Novel Use of Valve-in-Valve Transcatheter Mitral Replacement for Severe Prosthetic Stenosis Due to Drug Use-Associated Endocarditis. J Soc Cardiovasc Angiogr Interv. 2022 Oct 4;1(6):100498. doi: 10.1016/j.jscai.2022.100498. eCollection 2022 Nov-Dec.
Chakravartti J, Feser WJ, Plomondon ME, Valle JA, Rao SV, Gutierrez JA, Grunwald GK, Gunzburger E, Swaminathan RV Access Site Selection and Outcomes for Chronic Total Occlusion Percutaneous Coronary Interventions: Insights from the VA CART Program. J Soc Cardiovasc Angiogr Interv. 2022 Aug 24;1(6):100440. doi: 10.1016/j.jscai.2022.100440. eCollection 2022 Nov-Dec.
Prasad A, Palevsky PM, Bansal S, Chertow GM, Kaufman J, Kashani K, Kim ESH, Sridharan L, Amin AP, Bangalore S, Briguori C, Charytan DM, Eng M, Jneid H, Brown JR, Mehran R, Sarnak MJ, Solomon R, Thakar CV, Fowler K, Weisbord S Management of Patients With Kidney Disease in Need of Cardiovascular Catheterization: A Scientific Workshop Cosponsored by the National Kidney Foundation and the Society for Cardiovascular Angiography and Interventions. J Soc Cardiovasc Angiogr Interv. 2022 Aug 26;1(6):100445. doi: 10.1016/j.jscai.2022.100445. eCollection 2022 Nov-Dec.
Stathogiannis KE, Pogatchnik BP, Steinberg GK, Sharma RP Coronary Artery Disease in a Young Adult With Unilateral Moyamoya Disease. J Soc Cardiovasc Angiogr Interv. 2022 Sep 24;1(6):100459. doi: 10.1016/j.jscai.2022.100459. eCollection 2022 Nov-Dec.
Riley RF, Batchelor WB, Goldstein JA, Al-Lamee R, Shah S, Tremmel JA, Jaffer F, Henry TD The 2021 AHA/ACC Guideline for the Evaluation and Diagnosis of Chest Pain: An Interventionalist’s Viewpoint. J Soc Cardiovasc Angiogr Interv. 2022 Apr 8;1(3):100305. doi: 10.1016/j.jscai.2022.100305. eCollection 2022 May-Jun.
Seto AH, Estep JD, Tayal R, Tsai S, Messenger JC, Alraies MC, Schneider DB, Klein AJ, Duwayri Y, McCabe JM, Baron SJ, Vadlamudi V, Smith TD, Baran DA SCAI Position Statement on Best Practices for Percutaneous Axillary Arterial Access and Training. J Soc Cardiovasc Angiogr Interv. 2022 Apr 19;1(3):100041. doi: 10.1016/j.jscai.2022.100041. eCollection 2022 May-Jun.
Seto AH, Duffy PL, Don CW, Kaul P, Maran A, Cotton VR, Feldman DN, Hess CN, Bavry AA, Yakubov SJ, Saw J, Sorajja P, Guerrero ME, Rao SV SCAI Position Statement on Best Practices for Clinical Proctoring of New Technologies and Techniques. J Soc Cardiovasc Angiogr Interv. 2022 Mar 30;1(3):100036. doi: 10.1016/j.jscai.2022.100036. eCollection 2022 May-Jun.
Szerlip M, Al-Azizi K, Alasnag M, Ando T, Ang L, Bartel RC, Batlivala S, Brott B, Davidson L, Dehghani P, Elmariah S, Eng MH, Garcia S, Giri J, Goldsweig AM, Gordon BM, Guerrero ME, Herrmann HC, Jneid H, Kar S, Lansky A, Lata K, Madan M, Madder R, Rymer J, Senerth E, Smith T, Tehrani BN, Messenger JC SCAI Publications Committee Manual of Standard Operating Procedures: 2022 Update. J Soc Cardiovasc Angiogr Interv. 2022 Jul 29;1(4):100389. doi: 10.1016/j.jscai.2022.100389. eCollection 2022 Jul-Aug.
Rymer JA, Armstrong E, Secemsky EA Disrupting the Management of Calcified Femoropopliteal Peripheral Artery Disease: Mid-term Outcomes From Disrupt PAD III. J Soc Cardiovasc Angiogr Interv. 2022 May 19;1(4):100369. doi: 10.1016/j.jscai.2022.100369. eCollection 2022 Jul-Aug.
Rogers E, Torres C, Rao SV, Donatelle M, Beohar N Clinical Characteristics, Outcomes, and Epidemiological Trends of Patients Admitted With Type 2 Myocardial Infarction. J Soc Cardiovasc Angiogr Interv. 2022 Jun 29;1(5):100395. doi: 10.1016/j.jscai.2022.100395. eCollection 2022 Sep-Oct.
Naidu SS, Baran DA, Jentzer JC, Hollenberg SM, van Diepen S, Basir MB, Grines CL, Diercks DB, Hall S, Kapur NK, Kent W, Rao SV, Samsky MD, Thiele H, Truesdell AG, Henry TD SCAI SHOCK Stage Classification Expert Consensus Update: A Review and Incorporation of Validation Studies: This statement was endorsed by the American College of Cardiology (ACC), American College of Emergency Physicians (ACEP), American Heart Association (AHA), European Society of Cardiology (ESC) Association for Acute Cardiovascular Care (ACVC), International Society for Heart and Lung Transplantation (ISHLT), Society of Critical Care Medicine (SCCM), and Society of Thoracic Surgeons (STS) in December 2021. J Soc Cardiovasc Angiogr Interv. 2022 Jan 30;1(1):100008. doi: 10.1016/j.jscai.2021.100008. eCollection 2022 Jan-Feb.
Vogel RF, Delewi R, Badimon L, Angiolillo DJ, Vlachojannis GJ Current Status and Future Direction of Antithrombotic Therapy for Patients with STEMI Undergoing Primary PCI. Rev Cardiovasc Med. 2022 Sep 5;23(9):297. doi: 10.31083/j.rcm2309297. eCollection 2022 Sep.
Greco A, Mauro MS, Capodanno D, Angiolillo DJ P2Y12 Inhibitor Monotherapy: Considerations for Acute and Long-Term Secondary Prevention Post-PCI. Rev Cardiovasc Med. 2022 Oct 17;23(10):348. doi: 10.31083/j.rcm2310348. eCollection 2022 Oct.
Au M, Whitelaw S, Khan MS, Mamas MA, Mbuagbaw L, Mulvagh SL, Voors AA, Van Spall HGC A Systematic Review of Sex-Specific Reporting in Heart Failure Clinical Trials: Trial Flow and Results. JACC Adv. 2022 Sep 21;1(4):100079. doi: 10.1016/j.jacadv.2022.100079. eCollection 2022 Oct.
Pandey A, Willis B, Barlow CE, Leonard D, Agusala V, DeFina LF, Berry JD Mid-Life Cardiorespiratory Fitness, Obesity, and Risk of Atrial Fibrillation: The Cooper Center Longitudinal Study. JACC Adv. 2022 May 31;1(2):100040. doi: 10.1016/j.jacadv.2022.100040. eCollection 2022 Jun.
Zahid S, Tanveer Ud Din M, Minhas AS, Rai D, Kaur G, Carfagnini C, Khan MZ, Ullah W, Van Spall HGC, Hays AG, Michos ED Racial and Socioeconomic Disparities in Cardiovascular Outcomes of Preeclampsia Hospitalizations in the United States 2004-2019. JACC Adv. 2022 Aug 26;1(3):100062. doi: 10.1016/j.jacadv.2022.100062. eCollection 2022 Aug.
Sarma AA, Aggarwal NR, Briller JE, Davis M, Economy KE, Hameed AB, Januzzi JL, Lindley KJ, Mattina DJ, McBay B, Quesada O, Scott NS, American College of Cardiology Cardiovascular Disease in Women Committee and, Cardio-obstetrics Work Group The Utilization and Interpretation of Cardiac Biomarkers During Pregnancy: JACC: Advances Expert Panel. JACC Adv. 2022 Aug 26;1(3):100064. doi: 10.1016/j.jacadv.2022.100064. eCollection 2022 Aug.
Mamas MA, Van Spall HGC Why is it important for male cardiologists to enroll more women in cardiovascular trials? Am Heart J Plus. 2022 Jan 31;13:100090. doi: 10.1016/j.ahjo.2022.100090. eCollection 2022 Jan.
Filbey L, Khan MS, Van Spall HGC Protection by inclusion: Increasing enrollment of women in cardiovascular trials. Am Heart J Plus. 2022 Jan 31;13:100091. doi: 10.1016/j.ahjo.2022.100091. eCollection 2022 Jan.
Connors JM, Brooks MM, Sciurba FC, Krishnan JA, Bledsoe JR, Castro L, Eng H, Handberg E, Hou PC, Hulbert J, Kirwan BA, Lin JY, Martin D, Samuelson H, Shapiro NL, Zaharris E, Wisniewski SR, Ridker PM Outpatient Randomized Controlled Trials in the Covid-19 Era and Beyond. NEJM Evid. 2022 Dec;1(12):EVIDctcs2200149. doi: 10.1056/EVIDctcs2200149. Epub 2022 Nov 22.
Bhatt DL, Pollack CV, Mazer CD, Angiolillo DJ, Steg PG, James SK, Weitz JI, Ramnath R, Arnold SE, Mays MC, Umstead BR, White B, Hickey LL, Jennings LK, Curry BJ, Lee JS, Verma S Bentracimab for Ticagrelor Reversal in Patients Undergoing Urgent Surgery. NEJM Evid. 2022 Mar;1(3):EVIDoa2100047. doi: 10.1056/EVIDoa2100047. Epub 2021 Dec 1.
Paredes-Paucar C, Medina LV, Araiza-Garaygordobil D, Gopar-Nieto R, Martinez-Amezcua P, Cabello-Lopez A, Sierra-Lara D, Briseno De La Cruz JL, Gonzales Pacheco H, Arias Mendoza A [Prognostic value of the absolute decrease of the N-terminal portion of B-type natriuretic propeptide in decompensated heart failure: secondary analysis of the CLUSTER-HF study]. Arch Peru Cardiol Cir Cardiovasc. 2022 Mar 31;3(1):8-15. doi: 10.47487/apcyccv.v3i1.198. eCollection 2022 Jan-Mar.
Piayda K, Sievert K, Sievert H, Shaburishvili T, Gogorishvili I, Rothman M, Januzzi JL Jr, Lindenfeld J, Stone GW Endovascular Baroreflex Amplification With the MobiusHD Device in Patients With Heart Failure and Reduced Ejection Fraction: Interim Analysis of the First-in-Human Results. Struct Heart. 2022 Sep 16;6(5):100086. doi: 10.1016/j.shj.2022.100086. eCollection 2022 Oct.
Healy WJ, Jean-Louis G, Yancy CW, Billings ME, Khayat R, Kwon Y Reducing disparities in cardiovascular health in African Americans through integrated cardiovascular sleep care in outpatient setting. Sleep Adv. 2022 May 12;3(1):zpac016. doi: 10.1093/sleepadvances/zpac016. eCollection 2022.
Nowbar AN, Howard JP, Shun-Shin MJ, Rajkumar C, Foley M, Basu A, Goel A, Patel S, Adnan A, Beattie CJ, Keeble TR, Sohaib A, Collier D, McVeigh P, Harrell FE Jr, Francis DP, Al-Lamee RK Daily angina documentation versus subsequent recall: development of a symptom smartphone app. Eur Heart J Digit Health. 2022 Apr 11;3(2):276-283. doi: 10.1093/ehjdh/ztac015. eCollection 2022 Jun.
Averbuch T, Sullivan K, Sauer A, Mamas MA, Voors AA, Gale CP, Metra M, Ravindra N, Van Spall HGC Applications of artificial intelligence and machine learning in heart failure. Eur Heart J Digit Health. 2022 May 13;3(2):311-322. doi: 10.1093/ehjdh/ztac025. eCollection 2022 Jun.
Solis-Jimenez F, Gonzalez-Ortiz A, Larios-Lara JH, Castro-Garcia CA, Arteaga-Chan EI, Velazquez-Sanchez F, Vargas-Estrada JL, Ramirez-Marcano EY, Garaygordobil DA, Briseno De La Cruz JL, Gopar-Nieto R, Martinez DS, Arias-Mendoza A Case report: Polyarteritis nodosa as a substrate for a massive myocardial infarction. Front Cardiovasc Med. 2023 Jan 12;9:1070378. doi: 10.3389/fcvm.2022.1070378. eCollection 2022.
Mohammadnia N, Akyea RK, Qureshi N, Bax WA, Cornel JH Electronic health record-based facilitation of familial hypercholesterolaemia detection sensitivity of different algorithms in genetically confirmed patients. Eur Heart J Digit Health. 2022 Oct 17;3(4):578-586. doi: 10.1093/ehjdh/ztac059. eCollection 2022 Dec.
Neumiller JJ, Lienhard FJ, Alicic RZ, Tuttle KR Clinical Evidence and Proposed Mechanisms for Cardiovascular and Kidney Benefits from Sodium-Glucose Co-transporter-2 Inhibitors. touchREV Endocrinol. 2022 Nov;18(2):106-115. doi: 10.17925/EE.2022.18.2.106. Epub 2022 Nov 29.
Raja A, Osborn EA, Bergmark BA, Croce KD, Poulin MF, Tamez H, West N, Buccola J, Meinen J, Secemsky EA, LightLab Clinical Initiative Investigators OCT utilization: Summary statistics from the LightLab clinical initiative. Catheter Cardiovasc Interv. 2022 Nov;100 Suppl 1:S36-S43. doi: 10.1002/ccd.30397.
Khuddus MA, Darki A, Padaliya BB, West NEJ, Rapoza RJ, Buccola J, Amis G, Chehab BM, Secemsky EA, LightLab Initiative Investigators Improving efficiency and operator proficiency during percutaneous coronary interventions utilizing a standardized optical coherence tomography workflow. Catheter Cardiovasc Interv. 2022 Nov;100 Suppl 1:S14-S24. doi: 10.1002/ccd.30392.
Gunn LH, McKay AJ, Feng A, Louie MJ, Ballantyne CM, Ray KK Estimated cardiovascular benefits of bempedoic acid in patients with established cardiovascular disease. Atheroscler Plus. 2022 May 28;49:20-27. doi: 10.1016/j.athplu.2022.05.003. eCollection 2022 Aug.
Gouni-Berthold I, Schaper F, Schatz U, Tabbert-Zitzler A, Fraass U, Sauer S, Ray KK Low-density lipoprotein cholesterol goal attainment in Germany: Results from the DA VINCI study. Atheroscler Plus. 2022 Aug 8;50:10-16. doi: 10.1016/j.athplu.2022.07.024. eCollection 2022 Dec.
Tan S, Day D, Nicholls SJ, Segelov E Immune Checkpoint Inhibitor Therapy in Oncology: Current Uses and Future Directions: JACC: CardioOncology State-of-the-Art Review. JACC CardioOncol. 2022 Dec 20;4(5):579-597. doi: 10.1016/j.jaccao.2022.09.004. eCollection 2022 Dec.
Nakayama M, Goto S, Goto S Physical Characteristics of von Willebrand Factor Binding with Platelet Glycoprotein Iba Mutants at Residue 233 Causing Various Biological Functions. TH Open. 2022 Dec 7;6(4):e421-e428. doi: 10.1055/a-1937-9940. eCollection 2022 Oct.
Padam P, Barton L, Wilson S, David A, Walji S, de Lorenzo F, Ray KK, Jones B, Cegla J Lipid lowering with inclisiran: a real-world single-centre experience. Open Heart. 2022 Dec;9(2):e002184. doi: 10.1136/openhrt-2022-002184.
Saade MC, Clark AJ, Parikh SM States of quinolinic acid excess in urine: A systematic review of human studies. Front Nutr. 2022 Dec 16;9:1070435. doi: 10.3389/fnut.2022.1070435. eCollection 2022.
Carlisle MA, Shrader P, Fudim M, Pieper KS, Blanco RG, Fonarow GC, Naccarelli GV, Gersh BJ, Reiffel JA, Kowey PR, Steinberg BA, Freeman JV, Ezekowitz MD, Singer DE, Allen LA, Chan PS, Pokorney SD, Peterson ED, Piccini JP, ORBIT AF Patients and Investigators Residual stroke risk despite oral anticoagulation in patients with atrial fibrillation. Heart Rhythm O2. 2022 Sep 28;3(6Part A):621-628. doi: 10.1016/j.hroo.2022.09.018. eCollection 2022 Dec.
Ortega-Paz L, Arevalos V, Fernandez-Rodriguez D, Jimenez-Diaz V, Baneras J, Campo G, Rodriguez-Santamarta M, Diaz JF, Scardino C, Gomez-Alvarez Z, Pernigotti A, Alfonso F, Amat-Santos IJ, Silvestro A, Rampa L, de la Torre Hernandez JM, Bastidas G, Gomez-Lara J, Bikdeli B, Garcia-Garcia HM, Angiolillo DJ, Rodes-Cabau J, Sabate M, Brugaletta S, CV COVID-19 registry investigators One-year cardiovascular outcomes after coronavirus disease 2019: The cardiovascular COVID-19 registry. PLoS One. 2022 Dec 30;17(12):e0279333. doi: 10.1371/journal.pone.0279333. eCollection 2022.
White HD Value of expert opinion in recommending early intensive lipid lowering in patients with ACS. Eur Heart J Acute Cardiovasc Care. 2022 Dec 27;11(12):936-938. doi: 10.1093/ehjacc/zuac136.
Alrashidi S, d’Entremont MA, Alansari O, Winter J, Brochu B, Heenan L, Skuriat E, Tyrwhitt J, Raco M, Tsang MB, Valettas N, Velianou J, Sheth T, Sibbald M, Mehta SR, Pinilla-Echeverri N, Schwalm JD, Natarajan MK, Kelly A, Akl E, Tawadros S, Camargo M, Faidi W, Dutra G, Jolly SS Design and Rationale of Routine UltrasouNd GuIdance for Vascular AccEss foR Cardiac Procedures: A Randomized TriaL (UNIVERSAL). CJC Open. 2022 Aug 30;4(12):1074-1080. doi: 10.1016/j.cjco.2022.08.011. eCollection 2022 Dec.
Talha KM, Fonarow GC, Virani SS, Butler J Glucocentric Drugs in Cardiovascular Disease Protection and Heart Failure. Methodist Debakey Cardiovasc J. 2022 Dec 6;18(5):40-53. doi: 10.14797/mdcvj.1155. eCollection 2022.
Marschner S, Wing-Lun E, Chow C, Maple-Brown L, Graham S, Nicholls SJ, Brown A, Wood A, Ihdayhid A, Von Huben A, Zaman S Randomised clinical trial using Coronary Artery Calcium Scoring in Australian Women with Novel Cardiovascular Risk Factors (CAC-WOMEN Trial): study protocol. BMJ Open. 2022 Dec 22;12(12):e062685. doi: 10.1136/bmjopen-2022-062685.
Meyer EM, Reynolds MR Multidimensional Scaling of Cognitive Ability and Academic Achievement Scores. J Intell. 2022 Dec 1;10(4):117. doi: 10.3390/jintelligence10040117.
Docherty KF, Bayes-Genis A, Butler J, Coats AJS, Drazner MH, Joyce E, Lam CSP The four pillars of HFrEF therapy: is it time to treat heart failure regardless of ejection fraction? Eur Heart J Suppl. 2022 Dec 19;24(Suppl L):L10-L19. doi: 10.1093/eurheartjsupp/suac113. eCollection 2022 Dec.
Van Spall HGC, Mehran R, Januzzi JL Dear colleagues: enough with the men-only author panels. Eur Heart J Suppl. 2022 Dec 19;24(Suppl L):L53-L56. doi: 10.1093/eurheartjsupp/suac118. eCollection 2022 Dec.
Vardeny O, Fang JC, Desai AS, Jhund PS, Claggett B, Vaduganathan M, de Boer RA, Hernandez AF, Lam CSP, Inzucchi SE, Martinez FA, Kosiborod MN, DeMets D, O’Meara E, Zieroth S, Comin-Colet J, Drozdz J, Chiang CE, Kitakaze M, Petersson M, Lindholm D, Langkilde AM, McMurray JJV, Solomon SD Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial. Nat Med. 2022 Dec;28(12):2504-2511. doi: 10.1038/s41591-022-02102-9. Epub 2022 Dec 15.
Sharma A, Lam CSP, Tay WT, Yap J, MacDonald MR, Razaghizad A, Cooper LB, O’Connor C, Whellan DJ, Anand IS, Tromp J, Mentz RJ Cause of Death Among Patients With Diabetes and Heart Failure With Reduced Ejection Fraction. JACC Asia. 2022 Oct 18;2(5):648-650. doi: 10.1016/j.jacasi.2022.05.002. eCollection 2022 Oct.
Konigstein M, Redfors B, Zhang Z, Kotinkaduwa LN, Mintz GS, Smits PC, Serruys PW, von Birgelen C, Madhavan MV, Golomb M, Ben-Yehuda O, Mehran R, Leon MB, Stone GW Utility of the ACC/AHA Lesion Classification to Predict Outcomes After Contemporary DES Treatment: Individual Patient Data Pooled Analysis From 7 Randomized Trials. J Am Heart Assoc. 2022 Dec 20;11(24):e025275. doi: 10.1161/JAHA.121.025275. Epub 2022 Dec 14.
Soomro QH, Bansal N, Winkelmayer WC, Koplan BA, Costea AI, Roy-Chaudhury P, Tumlin JA, Kher V, Williamson DE, Pokhariyal S, McClure CK, Charytan DM, MiD Investigators Association of Bradycardia and Asystole Episodes with Dialytic Parameters: An Analysis of the Monitoring in Dialysis (MiD) Study. Kidney360. 2022 Oct 11;3(11):1871-1880. doi: 10.34067/KID.0003142022. eCollection 2022 Nov 24.
Lee K, Chuzi S, Katz J, Vela A, Wilson H, Wilcox JE, Ghafourian K, Yancy CW, Beach L, Pham DT Heart-Kidney Transplantation in a Transgender Woman. JACC Case Rep. 2022 Nov 3;4(23):101523. doi: 10.1016/j.jaccas.2022.06.013. eCollection 2022 Dec 7.
Alicic RZ, Neumiller JJ, Galindo RJ, Tuttle KR Use of Glucose-Lowering Agents in Diabetes and CKD. Kidney Int Rep. 2022 Sep 29;7(12):2589-2607. doi: 10.1016/j.ekir.2022.09.018. eCollection 2022 Dec.
Lam CSP, Ho JE Machine Learning for Diastology and Heart Failure With Preserved Ejection Fraction: Hype or Hope? J Am Soc Echocardiogr. 2022 Dec;35(12):1256-1258. doi: 10.1016/j.echo.2022.10.003. Epub 2022 Oct 29.
Anker SD, Butler J, Usman MS, Filippatos G, Ferreira JP, Bocchi E, Bohm M, Rocca HPB, Choi DJ, Chopra V, Chuquiure E, Giannetti N, Gomez-Mesa JE, Janssens S, Januzzi JL, Gonzalez-Juanatey JR, Merkely B, Nicholls SJ, Perrone SV, Pina IL, Ponikowski P, Senni M, Sim D, Spinar J, Squire I, Taddei S, Tsutsui H, Verma S, Vinereanu D, Zhang J, Iwata T, Schnee JM, Brueckmann M, Pocock SJ, Zannad F Efficacy of empagliflozin in heart failure with preserved versus mid-range ejection fraction: a pre-specified analysis of EMPEROR-Preserved. Nat Med. 2022 Dec;28(12):2512-2520. doi: 10.1038/s41591-022-02041-5. Epub 2022 Dec 5.
Secemsky EA, Korjian S Drug-coated balloons in the real world: do they hold up? EuroIntervention. 2022 Dec 2;18(11):e870-e871. doi: 10.4244/EIJ-E-22-00046.
Mittan S, Lee S, Mehra MR Artificial intelligence in cardiovascular disease: Challenges and benefits in developing nations. Prog Cardiovasc Dis. 2022 Sep-Oct;74:129-130. doi: 10.1016/j.pcad.2022.11.007.
Wang C, Zoungas S, Yan M, Wolfe R, Haydon A, Shackleton M, Voskoboynik M, Moore M, Andrews MC, Nicholls SJ, Mar V Immune checkpoint inhibitors and the risk of major atherosclerotic cardiovascular events in patients with high-risk or advanced melanoma: a retrospective cohort study. Cardiooncology. 2022 Dec 2;8(1):23. doi: 10.1186/s40959-022-00149-8.
Murphy SP, Ward JH, Pina IL, Felker GM, Butler J, Maisel AS, Meng X, Prescott MF, Solomon SD, Januzzi JL Age Differences in Effects of Sacubitril/Valsartan on Cardiac Remodeling, Biomarkers, and Health Status. JACC Heart Fail. 2022 Dec;10(12):976-988. doi: 10.1016/j.jchf.2022.07.001. Epub 2022 Sep 7.
Mehra MR, Nayak A, Morris AA, Lanfear DE, Nemeh H, Desai S, Bansal A, Guerrero-Miranda C, Hall S, Cleveland JC Jr, Goldstein DJ, Uriel N, Chen L, Bailey S, Anyanwu A, Heatley G, Chuang J, Estep JD Prediction of Survival After Implantation of a Fully Magnetically Levitated Left Ventricular Assist Device. JACC Heart Fail. 2022 Dec;10(12):948-959. doi: 10.1016/j.jchf.2022.08.002. Epub 2022 Oct 12.
Zile MR, Mehra MR, Ducharme A, Sears SF, Desai AS, Maisel A, Paul S, Smart F, Grafton G, Kumar S, Nossuli TO, Johnson N, Henderson J, Adamson PB, Costanzo MR, Lindenfeld J Hemodynamically-Guided Management of Heart Failure Across the Ejection Fraction Spectrum: The GUIDE-HF Trial. JACC Heart Fail. 2022 Dec;10(12):931-944. doi: 10.1016/j.jchf.2022.08.012. Epub 2022 Oct 12.
Eleid MF, Wang DD, Pursnani A, Kodali SK, George I, Palacios I, Russell H, Makkar RR, Kar S, Satler LF, Rajagopal V, Dangas G, Tang GHL, McCabe JM, Whisenant BK, Fang K, Kaptzan T, Lewis B, Douglas P, Hahn R, Thaden J, Oh JK, Leon M, O’Neill W, Rihal CS, Guerrero ME 2-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients With Annular Calcification, Rings, and Bioprostheses. J Am Coll Cardiol. 2022 Dec 6;80(23):2171-2183. doi: 10.1016/j.jacc.2022.09.037.
Taguchi K, Elias BC, Sugahara S, Sant S, Freedman BS, Waikar SS, Pozzi A, Zent R, Harris RC, Parikh SM, Brooks CR Cyclin G1 induces maladaptive proximal tubule cell dedifferentiation and renal fibrosis through CDK5 activation. J Clin Invest. 2022 Dec 1;132(23):e158096. doi: 10.1172/JCI158096.
Haas S, Farjat AE, Pieper K, Ageno W, Angchaisuksiri P, Bounameaux H, Goldhaber SZ, Goto S, Mantovani L, Prandoni P, Schellong S, Turpie AGG, Weitz JI, MacCallum P, Cate HT, Panchenko E, Carrier M, Jerjes-Sanchez C, Gibbs H, Jansky P, Kayani G, Kakkar AK, GARFIELD-VTE investigators On-treatment Comparative Effectiveness of Vitamin K Antagonists and Direct Oral Anticoagulants in GARFIELD-VTE, and Focus on Cancer and Renal Disease. TH Open. 2022 Nov 3;6(4):e354-e364. doi: 10.1055/s-0042-1757744. eCollection 2022 Oct.
Albertsen IE, Konstantinides SV, Piazza G, Goldhaber SZ, Larsen TB, Sogaard M, Nielsen PB Risk of Recurrent Venous Thromboembolism in Selected Subgroups of Men: A Danish Nationwide Cohort Study. TH Open. 2022 Nov 18;6(4):e378-e386. doi: 10.1055/a-1949-9404. eCollection 2022 Oct.
Agarwal R, Anand S, Eckardt KU, Luo W, Parfrey PS, Sarnak MJ, Solinsky CM, Vargo DL, Winkelmayer WC, Chertow GM Overall Adverse Event Profile of Vadadustat versus Darbepoetin Alfa for the Treatment of Anemia Associated with Chronic Kidney Disease in Phase 3 Trials. Am J Nephrol. 2022;53(10):701-710. doi: 10.1159/000528443. Epub 2022 Nov 30.
Robich MP, Iribarne A, Butzel D, DiScipio AW, Dauerman HL, Leavitt BJ, DeSimone JP, Coylewright M, Flynn JM, Westbrook BM, Ver Lee PN, Zaky M, Quinn R, Malenka DJ Multicenter experience with valve-in-valve transcatheter aortic valve replacement compared with primary, native valve transcatheter aortic valve replacement. J Card Surg. 2022 Dec;37(12):4382-4388. doi: 10.1111/jocs.17084. Epub 2022 Nov 30.
Spione F, Arevalos V, Gabani R, Ortega-Paz L, Gomez-Lara J, Jimenez-Diaz V, Jimenez M, Jimenez-Quevedo P, Diletti R, Pineda J, Campo G, Silvestro A, Maristany J, Flores X, Oyarzabal L, Bastos-Fernandez G, Iniguez A, Serra A, Escaned J, Ielasi A, Tespili M, Lenzen M, Gonzalo N, Bordes P, Tebaldi M, Biscaglia S, Al-Shaibani S, Romaguera R, Gomez-Hospital JA, Rodes-Cabau J, Serruys PW, Sabate M, Brugaletta S Impact of Diabetes on 10-Year Outcomes Following ST-Segment-Elevation Myocardial Infarction: Insights From the EXAMINATION-EXTEND Trial. J Am Heart Assoc. 2022 Dec 6;11(23):e025885. doi: 10.1161/JAHA.122.025885. Epub 2022 Nov 29.
Figtree GA, Adamson PD, Antoniades C, Blumenthal RS, Blaha M, Budoff M, Celermajer DS, Chan MY, Chow CK, Dey D, Dwivedi G, Giannotti N, Grieve SM, Hamilton-Craig C, Kingwell BA, Kovacic JC, Min JK, Newby DE, Patel S, Peter K, Psaltis PJ, Vernon ST, Wong DT, Nicholls SJ Noninvasive Plaque Imaging to Accelerate Coronary Artery Disease Drug Development. Circulation. 2022 Nov 29;146(22):1712-1727. doi: 10.1161/CIRCULATIONAHA.122.060308. Epub 2022 Nov 28.
German CA, Baum SJ, Ferdinand KC, Gulati M, Polonsky TS, Toth PP, Shapiro MD Defining preventive cardiology: A clinical practice statement from the American Society for Preventive Cardiology. Am J Prev Cardiol. 2022 Nov 16;12:100432. doi: 10.1016/j.ajpc.2022.100432. eCollection 2022 Dec.
Ferrante G, Condello F, Rao SV, Maurina M, Jolly S, Stefanini GG, Reimers B, Condorelli G, Lefevre T, Pancholy SB, Bertrand O, Valgimigli M Distal vs Conventional Radial Access for Coronary Angiography and/or Intervention: A Meta-Analysis of Randomized Trials. JACC Cardiovasc Interv. 2022 Nov 28;15(22):2297-2311. doi: 10.1016/j.jcin.2022.09.006.
Regan JA, Truby LK, Tahir UA, Katz DH, Nguyen M, Kwee LC, Deng S, Wilson JG, Mentz RJ, Kraus WE, Hernandez AF, Gerszten RE, Peterson ED, Holman RR, Shah SH Protein biomarkers of cardiac remodeling and inflammation associated with HFpEF and incident events. Sci Rep. 2022 Nov 22;12(1):20072. doi: 10.1038/s41598-022-24226-1.
Vart P, Vaduganathan M, Jongs N, Remuzzi G, Wheeler DC, Hou FF, McCausland F, Chertow GM, Heerspink HJL Estimated Lifetime Benefit of Combined RAAS and SGLT2 Inhibitor Therapy in Patients with Albuminuric CKD without Diabetes. Clin J Am Soc Nephrol. 2022 Dec;17(12):1754-1762. doi: 10.2215/CJN.08900722. Epub 2022 Nov 22.
Clark AJ, Saade MC, Parikh SM The Significance of NAD+ Biosynthesis Alterations in Acute Kidney Injury. Semin Nephrol. 2022 May;42(3):151287. doi: 10.1016/j.semnephrol.2022.10.013. Epub 2022 Nov 18.
Warady BA, Pergola PE, Agarwal R, Andreoli S, Appel GB, Bangalore S, Block GA, Chapman AB, Chin MP, Gibson KL, Goldsberry A, Iijima K, Inker LA, Kashtan CE, Knebelmann B, Mariani LH, Meyer CJ, Nozu K, O’Grady M, Rheault MN, Silva AL, Stenvinkel P, Torra R, Chertow GM Effects of Bardoxolone Methyl in Alport Syndrome. Clin J Am Soc Nephrol. 2022 Dec;17(12):1763-1774. doi: 10.2215/CJN.02400222. Epub 2022 Nov 21.
Mosarla RC, Secemsky EA From IMPERIALism to EMINENence: The Noble Rise of the Second-Generation Peripheral Drug-Eluting Stent. Circulation. 2022 Nov 22;146(21):1577-1580. doi: 10.1161/CIRCULATIONAHA.122.062255. Epub 2022 Nov 21.
Nicholls SJ, Nelson AJ CETP Inhibitors: Should We Continue to Pursue This Pathway? Curr Atheroscler Rep. 2022 Dec;24(12):915-923. doi: 10.1007/s11883-022-01070-2. Epub 2022 Nov 21.
Kaur G, Gulati M Considerations for treatment of lipid disorders during pregnancy and breastfeeding. Prog Cardiovasc Dis. 2022 Nov-Dec;75:33-39. doi: 10.1016/j.pcad.2022.11.001. Epub 2022 Nov 16.
Iqbal K, Kumar A, Rathore SS, Farid E, Ishaque A, Afzal H, Zahid M, Parwani P, Michos ED, Gulati M Gender and Racial/Ethnic Disparities in Award Distribution by Major Cardiovascular Societies From 2000 to 2021. J Am Coll Cardiol. 2022 Nov 22;80(21):2050-2053. doi: 10.1016/j.jacc.2022.09.016.
Sykes AV, Epstein E, Choubdar PA, Taub PR 2 Cases of Elusive Left Ventricular Outflow Tract Gradient. JACC Case Rep. 2022 Nov 2;4(21):1404-1408. doi: 10.1016/j.jaccas.2022.07.023. eCollection 2022 Nov 2.
Ray KK, Ference BA, Severin T, Blom D, Nicholls SJ, Shiba MH, Almahmeed W, Alonso R, Daccord M, Ezhov M, Olmo RF, Jankowski P, Lanas F, Mehta R, Puri R, Wong ND, Wood D, Zhao D, Gidding SS, Virani SS, Lloyd-Jones D, Pinto F, Perel P, Santos RD World Heart Federation Cholesterol Roadmap 2022. Glob Heart. 2022 Oct 14;17(1):75. doi: 10.5334/gh.1154. eCollection 2022.
Prabhakaran D, Singh K, Kondal D, Raspail L, Mohan B, Kato T, Sarrafzadegan N, Talukder SH, Akter S, Amin MR, Goma F, Gomez-Mesa J, Ntusi N, Inofomoh F, Deora S, Philippov E, Svarovskaya A, Konradi A, Puentes A, Ogah OS, Stanetic B, Issa A, Thienemann F, Juzar D, Zaidel E, Sheikh S, Ojji D, Lam CSP, Ge J, Banerjee A, Newby LK, Ribeiro ALP, Gidding S, Pinto F, Perel P, Sliwa K, WHF COVID-19 Study Collaborators Correction: Cardiovascular Risk Factors and Clinical Outcomes among Patients Hospitalized with COVID-19: Findings from the World Heart Federation COVID-19 Study. Glob Heart. 2022 Oct 31;17(1):79. doi: 10.5334/gh.1167. eCollection 2022.
Ganesananthan S, Rajkumar CA, Foley M, Francis D, Al-Lamee R Remote digital smart device follow-up in prospective clinical trials: early insights from ORBITA-2, ORBITA-COSMIC, and ORBITA-STAR. Eur Heart J Suppl. 2022 Nov 11;24(Suppl H):H32-H42. doi: 10.1093/eurheartjsupp/suac058. eCollection 2022 Nov.
Ziolkowski S, Liu S, Montez-Rath ME, Denburg M, Winkelmayer WC, Chertow GM, O’Shaughnessy MM Association between cause of kidney failure and fracture incidence in a national US dialysis population cohort study. Clin Kidney J. 2022 Sep 12;15(12):2245-2257. doi: 10.1093/ckj/sfac193. eCollection 2022 Dec.
Segar MW, Keshvani N, Rao S, Fonarow GC, Das SR, Pandey A Race, Social Determinants of Health, and Length of Stay Among Hospitalized Patients With Heart Failure: An Analysis From the Get With The Guidelines-Heart Failure Registry. Circ Heart Fail. 2022 Nov;15(11):e009401. doi: 10.1161/CIRCHEARTFAILURE.121.009401. Epub 2022 Nov 15.
Allen LA, Yancy CW, Fonarow GC Heart Failure Data Challenge: Democratizing Data, Modernizing Methods, and Interpreting Inequity. Circ Heart Fail. 2022 Nov;15(11):e010025. doi: 10.1161/CIRCHEARTFAILURE.122.010025. Epub 2022 Nov 15.
Seike F, Mintz GS, Matsumura M, Ali ZA, Liu M, Jeremias A, Ben-Yehuda O, De Bruyne B, Serruys PW, Yasuda K, Stone GW, Maehara A Impact of Intravascular Ultrasound-Derived Lesion-Specific Virtual Fractional Flow Reserve Predicts 3-Year Outcomes of Untreated Nonculprit Lesions: The PROSPECT Study. Circ Cardiovasc Interv. 2022 Nov;15(11):851-860. doi: 10.1161/CIRCINTERVENTIONS.121.011198. Epub 2022 Nov 15.
Harwood OE, Balgeman AJ, Weaver AJ, Ellis-Connell AL, Weiler AM, Erickson KN, Matschke LM, Golfinos AE, Vezys V, Skinner PJ, Safrit JT, Edlefsen PT, Reynolds MR, Friedrich TC, O’Connor SL Transient T Cell Expansion, Activation, and Proliferation in Therapeutically Vaccinated Simian Immunodeficiency Virus-Positive Macaques Treated with N-803. J Virol. 2022 Dec 14;96(23):e0142422. doi: 10.1128/jvi.01424-22. Epub 2022 Nov 15.
Al-Samkari H, Glaspy JA, Means RT Jr, Chertow GM, Auerbach M Risks for Anaphylaxis With Intravenous Iron Formulations. Ann Intern Med. 2022 Nov;175(11):W143. doi: 10.7326/L22-0282.
Rashid M, Warriach HJ, Lawson C, Alkhouli M, Van Spall HGC, Khan SU, Khan MS, Mohamed MO, Khan MZ, Shoaib A, Diwan M, Gosh R, Bhatt DL, Mamas MA Palliative Care Utilization Among Hospitalized Patients With Common Chronic Conditions in the United States. J Palliat Care. 2022 Nov 14:8258597221136733. doi: 10.1177/08258597221136733.
Inzucchi SE, Claggett BL, Vaduganathan M, Desai AS, Jhund PS, de Boer RA, Hernandez AF, Kosiborod MN, Lam CSP, Martinez F, Shah SJ, Verma S, Han Y, Kerr Saraiva JF, Bengtsson O, Petersson M, Langkilde AM, McMurray JJV, Solomon SD Efficacy and safety of dapagliflozin in patients with heart failure with mildly reduced or preserved ejection fraction by baseline glycaemic status (DELIVER): a subgroup analysis from an international, multicentre, double-blind, randomised, placebo-controlled trial. Lancet Diabetes Endocrinol. 2022 Dec;10(12):869-881. doi: 10.1016/S2213-8587(22)00308-4. Epub 2022 Nov 10.
Bonaca MP, Im K, Magnani G, Bansilal S, Dellborg M, Storey RF, Bhatt DL, Steg PG, Cohen M, Johanson P, Braunwald E, Sabatine MS Patient selection for long-term secondary prevention with ticagrelor: insights from PEGASUS-TIMI 54. Eur Heart J. 2022 Dec 21;43(48):5037-5044. doi: 10.1093/eurheartj/ehac402.
Gragnano F, Capolongo A, Terracciano F, Gargiulo G, De Sio V, Cesaro A, Moscarella E, Patti G, Porto I, Esposito G, Angiolillo DJ, Calabro P Escalation and De-Escalation of Antiplatelet Therapy after Acute Coronary Syndrome or PCI: Available Evidence and Implications for Practice. J Clin Med. 2022 Oct 23;11(21):6246. doi: 10.3390/jcm11216246.
Giustino G, Camaj A, Kapadia SR, Kar S, Abraham WT, Lindenfeld J, Lim DS, Grayburn PA, Cohen DJ, Redfors B, Zhou Z, Pocock SJ, Asch FM, Mack MJ, Stone GW Hospitalizations and Mortality in Patients With Secondary Mitral Regurgitation and Heart Failure: The COAPT Trial. J Am Coll Cardiol. 2022 Nov 15;80(20):1857-1868. doi: 10.1016/j.jacc.2022.08.803.
Charate R, Ahmed A, Della Rocca DG, Bloom S, Garg J, Pothineni NVK, DiBiase L, Turagam M, Gopinathannair R, Horton R, Kar S, Fontana G, Doshi SK, Swarup V, Finn A, Reddy V, Natale A, Lakkireddy D Evaluation of Multimodality LAA Leak Closure Methods Following Incomplete Occlusion: The LAA Leak Study. JACC Cardiovasc Interv. 2022 Nov 14;15(21):2158-2170. doi: 10.1016/j.jcin.2022.08.034.
Mehta SR, Pare G, Lonn EM, Jolly SS, Natarajan MK, Pinilla-Echeverri N, Schwalm JD, Sheth TN, Sibbald M, Tsang M, Valettas N, Velianou JL, Lee SF, Ferdous T, Nauman S, Nguyen H, McCready T, McQueen MJ Effects of routine early treatment with PCSK9 inhibitors in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a randomised, double-blind, sham-controlled trial. EuroIntervention. 2022 Dec 2;18(11):e888-e896. doi: 10.4244/EIJ-D-22-00735.
Navar AM, Kolkailah AA, Overton R, Shah NP, Rousseau JF, Flaker GC, Pignone MP, Peterson ED Trends in Oral Anticoagulant Use Among 436 864 Patients With Atrial Fibrillation in Community Practice, 2011 to 2020. J Am Heart Assoc. 2022 Nov 15;11(22):e026723. doi: 10.1161/JAHA.122.026723. Epub 2022 Nov 8.
Nicholls SJ, Ray KK, Nelson AJ, Kastelein JJP Can we revive CETP-inhibitors for the prevention of cardiovascular disease? Curr Opin Lipidol. 2022 Dec 1;33(6):319-325. doi: 10.1097/MOL.0000000000000854. Epub 2022 Oct 21.
Heerspink HJL, Chertow GM, Jongs N, Correa-Rotter R, Rossing P, Sjostrom CD, Langkilde AM, Wheeler DC, DAPA-CKD Trial Committee and Investigators Effects of Dapagliflozin in People without Diabetes and with Microalbuminuria. Clin J Am Soc Nephrol. 2022 Nov;17(11):1665-1668. doi: 10.2215/CJN.07290622. Epub 2022 Sep 9.
Shetty NS, Parcha V, Hasnie A, Pandey A, Arora G, Arora P Mechanical Circulatory Support Devices Among Patients With Familial Dilated Cardiomyopathy: Insights From the INTERMACS. Circulation. 2022 Nov 8;146(19):1486-1488. doi: 10.1161/CIRCULATIONAHA.122.061143. Epub 2022 Nov 7.
Yang M, Butt JH, Kondo T, Jering KS, Docherty KF, Jhund PS, de Boer RA, Claggett BL, Desai AS, Hernandez AF, Inzucchi SE, Kosiborod MN, Lam CSP, Langkilde AM, Martinez FA, Petersson M, Shah SJ, Vaduganathan M, Wilderang U, Solomon SD, McMurray JJV Dapagliflozin in patients with heart failure with mildly reduced and preserved ejection fraction treated with a mineralocorticoid receptor antagonist or sacubitril/valsartan. Eur J Heart Fail. 2022 Dec;24(12):2307-2319. doi: 10.1002/ejhf.2722. Epub 2022 Nov 7.
Das Pradhan A, Glynn RJ, Fruchart JC, MacFadyen JG, Zaharris ES, Everett BM, Campbell SE, Oshima R, Amarenco P, Blom DJ, Brinton EA, Eckel RH, Elam MB, Felicio JS, Ginsberg HN, Goudev A, Ishibashi S, Joseph J, Kodama T, Koenig W, Leiter LA, Lorenzatti AJ, Mankovsky B, Marx N, Nordestgaard BG, Pall D, Ray KK, Santos RD, Soran H, Susekov A, Tendera M, Yokote K, Paynter NP, Buring JE, Libby P, Ridker PM, PROMINENT Investigators Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk. N Engl J Med. 2022 Nov 24;387(21):1923-1934. doi: 10.1056/NEJMoa2210645. Epub 2022 Nov 5.
Gurol ME, Sposato LA Advances in Neurocardiology: Focus on Anticoagulation for Valvular Heart Disease With and Without Atrial Fibrillation. Stroke. 2022 Dec;53(12):3763-3768. doi: 10.1161/STROKEAHA.122.039310. Epub 2022 Nov 7.
Pokorney SD, Chertow GM, Al-Khalidi HR, Gallup D, Dignacco P, Mussina K, Bansal N, Gadegbeku CA, Garcia DA, Garonzik S, Lopes RD, Mahaffey KW, Matsuda K, Middleton JP, Rymer JA, Sands GH, Thadhani R, Thomas KL, Washam JB, Winkelmayer WC, Granger CB, RENAL-AF Investigators Apixaban for Patients With Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled Trial. Circulation. 2022 Dec 6;146(23):1735-1745. doi: 10.1161/CIRCULATIONAHA.121.054990. Epub 2022 Nov 6.
Oseran AS, Yeh RW Time to Treatment in ST-Segment Elevation Myocardial Infarction: Identifying Dangerous Delays or Diminishing Returns? JAMA. 2022 Nov 22;328(20):2016-2017. doi: 10.1001/jama.2022.19441.
Ray KK, Kallend D, Leiter LA, Raal FJ, Koenig W, Jaros MJ, Schwartz GG, Landmesser U, Garcia Conde L, Wright RS, ORION-11 Investigators Effect of inclisiran on lipids in primary prevention: the ORION-11 trial. Eur Heart J. 2022 Dec 21;43(48):5047-5057. doi: 10.1093/eurheartj/ehac615.
Schwartz GG, Szarek M, Zeiher A, White HD, Jukema JW, Harrington RA, Goodman SG, Diaz R, Bittner V, Bhatt DL, Steg PG Elevated C-Reactive Protein Amplifies Association of Lipoprotein(a) With Cardiovascular Risk and Clinical Benefit of Alirocumab. J Am Coll Cardiol. 2022 Dec 13;80(24):2356-2359. doi: 10.1016/j.jacc.2022.09.035. Epub 2022 Oct 31.
Nassif ME, Januzzi JL Jr Implementing Sodium-Glucose Cotransporter-2 Inhibitor Therapy for Heart Failure: What Is the Message to DELIVER? J Am Coll Cardiol. 2022 Nov 8;80(19):1785-1787. doi: 10.1016/j.jacc.2022.09.008.
Siddiqi TJ, Khan Minhas AM, Greene SJ, Van Spall HGC, Khan SS, Pandey A, Mentz RJ, Fonarow GC, Butler J, Khan MS Trends in Heart Failure-Related Mortality Among Older Adults in the United States From 1999-2019. JACC Heart Fail. 2022 Nov;10(11):851-859. doi: 10.1016/j.jchf.2022.06.012. Epub 2022 Sep 7.
Fielding-Singh V, Vanneman MW, Grogan T, Neelankavil JP, Winkelmayer WC, Chang TI, Liu VX, Lin E Association Between Preoperative Hemodialysis Timing and Postoperative Mortality in Patients With End-stage Kidney Disease. JAMA. 2022 Nov 8;328(18):1837-1848. doi: 10.1001/jama.2022.19626.
Pollock C, James G, Garcia Sanchez JJ, Carrero JJ, Arnold M, Lam CSP, Chen HT, Nolan S, Pecoits-Filho R, Wheeler DC Healthcare resource utilisation and related costs of patients with CKD from the UK: a report from the DISCOVER CKD retrospective cohort. Clin Kidney J. 2022 Jul 26;15(11):2124-2134. doi: 10.1093/ckj/sfac168. eCollection 2022 Nov.
Mehran R, Steg PG, Pfeffer MA, Jering K, Claggett B, Lewis EF, Granger C, Kober L, Maggioni A, Mann DL, McMurray JJV, Rouleau JL, Solomon SD, Ducrocq G, Berwanger O, De Pasquale CG, Landmesser U, Petrie M, Leng DSK, van der Meer P, Lefkowitz M, Zhou Y, Braunwald E The Effects of Angiotensin Receptor-Neprilysin Inhibition on Major Coronary Events in Patients With Acute Myocardial Infarction: Insights From the PARADISE-MI Trial. Circulation. 2022 Dec 6;146(23):1749-1757. doi: 10.1161/CIRCULATIONAHA.122.060841. Epub 2022 Nov 2.
Ganesan C, Stedman MR, Liu S, Conti SL, Chertow GM, Leppert JT, Pao AC National Imaging Trends for Suspected Urinary Stone Disease in the Emergency Department. JAMA Intern Med. 2022 Dec 1;182(12):1323-1325. doi: 10.1001/jamainternmed.2022.4939.
Varghese MS, Beatty AL, Song Y, Xu J, Sperling LS, Fonarow GC, Keteyian SJ, McConeghy KW, Penko J, Yeh RW, Figueroa JF, Wu WC, Kazi DS Cardiac Rehabilitation and the COVID-19 Pandemic: Persistent Declines in Cardiac Rehabilitation Participation and Access Among US Medicare Beneficiaries. Circ Cardiovasc Qual Outcomes. 2022 Dec;15(12):e009618. doi: 10.1161/CIRCOUTCOMES.122.009618. Epub 2022 Oct 31.
Bedlington N, Abifadel M, Beger B, Bourbon M, Bueno H, Ceska R, Cillikova K, Cimicka Z, Daccord M, de Beaufort C, Dharmayat KI, Ference BA, Freiberger T, Geanta M, Gidding SS, Groselj U, Halle M, Johnson N, Novakovic T, Majek O, Pallidis A, Peretti N, Pinto FJ, Ray KK, Rees B, Reeve J, Reiner Z, Santos RD, Schunkert H, Sikonja J, Sokolovic M, Tokgozoglu L, Vrablik M, Wiegman A, Gutierrez-Ibarluzea I The time is now: Achieving FH paediatric screening across Europe – The Prague Declaration. GMS Health Innov Technol. 2022 Sep 30;16:Doc04. doi: 10.3205/hta000136. eCollection 2022.
Schwantes-An TH, Robinson-Cohen C, Liu S, Zheng N, Stedman M, Wetherill L, Edenberg HJ, Vatta M, Foroud TM, Chertow GM, Moe SM APOL1 G3 Variant Is Associated with Cardiovascular Mortality and Sudden Cardiac Death in Patients Receiving Maintenance Hemodialysis of European Ancestry. Cardiorenal Med. 2022;12(5-6):229-235. doi: 10.1159/000525448. Epub 2022 Oct 28.
Korjian S, Yeh RW, Cutlip DE Ischemic Risk Prediction Scores: Practice-Changing or Just Practice? J Am Coll Cardiol. 2022 Nov 1;80(18):1748-1750. doi: 10.1016/j.jacc.2022.08.766.
Batra G, Lindback J, Becker RC, Harrington RA, Held C, James SK, Kempf T, Lopes RD, Mahaffey KW, Steg PG, Storey RF, Swahn E, Wollert KC, Siegbahn A, Wallentin L Biomarker-Based Prediction of Recurrent Ischemic Events in Patients With Acute Coronary Syndromes. J Am Coll Cardiol. 2022 Nov 1;80(18):1735-1747. doi: 10.1016/j.jacc.2022.08.767.
Sarraju A, Bakris G, Cannon CP, Cherney D, Damaraju CV, Figtree GA, Gogate J, Greene T, Heerspink HJL, Januzzi JL Jr, Neal B, Jardine MJ, Blais J, Kosiborod M, Levin A, Lingvay I, Weir MR, Perkovic V, Mahaffey KW Cardiovascular Effects of Canagliflozin in Relation to Renal Function and Albuminuria. J Am Coll Cardiol. 2022 Nov 1;80(18):1721-1731. doi: 10.1016/j.jacc.2022.08.772.
Essien UR, Chiswell K, Kaltenbach LA, Wang TY, Fonarow GC, Thomas KL, Turakhia MP, Benjamin EJ, Rodriguez F, Fang MC, Magnani JW, Yancy CW, Piccini JP Sr Association of Race and Ethnicity With Oral Anticoagulation and Associated Outcomes in Patients With Atrial Fibrillation: Findings From the Get With The Guidelines-Atrial Fibrillation Registry. JAMA Cardiol. 2022 Dec 1;7(12):1207-1217. doi: 10.1001/jamacardio.2022.3704.
Gaine SP, Sharma G, Tower-Rader A, Botros M, Kovell L, Parakh A, Wood MJ, Harrington CM Multimodality Imaging in the Detection of Ischemic Heart Disease in Women. J Cardiovasc Dev Dis. 2022 Oct 13;9(10):350. doi: 10.3390/jcdd9100350.
Zhou X, Angiolillo DJ, Ortega-Paz L P2Y(12) Inhibitor Monotherapy after Percutaneous Coronary Intervention. J Cardiovasc Dev Dis. 2022 Oct 6;9(10):340. doi: 10.3390/jcdd9100340.
Gibson CM, Kazmi SHA, Korjian S, Chi G, Phillips AT, Montazerin SM, Duffy D, Zheng B, Heise M, Liss C, Deckelbaum LI, Wright SD, Gille A CSL112 (Apolipoprotein A-I [Human]) Strongly Enhances Plasma Apoa-I and Cholesterol Efflux Capacity in Post-Acute Myocardial Infarction Patients: A PK/PD Substudy of the AEGIS-I Trial. J Cardiovasc Pharmacol Ther. 2022 Jan-Dec;27:10742484221121507. doi: 10.1177/10742484221121507.
Franklin BA, Eijsvogels TMH, Pandey A, Quindry J, Toth PP Physical activity, cardiorespiratory fitness, and cardiovascular health: A clinical practice statement of the American Society for Preventive Cardiology Part II: Physical activity, cardiorespiratory fitness, minimum and goal intensities for exercise training, prescriptive methods, and special patient populations. Am J Prev Cardiol. 2022 Oct 13;12:100425. doi: 10.1016/j.ajpc.2022.100425. eCollection 2022 Dec.
Franklin BA, Eijsvogels TMH, Pandey A, Quindry J, Toth PP Physical activity, cardiorespiratory fitness, and cardiovascular health: A clinical practice statement of the ASPC Part I: Bioenergetics, contemporary physical activity recommendations, benefits, risks, extreme exercise regimens, potential maladaptations. Am J Prev Cardiol. 2022 Oct 13;12:100424. doi: 10.1016/j.ajpc.2022.100424. eCollection 2022 Dec.
Friedman AN, Schauer PR, Beddhu S, Kramer H, le Roux CW, Purnell JQ, Sunwold D, Tuttle KR, Jastreboff AM, Kaplan LM Obstacles and Opportunities in Managing Coexisting Obesity and CKD: Report of a Scientific Workshop Cosponsored by the National Kidney Foundation and The Obesity Society. Am J Kidney Dis. 2022 Dec;80(6):783-793. doi: 10.1053/j.ajkd.2022.06.007. Epub 2022 Oct 21.
Patel KV, Khan MS, Segar MW, Bahnson JL, Garcia KR, Clark JM, Balasubramanyam A, Bertoni AG, Vaduganathan M, Farkouh ME, Januzzi JL Jr, Verma S, Espeland M, Pandey A Optimal cardiometabolic health and risk of heart failure in type 2 diabetes: an analysis from the Look AHEAD trial. Eur J Heart Fail. 2022 Nov;24(11):2037-2047. doi: 10.1002/ejhf.2723.
Abbasi MA, Blake AM, Sarnari R, Lee D, Anderson AS, Ghafourian K, Khan SS, Vorovich EE, Rich JD, Wilcox JE, Yancy CW, Carr JC, Markl M Multiparametric Cardiac Magnetic Resonance Imaging Detects Altered Myocardial Tissue and Function in Heart Transplantation Recipients Monitored for Cardiac Allograft Vasculopathy. J Cardiovasc Imaging. 2022 Oct;30(4):263-275. doi: 10.4250/jcvi.2022.0003.
Rossing P, Caramori ML, Chan JCN, Heerspink HJL, Hurst C, Khunti K, Liew A, Michos ED, Navaneethan SD, Olowu WA, Sadusky T, Tandon N, Tuttle KR, Wanner C, Wilkens KG, Zoungas S, Craig JC, Tunnicliffe DJ, Tonelli MA, Cheung M, Earley A, de Boer IH Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: an update based on rapidly emerging new evidence. Kidney Int. 2022 Nov;102(5):990-999. doi: 10.1016/j.kint.2022.06.013.
Assimon MM, Pun PH, Wang L, Al-Khatib SM, Brookhart MA, Weber DJ, Winkelmayer WC, Flythe JE letter to the editor. Kidney Int. 2022 Nov;102(5):1191-1192. doi: 10.1016/j.kint.2022.08.009.
Friedman AN, Schauer PR, Beddhu S, Kramer H, le Roux CW, Purnell JQ, Sunwold D, Tuttle KR, Jastreboff AM, Kaplan LM Obstacles and opportunities in managing coexisting obesity and CKD: Report of a scientific workshop cosponsored by the National Kidney Foundation and The Obesity Society. Obesity (Silver Spring). 2022 Dec;30(12):2340-2350. doi: 10.1002/oby.23599. Epub 2022 Oct 21.
Mosarla RC, Armstrong E, Bitton-Faiwiszewski Y, Schneider PA, Secemsky EA State-of-the-Art Endovascular Therapies for the Femoropopliteal Segment: Are We There Yet? J Soc Cardiovasc Angiogr Interv. 2022 Sep-Oct;1(5):100439. doi: 10.1016/j.jscai.2022.100439. Epub 2022 Aug 20.
Mehra MR, Boulet J, Pelletier-Galarneau M The Panvascular Interplay in Pathophysiology and Prognosis of Cardiac Allograft Vasculopathy. J Am Coll Cardiol. 2022 Oct 25;80(17):1629-1632. doi: 10.1016/j.jacc.2022.08.753.
Divakaran S, Parikh SA, Hawkins BM, Chen S, Song Y, Banerjee S, Rosenfield K, Secemsky EA Temporal Trends, Practice Variation, and Associated Outcomes With IVUS Use During Peripheral Arterial Intervention. JACC Cardiovasc Interv. 2022 Oct 24;15(20):2080-2090. doi: 10.1016/j.jcin.2022.07.050.
Damluji AA, Tehrani B, Sinha SS, Samsky MD, Henry TD, Thiele H, West NEJ, Senatore FF, Truesdell AG, Dangas GD, Smilowitz NR, Amin AP, deVore AD, Moazami N, Cigarroa JE, Rao SV, Krucoff MW, Morrow DA, Gilchrist IC Position Statement on Vascular Access Safety for Percutaneous Devices in AMI Complicated by Cardiogenic Shock. JACC Cardiovasc Interv. 2022 Oct 24;15(20):2003-2019. doi: 10.1016/j.jcin.2022.08.041.
Rotbain Curovic V, Roy N, Hansen TW, Luiza Caramori M, Cherney DZ, De Boer IH, Emanuele MA, Hirsch IB, Lingvay I, Mcgill JB, Polsky S, Pop-Busui R, Sigal RJ, Tuttle KR, Umpierrez GE, Wallia A, Rosas SE, Rossing P, PERL Study Group Baseline risk markers and visit-to-visit variability in relation to kidney outcomes – A post-hoc analysis of the PERL study. Diabetes Res Clin Pract. 2022 Nov;193:110119. doi: 10.1016/j.diabres.2022.110119. Epub 2022 Oct 17.
Masica AL, Velasco F, Nelson TL, Medford RJ, Hughes AE, Pandey A, Peterson ED, Lehmann CU The Texas Health Resources Clinical Scholars Program: Learning healthcare system workforce development through embedded translational research. Learn Health Syst. 2022 Sep 4;6(4):e10332. doi: 10.1002/lrh2.10332. eCollection 2022 Oct.
Pandey A, Patel KV Sex, lean body mass, and cardiac performance. Sci Transl Med. 2022 Oct 19;14(667):eadd5297. doi: 10.1126/scitranslmed.add5297. Epub 2022 Oct 19.
Sadeghipour P, Jenab Y, Moosavi J, Hosseini K, Mohebbi B, Hosseinsabet A, Chatterjee S, Pouraliakbar H, Shirani S, Shishehbor MH, Alizadehasl A, Farrashi M, Rezvani MA, Rafiee F, Jalali A, Rashedi S, Shafe O, Giri J, Monreal M, Jimenez D, Lang I, Maleki M, Goldhaber SZ, Krumholz HM, Piazza G, Bikdeli B Catheter-Directed Thrombolysis vs Anticoagulation in Patients With Acute Intermediate-High-risk Pulmonary Embolism: The CANARY Randomized Clinical Trial. JAMA Cardiol. 2022 Dec 1;7(12):1189-1197. doi: 10.1001/jamacardio.2022.3591.
Nadarajah R, Ludman P, Appelman Y, Brugaletta S, Budaj A, Bueno H, Huber K, Kunadian V, Leonardi S, Lettino M, Milasinovic D, Gale CP, NSTEMI Investigators Cohort profile: the ESC EURObservational Research Programme Non-ST-segment elevation myocardial infraction (NSTEMI) Registry. Eur Heart J Qual Care Clin Outcomes. 2022 Dec 13;9(1):8-15. doi: 10.1093/ehjqcco/qcac067.
Lahu S, Presch A, Ndrepepa G, Menichelli M, Valina C, Hemetsberger R, Witzenbichler B, Bernlochner I, Joner M, Xhepa E, Hapfelmeier A, Kufner S, Rifatov N, Sager HB, Mayer K, Kessler T, Laugwitz KL, Richardt G, Schunkert H, Neumann FJ, Sibbing D, Angiolillo DJ, Kastrati A, Cassese S Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome and High Bleeding Risk. Circ Cardiovasc Interv. 2022 Oct;15(10):e012204. doi: 10.1161/CIRCINTERVENTIONS.122.012204. Epub 2022 Oct 18.
Beattie JM, Baruah R, Dudek D, Vinereanu D, McDonagh TA How the on-going conflict in Ukraine is impacting cardiovascular health. Eur Heart J. 2022 Dec 7;43(46):4767-4768. doi: 10.1093/eurheartj/ehac550.
Nissen SE, Wolski K, Cho L, Nicholls SJ, Kastelein J, Leitersdorf E, Landmesser U, Blaha M, Lincoff AM, Morishita R, Tsimikas S, Liu J, Manning B, Kozlovski P, Lesogor A, Thuren T, Shibasaki T, Matei F, Silveira FS, Meunch A, Bada A, Vijan V, Bruun NE, Nordestgaard BG, Lp(a)HERITAGE Investigators Lipoprotein(a) levels in a global population with established atherosclerotic cardiovascular disease. Open Heart. 2022 Oct;9(2):e002060. doi: 10.1136/openhrt-2022-002060.
Filippatos G, Anker SD, Pitt B, McGuire DK, Rossing P, Ruilope LM, Butler J, Jankowska EA, Michos ED, Farmakis D, Farjat AE, Kolkhof P, Scalise A, Joseph A, Bakris GL, Agarwal R Finerenone efficacy in patients with chronic kidney disease, type 2 diabetes and atherosclerotic cardiovascular disease. Eur Heart J Cardiovasc Pharmacother. 2022 Dec 15;9(1):85-93. doi: 10.1093/ehjcvp/pvac054.
Rymer JA, Kaltenbach LA, Peterson ED, Cohen DJ, Fonarow GC, Choudhry NK, Henry TD, Cannon CP, Wang TY Does the Effectiveness of a Medicine Copay Voucher Vary by Baseline Medication Out-Of-Pocket Expenses? Insights From ARTEMIS. J Am Heart Assoc. 2022 Oct 18;11(20):e026421. doi: 10.1161/JAHA.122.026421. Epub 2022 Oct 17.
Butler J, Usman MS, Anstrom KJ, Blaustein RO, Bonaca MP, Ezekowitz JA, Freitas C, Lam CSP, Lewis EF, Lindenfeld J, McMullan CJ, Mentz RJ, O’Connor C, Rosano GMC, Saldarriaga CI, Senni M, Udelson J, Voors AA, Zannad F Soluble guanylate cyclase stimulators in patients with heart failure with reduced ejection fraction across the risk spectrum. Eur J Heart Fail. 2022 Nov;24(11):2029-2036. doi: 10.1002/ejhf.2720. Epub 2022 Nov 16.
Jain MK, De Lemos JA, McGuire DK, Ayers C, Eitson JL, Sanchez CL, Kamel D, Meisner JA, Thomas EV, Hegde AA, Mocherla S, Strebe JK, Li X, Williams NS, Xing C, Ahmed MS, Wang P, Sadek HA, Schoggins JW Atovaquone for treatment of COVID-19: A prospective randomized, double-blind, placebo-controlled clinical trial. Front Pharmacol. 2022 Sep 30;13:1020123. doi: 10.3389/fphar.2022.1020123. eCollection 2022.
Mazzone PM, Angiolillo DJ, Capodanno D Approaches to de-escalation of antiplatelet treatment in stabilized post-myocardial infarction patients with high ischemic risk. Expert Rev Cardiovasc Ther. 2022 Oct;20(10):839-849. doi: 10.1080/14779072.2022.2137492. Epub 2022 Oct 24.
Kontos MC, de Lemos JA, Deitelzweig SB, Diercks DB, Gore MO, Hess EP, McCarthy CP, McCord JK, Musey PI Jr, Villines TC, Wright LJ, Writing Committee 2022 ACC Expert Consensus Decision Pathway on the Evaluation and Disposition of Acute Chest Pain in the Emergency Department: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2022 Nov 15;80(20):1925-1960. doi: 10.1016/j.jacc.2022.08.750. Epub 2022 Oct 11.
Tuttle KR, Jones CR, Daratha KB, Koyama AK, Nicholas SB, Alicic RZ, Duru OK, Neumiller JJ, Norris KC, Rios Burrows N, Pavkov ME Incidence of Chronic Kidney Disease among Adults with Diabetes, 2015-2020. N Engl J Med. 2022 Oct 13;387(15):1430-1431. doi: 10.1056/NEJMc2207018.
Ikemura N, Nakanishi K, Spertus JA, Lam CSP, Kimura T, Katsumata Y, Fujisawa T, Ueda I, Ohki T, Fukuda K, Takatsuki S, Kohsaka S Left Ventricular Diastolic Indices and Their Impact on Outcomes in Patients with Recently Diagnosed Atrial Fibrillation. J Clin Med. 2022 Sep 28;11(19):5732. doi: 10.3390/jcm11195732.
Mohebi R, Liu Y, Pina IL, Prescott MF, Butler J, Felker GM, Ward JH, Solomon SD, Januzzi JL Jr Dose-Response to Sacubitril/Valsartan in Patients With Heart Failure and Reduced Ejection Fraction. J Am Coll Cardiol. 2022 Oct 18;80(16):1529-1541. doi: 10.1016/j.jacc.2022.08.737.
York M, Douglas PS, Damp JB, Fraiche AM, Gillam LD, Hayes SN, Rzeszut AK, Sulistio MS, Wood MJ Professional Preferences and Perceptions of Cardiology Among Internal Medicine Residents: Temporal Trends Over the Past Decade. JAMA Cardiol. 2022 Dec 1;7(12):1253-1258. doi: 10.1001/jamacardio.2022.3485.
Mori Y, Duru OK, Tuttle KR, Fukuma S, Taura D, Harada N, Inagaki N, Inoue K Sodium-Glucose Cotransporter 2 Inhibitors and New-onset Type 2 Diabetes in Adults With Prediabetes: Systematic Review and Meta-analysis of Randomized Controlled Trials. J Clin Endocrinol Metab. 2022 Dec 17;108(1):221-231. doi: 10.1210/clinem/dgac591.
Zaman S, Shaw E, Ellenberger K, Rosa M, Leung M, Kwan V, Liang R, Banerjee S, Bastiany A, Gulati M, Hayes S, Grines C, Mehran R, Burgess S Representation of Women in Internal Medicine Specialties in North America, the United Kingdom, and Australasia: Cardiology’s Outlier Status and the Importance of Diversity. Am J Cardiol. 2022 Dec 15;185:122-128. doi: 10.1016/j.amjcard.2022.08.030. Epub 2022 Oct 8.
Nelson AJ, Harrington JL, Kolkailah AA, Pagidipati NJ, McGuire DK Sodium-Glucose Cotransporter-2 Inhibitors: Impact on Atherosclerosis and Atherosclerotic Cardiovascular Disease Events. Heart Fail Clin. 2022 Oct;18(4):597-607. doi: 10.1016/j.hfc.2022.03.007.
Ganatra S, Dani SS, Kumar A, Khan SU, Wadhera R, Neilan TG, Thavendiranathan P, Barac A, Hermann J, Leja M, Deswal A, Fradley M, Liu JE, Sadler D, Asnani A, Baldassarre LA, Gupta D, Yang E, Guha A, Brown SA, Stevens J, Hayek SS, Porter C, Kalra A, Baron SJ, Ky B, Virani SS, Kazi D, Nasir K, Nohria A Impact of Social Vulnerability on Comorbid Cancer and Cardiovascular Disease Mortality in the United States. JACC CardioOncol. 2022 Sep 20;4(3):326-337. doi: 10.1016/j.jaccao.2022.06.005. eCollection 2022 Sep.
Connors JM, Iba T Vaccine-induced immune thrombotic thrombocytopenia and patients with cancer. Thromb Res. 2022 May;213 Suppl 1:S77-S83. doi: 10.1016/j.thromres.2022.02.009. Epub 2022 May 26.
Forst T, Mathieu C, Giorgino F, Wheeler DC, Papanas N, Schmieder RE, Halabi A, Schnell O, Streckbein M, Tuttle KR New strategies to improve clinical outcomes for diabetic kidney disease. BMC Med. 2022 Oct 10;20(1):337. doi: 10.1186/s12916-022-02539-2.
van Broekhoven A, Mohammadnia N, Silvis MJM, Los J, Fiolet ATL, Opstal TSJ, Mosterd A, Eikelboom JW, Nidorf SM, Budgeon CA, Byrnes E, Bax WA, Tijssen JGP, de Kleijn DPV, Thompson PL, El Messaoudi S, Cornel JH The Effect of Years-Long Exposure to Low-Dose Colchicine on Renal and Liver Function and Blood Creatine Kinase Levels: Safety Insights from the Low-Dose Colchicine 2 (LoDoCo2) Trial. Clin Drug Investig. 2022 Nov;42(11):977-985. doi: 10.1007/s40261-022-01209-8. Epub 2022 Oct 8.
Nicholls SJ Scratching the surface of atherosclerosis: Distinguishing phenotypes of plaque erosion. Atherosclerosis. 2022 Nov;360:42-43. doi: 10.1016/j.atherosclerosis.2022.09.003. Epub 2022 Sep 17.
Raskob GE, Ageno W, Albers G, Elliott CG, Halperin J, Maynard G, Steg PG, Weitz JI, Albanese J, Yuan Z, Levitan B, Lu W, Suh EY, Spiro T, Lipardi C, Barnathan ES, Spyropoulos AC Benefit-Risk Assessment of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness. J Am Heart Assoc. 2022 Oct 18;11(20):e026229. doi: 10.1161/JAHA.122.026229. Epub 2022 Oct 7.
de Boer IH, Khunti K, Sadusky T, Tuttle KR, Neumiller JJ, Rhee CM, Rosas SE, Rossing P, Bakris G Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2022 Nov;102(5):974-989. doi: 10.1016/j.kint.2022.08.012. Epub 2022 Oct 3.
Pacheco C, Luu J, Mehta PK, Wei J, Gulati M, Bairey Merz CN INOCA and MINOCA: Are Women’s Heart Centres the Answer to Understanding and Management of These Increasing Populations of Women (and Men)? Can J Cardiol. 2022 Oct;38(10):1611-1614. doi: 10.1016/j.cjca.2022.06.016. Epub 2022 Sep 7.
Kunadian V, Baber U, Pivato CA, Cao D, Dangas G, Sartori S, Zhang Z, Angiolillo DJ, Briguori C, Cohen DJ, Collier T, Dudek D, Gibson M, Gil R, Huber K, Kaul U, Kornowski R, Krucoff MW, Dehghani P, Mehta S, Moliterno DJ, Ohman EM, Escaned J, Sardella G, Sharma SK, Shlofmitz R, Weisz G, Witzenbichler B, Dzavik V, Gurbel P, Hamm CW, Henry T, Kastrati A, Marx SO, Oldroyd K, Steg PG, Pocock S, Mehran R Bleeding and Ischemic Outcomes With Ticagrelor Monotherapy According to Body Mass Index. JACC Cardiovasc Interv. 2022 Oct 10;15(19):1948-1960. doi: 10.1016/j.jcin.2022.07.039.
Shah N, Madhavan MV, Gray WA, Brener SJ, Ahmad Y, Lindenfeld J, Abraham WT, Grayburn PA, Kar S, Lim DS, Mishell JM, Whisenant BK, Zhang Z, Redfors B, Mack MJ, Stone GW Prediction of Death or HF Hospitalization in Patients With Severe FMR: The COAPT Risk Score. JACC Cardiovasc Interv. 2022 Oct 10;15(19):1893-1905. doi: 10.1016/j.jcin.2022.08.005.
Sedhom R, Megaly M, Elbadawi A, Yassa G, Weinberg I, Gulati M, Elgendy IY Sex Differences in Management and Outcomes Among Patients With High-Risk Pulmonary Embolism: A Nationwide Analysis. Mayo Clin Proc. 2022 Oct;97(10):1872-1882. doi: 10.1016/j.mayocp.2022.03.022.
Potere N, Barco S, Mahe I, Cesarman-Maus G, Angchaisuksiri P, Leader A, Okoye HC, Olayemi E, Ay C, Carrier M, Connors JM, Farmakis IT, Fumagalli RM, Jing ZC, Lee LH, McLintock C, Ni Ainle F, Giannakoulas G, Goto S, Guillermo Esposito MC, Jara-Palomares L, Szlaszynska M, Tan CW, Van Es N, Wang TF, Hunt BJ, Di Nisio M Awareness of venous thromboembolism among patients with cancer: Preliminary findings from a global initiative for World Thrombosis Day. J Thromb Haemost. 2022 Dec;20(12):2964-2971. doi: 10.1111/jth.15902. Epub 2022 Oct 21.
Manoogian ENC, Zadourian A, Lo HC, Gutierrez NR, Shoghi A, Rosander A, Pazargadi A, Ormiston CK, Wang X, Sui J, Hou Z, Fleischer JG, Golshan S, Taub PR, Panda S Feasibility of time-restricted eating and impacts on cardiometabolic health in 24-h shift workers: The Healthy Heroes randomized control trial. Cell Metab. 2022 Oct 4;34(10):1442-1456.e7. doi: 10.1016/j.cmet.2022.08.018.
Venkateshvaran A, Faxen UL, Hage C, Michaelsson E, Svedlund S, Saraste A, Beussink-Nelson L, Fermer ML, Gan LM, Tromp J, Lam CSP, Shah SJ, Lund LH Association of epicardial adipose tissue with proteomics, coronary flow reserve, cardiac structure and function, and quality of life in heart failure with preserved ejection fraction: insights from the PROMIS-HFpEF study. Eur J Heart Fail. 2022 Dec;24(12):2251-2260. doi: 10.1002/ejhf.2709. Epub 2022 Oct 20.
Filippatos G, Anker SD, Butler J, Farmakis D, Ferreira JP, Gollop ND, Brueckmann M, Iwata T, Pocock S, Zannad F, Packer M, EMPEROR-Reduced Trial Committees and Investigators Effects of empagliflozin on cardiovascular and renal outcomes in heart failure with reduced ejection fraction according to age: a secondary analysis of EMPEROR-Reduced. Eur J Heart Fail. 2022 Dec;24(12):2297-2304. doi: 10.1002/ejhf.2707. Epub 2022 Oct 24.
Aggarwal R, Yeh RW, Dahabreh IJ, Robertson SE, Wadhera RK Medicare eligibility and healthcare access, affordability, and financial strain for low- and higher-income adults in the United States: A regression discontinuity analysis. PLoS Med. 2022 Oct 4;19(10):e1004083. doi: 10.1371/journal.pmed.1004083. eCollection 2022 Oct.
Fudim M, Van Spall HGC In HFpEF, the benefit of empagliflozin on a composite of CV death or HF hospitalization at 26 mo did not vary by diabetes status. Ann Intern Med. 2022 Oct;175(10):JC111. doi: 10.7326/J22-0075. Epub 2022 Oct 4.
Vaduganathan M, Claggett BL, Jhund P, de Boer RA, Hernandez AF, Inzucchi SE, Kosiborod MN, Lam CSP, Martinez F, Shah SJ, Desai AS, Hegde SM, Lindholm D, Petersson M, Langkilde AM, McMurray JJV, Solomon SD Time to Clinical Benefit of Dapagliflozin in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Secondary Analysis of the DELIVER Randomized Clinical Trial. JAMA Cardiol. 2022 Dec 1;7(12):1259-1263. doi: 10.1001/jamacardio.2022.3750.
de Boer IH, Khunti K, Sadusky T, Tuttle KR, Neumiller JJ, Rhee CM, Rosas SE, Rossing P, Bakris G Diabetes Management in Chronic Kidney Disease: A Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO). Diabetes Care. 2022 Dec 1;45(12):3075-3090. doi: 10.2337/dci22-0027.
Earle W, Abdallah G, Meagher S, Shen K, Gibson CM, Ho KKL, Secemsky EA Reducing use of triple therapy after percutaneous coronary intervention: Results from a hospital-wide quality improvement initiative. Catheter Cardiovasc Interv. 2022 Nov;100(6):941-947. doi: 10.1002/ccd.30412. Epub 2022 Oct 2.
Januzzi JL, Omar AMS, Liu Y, Murphy S, Butler J, Felker GM, Pina IL, Ward J, Solomon S, Contreras J Association Between Sacubitril/Valsartan Initiation and Mitral Regurgitation Severity in Heart Failure With Reduced Ejection Fraction: The PROVE-HF Study. Circulation. 2022 Nov 22;146(21):1638-1640. doi: 10.1161/CIRCULATIONAHA.122.061693. Epub 2022 Oct 2.
Li HL, Tse YK, Chandramouli C, Hon NW, Cheung CL, Lam LY, Wu M, Huang JY, Yu SY, Leung KL, Fei Y, Feng Q, Ren Q, Cheung BMY, Tse HF, Verma S, Lam CSP, Yiu KH Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Pneumonia and Septic Shock. J Clin Endocrinol Metab. 2022 Nov 25;107(12):3442-3451. doi: 10.1210/clinem/dgac558.
Parikh SM, Agarwal A, Bajwa A, Kumar S, Mansour SG, Okusa MD, Cerda J, AKINow Initiative of the American Society of Nephrology Fostering Scientific Innovation to Impact AKI: A Roadmap from ASN’s AKINow Basic Science Workgroup. Kidney360. 2022 Jun 17;3(8):1445-1448. doi: 10.34067/KID.0007472021. eCollection 2022 Aug 25.
Shah SJ, Butler J, Shah SH, Kamphaus TN, Sachdev V Accelerating therapeutic discoveries for heart failure: a new public-private partnership. Nat Rev Drug Discov. 2022 Nov;21(11):781-782. doi: 10.1038/d41573-022-00158-3.
Lacaze P, Bakshi A, Riaz M, Polekhina G, Owen A, Bhatia HS, Natarajan P, Wolfe R, Beilin L, Nicholls SJ, Watts GF, McNeil JJ, Tonkin AM, Tsimikas S Aspirin for Primary Prevention of Cardiovascular Events in Relation to Lipoprotein(a) Genotypes. J Am Coll Cardiol. 2022 Oct 4;80(14):1287-1298. doi: 10.1016/j.jacc.2022.07.027.
Eckardt KU, Binet I, de Groot K, Floege J, Galle JC, Jordans I, Kribben A, Oberbauer R, Pavenstadt H, Rosenkranz A, Saemann M, Winkelmayer WC [Nomenclature for kidney function and kidney diseases – Improving assessment and prognosis through precision and comprehensibility]. Dtsch Med Wochenschr. 2022 Oct;147(21):1398-1406. doi: 10.1055/a-1908-5163. Epub 2022 Sep 29.
Boulet J, Nayak A, Mehra MR Hemodynamic Aberrancies in Left Ventricular Assist Device-Associated Heart Failure Syndromes. J Card Fail. 2022 Dec;28(12):1738-1740. doi: 10.1016/j.cardfail.2022.09.007. Epub 2022 Sep 26.
Mentias A, Desai MY, Keshvani N, Gillinov AM, Johnston D, Kumbhani DJ, Hirji SA, Sarrazin MV, Saad M, Peterson ED, Mack MJ, Cram P, Girotra S, Kapadia S, Svensson L, Pandey A Ninety-Day Risk-Standardized Home Time as a Performance Metric for Cardiac Surgery Hospitals in the United States. Circulation. 2022 Oct 25;146(17):1297-1309. doi: 10.1161/CIRCULATIONAHA.122.059496. Epub 2022 Sep 26.
Amarenco P, Kim JS, Labreuche J, Charles H, Giroud M, Lee BC, Lavallee PC, Mahagne MH, Meseguer E, Nighoghossian N, Steg PG, Vicaut E, Bruckert E, Treat Stroke to Target Investigators Yield of Dual Therapy With Statin and Ezetimibe in the Treat Stroke to Target Trial. Stroke. 2022 Nov;53(11):3260-3267. doi: 10.1161/STROKEAHA.122.039728. Epub 2022 Sep 26.
Moriarty PM, Steg PG, McGinniss J, Zeiher AM, White HD, Manvelian G, Pordy R, Loy M, Jukema JW, Harrington RA, Gray JV, Gorby LK, Goodman SG, Diaz R, Bittner VA, Bhatt DL, Szarek M, Schwartz GG, ODYSSEY OUTCOMES Investigators Relation of red blood cell distribution width to risk of major adverse cardiovascular events, death, and effect of alirocumab after acute coronary syndromes. J Clin Lipidol. 2022 Sep-Oct;16(5):747-756. doi: 10.1016/j.jacl.2022.08.004. Epub 2022 Aug 23.
Heerspink HJL, Sattar N, Pavo I, Haupt A, Duffin KL, Yang Z, Wiese RJ, Tuttle KR, Cherney DZI Effects of tirzepatide versus insulin glargine on kidney outcomes in type 2 diabetes in the SURPASS-4 trial: post-hoc analysis of an open-label, randomised, phase 3 trial. Lancet Diabetes Endocrinol. 2022 Nov;10(11):774-785. doi: 10.1016/S2213-8587(22)00243-1. Epub 2022 Sep 21.
Kandzari DE, Koolen JJ, Doros G, Garcia-Garcia HM, Bennett J, Roguin A, Gharib EG, Cutlip DE, Waksman R, BIOFLOW V Investigators Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents: BIOFLOW V Final 5-Year Outcomes. JACC Cardiovasc Interv. 2022 Sep 26;15(18):1852-1860. doi: 10.1016/j.jcin.2022.07.027.
Krishnan P, Farhan S, Schneider P, Kamran H, Iida O, Brodmann M, Micari A, Sachar R, Urasawa K, Scheinert D, Ando K, Tarricone A, Doros G, Tepe G, Yokoi H, Laird J, Zeller T Determinants of Drug-Coated Balloon Failure in Patients Undergoing Femoropopliteal Arterial Intervention. J Am Coll Cardiol. 2022 Sep 27;80(13):1241-1250. doi: 10.1016/j.jacc.2022.06.043.
Smits PC, Frigoli E, Vranckx P, Ozaki Y, Morice MC, Chevalier B, Onuma Y, Windecker S, Tonino PAL, Roffi M, Lesiak M, Mahfoud F, Bartunek J, Hildick-Smith D, Colombo A, Stankovic G, Iniguez A, Schultz C, Kornowski R, Ong PJL, Alasnag M, Rodriguez AE, Paradies V, Kala P, Kedev S, Al Mafragi A, Dewilde W, Heg D, Valgimigli M, MASTER DAPT Investigators Abbreviated Antiplatelet Therapy After Coronary Stenting in Patients With Myocardial Infarction at High Bleeding Risk. J Am Coll Cardiol. 2022 Sep 27;80(13):1220-1237. doi: 10.1016/j.jacc.2022.07.016.
Koshino A, Schechter M, Sen T, Vart P, Neuen BL, Neal B, Arnott C, Perkovic V, Ridker PM, Tuttle KR, Hansen MK, Heerspink HJL Interleukin-6 and Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: New Insights From CANVAS. Diabetes Care. 2022 Nov 1;45(11):2644-2652. doi: 10.2337/dc22-0866.
Kunadian V The ongoing conundrum of the best care for patients presenting with non-ST-segment elevation acute coronary syndrome. EuroIntervention. 2022 Sep 20;18(7):531-533. doi: 10.4244/EIJ-E-22-00029.
Ten Berg J, Rocca B, Angiolillo DJ, Hayashida K The search for optimal antithrombotic therapy in transcatheter aortic valve implantation: facts and uncertainties. Eur Heart J. 2022 Nov 21;43(44):4616-4634. doi: 10.1093/eurheartj/ehac385.
Mehta SR, Wang J, Wood DA, Spertus JA, Cohen DJ, Mehran R, Storey RF, Steg PG, Pinilla-Echeverri N, Sheth T, Bainey KR, Bangalore S, Cantor WJ, Faxon DP, Feldman LJ, Jolly SS, Kunadian V, Lavi S, Lopez-Sendon J, Madan M, Moreno R, Rao SV, Rodes-Cabau J, Stankovic G, Bangdiwala SI, Cairns JA, COMPLETE Trial Investigators Complete Revascularization vs Culprit Lesion-Only Percutaneous Coronary Intervention for Angina-Related Quality of Life in Patients With ST-Segment Elevation Myocardial Infarction: Results From the COMPLETE Randomized Clinical Trial. JAMA Cardiol. 2022 Nov 1;7(11):1091-1099. doi: 10.1001/jamacardio.2022.3032.
Ferreira JP, Zannad F, Butler J, Filippatos G, Pocock SJ, Brueckmann M, Steubl D, Schueler E, Anker SD, Packer M Association of Empagliflozin Treatment With Albuminuria Levels in Patients With Heart Failure: A Secondary Analysis of EMPEROR-Pooled. JAMA Cardiol. 2022 Nov 1;7(11):1148-1159. doi: 10.1001/jamacardio.2022.2924.
Albuloushi A, Rhoten M, Kelly J, Sylvester KW, Grandoni J, Connors JM Evaluation of the use of direct oral anticoagulants for the management of heparin-induced thrombocytopenia. J Thromb Thrombolysis. 2022 Nov;54(4):597-604. doi: 10.1007/s11239-022-02705-6. Epub 2022 Sep 21.
Mohebi R, Liu Y, Felker GM, Prescott MF, Ward JH, Pina IL, Butler J, Solomon SD, Januzzi JL Heart Failure Duration and Mechanistic Efficacy of Sacubitril/Valsartan in Heart Failure With Reduced Ejection Fraction. J Card Fail. 2022 Dec;28(12):1673-1682. doi: 10.1016/j.cardfail.2022.08.006. Epub 2022 Sep 17.
Talha KM, Anker SD, Burkhoff D, Filippatos G, Lam CSP, Stone GW, Wazni O, Butler J Role of Cardiac Contractility Modulation in Heart Failure With a Higher Ejection Fraction. J Card Fail. 2022 Dec;28(12):1717-1726. doi: 10.1016/j.cardfail.2022.08.013. Epub 2022 Sep 17.
Sharma T, Krishnan AM, Lahoud R, Polomsky M, Dauerman HL National Trends in TAVR and SAVR for Patients With Severe Isolated Aortic Stenosis. J Am Coll Cardiol. 2022 Nov 22;80(21):2054-2056. doi: 10.1016/j.jacc.2022.08.787. Epub 2022 Sep 16.
Chew DS, Whitelaw S, Vaduganathan M, Mark DB, Van Spall HGC Patient-Reported Outcome Measures in Cardiovascular Disease: An Evidence Map of the Psychometric Properties of Health Status Instruments. Ann Intern Med. 2022 Oct;175(10):1431-1439. doi: 10.7326/M22-2234. Epub 2022 Sep 20.
Al-Khatib SM, Wojdyla DM, Granger CB, Wallentin L, Garcia DA, Hijazi Z, Held C, Alexander JH, Vinereanu D, Flaker GC, Hylek EM, Lopes RD Duration of Anticoagulation Interruption Before Invasive Procedures and Outcomes in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial. Circulation. 2022 Sep 20;146(12):958-960. doi: 10.1161/CIRCULATIONAHA.122.059438. Epub 2022 Sep 19.
Lim DS, Smith RL, Gillam LD, Zahr F, Chadderdon S, Makkar R, von Bardeleben RS, Kipperman RM, Rassi AN, Szerlip M, Goldman S, Inglessis-Azuaje I, Yadav P, Lurz P, Davidson CJ, Mumtaz M, Gada H, Kar S, Kodali SK, Laham R, Hiesinger W, Fam NP, Kessler M, O’Neill WW, Whisenant B, Kliger C, Kapadia S, Rudolph V, Choo J, Hermiller J, Morse MA, Schofer N, Gafoor S, Latib A, Koulogiannis K, Marcoff L, Hausleiter J, CLASP IID Pivotal Trial Investigators Randomized Comparison of Transcatheter Edge-to-Edge Repair for Degenerative Mitral Regurgitation in Prohibitive Surgical Risk Patients. JACC Cardiovasc Interv. 2022 Dec 26;15(24):2523-2536. doi: 10.1016/j.jcin.2022.09.005. Epub 2022 Sep 17.
Kapadia SR, Makkar R, Leon M, Abdel-Wahab M, Waggoner T, Massberg S, Rottbauer W, Horr S, Sondergaard L, Karha J, Gooley R, Satler L, Stoler RC, Messe SR, Baron SJ, Seeger J, Kodali S, Krishnaswamy A, Thourani VH, Harrington K, Pocock S, Modolo R, Allocco DJ, Meredith IT, Linke A, PROTECTED TAVR Investigators Cerebral Embolic Protection during Transcatheter Aortic-Valve Replacement. N Engl J Med. 2022 Oct 6;387(14):1253-1263. doi: 10.1056/NEJMoa2204961. Epub 2022 Sep 17.
Jolly SS, AlRashidi S, d’Entremont MA, Alansari O, Brochu B, Heenan L, Skuriat E, Tyrwhitt J, Raco M, Tsang M, Valettas N, Velianou JL, Sheth T, Sibbald M, Mehta SR, Pinilla-Echeverri N, Schwalm JD, Natarajan MK, Kelly A, Akl E, Tawadros S, Camargo M, Faidi W, Bauer J, Moxham R, Nkurunziza J, Dutra G, Winter J Routine Ultrasonography Guidance for Femoral Vascular Access for Cardiac Procedures: The UNIVERSAL Randomized Clinical Trial. JAMA Cardiol. 2022 Nov 1;7(11):1110-1118. doi: 10.1001/jamacardio.2022.3399.
Hobeanu C, Lavallee PC, Charles H, Labreuche J, Albers GW, Caplan LR, Donnan GA, Ferro JM, Hennerici MG, Molina CA, Rothwell PM, Steg PG, Touboul PJ, Uchiyama S, Vicaut E, Wong KSL, Amarenco P, TIAregistry.org Investigators Risk of subsequent disabling or fatal stroke in patients with transient ischaemic attack or minor ischaemic stroke: an international, prospective cohort study. Lancet Neurol. 2022 Oct;21(10):889-898. doi: 10.1016/S1474-4422(22)00302-7.
Myhre PL, Vaduganathan M, Claggett BL, Miao ZM, Jhund PS, de Boer RA, Hernandez AF, Inzucchi SE, Kosiborod MN, Lam CSP, Martinez F, Shah SJ, Desai AS, Lindholm D, Petersson M, Langkilde AM, McMurray JJV, Solomon SD Influence of NT-proBNP on Efficacy of Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction. JACC Heart Fail. 2022 Dec;10(12):902-913. doi: 10.1016/j.jchf.2022.08.007. Epub 2022 Aug 27.
Zhang J, Van Spall HGC, Wang Y, Thabane L, Wang R, Li G Twenty-year trends in racial and ethnic enrollment in large diabetes randomized controlled trials. BMC Med. 2022 Sep 16;20(1):294. doi: 10.1186/s12916-022-02501-2.
Levine GN, McEvoy JW, Fang JC, Ibeh C, McCarthy CP, Misra A, Shah ZI, Shenoy C, Spinler SA, Vallurupalli S, Lip GYH, American Heart Association Council on Clinical Cardiology; Council on, Cardiovascular and Stroke Nursing; and Stroke Council Management of Patients at Risk for and With Left Ventricular Thrombus: A Scientific Statement From the American Heart Association. Circulation. 2022 Oct 11;146(15):e205-e223. doi: 10.1161/CIR.0000000000001092. Epub 2022 Sep 15.
Ratcovich H, Alkhalil M, Beska B, Holmvang L, Lawless M, Gede Dennis Sukadana I, Wilkinson C, Kunadian V Sex differences in long-term outcomes in older adults undergoing invasive treatment for non-ST elevation acute coronary syndrome: An ICON-1 sub-study. Int J Cardiol Heart Vasc. 2022 Sep 6;42:101118. doi: 10.1016/j.ijcha.2022.101118. eCollection 2022 Oct.
Myhre PL, Prescott MF, Claggett B, Felker GM, Butler J, Pina IL, Maisel AS, Williamson KM, Ward JH, Solomon SD, Januzzi JL Comparative Effect of Angiotensin Receptor Neprilysin Inhibition on B-type Natriuretic Peptide Levels Measured by Three Different Assays: The PROVE-HF Study. Clin Chem. 2022 Nov 3;68(11):1391-1398. doi: 10.1093/clinchem/hvac148.
Oseran AS, Sun T, Wadhera RK, Dahabreh IJ, de Lemos JA, Das SR, Rutan C, Asnani AH, Yeh RW, Kazi DS Enriching the American Heart Association COVID-19 Cardiovascular Disease Registry Through Linkage With External Data Sources: Rationale and Design. J Am Heart Assoc. 2022 Sep 20;11(18):e7743. doi: 10.1161/JAHA.122.027094. Epub 2022 Sep 14.
Jiang GY, Xu J, Manning WJ, Markson LJ, Khabbaz KR, Garan AR, Sabe MA, Strom JB Mitral Regurgitation and Mortality Risk in Medicare Beneficiaries With Heart Failure and Preserved Ejection Fraction. Am J Cardiol. 2022 Nov 15;183:40-47. doi: 10.1016/j.amjcard.2022.07.025. Epub 2022 Sep 11.
Butler J, Filippatos G, Siddiqi TJ, Ferreira JP, Brueckmann M, Bocchi E, Bohm M, Chopra VK, Giannetti N, Iwata T, Januzzi JL, Kaul S, Pina IL, Ponikowski P, Rauch-Krohnert U, Shah SJ, Senni M, Sumin M, Verma S, Zhang J, Pocock SJ, Zannad F, Packer M, Anker SD Effects of Empagliflozin in Women and Men With Heart Failure and Preserved Ejection Fraction. Circulation. 2022 Oct 4;146(14):1046-1055. doi: 10.1161/CIRCULATIONAHA.122.059755. Epub 2022 Sep 13.
Welsh P, Campbell RT, Mooney L, Kimenai DM, Hayward C, Campbell A, Porteous D, Mills NL, Lang NN, Petrie MC, Januzzi JL, McMurray JJV, Sattar N Reference Ranges for NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) and Risk Factors for Higher NT-proBNP Concentrations in a Large General Population Cohort. Circ Heart Fail. 2022 Oct;15(10):e009427. doi: 10.1161/CIRCHEARTFAILURE.121.009427. Epub 2022 Sep 13.
Greene SJ, Fonarow GC, Butler J Sodium-glucose cotransporter 2 inhibitors for heart failure with mildly reduced or preserved ejection fraction: time to deliver implementation. Eur J Heart Fail. 2022 Oct;24(10):1902-1905. doi: 10.1002/ejhf.2688. Epub 2022 Sep 26.
Tea V, Morelle JF, Gallet R, Cayla G, Lemesle G, Lhermusier T, Dillinger JG, Ducrocq G, Angouvant D, Cottin Y, Chamandi C, le Bras A, Steg PG, Montalescot G, Nelson AC, Simon T, Chatellier G, Danchin N, Puymirat E, FLOWER-MI study investigators Immediate versus staged complete myocardial revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease: A post hoc analysis of the randomized FLOWER-MI trial. Arch Cardiovasc Dis. 2022 Oct;115(10):496-504. doi: 10.1016/j.acvd.2022.05.011. Epub 2022 Sep 2.
Rossello X, Menon V, Vranckx P Acetazolamide for patients with acute decompensated heart failure with volume overload. Eur Heart J Acute Cardiovasc Care. 2022 Sep 29;11(9):712-713. doi: 10.1093/ehjacc/zuac108.
Galli M, Angiolillo DJ De-escalation of antiplatelet therapy in acute coronary syndromes: Why, how and when? Front Cardiovasc Med. 2022 Aug 25;9:975969. doi: 10.3389/fcvm.2022.975969. eCollection 2022.
Gulati M The role of the preventive cardiologist in addressing climate change. Am J Prev Cardiol. 2022 Aug 23;11:100375. doi: 10.1016/j.ajpc.2022.100375. eCollection 2022 Sep.
James G, Garcia Sanchez JJ, Carrero JJ, Kumar S, Pecoits-Filho R, Heerspink HJL, Nolan S, Lam CSP, Chen H, Kanda E, Kashihara N, Arnold M, Kosiborod MN, Lainscak M, Pollock C, Wheeler DC Low Adherence to Kidney Disease: Improving Global Outcomes 2012 CKD Clinical Practice Guidelines Despite Clear Evidence of Utility. Kidney Int Rep. 2022 Jun 8;7(9):2059-2070. doi: 10.1016/j.ekir.2022.05.033. eCollection 2022 Sep.
Butler J, Siddiqi TJ, Anker SD Patiromer use in patients with heart failure: lessons and clinical considerations from the DIAMOND trial. Eur J Heart Fail. 2022 Oct;24(10):1744-1747. doi: 10.1002/ejhf.2684. Epub 2022 Sep 20.
Bohm M, Butler J, Mahfoud F, Filippatos G, Ferreira JP, Pocock SJ, Slawik J, Brueckmann M, Linetzky B, Schuler E, Wanner C, Zannad F, Packer M, Anker SD, EMPEROR-Preserved Trial Committees and Investigators Heart failure outcomes according to heart rate and effects of empagliflozin in patients of the EMPEROR-Preserved trial. Eur J Heart Fail. 2022 Oct;24(10):1883-1891. doi: 10.1002/ejhf.2677. Epub 2022 Oct 4.
Kobo O, Van Spall HGC, Mamas MA Urban-rural disparities in diabetes-related mortality in the USA 1999-2019. Diabetologia. 2022 Dec;65(12):2078-2083. doi: 10.1007/s00125-022-05785-4. Epub 2022 Sep 10.
Yoon SH, Makar M, Kar S, Koseki K, Oakley L, Sekhon N, Patel D, Chakravarty T, Nakamura M, Hamilton M, Patel JK, Singh S, Sabah S, Siegel RJ, Bax JJ, Makkar RR Impact of Left Ventricular Global Longitudinal Strain on Outcomes After Transcatheter Edge-to-Edge Repair in Secondary Mitral Regurgitation. Am J Cardiol. 2022 Nov 1;182:69-76. doi: 10.1016/j.amjcard.2022.07.023. Epub 2022 Sep 6.
Fry ETA, Wood MJ, Walsh MN Maternal Health: The Heart of the Matter. J Am Coll Cardiol. 2022 Sep 13;80(11):1107-1109. doi: 10.1016/j.jacc.2022.08.001.
Sodhi N, Asch FM, Ruf T, Petrescu A, von Bardeleben RS, Lim DS, Maisano F, Kar S, Price MJ Clinical Outcomes With Transcatheter Edge-to-Edge Repair in Atrial Functional MR From the EXPAND Study. JACC Cardiovasc Interv. 2022 Sep 12;15(17):1723-1730. doi: 10.1016/j.jcin.2022.07.023.
Yoon SH, Makar M, Kar S, Chakravarty T, Oakley L, Sekhon N, Koseki K, Nakamura M, Hamilton M, Patel JK, Singh S, Skaf S, Siegel RJ, Bax JJ, Makkar RR Outcomes After Transcatheter Edge-to-Edge Mitral Valve Repair According to Mitral Regurgitation Etiology and Cardiac Remodeling. JACC Cardiovasc Interv. 2022 Sep 12;15(17):1711-1722. doi: 10.1016/j.jcin.2022.07.004.
Mehra MR, Goldstein DJ, Cleveland JC, Cowger JA, Hall S, Salerno CT, Naka Y, Horstmanshof D, Chuang J, Wang A, Uriel N Five-Year Outcomes in Patients With Fully Magnetically Levitated vs Axial-Flow Left Ventricular Assist Devices in the MOMENTUM 3 Randomized Trial. JAMA. 2022 Sep 27;328(12):1233-1242. doi: 10.1001/jama.2022.16197.
Bayes-Genis A, Aimo A, Jhund P, Richards M, de Boer RA, Arfsten H, Fabiani I, Lupon J, Anker SD, Gonzalez A, Castiglione V, Metra M, Mueller C, Nunez J, Rossignol P, Barison A, Butler J, Teerlink J, Filippatos G, Ponikowski P, Vergaro G, Zannad F, Seferovic P, Rosano G, Coats AJS, Emdin M, Januzzi JL Biomarkers in heart failure clinical trials. A review from the Biomarkers Working Group of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2022 Oct;24(10):1767-1777. doi: 10.1002/ejhf.2675. Epub 2022 Sep 20.
Kostantinis S, Simsek B, Karacsonyi J, Alaswad K, Krestyaninov O, Khelimskii D, Karmpaliotis D, Jaffer FA, Khatri JJ, Poommipanit P, Choi JW, Jaber WA, Rinfret S, Nicholson W, Patel MP, Mahmud E, Dattilo P, Gorgulu S, Koutouzis M, Tsiafoutis I, Elbarouni B, Sheikh AM, Uretsky BF, ElGuindy AM, Jefferson BK, Patel TN, Wollmuth J, Riley RF, Benton SM Jr, Davies RE, Chandwaney RH, Toma C, Yeh RW, Schimmel DR, Abi Rafeh N, Goktekin O, Kerrigan JL, Mastrodemos OC, Rangan BV, Garcia S, Sandoval Y, Burke MN, Brilakis E In-hospital outcomes and temporal trends of percutaneous coronary interventions for chronic total occlusion. EuroIntervention. 2022 Dec 2;18(11):e929-e932. doi: 10.4244/EIJ-D-22-00599.
Baker TS, Kellner CP, Colbourne F, Rincon F, Kollmar R, Badjatia N, Dangayach N, Mocco J, Selim MH, Lyden P, Polderman K, Mayer S Consensus recommendations on therapeutic hypothermia after minimally invasive intracerebral hemorrhage evacuation from the hypothermia for intracerebral hemorrhage (HICH) working group. Front Neurol. 2022 Aug 17;13:859894. doi: 10.3389/fneur.2022.859894. eCollection 2022.
Gidding SS, Wiegman A, Groselj U, Freiberger T, Peretti N, Dharmayat KI, Daccord M, Bedlington N, Sikonja J, Ray KK, Santos RD, Halle M, Tokgozoglu L, Gutierrez-Ibarluzea I, Pinto FJ, Geanta M Paediatric familial hypercholesterolaemia screening in Europe: public policy background and recommendations. Eur J Prev Cardiol. 2022 Dec 21;29(18):2301-2311. doi: 10.1093/eurjpc/zwac200.
Dafaalla M, Rashid M, Van Spall HGC, Mehta L, Parwani P, Sharma G, Palmer RB, Moledina S, Volgman AS, Mamas MA Women Are Less Likely to Survive AMI Presenting With Out-of-Hospital Cardiac Arrest: A Nationwide Study. Mayo Clin Proc. 2022 Sep;97(9):1608-1618. doi: 10.1016/j.mayocp.2022.06.011.
Kapur NK, Kim RJ, Moses JW, Stone GW, Udelson JE, Ben-Yehuda O, Redfors B, Issever MO, Josephy N, Polak SJ, O’Neill WW Primary left ventricular unloading with delayed reperfusion in patients with anterior ST-elevation myocardial infarction: Rationale and design of the STEMI-DTU randomized pivotal trial. Am Heart J. 2022 Dec;254:122-132. doi: 10.1016/j.ahj.2022.08.011. Epub 2022 Sep 1.
Chopard R, Campia U, Morin L, Jering KS, Almarzooq ZI, Snyder JE, Rizzo S, Waxman AB, Goldhaber SZ, Piazza G Trends in management and outcomes of pulmonary embolism with a multidisciplinary response team. J Thromb Thrombolysis. 2022 Oct;54(3):449-460. doi: 10.1007/s11239-022-02697-3. Epub 2022 Sep 3.
Scheitz JF, Sposato LA, Schulz-Menger J, Nolte CH, Backs J, Endres M Stroke-Heart Syndrome: Recent Advances and Challenges. J Am Heart Assoc. 2022 Sep 6;11(17):e026528. doi: 10.1161/JAHA.122.026528. Epub 2022 Sep 3.
Anderson HVS, Masri SC, Abdallah MS, Chang AM, Cohen MG, Elgendy IY, Gulati M, LaPoint K, Madan N, Moussa ID, Ramirez J, Simon AW, Singh V, Waldo SW, Williams MS, Writing Committee Members 2022 ACC/AHA Key Data Elements and Definitions for Chest Pain and Acute Myocardial Infarction: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Data Standards. J Am Coll Cardiol. 2022 Oct 25;80(17):1660-1700. doi: 10.1016/j.jacc.2022.05.012. Epub 2022 Aug 30.
Gibson CM, Gordon S, White A, Borja-Hart N, Santee J An assessment of patient experiences as teachers of cultural sensitivity in an interprofessional setting. Curr Pharm Teach Learn. 2022 Aug;14(8):1032-1039. doi: 10.1016/j.cptl.2022.07.011. Epub 2022 Jul 25.
Khan MS, Shahid I, Butler J Reporting and Definition of Kidney Death in Heart Failure Clinical Trials. Curr Probl Cardiol. 2022 Dec;47(12):101382. doi: 10.1016/j.cpcardiol.2022.101382. Epub 2022 Aug 30.
Gwozdz AM, de Jong CMM, Fialho LS, Likitabhorn T, Sossi F, Jaber PB, Hojen AA, Arcelus JI, Auger WR, Ay C, Barco S, Gazzana MB, Bayley J, Bertoletti L, Cate-Hoek AT, Cohen AT, Connors JM, Galanaud JP, Labropoulos N, Langlois N, Meissner MH, Noble S, Nossent EJ, de Leon Lovaton PP, Robert-Ebadi H, Rosovsky RP, Smolenaars N, Toshner M, Tromeur C, Wang KL, Westerlund E, de Wit K, Black SA, Klok FA Development of an international standard set of outcome measures for patients with venous thromboembolism: an International Consortium for Health Outcomes Measurement consensus recommendation. Lancet Haematol. 2022 Sep;9(9):e698-e706. doi: 10.1016/S2352-3026(22)00215-0.
Berwanger O, Pfeffer M, Claggett B, Jering KS, Maggioni AP, Steg PG, Mehran R, Lewis EF, Zhou Y, van der Meer P, De Pasquale C, Merkely B, Filippatos G, McMurray JJV, Granger CB, Solomon SD, Braunwald E Sacubitril/valsartan versus ramipril for patients with acute myocardial infarction: win-ratio analysis of the PARADISE-MI trial. Eur J Heart Fail. 2022 Oct;24(10):1918-1927. doi: 10.1002/ejhf.2663. Epub 2022 Sep 14.
Ostrominski JW, Vaduganathan M, Claggett BL, de Boer RA, Desai AS, Dobreanu D, Hernandez AF, Inzucchi SE, Jhund PS, Kosiborod M, Lam CSP, Langkilde AM, Lindholm D, Martinez FA, O’Meara E, Petersson M, Shah SJ, Thierer J, McMurray JJV, Solomon SD Dapagliflozin and New York Heart Association functional class in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial. Eur J Heart Fail. 2022 Oct;24(10):1892-1901. doi: 10.1002/ejhf.2652. Epub 2022 Aug 27.
Oseran AS, Sun T, Aggarwal R, Kyalwazi A, Yeh RW, Wadhera RK Association Between Medicare Program Type and Health Care Access, Acute Care Utilization, and Affordability Among Adults With Cardiovascular Disease. Circ Cardiovasc Qual Outcomes. 2022 Sep;15(9):e008762. doi: 10.1161/CIRCOUTCOMES.121.008762. Epub 2022 Sep 2.
Ostrominski JW, Vaduganathan M, Girish MP, Gupta P, Hendrickson MJ, Qamar A, Arora S, Pandey A, Bansal A, Batra V, Mahajan B, Mukhopadhyay S, Yusuf J, Tyagi S, Bhatt DL, Gupta MD, NORIN STEMI Investigators Missed Opportunities for Screening and Management of Dysglycemia among Patients Presenting with Acute Myocardial Infarction in North India: The Prospective NORIN STEMI Registry. Glob Heart. 2022 Aug 12;17(1):54. doi: 10.5334/gh.1140. eCollection 2022.
Tromp J, Jindal D, Redfern J, Bhatt A, Severin T, Banerjee A, Ge J, Itchhaporia D, Jaarsma T, Lanas F, Lopez-Jimenez F, Mohamed A, Perel P, Perez GE, Pinto F, Vedanthan R, Verstrael A, Yeo KK, Zulfiya K, Prabhakaran D, Lam CSP, Cowie MR World Heart Federation Roadmap for Digital Health in Cardiology. Glob Heart. 2022 Aug 26;17(1):61. doi: 10.5334/gh.1141. eCollection 2022.
Butt JH, Dewan P, Jhund PS, Anand IS, Atar D, Ge J, Desai AS, Echeverria LE, Kober L, Lam CSP, Maggioni AP, Martinez F, Packer M, Rouleau JL, Sim D, Van Veldhuisen DJ, Vrtovec B, Zannad F, Zile MR, Gong J, Lefkowitz MP, Rizkala AR, Solomon SD, McMurray JJV Sacubitril/Valsartan and Frailty in Patients With Heart Failure and Preserved Ejection Fraction. J Am Coll Cardiol. 2022 Sep 20;80(12):1130-1143. doi: 10.1016/j.jacc.2022.06.037. Epub 2022 Aug 29.
Armstrong PW, Zheng Y, Troughton RW, Lund LH, Zhang J, Lam CSP, Westerhout CM, Blaustein RO, Butler J, Hernandez AF, Roessig L, O’Connor CM, Voors AA, Ezekowitz JA, VICTORIA Study Group Sequential Evaluation of NT-proBNP in Heart Failure: Insights Into Clinical Outcomes and Efficacy of Vericiguat. JACC Heart Fail. 2022 Sep;10(9):677-688. doi: 10.1016/j.jchf.2022.04.015. Epub 2022 Jul 6.
Galli M, Rollini F, Been L, Zenni MM, Angiolillo DJ, Franchi F Impact of diabetes mellitus on the pharmacodynamic effects of prasugrel and ticagrelor after switching from clopidogrel in patients with coronary artery disease. J Thromb Thrombolysis. 2022 Oct;54(3):461-469. doi: 10.1007/s11239-022-02696-4. Epub 2022 Sep 1.
Kaneko H, Yano Y, Suzuki Y, Okada A, Itoh H, Matsuoka S, Fujiu K, Michihata N, Jo T, Takeda N, Morita H, Node K, Viera AJ, Lima JAC, Oparil S, Lam CSP, Carey RM, Yasunaga H, Komuro I Reduction in blood pressure for elevated blood pressure/stage 1 hypertension according to the American College of Cardiology/American Heart Association guideline and cardiovascular outcomes. Eur J Prev Cardiol. 2022 Oct 20;29(14):1921-1929. doi: 10.1093/eurjpc/zwac193.
Spyropoulos AC, Goldin M, Ageno W, Albers GW, Elliott CG, Hiatt WR, Halperin JL, Maynard G, Steg PG, Weitz JI, Spiro TE, Lu W, Marsigliano J, Raskob GE, Barnathan ES Rivaroxaban Plus Aspirin for Extended Thromboprophylaxis in Acutely Ill Medical Patients: Insights from the MARINER Trial. TH Open. 2022 Jul 11;6(3):e177-e183. doi: 10.1055/s-0042-1750379. eCollection 2022 Jul.
Nadarajah R, Wu J, Hurdus B, Asma S, Bhatt DL, Biondi-Zoccai G, Mehta LS, Ram CVS, Ribeiro ALP, Van Spall HGC, Deanfield JE, Luscher TF, Mamas M, Gale CP The collateral damage of COVID-19 to cardiovascular services: a meta-analysis. Eur Heart J. 2022 Sep 1;43(33):3164-3178. doi: 10.1093/eurheartj/ehac227.
Harrington J, Petrie MC, Anker SD, Bhatt DL, Jones WS, Udell JA, Hernandez AF, Butler J Evaluating the Application of Chronic Heart Failure Therapies and Developing Treatments in Individuals With Recent Myocardial Infarction: A Review. JAMA Cardiol. 2022 Oct 1;7(10):1067-1075. doi: 10.1001/jamacardio.2022.2847.
Cunningham JW, Vaduganathan M, Claggett BL, Kulac IJ, Desai AS, Jhund PS, de Boer RA, DeMets D, Hernandez AF, Inzucchi SE, Kosiborod MN, Lam CSP, Martinez F, Shah SJ, McGrath MM, O’Meara E, Wilderang U, Lindholm D, Petersson M, Langkilde AM, McMurray JJV, Solomon SD Dapagliflozin in Patients Recently Hospitalized With Heart Failure and Mildly Reduced or Preserved Ejection Fraction. J Am Coll Cardiol. 2022 Oct 4;80(14):1302-1310. doi: 10.1016/j.jacc.2022.07.021. Epub 2022 Aug 27.
Vaduganathan M, Claggett BL, Jhund P, de Boer RA, Hernandez AF, Inzucchi SE, Kosiborod MN, Lam CSP, Martinez F, Shah SJ, Desai AS, Lindholm D, Petersson M, Langkilde AM, McMurray JJV, Solomon SD Estimated Long-Term Benefit of Dapagliflozin in Patients With Heart Failure. J Am Coll Cardiol. 2022 Nov 8;80(19):1775-1784. doi: 10.1016/j.jacc.2022.08.745. Epub 2022 Aug 27.
Butt JH, Kondo T, Jhund PS, Comin-Colet J, de Boer RA, Desai AS, Hernandez AF, Inzucchi SE, Janssens SP, Kosiborod MN, Lam CSP, Langkilde AM, Lindholm D, Martinez F, Petersson M, Shah SJ, Thierer J, Vaduganathan M, Verma S, Wilderang U, Claggett BC, Solomon SD, McMurray JJV Atrial Fibrillation and Dapagliflozin Efficacy in Patients With Preserved or Mildly Reduced Ejection Fraction. J Am Coll Cardiol. 2022 Nov 1;80(18):1705-1717. doi: 10.1016/j.jacc.2022.08.718. Epub 2022 Aug 27.
Vaduganathan M, Docherty KF, Claggett BL, Jhund PS, de Boer RA, Hernandez AF, Inzucchi SE, Kosiborod MN, Lam CSP, Martinez F, Shah SJ, Desai AS, McMurray JJV, Solomon SD SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials. Lancet. 2022 Sep 3;400(10354):757-767. doi: 10.1016/S0140-6736(22)01429-5. Epub 2022 Aug 27.
Tuttle KR, Rangaswami J SGLT2 inhibitors as the bedrock of therapy for heart failure. Lancet. 2022 Sep 3;400(10354):711-713. doi: 10.1016/S0140-6736(22)01584-7. Epub 2022 Aug 27.
Chiu N, Aggarwal R, Hernandez I, Wadhera R, Dejong C, Tseng CW, Yeh RW, Kazi DS Spending on Insulin by U.S. Payers and Patients From 2008 to 2017. Diabetes Care. 2022 Nov 1;45(11):e163-e164. doi: 10.2337/dc22-0054.
Anderson HVS, Masri SC, Abdallah MS, Chang AM, Cohen MG, Elgendy IY, Gulati M, LaPoint K, Madan N, Moussa ID, Ramirez J, Simon AW, Singh V, Waldo SW, Williams MS 2022 ACC/AHA Key Data Elements and Definitions for Chest Pain and Acute Myocardial Infarction: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Data Standards. Circ Cardiovasc Qual Outcomes. 2022 Oct;15(10):e000112. doi: 10.1161/HCQ.0000000000000112. Epub 2022 Aug 30.
Okuno T, Dangas GD, Hengstenberg C, Sartori S, Herrmann HC, de Winter R, Gilard M, Tchetche D, Mollmann H, Makkar RR, Baldus S, De Backer O, Bendz B, Kini A, von Lewinski D, Mack M, Moreno R, Schafer U, Wohrle J, Seeger J, Snyder C, Nicolas J, Tijssen JGP, Welsh RC, Vranckx P, Valgimigli M, Mehran R, Kapadia S, Sondergaard L, Windecker S Two-year clinical outcomes after successful transcatheter aortic valve implantation with balloon-expandable versus self-expanding valves: A subanalysis of the GALILEO trial. Catheter Cardiovasc Interv. 2022 Oct;100(4):636-645. doi: 10.1002/ccd.30370. Epub 2022 Aug 30.
Nunez J, de la Espriella R, Rossignol P, Voors AA, Mullens W, Metra M, Chioncel O, Januzzi JL, Mueller C, Richards AM, de Boer RA, Thum T, Arfsten H, Gonzalez A, Abdelhamid M, Adamopoulos S, Anker SD, Gal TB, Biegus J, Cohen-Solal A, Bohm M, Emdin M, Jankowska EA, Gustafsson F, Hill L, Jaarsma T, Jhund PS, Lopatin Y, Lund LH, Milicic D, Moura B, Piepoli MF, Ponikowski P, Rakisheva A, Ristic A, Savarese G, Tocchetti CG, Van Linthout S, Volterrani M, Seferovic P, Rosano G, Coats AJS, Bayes-Genis A Congestion in heart failure: a circulating biomarker-based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology. Eur J Heart Fail. 2022 Oct;24(10):1751-1766. doi: 10.1002/ejhf.2664. Epub 2022 Sep 7.
Toth PP, Schwartz GG, Nicholls SJ, Khan A, Szarek M, Ginsberg HN, Johansson JO, Kalantar-Zadeh K, Kulikowski E, Lebioda K, Wong NCW, Sweeney M, Ray KK, BETonMACE Investigators Reduction in the risk of major adverse cardiovascular events with the BET protein inhibitor apabetalone in patients with recent acute coronary syndrome, type 2 diabetes, and moderate to high likelihood of non-alcoholic fatty liver disease. Am J Prev Cardiol. 2022 Aug 8;11:100372. doi: 10.1016/j.ajpc.2022.100372. eCollection 2022 Sep.
Farmakis IT, Valerio L, Bikdeli B, Connors JM, Giannakoulas G, Goldhaber SZ, Hobohm L, Hunt BJ, Keller K, Spyropoulos AC, Barco S Annual Mortality Related to Pulmonary Embolism in the U.S. Before and During the COVID-19 Pandemic. J Am Coll Cardiol. 2022 Oct 18;80(16):1579-1581. doi: 10.1016/j.jacc.2022.08.721. Epub 2022 Aug 26.
Franchi F, Schneider DJ, Prats J, Fan W, Rollini F, Been L, Taatjes-Sommer HS, Bhatt DL, Deliargyris EN, Angiolillo DJ Pharmacokinetic and pharmacodynamic profiles of a novel phospholipid-aspirin complex liquid formulation and low dose enteric-coated aspirin: results from a prospective, randomized, crossover study. J Thromb Thrombolysis. 2022 Oct;54(3):373-381. doi: 10.1007/s11239-022-02687-5. Epub 2022 Aug 29.
Kronenberg F, Mora S, Stroes ESG, Ference BA, Arsenault BJ, Berglund L, Dweck MR, Koschinsky M, Lambert G, Mach F, McNeal CJ, Moriarty PM, Natarajan P, Nordestgaard BG, Parhofer KG, Virani SS, von Eckardstein A, Watts GF, Stock JK, Ray KK, Tokgozoglu LS, Catapano AL Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement. Eur Heart J. 2022 Oct 14;43(39):3925-3946. doi: 10.1093/eurheartj/ehac361.
Bohula EA, Berg DD, Lopes MS, Connors JM, Babar I, Barnett CF, Chaudhry SP, Chopra A, Ginete W, Ieong MH, Katz JN, Kim EY, Kuder JF, Mazza E, McLean D, Mosier JM, Moskowitz A, Murphy SA, O’Donoghue ML, Park JG, Prasad R, Ruff CT, Shahrour MN, Sinha SS, Wiviott SD, Van Diepen S, Zainea M, Baird-Zars V, Sabatine MS, Morrow DA, COVID-PACT Investigators Anticoagulation and Antiplatelet Therapy for Prevention of Venous and Arterial Thrombotic Events in Critically Ill Patients With COVID-19: COVID-PACT. Circulation. 2022 Nov;146(18):1344-1356. doi: 10.1161/CIRCULATIONAHA.122.061533. Epub 2022 Aug 29.
Harrington J, Anker S, Butler J Putting the puzzle together: SGLT2 inhibitors from prevention to treatment of heart failure. Eur Heart J. 2022 Nov 1;43(41):4433-4435. doi: 10.1093/eurheartj/ehac483.
Gargiulo G, Giacoppo D, Jolly SS, Cairns J, Le May M, Bernat I, Romagnoli E, Rao SV, van Leeuwen MAH, Mehta SR, Bertrand OF, Wells GA, Meijers TA, Siontis GCM, Esposito G, Windecker S, Juni P, Valgimigli M, Radial Trialists’ Collaboration Effects on Mortality and Major Bleeding of Radial Versus Femoral Artery Access for Coronary Angiography or Percutaneous Coronary Intervention: Meta-Analysis of Individual Patient Data From 7 Multicenter Randomized Clinical Trials. Circulation. 2022 Nov;146(18):1329-1343. doi: 10.1161/CIRCULATIONAHA.122.061527. Epub 2022 Aug 29.
Bastiany A, Pacheco C, Sedlak T, Saw J, Miner SES, Liu S, Lavoie A, Kim DH, Gulati M, Graham MM A Practical Approach to Invasive Testing in Ischemia With No Obstructive Coronary Arteries (INOCA). CJC Open. 2022 May 4;4(8):709-720. doi: 10.1016/j.cjco.2022.04.009. eCollection 2022 Aug.
Paratz ED, van Heusden A, Smith K, Brennan A, Dinh D, Ball J, Lefkovits J, Kaye DM, Nicholls SJ, Pflaumer A, La Gerche A, Stub D, VCOR and EndUCD Investigators Factors predicting cardiac arrest in acute coronary syndrome patients under 50: A state-wide angiographic and forensic evaluation of outcomes. Resuscitation. 2022 Oct;179:124-130. doi: 10.1016/j.resuscitation.2022.08.016. Epub 2022 Aug 27.
Zarini S, Brozinick JT, Zemski Berry KA, Garfield A, Perreault L, Kerege A, Bui HH, Sanders P, Siddall P, Kuo MS, Bergman BC Serum dihydroceramides correlate with insulin sensitivity in humans and decrease insulin sensitivity in vitro. J Lipid Res. 2022 Oct;63(10):100270. doi: 10.1016/j.jlr.2022.100270. Epub 2022 Aug 27.
Rao SV, Kirsch B, Bhatt DL, Budaj A, Coppolecchia R, Eikelboom J, James SK, Jones WS, Merkely B, Keller L, Hermanides RS, Campo G, Ferreiro JL, Shibasaki T, Mundl H, Alexander JH, PACIFIC AMI Investigators A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction. Circulation. 2022 Oct 18;146(16):1196-1206. doi: 10.1161/CIRCULATIONAHA.122.061612. Epub 2022 Aug 27.
Jhund PS, Kondo T, Butt JH, Docherty KF, Claggett BL, Desai AS, Vaduganathan M, Gasparyan SB, Bengtsson O, Lindholm D, Petersson M, Langkilde AM, de Boer RA, DeMets D, Hernandez AF, Inzucchi SE, Kosiborod MN, Kober L, Lam CSP, Martinez FA, Sabatine MS, Shah SJ, Solomon SD, McMurray JJV Dapagliflozin across the range of ejection fraction in patients with heart failure: a patient-level, pooled meta-analysis of DAPA-HF and DELIVER. Nat Med. 2022 Sep;28(9):1956-1964. doi: 10.1038/s41591-022-01971-4. Epub 2022 Aug 27.
Stevens SR, Segar MW, Pandey A, Lokhnygina Y, Green JB, McGuire DK, Standl E, Peterson ED, Holman RR Development and validation of a model to predict cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke in patients with type 2 diabetes mellitus and established atherosclerotic cardiovascular disease. Cardiovasc Diabetol. 2022 Aug 27;21(1):166. doi: 10.1186/s12933-022-01603-8.
Peikert A, Martinez FA, Vaduganathan M, Claggett BL, Kulac IJ, Desai AS, Jhund PS, de Boer RA, DeMets D, Hernandez AF, Inzucchi SE, Kosiborod MN, Lam CSP, Shah SJ, Katova T, Merkely B, Vardeny O, Wilderang U, Lindholm D, Petersson M, Langkilde AM, McMurray JJV, Solomon SD Efficacy and Safety of Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction According to Age: The DELIVER Trial. Circ Heart Fail. 2022 Oct;15(10):e010080. doi: 10.1161/CIRCHEARTFAILURE.122.010080. Epub 2022 Aug 27.
Lam CSP, Solomon SD DELIVERing Therapeutic Efficacy Across the Ejection Fraction Spectrum of Heart Failure. Circulation. 2022 Oct 18;146(16):1193-1195. doi: 10.1161/CIRCULATIONAHA.122.062022. Epub 2022 Aug 27.
Butt JH, Jhund PS, Belohlavek J, de Boer RA, Chiang CE, Desai AS, Drozdz J, Hernandez AF, Inzucchi SE, Katova T, Kitakaze M, Kosiborod MN, Lam CSP, Maria Langkilde A, Lindholm D, Bachus E, Martinez F, Merkely B, Petersson M, Saraiva JFK, Shah SJ, Vaduganathan M, Vardeny O, Wilderang U, Claggett BL, Solomon SD, McMurray JJV Efficacy and Safety of Dapagliflozin According to Frailty in Patients With Heart Failure: A Prespecified Analysis of the DELIVER Trial. Circulation. 2022 Oct 18;146(16):1210-1224. doi: 10.1161/CIRCULATIONAHA.122.061754. Epub 2022 Aug 27.
Anker SD, Usman MS, Butler J ‘Normal weight’ is really not normal in chronic disease. Eur Heart J. 2022 Nov 1;43(41):4418-4420. doi: 10.1093/eurheartj/ehac486.
Adamson C, Kondo T, Jhund PS, de Boer RA, Cabrera Honorio JW, Claggett B, Desai AS, Alcocer Gamba MA, Al Habeeb W, Hernandez AF, Inzucchi SE, Kosiborod MN, Lam CSP, Langkilde AM, Lindholm D, Bachus E, Litwin SE, Martinez F, Petersson M, Shah SJ, Vaduganathan M, Nguyen Vinh P, Wilderang U, Solomon SD, McMurray JJV Dapagliflozin for heart failure according to body mass index: the DELIVER trial. Eur Heart J. 2022 Nov 1;43(41):4406-4417. doi: 10.1093/eurheartj/ehac481.
Strom JB, Xu J, Sun T, Song Y, Sevilla-Cazes J, Almarzooq ZI, Markson LJ, Wadhera RK, Yeh RW Characterizing the Accuracy of International Classification of Diseases, Tenth Revision Administrative Claims for Aortic Valve Disease. Circ Cardiovasc Qual Outcomes. 2022 Oct;15(10):e009162. doi: 10.1161/CIRCOUTCOMES.122.009162. Epub 2022 Aug 27.
Solomon SD, McMurray JJV, Claggett B, de Boer RA, DeMets D, Hernandez AF, Inzucchi SE, Kosiborod MN, Lam CSP, Martinez F, Shah SJ, Desai AS, Jhund PS, Belohlavek J, Chiang CE, Borleffs CJW, Comin-Colet J, Dobreanu D, Drozdz J, Fang JC, Alcocer-Gamba MA, Al Habeeb W, Han Y, Cabrera Honorio JW, Janssens SP, Katova T, Kitakaze M, Merkely B, O’Meara E, Saraiva JFK, Tereshchenko SN, Thierer J, Vaduganathan M, Vardeny O, Verma S, Pham VN, Wilderang U, Zaozerska N, Bachus E, Lindholm D, Petersson M, Langkilde AM, DELIVER Trial Committees and Investigators Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction. N Engl J Med. 2022 Sep 22;387(12):1089-1098. doi: 10.1056/NEJMoa2206286. Epub 2022 Aug 27.
Zannad F, Ferreira JP, Butler J, Filippatos G, Januzzi JL, Sumin M, Zwick M, Saadati M, Pocock SJ, Sattar N, Anker SD, Packer M Effect of empagliflozin on circulating proteomics in heart failure: mechanistic insights into the EMPEROR programme. Eur Heart J. 2022 Dec 21;43(48):4991-5002. doi: 10.1093/eurheartj/ehac495.
Ciltea R, Nicula AI, Bajdechi M, Scafa-Udriste A, Rimbas R, Iana G, Vinereanu D The Case of a 44-Year-Old Survivor of Unrepaired Tetralogy of Fallot, Right Aortic Arch and Abdominal Aortopulmonary Collateral Vessels. Medicina (Kaunas). 2022 Jul 28;58(8):1011. doi: 10.3390/medicina58081011.
Nelson AJ, Sniderman AD, Ditmarsch M, Dicklin MR, Nicholls SJ, Davidson MH, Kastelein JJP Cholesteryl Ester Transfer Protein Inhibition Reduces Major Adverse Cardiovascular Events by Lowering Apolipoprotein B Levels. Int J Mol Sci. 2022 Aug 20;23(16):9417. doi: 10.3390/ijms23169417.
Vidanapathirana AK, Goyne JM, Williamson AE, Pullen BJ, Chhay P, Sandeman L, Bensalem J, Sargeant TJ, Grose R, Crabtree MJ, Zhang R, Nicholls SJ, Psaltis PJ, Bursill CA Biological Sensing of Nitric Oxide in Macrophages and Atherosclerosis Using a Ruthenium-Based Sensor. Biomedicines. 2022 Jul 27;10(8):1807. doi: 10.3390/biomedicines10081807.
Gabani R, Spione F, Arevalos V, Grima Sopesens N, Ortega-Paz L, Gomez-Lara J, Jimenez-Diaz V, Jimenez M, Jimenez-Quevedo P, Diletti R, Pineda J, Campo G, Silvestro A, Maristany J, Flores X, Oyarzabal L, Bastos-Fernandez G, Iniguez A, Serra A, Escaned J, Ielasi A, Tespili M, Lenzen M, Gonzalo N, Bordes P, Tebaldi M, Biscaglia S, Al-Shaibani S, Romaguera R, Gomez-Hospital JA, Rodes-Cabau J, Serruys PW, Sabate M, Brugaletta S Sex Differences in 10-Year Outcomes Following STEMI: A Subanalysis From the EXAMINATION-EXTEND Trial. JACC Cardiovasc Interv. 2022 Oct 10;15(19):1965-1973. doi: 10.1016/j.jcin.2022.07.038. Epub 2022 Aug 22.
Murray EM, Greene SJ, Rao VN, Sun JL, Alhanti BA, Blumer V, Butler J, Ahmad T, Mentz RJ Machine learning to define phenotypes and outcomes of patients hospitalized for heart failure with preserved ejection fraction: Findings from ASCEND-HF. Am Heart J. 2022 Dec;254:112-121. doi: 10.1016/j.ahj.2022.08.009. Epub 2022 Aug 23.
Ademi Z, Morton JI, Liew D, Nicholls SJ, Zoungas S, Ference BA Integrating the Biology of Cardiovascular Disease into the Epidemiology of Economic Decision Modelling via Mendelian Randomisation. Pharmacoeconomics. 2022 Nov;40(11):1033-1042. doi: 10.1007/s40273-022-01183-1. Epub 2022 Aug 25.
Coursen J, Simpson CE, Mukherjee M, Vaught AJ, Kutty S, Al-Talib TK, Wood MJ, Scott NS, Mathai SC, Sharma G Pregnancy Considerations in the Multidisciplinary Care of Patients with Pulmonary Arterial Hypertension. J Cardiovasc Dev Dis. 2022 Aug 11;9(8):260. doi: 10.3390/jcdd9080260.
Cader FA, Banerjee S, Gulati M Sex Differences in Acute Coronary Syndromes: A Global Perspective. J Cardiovasc Dev Dis. 2022 Jul 27;9(8):239. doi: 10.3390/jcdd9080239.
McGuire DK, D’Alessio D, Nicholls SJ, Nissen SE, Riesmeyer JS, Pavo I, Sethuraman S, Heilmann CR, Kaiser JJ, Weerakkody GJ Transitioning to active-controlled trials to evaluate cardiovascular safety and efficacy of medications for type 2 diabetes. Cardiovasc Diabetol. 2022 Aug 24;21(1):163. doi: 10.1186/s12933-022-01601-w.
Ferro EG, Capodanno D, Yeh RW The Need to Standardize Our Language Around Dual Antiplatelet Therapy-A Call to Action. JAMA Cardiol. 2022 Oct 1;7(10):995-996. doi: 10.1001/jamacardio.2022.2711.
Sykes AV, Patel N, Lee D, Taub PR Integrating Advanced Lipid Testing and Biomarkers in Assessment and Treatment. Curr Cardiol Rep. 2022 Nov;24(11):1647-1655. doi: 10.1007/s11886-022-01775-5. Epub 2022 Aug 24.
Divakaran S, Meissner MH, Kohi MP, Chen S, Song Y, Hawkins BM, Rosenfield K, Parikh SA, Secemsky EA Utilization of and Outcomes Associated with Intravascular Ultrasound during Deep Venous Stent Placement among Medicare Beneficiaries. J Vasc Interv Radiol. 2022 Dec;33(12):1476-1484.e2. doi: 10.1016/j.jvir.2022.08.018. Epub 2022 Aug 23.
Navar AM, Peterson ED Statin Recommendations for Primary Prevention: More of the Same or Time for a Change? JAMA. 2022 Aug 23;328(8):716-718. doi: 10.1001/jama.2022.12982.
Aggarwal R, Bhatt DL, Rodriguez F, Yeh RW, Wadhera RK Trends in Lipid Concentrations and Lipid Control Among US Adults, 2007-2018. JAMA. 2022 Aug 23;328(8):737-745. doi: 10.1001/jama.2022.12567.
Mosenzon O, Raz I, Wiviott SD, Schechter M, Goodrich EL, Yanuv I, Rozenberg A, Murphy SA, Zelniker TA, Langkilde AM, Gause-Nilsson IAM, Fredriksson M, Johansson PA, Wilding JPH, McGuire DK, Bhatt DL, Leiter LA, Cahn A, Dwyer JP, Heerspink HJL, Sabatine MS Dapagliflozin and Prevention of Kidney Disease Among Patients With Type 2 Diabetes: Post Hoc Analyses From the DECLARE-TIMI 58 Trial. Diabetes Care. 2022 Oct 1;45(10):2350-2359. doi: 10.2337/dc22-0382.
Baron SJ Atrial Fibrillation After Percutaneous PFO Closure: Not So Rare After All. JACC Cardiovasc Interv. 2022 Nov 28;15(22):2323-2325. doi: 10.1016/j.jcin.2022.08.022. Epub 2022 Aug 22.
Pollack CV Jr, Steg PG, James S, Jolly S, Kosiborod M, Bonaca MP International Perspectives on the Impact of the COVID-19 Pandemic on Adherence to Prescribed Dual Antiplatelet Therapy: A Window Into Acute Cardiovascular Care. Crit Pathw Cardiol. 2022 Sep 1;21(3):114-122. doi: 10.1097/HPC.0000000000000292. Epub 2022 Jun 17.
Cosentino F, Cannon CP, Frederich R, Cherney DZI, Dagogo-Jack S, Pratley RE, Mancuso JP, Maldonado M, Cater NB, Wang S, McGuire DK Cardiorenal Outcomes With Ertugliflozin by Baseline Metformin Use: Post Hoc Analyses of the VERTIS CV Trial. Circulation. 2022 Aug 23;146(8):652-654. doi: 10.1161/CIRCULATIONAHA.121.058294. Epub 2022 Aug 22.
Foley M, Hall K, Howard JP, Ahmad Y, Gandhi M, Mahboobani S, Okafor J, Rahman H, Hadjiloizou N, Ruparelia N, Mikhail G, Malik I, Kanaganayagam G, Sutaria N, Rana B, Ariff B, Barden E, Anderson J, Afoke J, Petraco R, Al-Lamee R, Sen S Aortic Valve Calcium Score Is Associated With Acute Stroke in Transcatheter Aortic Valve Replacement Patients. J Soc Cardiovasc Angiogr Interv. 2022 May 12;1(4):100349. doi: 10.1016/j.jscai.2022.100349. eCollection 2022 Jul-Aug.
Honigberg MC, Ye Y, Dattilo L, Sarma AA, Scott NS, Smoller JW, Zhao H, Wood MJ, Natarajan P Low depression frequency is associated with decreased risk of cardiometabolic disease. Nat Cardiovasc Res. 2022 Feb;1(2):125-131. doi: 10.1038/s44161-021-00011-7. Epub 2022 Feb 14.
Navar AM, Cosmatos I, Purinton S, Ramsey JL, Taylor RJ, Sobel RE, Barlow G, Dieck GS, Bulgrein ML, Peterson ED Using EHR data to identify coronavirus infections in hospitalized patients: Impact of case definitions on disease surveillance. Int J Med Inform. 2022 Oct;166:104842. doi: 10.1016/j.ijmedinf.2022.104842. Epub 2022 Aug 8.
Lennon KM, Saftics A, Abuelreich S, Sahu P, Lehmann HI, Maddox AL, Bagabas R, Januzzi JL, Van Keuren-Jensen K, Shah R, Das S, Jovanovic-Talisman T Cardiac troponin T in extracellular vesicles as a novel biomarker in human cardiovascular disease. Clin Transl Med. 2022 Aug;12(8):e979. doi: 10.1002/ctm2.979.
Sacco S, Sposato LA The Challenging Puzzle of Migraine, Age, and Vascular Health. Neurology. 2022 Oct 17;99(16):681-682. doi: 10.1212/WNL.0000000000201071.
Havasi A, Heybeli C, Leung N, Angel-Korman A, Sanchorawala V, Cohen O, Wechalekar A, Bridoux F, Jaffer I, Gutgarts V, Hassoun H, Levinson M, Rosenbaum C, Milani P, Palladini G, Merlini G, Hegenbart U, Schonland S, Veelken K, Pogrebinsky A, Doros G, Landau H Outcomes of renal transplantation in patients with AL amyloidosis: an international collaboration through The International Kidney and Monoclonal Gammopathy Research Group. Blood Cancer J. 2022 Aug 18;12(8):119. doi: 10.1038/s41408-022-00714-5.
McBride K, Howard NJ, Franks C, King V, Wade V, Dowling A, Rigney J, Burton N, Mitchell JA, Hillier S, Nicholls SJ, Paquet C, Brown A Providing guideline-recommended preventive cardiovascular care to Aboriginal and Torres Strait Islander women: exploring gender differences with a medical record review in primary health care. Aust J Prim Health. 2022 Dec;28(6):498-507. doi: 10.1071/PY22064.
Valgimigli M, Frigoli E, Vranckx P, Ozaki Y, Morice MC, Chevalier B, Onuma Y, Windecker S, Delorme L, Kala P, Kedev S, Abhaichand RK, Velchev V, Dewilde W, Podolec J, Leibundgut G, Topic D, Schultz C, Stankovic G, Lee A, Johnson T, Tonino PAL, Klotzka A, Lesiak M, Lopes RD, Smits PC, Heg D, MASTER DAPT Investigators Impact of Medication Nonadherence in a Clinical Trial of Dual Antiplatelet Therapy. J Am Coll Cardiol. 2022 Aug 23;80(8):766-778. doi: 10.1016/j.jacc.2022.04.065.
Kaplan JM, Niu J, Ho V, Winkelmayer WC, Erickson KF A Comparison of US Medicare Expenditures for Hemodialysis and Peritoneal Dialysis. J Am Soc Nephrol. 2022 Nov;33(11):2059-2070. doi: 10.1681/ASN.2022020221. Epub 2022 Aug 18.
Khan MS, Butler J Stability of Changes in Health Status: Next Step in Comprehensively Assessing Patient-Reported Outcomes. JAMA. 2022 Sep 13;328(10):923-924. doi: 10.1001/jama.2022.13551.
Sardella G, Beerkens FJ, Dangas G, Cao D, Baber U, Sartori S, Cohen DJ, Briguori C, Gil R, Nicolas J, Zhang Z, Dudek D, Kunadian V, Kornowski R, Weisz G, Claessen B, Marx S, Escaned J, Huber K, Collier T, Moliterno DJ, Ohman EM, Krucoff MW, Kastrati A, Steg PG, Angiolillo DJ, Mehta S, Shlofmitz R, Sharma S, Pocock S, Gibson CM, Mehran R Ticagrelor with and without aspirin in patients with a prior coronary artery bypass graft undergoing percutaneous coronary intervention: the TWILIGHT-CABG study. EuroIntervention. 2022 Dec 2;18(11):e897-e909. doi: 10.4244/EIJ-D-22-00319.
Leiva O, Campia U, Snyder J, Barns BM, Rizzo S, Khairani CD, Brunner A, Al-Samkari H, Leaf RK, Rosovsky R, Goodarzi K, Bornikova L, Fathi A, Goldhaber SZ, Hobbs G, Piazza G Patients with myeloproliferative neoplasms and COVID-19 have increased rates of arterial thrombosis. Res Pract Thromb Haemost. 2022 Aug 11;6(5):e12752. doi: 10.1002/rth2.12752. eCollection 2022 Jul.
Jongs N, Chertow GM, Greene T, McMurray JJV, Langkilde AM, Correa-Rotter R, Kashihara N, Rossing P, Sjostrom CD, Stefansson BV, Toto RD, Wheeler DC, Heerspink HJL, DAPA-CKD Trial Committees and Investigators, Members of the DAPA-CKD Trial Committees and Investigators Correlates and Consequences of an Acute Change in eGFR in Response to the SGLT2 Inhibitor Dapagliflozin in Patients with CKD. J Am Soc Nephrol. 2022 Nov;33(11):2094-2107. doi: 10.1681/ASN.2022030306. Epub 2022 Aug 17.
Idowu TO, Parikh SM A new chapter in lipid signaling and kidney fibrosis. Sci Transl Med. 2022 Aug 17;14(658):eadd2826. doi: 10.1126/scitranslmed.add2826. Epub 2022 Aug 17.
Butala NM, Oseran AS, Yeh RW Innovation’s Disjointed Path From Approval to Payment-The Case of Embolic Protection Devices for Transcatheter Aortic Valve Replacement. JAMA Cardiol. 2022 Sep 1;7(9):953-954. doi: 10.1001/jamacardio.2022.2614.
Montez-Rath ME, Garcia P, Han J, Cadden L, Hunsader P, Morgan C, Kerschmann R, Beyer P, Dittrich M, Block GA, Parsonnet J, Chertow GM, Anand S SARS-CoV-2 Infection during the Omicron Surge among Patients Receiving Dialysis: The Role of Circulating Receptor-Binding Domain Antibodies and Vaccine Doses. J Am Soc Nephrol. 2022 Oct;33(10):1832-1839. doi: 10.1681/ASN.2022040504. Epub 2022 Aug 16.
Hamid A, Handelsman Y, Butler J DCRM Multispecialty Recommendations in Patients With Heart Failure. J Card Fail. 2022 Nov;28(11):1642-1645. doi: 10.1016/j.cardfail.2022.07.053. Epub 2022 Aug 13.
Chaitman BR, Cyr DD, Alexander KP, Pracon R, Bainey KR, Mathew A, Acharya A, Kunichoff DF, Fleg JL, Lopes RD, Sidhu MS, Anthopolos R, Rockhold FW, Stone GW, Maron DJ, Hochman JS, Bangalore S Cardiovascular and Renal Implications of Myocardial Infarction in the ISCHEMIA-CKD Trial. Circ Cardiovasc Interv. 2022 Aug;15(8):e012103. doi: 10.1161/CIRCINTERVENTIONS.122.012103. Epub 2022 Aug 16.
Gonzalez-Pacheco H, Gopar-Nieto R, Araiza-Garaygordobil D, Briseno-Cruz JL, Eid-Lidt G, Ortega-Hernandez JA, Sierra-Lara D, Altamirano-Castillo A, Mendoza-Garcia S, Manzur-Sandoval D, Aguilar-Montano KM, Ontiveros-Mercado H, Garcia-Espinosa JI, Perez-Pinetta PE, Arias-Mendoza A Application of the SCAI classification to admission of patients with cardiogenic shock: Analysis of a tertiary care center in a middle-income country. PLoS One. 2022 Aug 16;17(8):e0273086. doi: 10.1371/journal.pone.0273086. eCollection 2022.
Dykun I, Clark D 3rd, Carlo J, Lincoff AM, Menon V, Nissen SE, Nicholls SJ, Puri R Longitudinal High-Sensitivity C-Reactive Protein and Longer-Term Cardiovascular Outcomes in Optimally-Treated Patients With High-Risk Vascular Disease. Am J Cardiol. 2022 Oct 15;181:1-8. doi: 10.1016/j.amjcard.2022.06.061. Epub 2022 Aug 13.
Sarnak MJ, Auguste BL, Brown E, Chang AR, Chertow GM, Hannan M, Herzog CA, Nadeau-Fredette AC, Tang WHW, Wang AY, Weiner DE, Chan CT, American Heart Association Council on the Kidney in Cardiovascular Disease;, Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on, Cardiovascular Radiology and Intervention; Council on Clinical Cardiology;, Council on Hypertension; and Council on Lifestyle and Cardiometabolic Health Cardiovascular Effects of Home Dialysis Therapies: A Scientific Statement From the American Heart Association. Circulation. 2022 Sep 13;146(11):e146-e164. doi: 10.1161/CIR.0000000000001088. Epub 2022 Aug 15.
Blonde L, Umpierrez GE, Reddy SS, McGill JB, Berga SL, Bush M, Chandrasekaran S, DeFronzo RA, Einhorn D, Galindo RJ, Gardner TW, Garg R, Garvey WT, Hirsch IB, Hurley DL, Izuora K, Kosiborod M, Olson D, Patel SB, Pop-Busui R, Sadhu AR, Samson SL, Stec C, Tamborlane WV Jr, Tuttle KR, Twining C, Vella A, Vellanki P, Weber SL American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. Endocr Pract. 2022 Oct;28(10):923-1049. doi: 10.1016/j.eprac.2022.08.002. Epub 2022 Aug 11.
Dungan JR, Qin X, Gregory SG, Cooper-Dehoff R, Duarte JD, Qin H, Gulati M, Taylor JY, Pepine CJ, Hauser ER, Kraus WE Sex-dimorphic gene effects on survival outcomes in people with coronary artery disease. Am Heart J Plus. 2022 May;17:100152. doi: 10.1016/j.ahjo.2022.100152. Epub 2022 Jun 14.
Boulet J, Cunningham JW, Mehra MR Cardiac Xenotransplantation: Challenges, Evolution, and Advances. JACC Basic Transl Sci. 2022 Jun 15;7(7):716-729. doi: 10.1016/j.jacbts.2022.05.003. eCollection 2022 Jul.
Nicholls SJ, Ditmarsch M, Kastelein JJ, Rigby SP, Kling D, Curcio DL, Alp NJ, Davidson MH Lipid lowering effects of the CETP inhibitor obicetrapib in combination with high-intensity statins: a randomized phase 2 trial. Nat Med. 2022 Aug;28(8):1672-1678. doi: 10.1038/s41591-022-01936-7. Epub 2022 Aug 11.
McKay AJ, Gunn LH, Ray KK Assessing the external validity of the SAFEHEART risk prediction model in patients with familial hypercholesterolaemia in an English routine care cohort. Atherosclerosis. 2022 Oct;358:68-74. doi: 10.1016/j.atherosclerosis.2022.07.011. Epub 2022 Jul 21.
Schmidt JK, Reynolds MR, Golos TG, Slukvin II CRISPR/Cas9 genome editing to create nonhuman primate models for studying stem cell therapies for HIV infection. Retrovirology. 2022 Aug 10;19(1):17. doi: 10.1186/s12977-022-00604-5.
Ridker PM, Tuttle KR, Perkovic V, Libby P, MacFadyen JG Inflammation drives residual risk in chronic kidney disease: a CANTOS substudy. Eur Heart J. 2022 Dec 7;43(46):4832-4844. doi: 10.1093/eurheartj/ehac444.
Rao SV, Ohman EM Balancing the Risks and Benefits of Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery. JAMA. 2022 Aug 9;328(6):532-533. doi: 10.1001/jama.2022.12444.
Sandner S, Redfors B, Angiolillo DJ, Audisio K, Fremes SE, Janssen PWA, Kulik A, Mehran R, Peper J, Ruel M, Saw J, Soletti GJ, Starovoytov A, Ten Berg JM, Willemsen LM, Zhao Q, Zhu Y, Gaudino M Association of Dual Antiplatelet Therapy With Ticagrelor With Vein Graft Failure After Coronary Artery Bypass Graft Surgery: A Systematic Review and Meta-analysis. JAMA. 2022 Aug 9;328(6):554-562. doi: 10.1001/jama.2022.11966.
Bledsoe JR, Knox D, Peltan ID, Woller SC, Lloyd JF, Snow GL, Horne BD, Connors JM, Kline JA D-dimer Thresholds to Exclude Pulmonary Embolism among COVID-19 Patients in the Emergency Department: Derivation with Independent Validation. Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221117997. doi: 10.1177/10760296221117997.
Araiza-Garaygordobil D, Arias-Mendoza A, Gonzalez-Gutierrez JC, Sierra-Lara Martinez D, Alfaro-Ponce DL, Sarabia-Chao V, Belderrain-Morales N, Ruiz-Fuentes OI, Gopar-Nieto R, De Los Rios-Arce LF, Gonzalez-Pacheco H Coronary artery ectasia in ST-elevation myocardial infarction: prevalence and prognostic implications. Coron Artery Dis. 2022 Dec 1;33(8):671-673. doi: 10.1097/MCA.0000000000001175. Epub 2022 Aug 9.
Mohebi R, Murphy S, Jackson L, McCarthy C, Abboud A, Murtagh G, Gawel S, Miksenas H, Gaggin H, Januzzi JL Jr Biomarker prognostication across Universal Definition of Heart Failure stages. ESC Heart Fail. 2022 Dec;9(6):3876-3887. doi: 10.1002/ehf2.14071. Epub 2022 Aug 8.
Myers SJ, Jimenez-Ruiz A, Sposato LA, Whitehead SN Atrial cardiopathy and cognitive impairment. Front Aging Neurosci. 2022 Jul 22;14:914360. doi: 10.3389/fnagi.2022.914360. eCollection 2022.
Chow CK, Nicholls SJ Change Over 70 Years of Cardiac Society of Australia and New Zealand. Heart Lung Circ. 2022 Sep;31(9):1183-1184. doi: 10.1016/j.hlc.2022.07.009. Epub 2022 Aug 6.
Galli M, Ortega-Paz L, Franchi F, Rollini F, Angiolillo DJ Precision medicine in interventional cardiology: implications for antiplatelet therapy in patients undergoing percutaneous coronary intervention. Pharmacogenomics. 2022 Aug;23(13):723-737. doi: 10.2217/pgs-2022-0057. Epub 2022 Aug 8.
Altin SE, Gitto M, Secemsky EA, Rao SV, Hess CN Sex-Based Differences in Periprocedural Complications Following Lower Extremity Peripheral Vascular Intervention. Circ Cardiovasc Interv. 2022 Aug;15(8):e011768. doi: 10.1161/CIRCINTERVENTIONS.121.011768. Epub 2022 Aug 8.
Usman MS, Butler J, Khan MS Pragmatism in clinical trials: essential, not optional. Eur Heart J. 2022 Sep 14;43(35):3285-3287. doi: 10.1093/eurheartj/ehac400.
Hsu JY, Liu PP, Sposato LA, Huang HK, Liu AB, Lai EC, Lin SJ, Hsieh CY, Loh CH Oral anticoagulant decreases stroke recurrence in patients with atrial fibrillation detected after stroke. Front Cardiovasc Med. 2022 Jul 22;9:929304. doi: 10.3389/fcvm.2022.929304. eCollection 2022.
Zheng B, Goto S, Clementi R, Feaster J, Duffy D, Dalitz P, Airey J, Korjian S, Tortorici MA, Roberts J, Gibson CM Effect of CSL112 (apolipoprotein A-I [human]) on cholesterol efflux capacity in Japanese subjects: Findings from a phase I study and a cross-study comparison. Clin Transl Sci. 2022 Oct;15(10):2331-2341. doi: 10.1111/cts.13361. Epub 2022 Aug 7.
Davison BA, Takagi K, Edwards C, Adams KF Jr, Butler J, Collins SP, Dorobantu MI, Ezekowitz JA, Filippatos G, Greenberg BH, Levy PD, Masip J, Metra M, Pang PS, Ponikowski P, Severin TM, Teerlink JR, Teichman SL, Voors AA, Werdan K, Cotter G Neutrophil-to-Lymphocyte Ratio and Outcomes in Patients Admitted for Acute Heart Failure (As Seen in the BLAST-AHF, Pre-RELAX-AHF, and RELAX-AHF Studies). Am J Cardiol. 2022 Oct 1;180:72-80. doi: 10.1016/j.amjcard.2022.06.037. Epub 2022 Aug 4.
Pandey A, Adedinsewo D The Future of AI-Enhanced ECG Interpretation for Valvular Heart Disease Screening. J Am Coll Cardiol. 2022 Aug 9;80(6):627-630. doi: 10.1016/j.jacc.2022.05.034.
Kalogeropoulos AP, Butler J Worsening Cardiovascular Disease Epidemiology in the United States: The Time for Preparation Is Now. J Am Coll Cardiol. 2022 Aug 9;80(6):579-583. doi: 10.1016/j.jacc.2022.05.035.
Mohebi R, Chen C, Ibrahim NE, McCarthy CP, Gaggin HK, Singer DE, Hyle EP, Wasfy JH, Januzzi JL Jr Cardiovascular Disease Projections in the United States Based on the 2020 Census Estimates. J Am Coll Cardiol. 2022 Aug 9;80(6):565-578. doi: 10.1016/j.jacc.2022.05.033.
Secemsky EA, Mosarla RC, Rosenfield K, Kohi M, Lichtenberg M, Meissner M, Varcoe R, Holden A, Jaff MR, Chalyan D, Clair D, Hawkins BM, Parikh SA Appropriate Use of Intravascular Ultrasound During Arterial and Venous Lower Extremity Interventions. JACC Cardiovasc Interv. 2022 Aug 8;15(15):1558-1568. doi: 10.1016/j.jcin.2022.04.034.
Ferencik M, Mayrhofer T, Lu MT, Bittner DO, Emami H, Puchner SB, Meyersohn NM, Ivanov AV, Adami EC, Voora D, Ginsburg GS, Januzzi JL, Douglas PS, Hoffmann U Coronary Atherosclerosis, Cardiac Troponin, and Interleukin-6 in Patients With Chest Pain: The PROMISE Trial Results. JACC Cardiovasc Imaging. 2022 Aug;15(8):1427-1438. doi: 10.1016/j.jcmg.2022.03.016. Epub 2022 May 11.
De Caterina R, Agewall S, Andreotti F, Angiolillo DJ, Bhatt DL, Byrne RA, Collet JP, Eikelboom J, Fanaroff AC, Gibson CM, Goette A, Hindricks G, Lip GYH, Potpara T, Thiele H, Lopes RD, Galli M Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week. Eur Heart J. 2022 Oct 7;43(37):3512-3527. doi: 10.1093/eurheartj/ehac294.
Bedrouni W, Sharma A, Pitt B, Lam CSP, Ni J, Ferreira JP, McMurray J, Giannetti N, Girerd N, Rossignol P, Solomon SD, Claggett B, Pocock S, Huynh T, Zannad F Timing of Statistical Benefit of Mineralocorticoid Receptor Antagonists Among Patients With Heart Failure and Post-Myocardial Infarction. Circ Heart Fail. 2022 Oct;15(10):e009295. doi: 10.1161/CIRCHEARTFAILURE.121.009295. Epub 2022 Aug 4.
Goto S, Goto S Potent antithrombotic treatments in Asian vs. non-Asian patients. Eur Heart J. 2022 Oct 7;43(37):3553-3555. doi: 10.1093/eurheartj/ehac390.
Siddiqi TJ, Ahmed A, Greene SJ, Shahid I, Usman MS, Oshunbade A, Alkhouli M, Hall ME, Murad MH, Khera R, Jain V, Van Spall HGC, Khan MS Performance of current risk stratification models for predicting mortality in patients with heart failure: a systematic review and meta-analysis. Eur J Prev Cardiol. 2022 Nov 8;29(15):2027-2048. doi: 10.1093/eurjpc/zwac148.
Mills GB, Ratcovich H, Adams-Hall J, Beska B, Kirkup E, Raharjo DE, Veerasamy M, Wilkinson C, Kunadian V Is the contemporary care of the older persons with acute coronary syndrome evidence-based? Eur Heart J Open. 2021 Dec 17;2(1):oeab044. doi: 10.1093/ehjopen/oeab044. eCollection 2022 Jan.
Ratcovich H, Beska B, Mills G, Holmvang L, Adams-Hall J, Stevenson H, Veerasamy M, Wilkinson C, Kunadian V Five-year clinical outcomes in patients with frailty aged >/=75 years with non-ST elevation acute coronary syndrome undergoing invasive management. Eur Heart J Open. 2022 May 16;2(3):oeac035. doi: 10.1093/ehjopen/oeac035. eCollection 2022 May.
Masson W, Corral P, Barbagelata L, Lavalle-Cobo A, Nogueira JP, Siniawski D, Ray KK Reduction of cardiovascular events with the use of lipid-lowering medication in patients with familial hypercholesterolemia or severe primary hypercholesterolemia: A systematic review. J Clin Lipidol. 2022 Sep-Oct;16(5):562-573. doi: 10.1016/j.jacl.2022.07.004. Epub 2022 Jul 22.
Gibson CM, Ajmi I, von Koenig CL, Turco MA, Stone GW Pressure-Controlled Intermittent Coronary Sinus Occlusion: A Novel Approach to Improve Microvascular Flow and Reduce Infarct Size in STEMI. Cardiovasc Revasc Med. 2022 Dec;45:9-14. doi: 10.1016/j.carrev.2022.07.007. Epub 2022 Jul 28.
Ballantyne CM, Bays HE, Louie MJ, Smart J, Zhang Y, Ray KK Factors Associated With Enhanced Low-Density Lipoprotein Cholesterol Lowering With Bempedoic Acid. J Am Heart Assoc. 2022 Aug 2;11(15):e024531. doi: 10.1161/JAHA.121.024531. Epub 2022 Aug 2.
Chow LS, Gerszten RE, Taylor JM, Pedersen BK, van Praag H, Trappe S, Febbraio MA, Galis ZS, Gao Y, Haus JM, Lanza IR, Lavie CJ, Lee CH, Lucia A, Moro C, Pandey A, Robbins JM, Stanford KI, Thackray AE, Villeda S, Watt MJ, Xia A, Zierath JR, Goodpaster BH, Snyder M Reply to ‘Lactate as a major myokine and exerkine’. Nat Rev Endocrinol. 2022 Nov;18(11):713. doi: 10.1038/s41574-022-00726-y.
Kobo O, Raisi-Estabragh Z, Gevaert S, Rana JS, Van Spall HGC, Roguin A, Petersen SE, Ky B, Mamas MA Impact of cancer diagnosis on distribution and trends of cardiovascular hospitalizations in the USA between 2004 and 2017. Eur Heart J Qual Care Clin Outcomes. 2022 Oct 26;8(7):787-797. doi: 10.1093/ehjqcco/qcac045.
Schulman S, Sholzberg M, Spyropoulos AC, Zarychanski R, Resnick HE, Bradbury CA, Broxmeyer L, Connors JM, Falanga A, Iba T, Kaatz S, Levy JH, Middeldorp S, Minichiello T, Ramacciotti E, Samama CM, Thachil J, International Society on Thrombosis and Haemostasis ISTH guidelines for antithrombotic treatment in COVID-19. J Thromb Haemost. 2022 Oct;20(10):2214-2225. doi: 10.1111/jth.15808. Epub 2022 Jul 29.
Spyropoulos AC, Connors JM, Douketis JD, Goldin M, Hunt BJ, Kotila TR, Lopes RD, Schulman S, International Society on Thrombosis and Haemostasis Good practice statements for antithrombotic therapy in the management of COVID-19: Guidance from the SSC of the ISTH. J Thromb Haemost. 2022 Oct;20(10):2226-2236. doi: 10.1111/jth.15809. Epub 2022 Jul 29.
Rao VN, Kaltenbach LA, Granger BB, Fonarow GC, Al-Khalidi HR, Albert NM, Butler J, Allen LA, Lanfear DE, Ariely D, Miller JM, Brodsky MA, Lalonde TA, Lafferty JC, Granger CB, Hernandez AF, Devore AD, Durham, North Carolina; Los Angeles, California; Cleveland, Ohio; Jackson,, Misssissippi, Aurora, Colorado; Detroit, Michigan; Ewa Beach, Hawaii; Staten, Island, New York The Association of Digital Health Application Use With Heart Failure Care and Outcomes: Insights From CONNECT-HF. J Card Fail. 2022 Oct;28(10):1487-1496. doi: 10.1016/j.cardfail.2022.07.050. Epub 2022 Jul 26.
Cowie MR, Bozkurt B, Butler J, Briggs A, Kubin M, Jonas A, Adler AI, Patrick-Lake B, Zannad F How can we optimise health technology assessment and reimbursement decisions to accelerate access to new cardiovascular medicines? Int J Cardiol. 2022 Oct 15;365:61-68. doi: 10.1016/j.ijcard.2022.07.020. Epub 2022 Jul 26.
Araiza-Garaygordobil D, Gopar-Nieto R, Sierra-Lara Martinez D, Belderrain-Morales N, Sarabia-Chao V, Alfaro-Ponce DL, Ontiveros-Mercado H, Mendoza-Garcia S, Altamirano-Castillo A, Martinez-Amezcua P, Cabello-Lopez A, Briseno-De la Cruz JL, Ruiz-Beltran M, Martinez-Rios MA, Pina-Reyna Y, Gonzalez-Pacheco H, Arias-Mendoza A Dual Antiplatelet Therapy Versus Antiplatelet Monotherapy Plus Oral Anticoagulation in Patients with Acute Coronary Syndrome and Coronary Artery Ectasia: Design and Rationale of OVER-TIME Randomized Clinical Trial. High Blood Press Cardiovasc Prev. 2022 Sep;29(5):463-468. doi: 10.1007/s40292-022-00535-4. Epub 2022 Jul 29.
Almarzooq ZI, Yeh RW Rising Use of Percutaneous Ventricular Assist Devices: What Can Be Learned From the Data? Circ Cardiovasc Interv. 2022 Aug;15(8):e012266. doi: 10.1161/CIRCINTERVENTIONS.122.012266. Epub 2022 Jul 29.
Bjarnason TA, Mentias A, Panaich S, Vaughan Sarrazin M, Gao Y, Desai M, Pandey A, Dhruva SS, Desai NR, Girotra S Diffusion of Percutaneous Ventricular Assist Devices in US Markets. Circ Cardiovasc Interv. 2022 Aug;15(8):e011778. doi: 10.1161/CIRCINTERVENTIONS.121.011778. Epub 2022 Jul 29.
Dukkipati SR, Holmes DR Jr, Doshi SK, Kar S, Singh SM, Gibson D, Price MJ, Natale A, Mansour M, Sievert H, Houle VM, Allocco DJ, Reddy VY Impact of Peridevice Leak on 5-Year Outcomes After Left Atrial Appendage Closure. J Am Coll Cardiol. 2022 Aug 2;80(5):469-483. doi: 10.1016/j.jacc.2022.04.062.
Shah S, Segar MW, Kondamudi N, Ayers C, Chandra A, Matulevicius S, Agusala K, Peshock R, Abbara S, Michos ED, Drazner MH, Lima JAC, Longstreth WT Jr, Pandey A Supranormal Left Ventricular Ejection Fraction, Stroke Volume, and Cardiovascular Risk: Findings From Population-Based Cohort Studies. JACC Heart Fail. 2022 Aug;10(8):583-594. doi: 10.1016/j.jchf.2022.05.007.
Minhas AMK, Jain V, Maqsood MH, Pandey A, Khan SS, Fudim M, Fonarow GC, Butler J, Khan MS Non-Alcoholic Fatty Liver Disease, Heart Failure, and Long-Term Mortality: Insights From the National Health and Nutrition Examination Survey. Curr Probl Cardiol. 2022 Dec;47(12):101333. doi: 10.1016/j.cpcardiol.2022.101333. Epub 2022 Jul 25.
Butler J, Anker SD, Lund LH, Coats AJS, Filippatos G, Siddiqi TJ, Friede T, Fabien V, Kosiborod M, Metra M, Pina IL, Pinto F, Rossignol P, van der Meer P, Bahit C, Belohlavek J, Bohm M, Brugts JJ, Cleland JGF, Ezekowitz J, Bayes-Genis A, Gotsman I, Goudev A, Khintibidze I, Lindenfeld J, Mentz RJ, Merkely B, Montes EC, Mullens W, Nicolau JC, Parkhomenko A, Ponikowski P, Seferovic PM, Senni M, Shlyakhto E, Cohen-Solal A, Szecsody P, Jensen K, Dorigotti F, Weir MR, Pitt B Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial. Eur Heart J. 2022 Nov 1;43(41):4362-4373. doi: 10.1093/eurheartj/ehac401.
Xian Y, Xu H, Matsouaka R, Laskowitz DT, Maisch L, Hannah D, Smith EE, Fonarow GC, Bhatt DL, Schwamm LH, Mac Grory B, Feng W, Fosbol EL, Peterson ED, Johnson M Analysis of Prescriptions for Dual Antiplatelet Therapy After Acute Ischemic Stroke. JAMA Netw Open. 2022 Jul 1;5(7):e2224157. doi: 10.1001/jamanetworkopen.2022.24157.
Velcea AE, Mihaila Baldea S, Nicula AI, Vinereanu D The role of multimodality imaging in the selection for implantable cardioverter-defibrillators in heart failure: A narrative review. J Clin Ultrasound. 2022 Oct;50(8):1066-1072. doi: 10.1002/jcu.23281. Epub 2022 Jul 28.
Jain V, Minhas AMK, Morris AA, Greene SJ, Pandey A, Khan SS, Fonarow GC, Mentz RJ, Butler J, Khan MS Demographic and Regional Trends of Heart Failure-Related Mortality in Young Adults in the US, 1999-2019. JAMA Cardiol. 2022 Sep 1;7(9):900-904. doi: 10.1001/jamacardio.2022.2213.
Breathett K, Knapp SM, Addison D, Johnson A, Shah RU, Flint K, Van Spall HGC, Sweitzer NK, Mazimba S Relationships between 2018 UNOS heart policy and transplant outcomes in metropolitan, micropolitan, and rural settings. J Heart Lung Transplant. 2022 Sep;41(9):1228-1236. doi: 10.1016/j.healun.2022.06.015. Epub 2022 Jun 26.
Beska B, Mills GB, Ratcovich H, Wilkinson C, Damluji AA, Kunadian V Impact of multimorbidity on long-term outcomes in older adults with non-ST elevation acute coronary syndrome in the North East of England: a multi-centre cohort study of patients undergoing invasive care. BMJ Open. 2022 Jul 26;12(7):e061830. doi: 10.1136/bmjopen-2022-061830.
Usman MS, Minhas AMK, Greene SJ, Van Spall HG, Mentz RJ, Fonarow GC, Al-Khatib SM, Butler J, Khan MS Utilization of Implantable Cardioverter Defibrillators Among Patients with a Left Ventricular Assist Device: Insights From a National Database. Curr Probl Cardiol. 2022 Nov;47(11):101334. doi: 10.1016/j.cpcardiol.2022.101334. Epub 2022 Jul 23.
Anker SD, Usman MS, Butler J SGLT2 Inhibitors: From Antihyperglycemic Agents to All-Around Heart Failure Therapy. Circulation. 2022 Jul 26;146(4):299-302. doi: 10.1161/CIRCULATIONAHA.122.060348. Epub 2022 Jul 25.
Pandey A, Keshvani N, Wang TJ Should Polypills Be Used for Heart Failure With Reduced Ejection Fraction? Circulation. 2022 Jul 26;146(4):276-278. doi: 10.1161/CIRCULATIONAHA.122.059661. Epub 2022 Jul 25.
Tamirisa KP, Dye C, Bond RM, Hollier LM, Marinescu K, Vaseghi M, Russo AM, Gulati M, Volgman AS Arrhythmias and Heart Failure in Pregnancy: A Dialogue on Multidisciplinary Collaboration. J Cardiovasc Dev Dis. 2022 Jun 24;9(7):199. doi: 10.3390/jcdd9070199.
O’Kelly AC, Ludmir J, Wood MJ Acute Coronary Syndrome in Pregnancy and the Post-Partum Period. J Cardiovasc Dev Dis. 2022 Jun 23;9(7):198. doi: 10.3390/jcdd9070198.
Selim MH Time for a New Perspective on Intracerebral Hemorrhage. JAMA Neurol. 2022 Sep 1;79(9):844-845. doi: 10.1001/jamaneurol.2022.1988.
Hamid A, Anker MS, Ruckdeschel JC, Khan MS, Tharwani A, Oshunbade AA, Kipchumba RK, Thigpen SC, Anker SD, Fonarow GC, Hall ME, Butler J Cardiovascular Safety Reporting in Contemporary Breast Cancer Clinical Trials. J Am Heart Assoc. 2022 Aug 2;11(15):e025206. doi: 10.1161/JAHA.121.025206. Epub 2022 Jul 25.
Figtree GA, Vernon ST, Hadziosmanovic N, Sundstrom J, Alfredsson J, Nicholls SJ, Chow CK, Psaltis P, Rosjo H, Leosdottir M, Hagstrom E Mortality and Cardiovascular Outcomes in Patients Presenting With Non-ST Elevation Myocardial Infarction Despite No Standard Modifiable Risk Factors: Results From the SWEDEHEART Registry. J Am Heart Assoc. 2022 Aug 2;11(15):e024818. doi: 10.1161/JAHA.121.024818. Epub 2022 Jul 25.
Metra M, Jankowska EA, Pagnesi M, Anker SD, Butler J, Dorigotti F, Fabien V, Filippatos G, Kirwan BA, Macdougall IC, Rosano G, Ruschitzka F, Tomasoni D, van der Meer P, Ponikowski P, AFFIRM-AHF Investigators Impact of ischaemic aetiology on the efficacy of intravenous ferric carboxymaltose in patients with iron deficiency and acute heart failure: insights from the AFFIRM-AHF trial. Eur J Heart Fail. 2022 Oct;24(10):1928-1939. doi: 10.1002/ejhf.2630. Epub 2022 Sep 23.
Vranckx P, Valgimigli M Antithrombotic therapy in patients with atrial fibrillation undergoing PCI remains a moving target, yet with a clearer direction! EuroIntervention. 2022 Jul 22;18(4):e267-e268. doi: 10.4244/EIJ-E-22-00004.
Bainey KR, Abulhamayel A, Aziz A, Becher H Sonothrombolysis Augments Reperfusion in ST-Elevation Myocardial Infarction With Primary Percutaneous Coronary Intervention: Insights From the SONOSTEMI Study. CJC Open. 2022 Mar 12;4(7):644-646. doi: 10.1016/j.cjco.2022.03.004. eCollection 2022 Jul.
Parry M, Van Spall HGC, Mullen KA, Mulvagh SL, Pacheco C, Colella TJF, Clavel MA, Jaffer S, Foulds HJA, Grewal J, Hardy M, Price JAD, Levinsson ALE, Gonsalves CA, Norris CM The Canadian Women’s Heart Health Alliance Atlas on the Epidemiology, Diagnosis, and Management of Cardiovascular Disease in Women – Chapter 6: Sex- and Gender-Specific Diagnosis and Treatment. CJC Open. 2022 Apr 19;4(7):589-608. doi: 10.1016/j.cjco.2022.04.002. eCollection 2022 Jul.
Verma KP, Inouye M, Meikle PJ, Nicholls SJ, Carrington MJ, Marwick TH New Cardiovascular Risk Assessment Techniques for Primary Prevention: JACC Review Topic of the Week. J Am Coll Cardiol. 2022 Jul 26;80(4):373-387. doi: 10.1016/j.jacc.2022.05.015.
Simsek B, Kostantinis S, Karacsonyi J, Alaswad K, Krestyaninov O, Khelimskii D, Davies R, Rier J, Goktekin O, Gorgulu S, ElGuindy A, Chandwaney RH, Patel M, Abi Rafeh N, Karmpaliotis D, Masoumi A, Khatri JJ, Jaffer FA, Doshi D, Poommipanit PB, Rangan BV, Sanvodal Y, Choi JW, Elbarouni B, Nicholson W, Jaber WA, Rinfret S, Koutouzis M, Tsiafoutis I, Yeh RW, Burke MN, Allana S, Mastrodemos OC, Brilakis ES Predicting Periprocedural Complications in Chronic Total Occlusion Percutaneous Coronary Intervention: The PROGRESS-CTO Complication Scores. JACC Cardiovasc Interv. 2022 Jul 25;15(14):1413-1422. doi: 10.1016/j.jcin.2022.06.007.
Matsoukas S, Chennareddy S, Kalagara R, Scaggiante J, Smith CJ, Bazil MJ, Reford E, Liu K, Delman BN, Selim MH, Mocco J, Fifi JT, Kellner CP Pilot Deployment of Viz-Intracranial Hemorrhage for Intracranial Hemorrhage Detection: Real-World Performance in a Stroke Code Cohort. Stroke. 2022 Sep;53(9):e418-e419. doi: 10.1161/STROKEAHA.122.039711. Epub 2022 Jul 11.
Islam SJ, Malla G, Yeh RW, Quyyumi AA, Kazi DS, Tian W, Song Y, Nayak A, Mehta A, Ko YA, de Lemos JA, Rodriguez F, Goyal A, Wadhera RK County-Level Social Vulnerability is Associated With In-Hospital Death and Major Adverse Cardiovascular Events in Patients Hospitalized With COVID-19: An Analysis of the American Heart Association COVID-19 Cardiovascular Disease Registry. Circ Cardiovasc Qual Outcomes. 2022 Aug;15(8):e008612. doi: 10.1161/CIRCOUTCOMES.121.008612. Epub 2022 Jul 18.
Kyalwazi AN, Loccoh EC, Brewer LC, Ofili EO, Xu J, Song Y, Joynt Maddox KE, Yeh RW, Wadhera RK Disparities in Cardiovascular Mortality Between Black and White Adults in the United States, 1999 to 2019. Circulation. 2022 Jul 19;146(3):211-228. doi: 10.1161/CIRCULATIONAHA.122.060199. Epub 2022 Jul 18.
Ortega-Paz L, Angiolillo DJ Optimal antiplatelet therapy in patients at high bleeding risk undergoing complex percutaneous coronary intervention. Eur Heart J. 2022 Sep 1;43(33):3115-3117. doi: 10.1093/eurheartj/ehac369.
Lam CSP, Gerstein HC, AMPLITUDE-O Investigators Response by Lam and Gerstein to Letter Regarding Article, “Efpeglenatide and Clinical Outcomes With and Without Concomitant Sodium-Glucose Cotransporter-2 Inhibition Use in Type 2 Diabetes: Exploratory Analysis of the AMPLITUDE-O Trial”. Circulation. 2022 Jul 12;146(2):e7. doi: 10.1161/CIRCULATIONAHA.122.060526. Epub 2022 Jul 11.
Sattar N, McGuire DK, Gill JMR High Circulating Triglycerides Are Most Commonly a Marker of Ectopic Fat Accumulation: Connecting the Clues to Advance Lifestyle Interventions. Circulation. 2022 Jul 12;146(2):77-79. doi: 10.1161/CIRCULATIONAHA.122.060411. Epub 2022 Jul 11.
Oyama K, Raz I, Cahn A, Goodrich EL, Bhatt DL, Leiter LA, McGuire DK, Wilding JPH, Gause-Nilsson IAM, Mosenzon O, Sabatine MS, Wiviott SD Efficacy and Safety of Dapagliflozin According to Background Use of Cardiovascular Medications in Patients With Type 2 Diabetes: A Prespecified Secondary Analysis of a Randomized Clinical Trial. JAMA Cardiol. 2022 Sep 1;7(9):914-923. doi: 10.1001/jamacardio.2022.2006.
Tardif JC, Pfeffer MA, Kouz S, Koenig W, Maggioni AP, McMurray JJV, Mooser V, Waters DD, Gregoire JC, L’Allier PL, Wouter Jukema J, White HD, Heinonen T, Black DM, Laghrissi-Thode F, Levesque S, Guertin MC, Dube MP, dal-GenE Investigators Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome: the dal-GenE trial. Eur Heart J. 2022 Oct 14;43(39):3947-3956. doi: 10.1093/eurheartj/ehac374.
Di Giovanni G, Nicholls SJ Intensive lipid lowering agents and coronary atherosclerosis: Insights from intravascular imaging. Am J Prev Cardiol. 2022 Jul 1;11:100366. doi: 10.1016/j.ajpc.2022.100366. eCollection 2022 Sep.
Weinfurter JT, D’Souza SS, Matschke LM, Bennett S, Kelnhofer-Millevolte LE, Suknuntha K, Kumar A, Coonen J, Capitini CM, Hematti P, Golos TG, Slukvin II, Reynolds MR Allogeneic MHC-matched T-cell receptor alpha/beta-depleted bone marrow transplants in SHIV-infected, ART-suppressed Mauritian cynomolgus macaques. Sci Rep. 2022 Jul 19;12(1):12345. doi: 10.1038/s41598-022-16306-z.
Gregg LP, Van Buren PN, Ramsey DJ, Maydon A, Banerjee S, Walther CP, Virani SS, Winkelmayer WC, Navaneethan SD, Hedayati SS Natriuretic peptides, extracellular volume, and subclinical cardiovascular changes in chronic kidney disease stages 1-3: a pilot study. J Investig Med. 2022 Jul 19:jim-2022-002467. doi: 10.1136/jim-2022-002467.
Ormiston CK, Swiatkiewicz I, Taub PR Postural orthostatic tachycardia syndrome as a sequela of COVID-19. Heart Rhythm. 2022 Nov;19(11):1880-1889. doi: 10.1016/j.hrthm.2022.07.014. Epub 2022 Jul 16.
Chunawala ZS, Qamar A, Arora S, Pandey A, Fudim M, Vaduganathan M, Mentz RJ, Bhatt DL, Caughey MC Prognostic significance of obstructive coronary artery disease in patients admitted with acute decompensated heart failure: the ARIC study community surveillance. Eur J Heart Fail. 2022 Nov;24(11):2140-2149. doi: 10.1002/ejhf.2617. Epub 2022 Aug 7.
Bainey KR, Marquis-Gravel G, Mehta SR, Tanguay JF The Evolution of Anticoagulation for Percutaneous Coronary Intervention: A 40-Year Journey. Can J Cardiol. 2022 Oct;38(10 Suppl1):S89-S98. doi: 10.1016/j.cjca.2022.07.007. Epub 2022 Jul 16.
Oseran AS, Ati S, Feldman WB, Gondi S, Yeh RW, Wadhera RK Assessment of Prices for Cardiovascular Tests and Procedures at Top-Ranked US Hospitals. JAMA Intern Med. 2022 Sep 1;182(9):996-999. doi: 10.1001/jamainternmed.2022.2602.
Tamargo J, Kaski JC, Kimura T, Barton JC, Yamamoto K, Komiyama M, Drexel H, Lewis BS, Agewall S, Hasegawa K Racial and ethnic differences in pharmacotherapy to prevent coronary artery disease and thrombotic events. Eur Heart J Cardiovasc Pharmacother. 2022 Sep 29;8(7):738-751. doi: 10.1093/ehjcvp/pvac040.
Teng AE, Kennedy KF, Parikh RV, Armstrong EJ, Hsue PY, Secemsky EA Temporal trends and outcomes of peripheral artery disease revascularization and amputation among the HIV population. AIDS. 2022 Oct 1;36(12):1717-1724. doi: 10.1097/QAD.0000000000003309. Epub 2022 Jul 15.
Cardoso R, Shaw LJ, Blumenthal RS, Nasir K, Ferraro R, Maron DJ, Blaha MJ, Gulati M, Bhatt DL, Blankstein R Preventive cardiology advances in the 2021 AHA/ACC chest pain guideline. Am J Prev Cardiol. 2022 Jun 30;11:100365. doi: 10.1016/j.ajpc.2022.100365. eCollection 2022 Sep.
Khan MS, Butler J, Vaduganathan M, Greene SJ Heart Failure Specific Versus All-cause End Points in Heart Failure Clinical Trials. J Card Fail. 2022 Sep;28(9):1398-1400. doi: 10.1016/j.cardfail.2022.07.001. Epub 2022 Jul 14.
Ahmad FS, Jackson KL, Yount SE, Rothrock NE, Kallen MA, Lacson L, Bilimoria KY, Kho AN, Mutharasan RK, McCullough PA, Bruckel J, Fedson S, Kimmel SE, Eton DT, Grady KL, Yancy CW, Cella D The development and initial validation of the PROMIS(R)+HF-27 and PROMIS+HF-10 profiles. ESC Heart Fail. 2022 Oct;9(5):3380-3392. doi: 10.1002/ehf2.14061. Epub 2022 Jul 15.
Murai K, Kataoka Y, Nicholls SJ, Puri R, Nakaoku Y, Nishimura K, Kitahara S, Iwai T, Sawada K, Matama H, Honda S, Fujino M, Yoneda S, Takagi K, Nishihira K, Otsuka F, Asaumi Y, Tsujita K, Noguchi T The Residual Lipid-Rich Coronary Atheroma Behind the Implanted Newer-Generation Drug-Eluting Stent and Future Stent-Related Event Risks. Can J Cardiol. 2022 Oct;38(10):1504-1515. doi: 10.1016/j.cjca.2022.07.004. Epub 2022 Jul 14.
Horton AE, Martin AC, Srinivasan S, Justo RN, Poplawski NK, Sullivan D, Brett T, Chow CK, Nicholls SJ, Pang J, Watts GF, FH Australasia Network Consensus Working Group Integrated guidance to enhance the care of children and adolescents with familial hypercholesterolaemia: Practical advice for the community clinician. J Paediatr Child Health. 2022 Aug;58(8):1297-1312. doi: 10.1111/jpc.16096. Epub 2022 Jul 15.
Prabhakaran D, Singh K, Kondal D, Raspail L, Mohan B, Kato T, Sarrafzadegan N, Talukder SH, Akter S, Amin MR, Goma F, Gomez-Mesa J, Ntusi N, Inofomoh F, Deora S, Philippov E, Svarovskaya A, Konradi A, Puentes A, Ogah OS, Stanetic B, Issa A, Thienemann F, Juzar D, Zaidel E, Sheikh S, Ojji D, Lam CSP, Ge J, Banerjee A, Newby LK, Ribeiro ALP, Gidding S, Pinto F, Perel P, Sliwa K, WHF COVID-19 Study Collaborators Cardiovascular Risk Factors and Clinical Outcomes among Patients Hospitalized with COVID-19: Findings from the World Heart Federation COVID-19 Study. Glob Heart. 2022 Jun 15;17(1):40. doi: 10.5334/gh.1128. eCollection 2022.
Tanriover C, Ucku D, Basile C, Tuttle KR, Kanbay M On the importance of the interplay of residual renal function with clinical outcomes in end-stage kidney disease. J Nephrol. 2022 Dec;35(9):2191-2204. doi: 10.1007/s40620-022-01388-9. Epub 2022 Jul 11.
Akbari T, Al-Lamee R Percutaneous Coronary Intervention in Multi-Vessel Disease. Cardiovasc Revasc Med. 2022 Nov;44:80-91. doi: 10.1016/j.carrev.2022.06.254. Epub 2022 Jun 24.
Kumar R, Bainey KR Percutaneous coronary intervention with peripheral artery disease in the contemporary era: Still life or limb? Atherosclerosis. 2022 Aug;355:45-47. doi: 10.1016/j.atherosclerosis.2022.06.1022. Epub 2022 Jul 3.
Chandramouli C, Lam CSP Sex, fat and the heart: it’s all in the waist. Eur J Heart Fail. 2022 Aug;24(8):1371-1376. doi: 10.1002/ejhf.2615. Epub 2022 Jul 19.
Raparelli V, Wright CX, Corica B, Sharma G, Lindley K, Brackett A, Pilote L, Wood MJ, Dreyer RP Interventions Targeted to Address Social Determinants of Health in Ischemic Heart Disease: A Sex- and Gender-Oriented Scoping Review. Can J Cardiol. 2022 Dec;38(12):1881-1892. doi: 10.1016/j.cjca.2022.06.025. Epub 2022 Jul 6.
Khunti K, Aroda VR, Bhatt DL, Bozkurt B, Buse JB, Heerspink HL, Inzucchi SE, Lam CSP, Marx N, McMurray JJV, Solomon SD, Kosiborod MN Re-examining the widespread policy of stopping sodium-glucose cotransporter-2 inhibitors during acute illness: A perspective based on the updated evidence. Diabetes Obes Metab. 2022 Nov;24(11):2071-2080. doi: 10.1111/dom.14805. Epub 2022 Aug 4.
Simonato M, Vemulapalli S, Ben-Yehuda O, Krucoff M Reply: Improving the Patient Relevance and Generalizability of TAVR Core Data Elements. JACC Cardiovasc Interv. 2022 Jul 11;15(13):1387-1388. doi: 10.1016/j.jcin.2022.05.042.
Januzzi JL Jr, Butler J The Importance of Worsening Heart Failure: Hiding in Plain Sight. J Am Coll Cardiol. 2022 Jul 12;80(2):123-125. doi: 10.1016/j.jacc.2022.04.044.
Schawkat K, Litmanovich D, Appel E, Ghorishi A, Selim M, Manning WJ, Nakhaei M, Biglione B, Camacho A, Brook OR Embolic Events After Computed Tomography Contrast Injection in Patients With Interatrial Shunts: A Cohort Study. J Thorac Imaging. 2022 Sep 1;37(5):331-335. doi: 10.1097/RTI.0000000000000663. Epub 2022 Jun 23.
Pop-Busui R, Januzzi JL, Bruemmer D, Butalia S, Green JB, Horton WB, Knight C, Levi M, Rasouli N, Richardson CR Heart Failure: An Underappreciated Complication of Diabetes. A Consensus Report of the American Diabetes Association. Diabetes Care. 2022 Jul 7;45(7):1670-1690. doi: 10.2337/dci22-0014.
Pocock SJ, Ferreira JP, Packer M, Zannad F, Filippatos G, Kondo T, McMurray JJV, Solomon SD, Januzzi JL, Iwata T, Salsali A, Butler J, Anker SD Biomarker-driven prognostic models in chronic heart failure with preserved ejection fraction: the EMPEROR-Preserved trial. Eur J Heart Fail. 2022 Oct;24(10):1869-1878. doi: 10.1002/ejhf.2607. Epub 2022 Jul 24.
Assimon MM, Pun PH, Al-Khatib SM, Brookhart MA, Gaynes BN, Winkelmayer WC, Flythe JE The modifying effect of the serum-to-dialysate potassium gradient on the cardiovascular safety of SSRIs in the hemodialysis population: a pharmacoepidemiologic study. Nephrol Dial Transplant. 2022 Oct 19;37(11):2241-2252. doi: 10.1093/ndt/gfac214.
Yancy CW, Khan SS Replacing Race With Social Determinants of Health in Risk Prediction-Getting It Right. JAMA Cardiol. 2022 Aug 1;7(8):856. doi: 10.1001/jamacardio.2022.1909.
Segar MW, Hall JL, Jhund PS, Powell-Wiley TM, Morris AA, Kao D, Fonarow GC, Hernandez R, Ibrahim NE, Rutan C, Navar AM, Stevens LM, Pandey A Machine Learning-Based Models Incorporating Social Determinants of Health vs Traditional Models for Predicting In-Hospital Mortality in Patients With Heart Failure. JAMA Cardiol. 2022 Aug 1;7(8):844-854. doi: 10.1001/jamacardio.2022.1900.
Senni M, Alemayehu WG, Sim D, Edelmann F, Butler J, Ezekowitz J, Hernandez AF, Lam CSP, O’Connor CM, Pieske B, Ponikowski P, Roessig L, Voors AA, Westerhout CM, McMullan C, Armstrong PW, VICTORIA Study Group Efficacy and safety of vericiguat in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan: insights from the VICTORIA trial. Eur J Heart Fail. 2022 Sep;24(9):1614-1622. doi: 10.1002/ejhf.2608. Epub 2022 Jul 20.
Talha KM, Butler J Breakthroughs in the treatment of heart failure with mildly reduced and preserved ejection fraction. Clin Cardiol. 2022 Jun;45 Suppl 1(Suppl 1):S31-S39. doi: 10.1002/clc.23846.
Chandramouli C, Stewart S, Almahmeed W, Lam CSP Clinical implications of the universal definition for the prevention and treatment of heart failure. Clin Cardiol. 2022 Jun;45 Suppl 1(Suppl 1):S2-S12. doi: 10.1002/clc.23842.
Doehner W, Anker SD, Butler J, Zannad F, Filippatos G, Ferreira JP, Salsali A, Kaempfer C, Brueckmann M, Pocock SJ, Januzzi JL, Packer M Uric acid and sodium-glucose cotransporter-2 inhibition with empagliflozin in heart failure with reduced ejection fraction: the EMPEROR-reduced trial. Eur Heart J. 2022 Sep 21;43(36):3435-3446. doi: 10.1093/eurheartj/ehac320.
Staron A, Zheng L, Doros G, Sanchorawala V Differences in the cytogenetic underpinnings of AL amyloidosis among African Americans and Caucasian Americans. Blood Cancer J. 2022 Jul 4;12(7):100. doi: 10.1038/s41408-022-00697-3.
Shafi T, Zhu X, Lirette ST, Rule AD, Mosley T, Butler KR, Hall ME, Vaitla P, Wynn JJ, Tio MC, Dossabhoy NR, Guallar E, Butler J Quantifying Individual-Level Inaccuracy in Glomerular Filtration Rate Estimation : A Cross-Sectional Study. Ann Intern Med. 2022 Aug;175(8):1073-1082. doi: 10.7326/M22-0610. Epub 2022 Jul 5.
Butler J, Shahzeb Khan M, Lindenfeld J, Abraham WT, Savarese G, Salsali A, Zeller C, Peil B, Filippatos G, Ponikowski P, Anker SD Minimally Clinically Important Difference in Health Status Scores in Patients With HFrEF vs HFpEF. JACC Heart Fail. 2022 Sep;10(9):651-661. doi: 10.1016/j.jchf.2022.03.003. Epub 2022 Jun 8.
Connors JM, Ridker PM Antithrombotic prophylaxis for symptomatic outpatients with COVID-19: less is consistently more. Lancet Haematol. 2022 Aug;9(8):e551-e553. doi: 10.1016/S2352-3026(22)00205-8. Epub 2022 Jun 30.
Gaba P, Bhatt DL, Mason RP, Miller M, Verma S, Steg PG, Boden WE, REDUCE-IT Investigators Benefits of icosapent ethyl for enhancing residual cardiovascular risk reduction: A review of key findings from REDUCE-IT. J Clin Lipidol. 2022 Jul-Aug;16(4):389-402. doi: 10.1016/j.jacl.2022.05.067. Epub 2022 Jun 4.
Zhu JW, D’Angelo F, Miranda JJ, Yancy CW, Cupido B, Zannad F, Van Spall HGC Incorporating Cultural Competence and Cultural Humility in Cardiovascular Clinical Trials to Increase Diversity Among Participants. J Am Coll Cardiol. 2022 Jul 5;80(1):89-92. doi: 10.1016/j.jacc.2022.05.001.
Bohm M, Butler J, Filippatos G, Ferreira JP, Pocock SJ, Abdin A, Mahfoud F, Brueckmann M, Gollop ND, Iwata T, Ponikowski P, Wanner C, Zannad F, Packer M, Anker SD, EMPEROR-Preserved Trial Committees and Investigators Empagliflozin Improves Outcomes in Patients With Heart Failure and Preserved Ejection Fraction Irrespective of Age. J Am Coll Cardiol. 2022 Jul 5;80(1):1-18. doi: 10.1016/j.jacc.2022.04.040.
Tromp J, Ouwerkerk W, Lam CSP, Voors AA Reply: Assessing Pharmacologic Treatment Effect From a Meta-Analysis in Heart Failure. JACC Heart Fail. 2022 Jul;10(7):527-528. doi: 10.1016/j.jchf.2022.04.011.
Smeijer JD, Koomen J, Kohan DE, McMurray JJV, Bakris GL, Correa-Rotter R, Hou FF, Januzzi JL, Kitzman DW, Kolansky DM, Makino H, Perkovic V, Tobe S, Parving HH, de Zeeuw D, Heerspink HJL Increase in BNP in Response to Endothelin-Receptor Antagonist Atrasentan Is Associated With Incident Heart Failure. JACC Heart Fail. 2022 Jul;10(7):498-507. doi: 10.1016/j.jchf.2022.03.004. Epub 2022 May 4.
Huynh K, Ayers C, Butler J, Neeland I, Kritchevsky S, Pandey A, Barton G, Berry JD Association Between Thigh Muscle Fat Infiltration and Incident Heart Failure: The Health ABC Study. JACC Heart Fail. 2022 Jul;10(7):485-493. doi: 10.1016/j.jchf.2022.04.012.
Vidula H, Takeda K, Estep JD, Silvestry SC, Milano C, Cleveland JC Jr, Goldstein DJ, Uriel N, Kormos RL, Dirckx N, Mehra MR Hospitalization Patterns and Impact of a Magnetically-Levitated Left Ventricular Assist Device in the MOMENTUM 3 Trial. JACC Heart Fail. 2022 Jul;10(7):470-481. doi: 10.1016/j.jchf.2022.03.007. Epub 2022 Jun 8.
Farge D, Frere C, Connors JM, Khorana AA, Kakkar A, Ay C, Munoz A, Brenner B, Prata PH, Brilhante D, Antic D, Casais P, Guillermo Esposito MC, Ikezoe T, Abutalib SA, Meillon-Garcia LA, Bounameaux H, Pabinger I, Douketis J, International Initiative on Thrombosis and Cancer (ITAC) advisory panel 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19. Lancet Oncol. 2022 Jul;23(7):e334-e347. doi: 10.1016/S1470-2045(22)00160-7.
Hagstrom E, Steg PG, Szarek M, Bhatt DL, Bittner VA, Danchin N, Diaz R, Goodman SG, Harrington RA, Jukema JW, Liberopoulos E, Marx N, McGinniss J, Manvelian G, Pordy R, Scemama M, White HD, Zeiher AM, Schwartz GG, ODYSSEY OUTCOMES Investigators Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab. Circulation. 2022 Aug 30;146(9):657-672. doi: 10.1161/CIRCULATIONAHA.121.057807. Epub 2022 Jun 30.
Morris PD, Al-Lamee RK, Berry C, BCIS Research and Development Committee Coronary physiological assessment in the catheter laboratory: haemodynamics, clinical assessment and future perspectives. Heart. 2022 Oct 13;108(21):1737-1746. doi: 10.1136/heartjnl-2020-318743.
Bangalore S, Hochman JS, Stevens SR, Jones PG, Spertus JA, O’Brien SM, Reynolds HR, Boden WE, Fleg JL, Williams DO, Stone GW, Sidhu MS, Mathew RO, Chertow GM, Maron DJ Clinical and Quality-of-Life Outcomes Following Invasive vs Conservative Treatment of Patients With Chronic Coronary Disease Across the Spectrum of Kidney Function. JAMA Cardiol. 2022 Aug 1;7(8):825-835. doi: 10.1001/jamacardio.2022.1763.
Stewart RAH, Kirby A, White HD, Marschner SL, West M, Thompson PL, Sullivan D, Janus E, Hunt D, Kritharides L, Keech A, Simes J, Tonkin AM B-Type Natriuretic Peptide and Long-Term Cardiovascular Mortality in Patients With Coronary Heart Disease. J Am Heart Assoc. 2022 Jul 5;11(13):e024616. doi: 10.1161/JAHA.121.024616. Epub 2022 Jun 29.
Goyal P, Kim M, Krishnan U, Mccullough SA, Cheung JW, Kim LK, Pandey A, Borlaug BA, Horn EM, Safford MM, Kamel H Post-operative atrial fibrillation and risk of heart failure hospitalization. Eur Heart J. 2022 Aug 14;43(31):2971-2980. doi: 10.1093/eurheartj/ehac285.
Restrepo JA, MacLean R, Celano CM, Huffman JC, Januzzi JL, Beach SR The assessment of cardiac risk in patients taking lamotrigine; a systematic review. Gen Hosp Psychiatry. 2022 Sep-Oct;78:14-27. doi: 10.1016/j.genhosppsych.2022.06.004. Epub 2022 Jun 22.
Filippatos G, Butler J, Farmakis D, Zannad F, Ofstad AP, Ferreira JP, Green JB, Rosenstock J, Schnaidt S, Brueckmann M, Pocock SJ, Packer M, Anker SD, EMPEROR-Preserved Trial Committees and Investigators Empagliflozin for Heart Failure With Preserved Left Ventricular Ejection Fraction With and Without Diabetes. Circulation. 2022 Aug 30;146(9):676-686. doi: 10.1161/CIRCULATIONAHA.122.059785. Epub 2022 Jun 28.
Ridker PM, Rifai N, MacFadyen J, Glynn RJ, Jiao L, Steg PG, Miller M, Brinton EA, Jacobson TA, Tardif JC, Ballantyne CM, Mason RP, Bhatt DL Effects of Randomized Treatment With Icosapent Ethyl and a Mineral Oil Comparator on Interleukin-1beta, Interleukin-6, C-Reactive Protein, Oxidized Low-Density Lipoprotein Cholesterol, Homocysteine, Lipoprotein(a), and Lipoprotein-Associated Phospholipase A2: A REDUCE-IT Biomarker Substudy. Circulation. 2022 Aug 2;146(5):372-379. doi: 10.1161/CIRCULATIONAHA.122.059410. Epub 2022 Jun 28.
Gulati M, Kohli P Mentorship in cardiology: building the mentoring relationship. Nat Rev Cardiol. 2022 Nov;19(11):711-712. doi: 10.1038/s41569-022-00740-7.
Sheth KN, Selim M Focused Update on Vascular Risk and Secondary Prevention in Survivors of Intracerebral Hemorrhage. Stroke. 2022 Jul;53(7):2128-2130. doi: 10.1161/STROKEAHA.122.039819. Epub 2022 Jun 27.
Bozkurt B, Das SR, Addison D, Gupta A, Jneid H, Khan SS, Koromia GA, Kulkarni PA, LaPoint K, Lewis EF, Michos ED, Peterson PN, Turagam MK, Wang TY, Yancy CW, Writing Committee Members 2022 AHA/ACC Key Data Elements and Definitions for Cardiovascular and Noncardiovascular Complications of COVID-19: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards. J Am Coll Cardiol. 2022 Jul 26;80(4):388-465. doi: 10.1016/j.jacc.2022.03.355. Epub 2022 Jun 23.
Wu MZ, Chandramouli C, Wong PF, Chan YH, Li HL, Yu SY, Tse YK, Ren QW, Yu SY, Tse HF, Lam CSP, Yiu KH Risk of sepsis and pneumonia in patients initiated on SGLT2 inhibitors and DPP-4 inhibitors. Diabetes Metab. 2022 Nov;48(6):101367. doi: 10.1016/j.diabet.2022.101367. Epub 2022 Jun 23.
Landi A, Branca M, Vranckx P, Leonardi S, Frigoli E, Heg D, Calabro P, Esposito G, Sardella G, Tumscitz C, Garducci S, Ando G, Limbruno U, Sganzerla P, Santarelli A, Briguori C, de la Torre Hernandez JM, Pedrazzini G, Windecker S, Valgimigli M, MATRIX Investigators Radial vs Femoral Access in ACS Patients Undergoing Complex PCI Is Associated With Consistent Bleeding Benefit and No Excess of Risks. Can J Cardiol. 2022 Oct;38(10):1488-1500. doi: 10.1016/j.cjca.2022.06.014. Epub 2022 Jun 24.
Mohebi R, McCarthy CP, Gaggin HK, van Kimmenade RRJ, Januzzi JL Inflammatory biomarkers and risk of cardiovascular events in patients undergoing coronary angiography. Am Heart J. 2022 Oct;252:51-59. doi: 10.1016/j.ahj.2022.06.004. Epub 2022 Jun 23.
Assimon MM, Pun PH, Wang L, Al-Khatib SM, Brookhart MA, Weber DJ, Winkelmayer WC, Flythe JE Azithromycin use increases the risk of sudden cardiac death in patients with hemodialysis-dependent kidney failure. Kidney Int. 2022 Oct;102(4):894-903. doi: 10.1016/j.kint.2022.05.024. Epub 2022 Jun 23.
Koury MJ, Agarwal R, Chertow GM, Eckardt KU, Fishbane S, Ganz T, Haase VH, Hanudel MR, Parfrey PS, Pergola PE, Roy-Chaudhury P, Tumlin JA, Anders R, Farag YMK, Luo W, Minga T, Solinsky C, Vargo DL, Winkelmayer WC Erythropoietic effects of vadadustat in patients with anemia associated with chronic kidney disease. Am J Hematol. 2022 Sep;97(9):1178-1188. doi: 10.1002/ajh.26644. Epub 2022 Jul 15.
Udell JA, Behrouzi B, Sivaswamy A, Chu A, Ferreira-Legere LE, Fang J, Goodman SG, Ezekowitz JA, Bainey KR, van Diepen S, Kaul P, McAlister FA, Bogoch II, Jackevicius CA, Abdel-Qadir H, Wijeysundera HC, Ko DT, Austin PC, Lee DS Clinical risk, sociodemographic factors, and SARS-CoV-2 infection over time in Ontario, Canada. Sci Rep. 2022 Jun 24;12(1):10534. doi: 10.1038/s41598-022-13598-z.
Galli M, Angiolillo DJ Dual Versus Triple Antithrombotic Therapy for Atrial Fibrillation-ACS/PCI: One Size Does Not Fit All. Cardiovasc Revasc Med. 2022 Oct;43:152-154. doi: 10.1016/j.carrev.2022.06.003. Epub 2022 Jun 18.
Baron SJ Cost-effectiveness of an FFR-guided strategy during STEMI – no rose without a thorn. EuroIntervention. 2022 Jun 24;18(3):188-189. doi: 10.4244/EIJ-E-22-00014.
Romero JE, Goldhaber SZ Uninterrupted Oral Anticoagulation During Catheter Ablation of Ventricular Tachycardia: Is the Riskier Option the Safest? JACC Clin Electrophysiol. 2022 Jun;8(6):749-753. doi: 10.1016/j.jacep.2022.04.007.
Bozkurt B, Das SR, Addison D, Gupta A, Jneid H, Khan SS, Koromia GA, Kulkarni PA, LaPoint K, Lewis EF, Michos ED, Peterson PN, Turagam MK, Wang TY, Yancy CW 2022 AHA/ACC Key Data Elements and Definitions for Cardiovascular and Noncardiovascular Complications of COVID-19: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards. Circ Cardiovasc Qual Outcomes. 2022 Jul;15(7):e000111. doi: 10.1161/HCQ.0000000000000111. Epub 2022 Jun 23.
Yaghi S, Ryan MP, Gunnarsson CL, Irish W, Rosemas SC, Neisen K, Ziegler PD, Reynolds MR Longitudinal outcomes in cryptogenic stroke patients with and without long-term cardiac monitoring for atrial fibrillation. Heart Rhythm O2. 2022 Feb 13;3(3):223-230. doi: 10.1016/j.hroo.2022.02.006. eCollection 2022 Jun.
Velcea AE, Baldea SM, Cinteza M, Vinereanu D Three-Dimensional Echocardiography is a Feasible and Reproducible Method for the Measurement of Left Atrial Volumes, Regardless of Expertise Level. Maedica (Bucur). 2022 Mar;17(1):4-13. doi: 10.26574/maedica.2022.17.1.4.
Taub PR, Panda S Time for better time-restricted eating trials to lessen the burden of metabolic diseases. Cell Rep Med. 2022 Jun 21;3(6):100665. doi: 10.1016/j.xcrm.2022.100665.
Bressi E, Crawford TC, Bogun FM, Gu X, Ellenbogen KA, Chicos AB, Roukoz H, Zimetbaum PJ, Kalbfleisch SJ, Murgatroyd FD, Steckman DA, Rosenfeld LE, Garlitski AC, Soejima K, Bhan AK, Vedantham V, Dickfeld TM, De Lurgio DB, Platonov PG, Zipse MM, Nishiuchi S, Ortman ML, Narasimhan C, Patton KK, Rosenthal DG, Mukerji SS, Hoogendoorn JC, Zeppenfeld K, Sauer WH, Kron J, Cardiac Sarcoidosis Consortium * Arrhythmia Monitoring and Outcomes in Patients With Cardiac Sarcoidosis: Insights From the Cardiac Sarcoidosis Consortium. J Am Heart Assoc. 2022 Jul 5;11(13):e024924. doi: 10.1161/JAHA.121.024924. Epub 2022 Jun 22.
Vukadinovic D, Abdin A, Anker SD, Rosano GMC, Mahfoud F, Packer M, Butler J, Bohm M Side effects and treatment initiation barriers of sodium-glucose cotransporter 2 inhibitors in heart failure: a systematic review and meta-analysis. Eur J Heart Fail. 2022 Sep;24(9):1625-1632. doi: 10.1002/ejhf.2584. Epub 2022 Jul 8.
Butler J, Talha KM, Aktas MK, Zareba W, Goldenberg I Role of Implantable Cardioverter Defibrillator in Heart Failure With Contemporary Medical Therapy. Circ Heart Fail. 2022 Aug;15(8):e009634. doi: 10.1161/CIRCHEARTFAILURE.122.009634. Epub 2022 Jun 21.
Gulati M, Parwani P Myocardial Blood Flow Reserve: The Achilles’ Heel of CAD Prognostication? JACC Cardiovasc Imaging. 2022 Sep;15(9):1645-1647. doi: 10.1016/j.jcmg.2022.04.023. Epub 2022 Jun 15.
Perreault L, Davies M, Frias JP, Laursen PN, Lingvay I, Machineni S, Varbo A, Wilding JPH, Wallenstein SOR, le Roux CW Changes in Glucose Metabolism and Glycemic Status With Once-Weekly Subcutaneous Semaglutide 2.4 mg Among Participants With Prediabetes in the STEP Program. Diabetes Care. 2022 Oct 1;45(10):2396-2405. doi: 10.2337/dc21-1785.
Sukumar S, Orkaby AR, Schwartz JB, Marcum Z, Januzzi JL, Vaduganathan M, Warraich HJ Polypharmacy in Older Heart Failure Patients: a Multidisciplinary Approach. Curr Heart Fail Rep. 2022 Oct;19(5):290-302. doi: 10.1007/s11897-022-00559-w. Epub 2022 Jun 20.
Weissler EH, Wang Y, Gales JM, Feldman DN, Arya S, Secemsky EA, Aronow HD, Hawkins BM, Gutierrez JA, Patel MR, Curtis JP, Jones WS, Swaminathan RV Cardiovascular and Limb Events Following Endovascular Revascularization Among Patients >/=65 Years Old: An American College of Cardiology PVI Registry Analysis. J Am Heart Assoc. 2022 Jun 20;11(12):e024279. doi: 10.1161/JAHA.121.024279.
Chapman B, Hellkamp AS, Thomas LE, Albert NM, Butler J, Patterson JH, Hernandez AF, Williams FB, Shen X, Spertus JA, Fonarow GC, DeVore AD Angiotensin Receptor Neprilysin Inhibition and Associated Outcomes by Race and Ethnicity in Patients With Heart Failure With Reduced Ejection Fraction: Data From CHAMP-HF. J Am Heart Assoc. 2022 Jun 20;11(12):e022889. doi: 10.1161/JAHA.121.022889.
Ghuman JK, Tuttle KR Perspective on Nonsteroidal Mineralocorticoid Receptor Antagonism in Diabetic Kidney Disease. Kidney360. 2022 Jan 19;3(4):744-748. doi: 10.34067/KID.0007072021. eCollection 2022 Apr 28.
Hoenig MP, Parikh SM Mind the Cast: FENa versus Microscopy in AKI. Kidney360. 2022 Feb 17;3(4):583-585. doi: 10.34067/KID.0001212022. eCollection 2022 Apr 28.
Abra G, Poyan Mehr A, Chan CT, Schiller B The Implementation of a Virtual Home Dialysis Mentoring Program for Nephrologists. Kidney360. 2022 Jan 26;3(4):734-736. doi: 10.34067/KID.0000202022. eCollection 2022 Apr 28.
Kolkailah AA, Abougergi MS, Desai PV, Patel A, Fugar S, Okoh AK, Al-Ogaili A, Hirji SA, Kaneko T, Volgman AS, Doukky R, Grodin JL, McGuire DK Does the “July effect” of new trainees at teaching hospitals impact outcomes for patients hospitalized with heart failure? Real-world analyses of more than half a million US admissions. Am Heart J Plus. 2022 Jan;13:100072. doi: 10.1016/j.ahjo.2021.100072. Epub 2021 Nov 27.
Gorski M, Rasheed H, Teumer A, Thomas LF, Graham SE, Sveinbjornsson G, Winkler TW, Gunther F, Stark KJ, Chai JF, Tayo BO, Wuttke M, Li Y, Tin A, Ahluwalia TS, Arnlov J, Asvold BO, Bakker SJL, Banas B, Bansal N, Biggs ML, Biino G, Bohnke M, Boerwinkle E, Bottinger EP, Brenner H, Brumpton B, Carroll RJ, Chaker L, Chalmers J, Chee ML, Chee ML, Cheng CY, Chu AY, Ciullo M, Cocca M, Cook JP, Coresh J, Cusi D, de Borst MH, Degenhardt F, Eckardt KU, Endlich K, Evans MK, Feitosa MF, Franke A, Freitag-Wolf S, Fuchsberger C, Gampawar P, Gansevoort RT, Ghanbari M, Ghasemi S, Giedraitis V, Gieger C, Gudbjartsson DF, Hallan S, Hamet P, Hishida A, Ho K, Hofer E, Holleczek B, Holm H, Hoppmann A, Horn K, Hutri-Kahonen N, Hveem K, Hwang SJ, Ikram MA, Josyula NS, Jung B, Kahonen M, Karabegovic I, Khor CC, Koenig W, Kramer H, Kramer BK, Kuhnel B, Kuusisto J, Laakso M, Lange LA, Lehtimaki T, Li M, Lieb W, Lind L, Lindgren CM, Loos RJF, Lukas MA, Lyytikainen LP, Mahajan A, Matias-Garcia PR, Meisinger C, Meitinger T, Melander O, Milaneschi Y, Mishra PP, Mononen N, Morris AP, Mychaleckyj JC, Nadkarni GN, Naito M, Nakatochi M, Nalls MA, Nauck M, Nikus K, Ning B, Nolte IM, Nutile T, O’Donoghue ML, O’Connell J, Olafsson I, Orho-Melander M, Parsa A, Pendergrass SA, Penninx BWJH, Pirastu M, Preuss MH, Psaty BM, Raffield LM, Raitakari OT, Rheinberger M, Rice KM, Rizzi F, Rosenkranz AR, Rossing P, Rotter JI, Ruggiero D, Ryan KA, Sabanayagam C, Salvi E, Schmidt H, Schmidt R, Scholz M, Schottker B, Schulz CA, Sedaghat S, Shaffer CM, Sieber KB, Sim X, Sims M, Snieder H, Stanzick KJ, Thorsteinsdottir U, Stocker H, Strauch K, Stringham HM, Sulem P, Szymczak S, Taylor KD, Thio CHL, Tremblay J, Vaccargiu S, van der Harst P, van der Most PJ, Verweij N, Volker U, Wakai K, Waldenberger M, Wallentin L, Wallner S, Wang J, Waterworth DM, White HD, Willer CJ, Wong TY, Woodward M, Yang Q, Yerges-Armstrong LM, Zimmermann M, Zonderman AB, Bergler T, Stefansson K, Boger CA, Pattaro C, Kottgen A, Kronenberg F, Heid IM, Lifelines Cohort Study Genetic loci and prioritization of genes for kidney function decline derived from a meta-analysis of 62 longitudinal genome-wide association studies. Kidney Int. 2022 Sep;102(3):624-639. doi: 10.1016/j.kint.2022.05.021. Epub 2022 Jun 16.
Pandey AK, Bhatt DL, Cosentino F, Marx N, Rotstein O, Pitt B, Pandey A, Butler J, Verma S Non-steroidal mineralocorticoid receptor antagonists in cardiorenal disease. Eur Heart J. 2022 Aug 14;43(31):2931-2945. doi: 10.1093/eurheartj/ehac299.
Zannad F, Ferreira JP, Gregson J, Kraus BJ, Mattheus M, Hauske SJ, Butler J, Filippatos G, Wanner C, Anker SD, Pocock SJ, Packer M, EMPEROR-Reduced Trial Committees and Investigators Early changes in estimated glomerular filtration rate post-initiation of empagliflozin in EMPEROR-Reduced. Eur J Heart Fail. 2022 Oct;24(10):1829-1839. doi: 10.1002/ejhf.2578. Epub 2022 Jul 7.
Tan S, Day D, Nicholls SJ, Segelov E Atherosclerotic Cardiovascular Risk With Combination Avelumab and Axitinib. J Clin Oncol. 2022 Oct 10;40(29):3467-3469. doi: 10.1200/JCO.22.00712. Epub 2022 Jun 16.
Landmesser U, McGinniss J, Steg PG, Bhatt DL, Bittner VA, Diaz R, Dilic M, Goodman SG, Jukema JW, Loy M, Pecin I, Pordy R, Poulsen SH, Szarek M, White HD, Schwartz GG, ODYSSEY OUTCOMES Investigators Achievement of ESC/EAS LDL-C treatment goals after an acute coronary syndrome with statin and alirocumab. Eur J Prev Cardiol. 2022 Oct 20;29(14):1842-1851. doi: 10.1093/eurjpc/zwac107.
Li G, Zhang J, Van Spall HGC, Douglas PS, Wang Y, Sun X, Thabane L Exploring ethnic representativeness in diabetes clinical trial enrolment from 2000 to 2020: a chronological survey. Diabetologia. 2022 Sep;65(9):1461-1472. doi: 10.1007/s00125-022-05736-z. Epub 2022 Jun 16.
Deloughery TG, Hunt BJ, Barnes GD, Connors JM, WTD Steering Committee A call to action: MTHFR polymorphisms should not be a part of inherited thrombophilia testing. Res Pract Thromb Haemost. 2022 Jun 8;6(4):e12739. doi: 10.1002/rth2.12739. eCollection 2022 May.
Tan S, Thang YW, Mulley WR, Polkinghorne KR, Ramkumar S, Cheng K, Chan J, Galligan J, Nolan M, Brown AJ, Moir S, Cameron JD, Nicholls SJ, Mottram PM, Nerlekar N Prognostic Value of Exercise Capacity in Kidney Transplant Candidates. J Am Heart Assoc. 2022 Jun 21;11(12):e025862. doi: 10.1161/JAHA.121.025862. Epub 2022 Jun 14.
Winkler TW, Rasheed H, Teumer A, Gorski M, Rowan BX, Stanzick KJ, Thomas LF, Tin A, Hoppmann A, Chu AY, Tayo B, Thio CHL, Cusi D, Chai JF, Sieber KB, Horn K, Li M, Scholz M, Cocca M, Wuttke M, van der Most PJ, Yang Q, Ghasemi S, Nutile T, Li Y, Pontali G, Gunther F, Dehghan A, Correa A, Parsa A, Feresin A, de Vries APJ, Zonderman AB, Smith AV, Oldehinkel AJ, De Grandi A, Rosenkranz AR, Franke A, Teren A, Metspalu A, Hicks AA, Morris AP, Tonjes A, Morgan A, Podgornaia AI, Peters A, Korner A, Mahajan A, Campbell A, Freedman BI, Spedicati B, Ponte B, Schottker B, Brumpton B, Banas B, Kramer BK, Jung B, Asvold BO, Smith BH, Ning B, Penninx BWJH, Vanderwerff BR, Psaty BM, Kammerer CM, Langefeld CD, Hayward C, Spracklen CN, Robinson-Cohen C, Hartman CA, Lindgren CM, Wang C, Sabanayagam C, Heng CK, Lanzani C, Khor CC, Cheng CY, Fuchsberger C, Gieger C, Shaffer CM, Schulz CA, Willer CJ, Chasman DI, Gudbjartsson DF, Ruggiero D, Toniolo D, Czamara D, Porteous DJ, Waterworth DM, Mascalzoni D, Mook-Kanamori DO, Reilly DF, Daw EW, Hofer E, Boerwinkle E, Salvi E, Bottinger EP, Tai ES, Catamo E, Rizzi F, Guo F, Rivadeneira F, Guilianini F, Sveinbjornsson G, Ehret G, Waeber G, Biino G, Girotto G, Pistis G, Nadkarni GN, Delgado GE, Montgomery GW, Snieder H, Campbell H, White HD, Gao H, Stringham HM, Schmidt H, Li H, Brenner H, Holm H, Kirsten H, Kramer H, Rudan I, Nolte IM, Tzoulaki I, Olafsson I, Martins J, Cook JP, Wilson JF, Halbritter J, Felix JF, Divers J, Kooner JS, Lee JJ, O’Connell J, Rotter JI, Liu J, Xu J, Thiery J, Arnlov J, Kuusisto J, Jakobsdottir J, Tremblay J, Chambers JC, Whitfield JB, Gaziano JM, Marten J, Coresh J, Jonas JB, Mychaleckyj JC, Christensen K, Eckardt KU, Mohlke KL, Endlich K, Dittrich K, Ryan KA, Rice KM, Taylor KD, Ho K, Nikus K, Matsuda K, Strauch K, Miliku K, Hveem K, Lind L, Wallentin L, Yerges-Armstrong LM, Raffield LM, Phillips LS, Launer LJ, Lyytikainen LP, Lange LA, Citterio L, Klaric L, Ikram MA, Ising M, Kleber ME, Francescatto M, Concas MP, Ciullo M, Piratsu M, Orho-Melander M, Laakso M, Loeffler M, Perola M, de Borst MH, Gogele M, Bianca M, Lukas MA, Feitosa MF, Biggs ML, Wojczynski MK, Kavousi M, Kanai M, Akiyama M, Yasuda M, Nauck M, Waldenberger M, Chee ML, Chee ML, Boehnke M, Preuss MH, Stumvoll M, Province MA, Evans MK, O’Donoghue ML, Kubo M, Kahonen M, Kastarinen M, Nalls MA, Kuokkanen M, Ghanbari M, Bochud M, Josyula NS, Martin NG, Tan NYQ, Palmer ND, Pirastu N, Schupf N, Verweij N, Hutri-Kahonen N, Mononen N, Bansal N, Devuyst O, Melander O, Raitakari OT, Polasek O, Manunta P, Gasparini P, Mishra PP, Sulem P, Magnusson PKE, Elliott P, Ridker PM, Hamet P, Svensson PO, Joshi PK, Kovacs P, Pramstaller PP, Rossing P, Vollenweider P, van der Harst P, Dorajoo R, Sim RZH, Burkhardt R, Tao R, Noordam R, Magi R, Schmidt R, de Mutsert R, Rueedi R, van Dam RM, Carroll RJ, Gansevoort RT, Loos RJF, Felicita SC, Sedaghat S, Padmanabhan S, Freitag-Wolf S, Pendergrass SA, Graham SE, Gordon SD, Hwang SJ, Kerr SM, Vaccargiu S, Patil SB, Hallan S, Bakker SJL, Lim SC, Lucae S, Vogelezang S, Bergmann S, Corre T, Ahluwalia TS, Lehtimaki T, Boutin TS, Meitinger T, Wong TY, Bergler T, Rabelink TJ, Esko T, Haller T, Thorsteinsdottir U, Volker U, Foo VHX, Salomaa V, Vitart V, Giedraitis V, Gudnason V, Jaddoe VWV, Huang W, Zhang W, Wei WB, Kiess W, Marz W, Koenig W, Lieb W, Gao X, Sim X, Wang YX, Friedlander Y, Tham YC, Kamatani Y, Okada Y, Milaneschi Y, Yu Z, Stark KJ, Stefansson K, Boger CA, Hung AM, Kronenberg F, Kottgen A, Pattaro C, Heid IM, Lifelines cohort study, DiscovEHR/MyCode study, VA Million Veteran Program Differential and shared genetic effects on kidney function between diabetic and non-diabetic individuals. Commun Biol. 2022 Jun 13;5(1):580. doi: 10.1038/s42003-022-03448-z.
Capodanno D, Baber U, Bhatt DL, Collet JP, Dangas G, Franchi F, Gibson CM, Gwon HC, Kastrati A, Kimura T, Lemos PA, Lopes RD, Mehran R, O’Donoghue ML, Rao SV, Rollini F, Serruys PW, Steg PG, Storey RF, Valgimigli M, Vranckx P, Watanabe H, Windecker S, Angiolillo DJ P2Y(12) inhibitor monotherapy in patients undergoing percutaneous coronary intervention. Nat Rev Cardiol. 2022 Dec;19(12):829-844. doi: 10.1038/s41569-022-00725-6. Epub 2022 Jun 13.
Lee KK, Doudesis D, Anwar M, Astengo F, Chenevier-Gobeaux C, Claessens YE, Wussler D, Kozhuharov N, Strebel I, Sabti Z, deFilippi C, Seliger S, Moe G, Fernando C, Bayes-Genis A, van Kimmenade RRJ, Pinto Y, Gaggin HK, Wiemer JC, Mockel M, Rutten JHW, van den Meiracker AH, Gargani L, Pugliese NR, Pemberton C, Ibrahim I, Gegenhuber A, Mueller T, Neumaier M, Behnes M, Akin I, Bombelli M, Grassi G, Nazerian P, Albano G, Bahrmann P, Newby DE, Japp AG, Tsanas A, Shah ASV, Richards AM, McMurray JJV, Mueller C, Januzzi JL, Mills NL, CoDE-HF investigators Development and validation of a decision support tool for the diagnosis of acute heart failure: systematic review, meta-analysis, and modelling study. BMJ. 2022 Jun 13;377:e068424. doi: 10.1136/bmj-2021-068424.
Al-Lamee RK, Foley M, Rajkumar CA, Francis DP Revascularization in stable coronary artery disease. BMJ. 2022 Jun 13;377:e067085. doi: 10.1136/bmj-2021-067085.
Krawisz AK, Natesan S, Wadhera RK, Chen S, Song Y, Yeh RW, Jaff MR, Giri J, Julien H, Secemsky EA Differences in Comorbidities Explain Black-White Disparities in Outcomes After Femoropopliteal Endovascular Intervention. Circulation. 2022 Jul 19;146(3):191-200. doi: 10.1161/CIRCULATIONAHA.122.058998. Epub 2022 Jun 13.
Don CW, Zwischenberger BA, Kurlansky PA, Rao SV, Sharma G, Lawton JS, Tamis-Holland JE 2021 ACC/AHA/SCAI Coronary Artery Revascularization Guidelines for Managing the Nonculprit Artery in STEMI. JACC Case Rep. 2022 Apr 6;4(7):377-384. doi: 10.1016/j.jaccas.2022.02.003. eCollection 2022 Apr 6.
Cherney DZI, Cosentino F, Dagogo-Jack S, McGuire DK, Pratley RE, Frederich R, Maldonado M, Liu CC, Pong A, Cannon CP, VERTIS CV Investigators Initial eGFR Changes with Ertugliflozin and Associations with Clinical Parameters: Analyses from the VERTIS CV Trial. Am J Nephrol. 2022;53(7):516-525. doi: 10.1159/000524889. Epub 2022 Jun 10.
McCormick F, Held PJ, Chertow GM, Peters TG, Roberts JP Projecting the Economic Impact of Compensating Living Kidney Donors in the United States: Cost-Benefit Analysis Demonstrates Substantial Patient and Societal Gains. Value Health. 2022 Dec;25(12):2028-2033. doi: 10.1016/j.jval.2022.04.1732. Epub 2022 Jun 9.
Yuvaraj J, Isa M, Che ZC, Lim E, Nerlekar N, Nicholls SJ, Seneviratne S, Lin A, Dey D, Wong DTL Atherogenic index of plasma is associated with epicardial adipose tissue volume assessed on coronary computed tomography angiography. Sci Rep. 2022 Jun 10;12(1):9626. doi: 10.1038/s41598-022-13479-5.
Bose R, Montealegre-Gallegos M, Mitchell JD, Sharkey A, Sehgal S, Krajewski ML, Robitaille MJ, Katsiampoura A, Haering JM, Laham R, Mahmood F Curriculum for Subspecialty Anesthesia Training in Adult Structural Heart Disease Imaging: A Single-Center Experience. J Cardiothorac Vasc Anesth. 2022 Sep;36(9):3469-3474. doi: 10.1053/j.jvca.2022.04.047. Epub 2022 May 7.
Peters AE, Mentz RJ, Sun JL, Harrington JL, Fudim M, Alhanti B, Hernandez AF, Butler J, Starling RC, Greene SJ Patient-reported and Clinical Outcomes Among Patients Hospitalized for Heart Failure With Reduced Versus Preserved Ejection Fraction. J Card Fail. 2022 Dec;28(12):1652-1660. doi: 10.1016/j.cardfail.2022.05.010. Epub 2022 Jun 7.
Ferreira JP, Zannad F, Butler J, Filipattos G, Ritter I, Schuler E, Kraus BJ, Pocock SJ, Anker SD, Packer M Empagliflozin and serum potassium in heart failure: an analysis from EMPEROR-Pooled. Eur Heart J. 2022 Aug 14;43(31):2984-2993. doi: 10.1093/eurheartj/ehac306.
Mompeon A, Perez-Cremades D, Paes AB, Sanchis J, Ortega-Paz L, Andrea R, Brugaletta S, Sabate M, Novella S, Dantas AP, Hermenegildo C Circulating miRNA Fingerprint and Endothelial Function in Myocardial Infarction: Comparison at Acute Event and One-Year Follow-Up. Cells. 2022 Jun 2;11(11):1823. doi: 10.3390/cells11111823.
Iwai T, Kataoka Y, Nicholls SJ, Puri R, Murata S, Nishimura K, Murai K, Kitahara S, Sawada K, Matama H, Honda S, Takagi K, Fujino M, Yoneda S, Otsuka F, Nishihira K, Asaumi Y, Miyamoto Y, Yasuda S, Noguchi T Phenotypic Features of Coronary Atheroma in Diabetic and Nondiabetic Patients With Low-Density Lipoprotein Cholesterol <55 mg/dL. JACC Cardiovasc Imaging. 2022 Jun;15(6):1166-1169. doi: 10.1016/j.jcmg.2022.02.005. Epub 2022 Apr 13.
Figtree GA, Redfors B, Kozor R, Vernon ST, Grieve SM, Mazhar J, Thiele H, Patel MR, Udelson JE, Selker HP, Ohman EM, Maehara A, Karmpaliotis D, Eitel I, Granger CB, Ben-Yehuda O, Stone GW, Kosmidou I Clinical Outcomes in Patients With ST-Segment Elevation MI and No Standard Modifiable Cardiovascular Risk Factors. JACC Cardiovasc Interv. 2022 Jun 13;15(11):1167-1175. doi: 10.1016/j.jcin.2022.03.036.
Verma S, Pandey A, Bhatt DL Forecasting Heart Failure Risk in Diabetes. J Am Coll Cardiol. 2022 Jun 14;79(23):2294-2297. doi: 10.1016/j.jacc.2022.04.011.
Martin TR, Zemans RL, Ware LB, Schmidt EP, Riches DWH, Bastarache L, Calfee CS, Desai TJ, Herold S, Hough CL, Looney MR, Matthay MA, Meyer N, Parikh SM, Stevens T, Thompson BT New Insights into Clinical and Mechanistic Heterogeneity of the Acute Respiratory Distress Syndrome: Summary of the Aspen Lung Conference 2021. Am J Respir Cell Mol Biol. 2022 Sep;67(3):284-308. doi: 10.1165/rcmb.2022-0089WS.
Rawshani A, Sattar N, McGuire DK, Wallstrom O, Smith U, Boren J, Bergstrom G, Omerovic E, Rosengren A, Eliasson B, Bhatt DL, Rawshani A Left-Sided Degenerative Valvular Heart Disease in Type 1 and Type 2 Diabetes. Circulation. 2022 Aug 2;146(5):398-411. doi: 10.1161/CIRCULATIONAHA.121.058072. Epub 2022 Jun 9.
Lee KH, Lioutas VA, Marchina S, Selim M, iDEF Investigators The Prognostic Roles of Perihematomal Edema and Ventricular Size in Patients with Intracerebral Hemorrhage. Neurocrit Care. 2022 Oct;37(2):455-462. doi: 10.1007/s12028-022-01532-0. Epub 2022 Jun 8.
Vogel RF, Delewi R, Wilschut JM, Lemmert ME, Diletti R, van Vliet R, van der Waarden NWPL, Nuis RJ, Paradies V, Alexopoulos D, Zijlstra F, Montalescot G, Angiolillo DJ, Krucoff MW, Smits PC, Van Mieghem NM, Vlachojannis GJ Pre-hospital treatment with crushed versus integral tablets of prasugrel in patients presenting with ST-Segment Elevation Myocardial Infarction-1-year follow-up results of the COMPARE CRUSH trial. Am Heart J. 2022 Oct;252:26-30. doi: 10.1016/j.ahj.2022.05.022. Epub 2022 Jun 6.
Nicolajsen CW, Sogaard M, Eldrup N, Jensen M, Larsen TB, Goldhaber SZ, Nielsen PB Temporal trends in abdominal aortic aneurysmal disease: a nationwide cohort study on cardiovascular morbidity and medical cardioprotective therapy. Eur J Prev Cardiol. 2022 Nov 8;29(15):1957-1964. doi: 10.1093/eurjpc/zwac105.
Nayak A, Mehra MR Global challenges in left ventricular assist device therapy: a tale across two continents. Eur J Heart Fail. 2022 Jul;24(7):1316-1318. doi: 10.1002/ejhf.2570. Epub 2022 Jun 19.
Januzzi JL Jr, Butler J, Zannad F, Filippatos G, Ferreira JP, Pocock SJ, Sattar N, Verma S, Vedin O, Iwata T, Brueckmann M, Packer M, Anker SD, EMPEROR-Preserved Trial Study Group Prognostic Implications of N-Terminal Pro-B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin T in EMPEROR-Preserved. JACC Heart Fail. 2022 Jul;10(7):512-524. doi: 10.1016/j.jchf.2022.05.004. Epub 2022 Jun 1.
Sinha A, Bavishi A, Hibler EA, Yang EH, Parashar S, Okwuosa T, DeCara JM, Brown SA, Guha A, Sadler D, Khan SS, Shah SJ, Yancy CW, Akhter N Interconnected Clinical and Social Risk Factors in Breast Cancer and Heart Failure. Front Cardiovasc Med. 2022 May 20;9:847975. doi: 10.3389/fcvm.2022.847975. eCollection 2022.
Damman K, Van Spall HGC In HF with mitral regurgitation, adding transcatheter mitral valve repair to medical therapy improved renal outcomes at 2 y. Ann Intern Med. 2022 Jun;175(6):JC65. doi: 10.7326/J22-0037. Epub 2022 Jun 7.
Sharma A, Verma S, Bhatt DL, Connelly KA, Swiggum E, Vaduganathan M, Zieroth S, Butler J Optimizing Foundational Therapies in Patients With HFrEF: How Do We Translate These Findings Into Clinical Care? JACC Basic Transl Sci. 2022 Mar 2;7(5):504-517. doi: 10.1016/j.jacbts.2021.10.018. eCollection 2022 May.
Tuttle KR, Agarwal R, Alpers CE, Bakris GL, Brosius FC, Kolkhof P, Uribarri J Molecular mechanisms and therapeutic targets for diabetic kidney disease. Kidney Int. 2022 Aug;102(2):248-260. doi: 10.1016/j.kint.2022.05.012. Epub 2022 Jun 3.
Shoamanesh A, Selim M Use of Lipid-Lowering Drugs After Intracerebral Hemorrhage. Stroke. 2022 Jul;53(7):2161-2170. doi: 10.1161/STROKEAHA.122.036889. Epub 2022 Jun 6.
Lavie CJ, daSilva-deAbreu A, Ventura HO, Mehra MR Is There an Obesity Paradox in Cardiogenic Shock? J Am Heart Assoc. 2022 Jun 7;11(11):e026088. doi: 10.1161/JAHA.122.026088. Epub 2022 Jun 6.
Tripathi R, Morales J, Lee V, Gibson CM, Mack MJ, Schneider DJ, Douketis J, Sellke FW, Ohman ME, Thourani VH, Storey RF, Deliargyris EN Antithrombotic drug removal from whole blood using Haemoadsorption with a porous polymer bead sorbent. Eur Heart J Cardiovasc Pharmacother. 2022 Dec 2;8(8):847-856. doi: 10.1093/ehjcvp/pvac036.
Segar MW, Patel KV, Hellkamp AS, Vaduganathan M, Lokhnygina Y, Green JB, Wan SH, Kolkailah AA, Holman RR, Peterson ED, Kannan V, Willett DL, McGuire DK, Pandey A Validation of the WATCH-DM and TRS-HF(DM) Risk Scores to Predict the Risk of Incident Hospitalization for Heart Failure Among Adults With Type 2 Diabetes: A Multicohort Analysis. J Am Heart Assoc. 2022 Jun 7;11(11):e024094. doi: 10.1161/JAHA.121.024094. Epub 2022 Jun 3.
Butler J, Stebbins A, Melenovsky V, Sweitzer NK, Cowie MR, Stehlik J, Khan MS, Blaustein RO, Ezekowitz JA, Hernandez AF, Lam CSP, Nkulikiyinka R, O’Connor CM, Pieske BM, Ponikowski P, Spertus JA, Voors AA, Anstrom KJ, Armstrong PW, VICTORIA Study Group Vericiguat and Health-Related Quality of Life in Patients With Heart Failure With Reduced Ejection Fraction: Insights From the VICTORIA Trial. Circ Heart Fail. 2022 Jun;15(6):e009337. doi: 10.1161/CIRCHEARTFAILURE.121.009337. Epub 2022 Jun 3.
Harrington J, Jones WS, Udell JA, Hannan K, Bhatt DL, Anker SD, Petrie MC, Vedin O, Butler J, Hernandez AF Acute Decompensated Heart Failure in the Setting of Acute Coronary Syndrome. JACC Heart Fail. 2022 Jun;10(6):404-414. doi: 10.1016/j.jchf.2022.02.008. Epub 2022 May 4.
Tayal U, Verdonschot JAJ, Hazebroek MR, Howard J, Gregson J, Newsome S, Gulati A, Pua CJ, Halliday BP, Lota AS, Buchan RJ, Whiffin N, Kanapeckaite L, Baruah R, Jarman JWE, O’Regan DP, Barton PJR, Ware JS, Pennell DJ, Adriaans BP, Bekkers SCAM, Donovan J, Frenneaux M, Cooper LT, Januzzi JL Jr, Cleland JGF, Cook SA, Deo RC, Heymans SRB, Prasad SK Precision Phenotyping of Dilated Cardiomyopathy Using Multidimensional Data. J Am Coll Cardiol. 2022 Jun 7;79(22):2219-2232. doi: 10.1016/j.jacc.2022.03.375.
Park DY, Wang P, An S, Grimshaw AA, Frampton J, Ohman EM, Rao SV, Nanna MG Shortening the duration of dual antiplatelet therapy after percutaneous coronary intervention for acute coronary syndrome: A systematic review and meta-analysis. Am Heart J. 2022 Sep;251:101-114. doi: 10.1016/j.ahj.2022.05.019. Epub 2022 May 30.
Kerneis M, Cosentino F, Ferrari R, Georges JL, Kosmachova E, Laroche C, Maggioni AP, Rittger H, Steg PG, Maczynska J, Tavazzi L, Valgimigli M, Gale CP, Komajda M, CICD investigators group Impact of chronic coronary syndromes on cardiovascular hospitalization and mortality: the ESC-EORP CICD-LT registry. Eur J Prev Cardiol. 2022 Nov 8;29(15):1945-1954. doi: 10.1093/eurjpc/zwac089.
Giannopoulos S, Secemsky EA, Schneider PA, Armstrong EJ Concomitant Drug-Coated Balloon Angioplasty With Bail-Out Use of Eluvia Drug-Eluting Stent: Is There Any Downside to a Double Dose of Paclitaxel? J Invasive Cardiol. 2022 Jun;34(6):E469-E476. doi: 10.25270/jic/21.00354.
Sadeh B, Ugolini S, Pinzon OW, Potapov EV, Selzman CH, Bader F, Zuckermann AO, Gomez-Mesa JE, Shah KS, Alharethi R, Morejon-Barragan P, Hanff T, Goldraich LA, Farrero M, MacDonald PS, Drakos S, Mehra MR, Stehlik J Medical decisions in organ donors and heart transplant candidates with history of COVID-19 infection: An international practice survey. Clin Transplant. 2022 Jul;36(7):e14733. doi: 10.1111/ctr.14733. Epub 2022 Jun 8.
Nguyen DQ, Huntley GD, Zaki TA, McGuire DK Recurrent pericardial effusion and tamponade after epicardial pacemaker lead placement: a case report. Eur Heart J Case Rep. 2022 Mar 11;6(4):ytac114. doi: 10.1093/ehjcr/ytac114. eCollection 2022 Apr.
Tuttle KR, Wong L, St Peter W, Roberts G, Rangaswami J, Mottl A, Kliger AS, Harris RC, Gee PO, Fowler K, Cherney D, Brosius FC 3rd, Argyropoulos C, Quaggin SE, Diabetic Kidney Disease Collaborative Task Force Moving from Evidence to Implementation of Breakthrough Therapies for Diabetic Kidney Disease. Clin J Am Soc Nephrol. 2022 Jul;17(7):1092-1103. doi: 10.2215/CJN.02980322. Epub 2022 Jun 1.
Baumhove L, Tromp J, Figarska S, van Essen BJ, Anker SD, Dickstein K, Cleland JG, Lang CC, Filippatos G, Ng LL, Samani NJ, Metra M, van Veldhuisen DJ, Lam CSP, Voors AA, van der Meer P Heart failure with normal LVEF in BIOSTAT-CHF. Int J Cardiol. 2022 Oct 1;364:85-90. doi: 10.1016/j.ijcard.2022.05.054. Epub 2022 May 29.
Sax DR, Mark DG, Rana JS, Reed ME, Lindenfeld J, Stevenson LW, Storrow AB, Butler J, Pang PS, Collins SP Current Emergency Department Disposition of Patients With Acute Heart Failure: An Opportunity for Improvement. J Card Fail. 2022 Oct;28(10):1545-1559. doi: 10.1016/j.cardfail.2022.05.006. Epub 2022 May 29.
Bikdeli B, Zahedi Tajrishi F, Sadeghipour P, Talasaz AH, Fanikos J, Lippi G, Siegal DM, Eikelboom JW, Monreal M, Jimenez D, Connors JM, Ageno W, Barnes GD, Piazza G, Angiolillo DJ, Parikh SA, Kirtane AJ, Lopes RD, Bhatt DL, Weitz JI, Mehran R, Krumholz HM, Goldhaber SZ, Lip GYH Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants: A Review. JAMA Cardiol. 2022 Jul 1;7(7):747-759. doi: 10.1001/jamacardio.2022.1292.
Navarese EP, Grzelakowska K, Mangini F, Kubica J, Banach M, Benn M, Binder CJ, Boren J, Catapano A, Kronenberg F, Mallat Z, Moulin P, Oorni K, Ray KK, Roeters van Lennep JE, Romeo S, Tokgozoglu L, von Eckardstein A, Zambon A, Raggi P The spoils of war and the long-term spoiling of health conditions of entire nations. Atherosclerosis. 2022 Jul;352:76-79. doi: 10.1016/j.atherosclerosis.2022.05.012. Epub 2022 May 21.
Chiang CE, Schwartz GG, Elbez Y, Szarek M, Bhatt DL, Bittner VA, Diaz R, Erglis A, Goodman SG, Hagstrom E, Jukema JW, Liberopoulos E, Loy M, Pordy R, White HD, Simon T, Steg PG, ODYSSEY OUTCOMES Investigators Alirocumab and Cardiovascular Outcomes in Patients With Previous Myocardial Infarction: Prespecified Subanalysis From ODYSSEY OUTCOMES. Can J Cardiol. 2022 Oct;38(10):1542-1549. doi: 10.1016/j.cjca.2022.05.021. Epub 2022 May 27.
Rimsans J, Sylvester K, Kim M, Connors JM, Gabardi S A Review of Direct-acting Oral Anticoagulants and Their Use in Solid Organ Transplantation. Transplantation. 2022 Nov 1;106(11):2143-2154. doi: 10.1097/TP.0000000000004195. Epub 2022 Jun 1.
Greene SJ, Lautsch D, Gaggin HK, Djatche LM, Zhou M, Song Y, Signorovitch J, Stevenson AS, Blaustein RO, Butler J Contemporary outpatient management of patients with worsening heart failure with reduced ejection fraction: Rationale and design of the CHART-HF study. Am Heart J. 2022 Sep;251:127-136. doi: 10.1016/j.ahj.2022.05.016. Epub 2022 May 29.
Ganesananthan S, Rajkumar CA, Foley M, Thompson D, Nowbar AN, Seligman H, Petraco R, Sen S, Nijjer S, Thom SA, Wensel R, Davies J, Francis D, Shun-Shin M, Howard J, Al-Lamee R Cardiopulmonary exercise testing and efficacy of percutaneous coronary intervention: a substudy of the ORBITA trial. Eur Heart J. 2022 Sep 1;43(33):3132-3145. doi: 10.1093/eurheartj/ehac260.
Suzuki Y, Kaneko H, Yano Y, Okada A, Itoh H, Matsuoka S, Fujiu K, Michihata N, Jo T, Takeda N, Morita H, Matsunaga A, Node K, McEvoy JW, Lam CSP, Oparil S, Yasunaga H, Komuro I Association of Cardiovascular Health Metrics With Risk of Transition to Hypertension in Non-Hypertensive Young Adults. Am J Hypertens. 2022 Oct 3;35(10):858-866. doi: 10.1093/ajh/hpac057.
Kam AW, Pasquale DD, Serrone JC, Reynolds MR Commentary on “Outcomes of Stroke Thrombectomy Performed by Interventional Radiologists versus Neurointerventional Physicians”. J Vasc Interv Radiol. 2022 Jun;33(6):627-630. doi: 10.1016/j.jvir.2022.04.001.
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M, Burri H, Butler J, Celutkiene J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Piepoli MF, Price S, Rosano GMC, Ruschitzka F, Skibelund AK, ESC Scientific Document Group 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. Rev Esp Cardiol (Engl Ed). 2022 Jun;75(6):523. doi: 10.1016/j.rec.2022.05.005.
McDonald SA, Peterson ED The HEART Pathway: Just a HEART score permutation or the future of clinical decision rules? Acad Emerg Med. 2022 Aug;29(8):1037-1039. doi: 10.1111/acem.14542. Epub 2022 Jun 19.
Ebrahimzadeh SA, Manzoor K, Edlow JA, Selim M, Chang YM, Bhadelia RA, Mehta P Diagnostic yield of CT angiography performed for suspected cervical artery dissection in the emergency department. Emerg Radiol. 2022 Oct;29(5):825-832. doi: 10.1007/s10140-022-02065-x. Epub 2022 May 30.
Rymer JA, Bhatt DL, Angiolillo DJ, Diaz M, Garratt KN, Waksman R, Edwards L, Tasissa G, Salahuddin K, El-Sabae H, Dell’Anna C, Davidson-Ray L, Washam JB, Ohman EM, Wang TY Cangrelor Use Patterns and Transition to Oral P2Y(12) Inhibitors Among Patients With Myocardial Infarction: Initial Results From the CAMEO Registry. J Am Heart Assoc. 2022 Jun 7;11(11):e024513. doi: 10.1161/JAHA.121.024513. Epub 2022 May 27.
Araiza-Garaygordobil D, Baeza-Herrera LA, Gopar-Nieto R, Solis-Jimenez F, Cabello-Lopez A, Martinez-Amezcua P, Sarabia-Chao V, Gonzalez-Pacheco H, Sierra-Lara Martinez D, Briseno-De la Cruz JL, Arias-Mendoza A Pulmonary Congestion Assessed by Lung Ultrasound and Cardiovascular Outcomes in Patients With ST-Elevation Myocardial Infarction. Front Physiol. 2022 May 10;13:881626. doi: 10.3389/fphys.2022.881626. eCollection 2022.
Ormiston CK, Padilla E, Van DT, Boone C, You S, Roberts AC, Hsiao A, Taub PR May-Thurner syndrome in patients with postural orthostatic tachycardia syndrome and Ehlers-Danlos syndrome: a case series. Eur Heart J Case Rep. 2022 Apr 9;6(4):ytac161. doi: 10.1093/ehjcr/ytac161. eCollection 2022 Apr.
Zullig LL, Peterson ED, Shah BR, Grambow SC, Oddone EZ, McCant F, Lindquist JH, Bosworth HB Secondary Prevention Risk Interventions via Telemedicine and Tailored Patient Education (SPRITE): A randomized trial to improve post myocardial infarction management. Patient Educ Couns. 2022 Sep;105(9):2962-2968. doi: 10.1016/j.pec.2022.05.011. Epub 2022 May 18.
Rajkumar CA, Wereski R, Parsonage W, Cullen L, Khamis R, Foley M, Harrell FE Jr, Shun-Shin MJ, Mills NL, Al-Lamee RK Association Between High-Sensitivity Cardiac Troponin, Myocardial Ischemia, and Revascularization in Stable Coronary Artery Disease. J Am Coll Cardiol. 2022 May 31;79(21):2185-2187. doi: 10.1016/j.jacc.2022.03.369.
Wolf C, Mandel E, Peniuta M, Lazure P, Smith NE, Peterson ED, Peloquin S Do Physician Assistant Training Programs Adequately Prepare PAs to Address Nutritional Issues in Clinical Practice? J Physician Assist Educ. 2022 Jun 1;33(2):94-100. doi: 10.1097/JPA.0000000000000426.
Pandey A, Segar MW, Singh S, Reeves GR, O’Connor C, Pina I, Whellan D, Kraus WE, Mentz RJ, Kitzman DW Frailty Status Modifies the Efficacy of Exercise Training Among Patients With Chronic Heart Failure and Reduced Ejection Fraction: An Analysis From the HF-ACTION Trial. Circulation. 2022 Jul 12;146(2):80-90. doi: 10.1161/CIRCULATIONAHA.122.059983. Epub 2022 May 26.
Narang N, Thibodeau JT, Parker WF, Grodin JL, Garg S, Tedford RJ, Levine BD, McGuire DK, Drazner MH Comparison of Accuracy of Estimation of Cardiac Output by Thermodilution Versus the Fick Method Using Measured Oxygen Uptake. Am J Cardiol. 2022 Aug 1;176:58-65. doi: 10.1016/j.amjcard.2022.04.026. Epub 2022 May 22.
Zhang J, Van Spall HGC, Wang Y, Thabane L, Wang R, Li G Enrollment of Black, Indigenous, and Other People of Color in Multicountry Randomized Controlled Trials of Diabetes Conducted in North America and Europe. Diabetes Care. 2022 Jul 7;45(7):e116-e117. doi: 10.2337/dc22-0261.
Anker SD, Butler J, Packer M Empagliflozin in Heart Failure with a Preserved Ejection Fraction. Reply. N Engl J Med. 2022 May 26;386(21):e57. doi: 10.1056/NEJMc2118470.
Bahit MC, Vora AN, Li Z, Wojdyla DM, Thomas L, Goodman SG, Aronson R, Jordan JD, Kolls BJ, Dombrowski KE, Vinereanu D, Halvorsen S, Berwanger O, Windecker S, Mehran R, Granger CB, Alexander JH, Lopes RD Apixaban or Warfarin and Aspirin or Placebo After Acute Coronary Syndrome or Percutaneous Coronary Intervention in Patients With Atrial Fibrillation and Prior Stroke: A Post Hoc Analysis From the AUGUSTUS Trial. JAMA Cardiol. 2022 Jul 1;7(7):682-689. doi: 10.1001/jamacardio.2022.1166.
Dauerman HL Medicine, Writing, and the Limits of Language. JAMA Cardiol. 2022 Aug 1;7(8):783-784. doi: 10.1001/jamacardio.2022.0995.
Lin D, Minyetty M, Selim M, Marchina S, Carvalho F, Heistand E, Bhanu G, Hasan S, Kumar S Predicting Gastrostomy Tube Placement After Intracerebral Hemorrhage: External Validation of the GRAVo Score. Neurocrit Care. 2022 Oct;37(2):506-513. doi: 10.1007/s12028-022-01523-1. Epub 2022 May 23.
Mehta A, Jain V, Saeed A, Saseen JJ, Gulati M, Ballantyne CM, Virani SS Lipoprotein(a) and ethnicities. Atherosclerosis. 2022 May;349:42-52. doi: 10.1016/j.atherosclerosis.2022.04.005.
Przewlocka-Kosmala M, Butler J, Donal E, Ponikowski P, Kosmala W Prognostic Value of the MAGGIC Score, H(2)FPEF Score, and HFA-PEFF Algorithm in Patients with Exertional Dyspnea and the Incremental Value of Exercise Echocardiography. J Am Soc Echocardiogr. 2022 Sep;35(9):966-975. doi: 10.1016/j.echo.2022.05.006. Epub 2022 May 21.
Taegtmeyer H, Zaha VG, McGuire DK 2022 Beijing Winter Olympics: Spotlight on Cardiac Metabolism. Circulation. 2022 May 24;145(21):1561-1562. doi: 10.1161/CIRCULATIONAHA.122.059905. Epub 2022 May 23.
Anker SD, Siddiqi TJ, Filippatos G, Zannad F, Ferreira JP, Pocock SJ, Brueckmann M, Zeller C, Packer M, Butler J Outcomes with empagliflozin in heart failure with preserved ejection fraction using DELIVER-like endpoint definitions. Eur J Heart Fail. 2022 Aug;24(8):1400-1405. doi: 10.1002/ejhf.2558. Epub 2022 Jun 5.
Segar MW, Kolkailah AA, Frederich R, Pong A, Cannon CP, Cosentino F, Dagogo-Jack S, McGuire DK, Pratley RE, Liu CC, Maldonado M, Liu J, Cater NB, Pandey A, Cherney DZI Mediators of ertugliflozin effects on heart failure and kidney outcomes among patients with type 2 diabetes mellitus. Diabetes Obes Metab. 2022 Sep;24(9):1829-1839. doi: 10.1111/dom.14769. Epub 2022 Jun 15.
Selvaraj S, Fu Z, Jones P, Kwee LC, Windsor SL, Ilkayeva O, Newgard CB, Margulies KB, Husain M, Inzucchi SE, McGuire DK, Pitt B, Scirica BM, Lanfear DE, Nassif ME, Javaheri A, Mentz RJ, Kosiborod MN, Shah SH, DEFINE-HF Investigators Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HF. Circulation. 2022 Sep 13;146(11):808-818. doi: 10.1161/CIRCULATIONAHA.122.060402. Epub 2022 May 23.
Gibson CM, Hall B, Kwon HI, Davis S, Bradford D, Howard ML Safety and Efficacy of Indomethacin for Reducing Chest Tube Duration After Coronary Artery Bypass Grafting Surgery. J Pharm Technol. 2022 Jun;38(3):148-154. doi: 10.1177/87551225221074588. Epub 2022 Jan 28.
Welsh RC, Kay R, Bainey KR Evaluation and management of chronic kidney disease patients with stable ischemic heart disease. Atherosclerosis. 2022 Jun;351:26-28. doi: 10.1016/j.atherosclerosis.2022.05.005. Epub 2022 May 16.
Frere C, Farge D, Schrag D, Prata PH, Connors JM Direct oral anticoagulant versus low molecular weight heparin for the treatment of cancer-associated venous thromboembolism: 2022 updated systematic review and meta-analysis of randomized controlled trials. J Hematol Oncol. 2022 May 21;15(1):69. doi: 10.1186/s13045-022-01289-1.
Rampon G, Jia S, Agrawal R, Arnold N, Martin-Quiromicrons A, Fischer EA, Malatack J, Jagan N, Sergew A, Case AH, Miller K, Tanios M, Doros G, Ross CS, Garcia MA, Gillmeyer KR, Griffiths NG, Jandali B, Modzelewski KL, Rucci JM, Simpson SQ, Walkey AJ, Bosch NA Smartphone-Guided Self-prone Positioning vs Usual Care in Nonintubated Hospital Ward Patients With COVID-19: A Pragmatic Randomized Clinical Trial. Chest. 2022 Oct;162(4):782-791. doi: 10.1016/j.chest.2022.05.009. Epub 2022 May 18.
Ravera A, Santema BT, de Boer RA, Anker SD, Samani NJ, Lang CC, Ng L, Cleland JGF, Dickstein K, Lam CSP, Van Spall HGC, Filippatos G, van Veldhuisen DJ, Metra M, Voors AA, Sama IE Distinct pathophysiological pathways in women and men with heart failure. Eur J Heart Fail. 2022 Sep;24(9):1532-1544. doi: 10.1002/ejhf.2534. Epub 2022 Jun 3.
Girerd N, Cleland J, Anker SD, Byra W, Lam CSP, Lapolice D, Mehra MR, van Veldhuisen DJ, Bresso E, Lamiral Z, Greenberg B, Zannad F Inflammation and remodeling pathways and risk of cardiovascular events in patients with ischemic heart failure and reduced ejection fraction. Sci Rep. 2022 May 20;12(1):8574. doi: 10.1038/s41598-022-12385-0.
Harrington J, Udell JA, Jones WS, Anker SD, Bhatt DL, Petrie MC, Vedin O, Sumin M, Zwiener I, Hernandez AF, Butler J Empagliflozin in patients post myocardial infarction rationale and design of the EMPACT-MI trial. Am Heart J. 2022 Nov;253:86-98. doi: 10.1016/j.ahj.2022.05.010. Epub 2022 May 17.
Secemsky EA, Song Y, Schermerhorn M, Yeh RW Update From the Longitudinal Assessment of Safety of Femoropopliteal Endovascular Treatment With Paclitaxel-Coated Devices Among Medicare Beneficiaries: The SAFE-PAD Study. Circ Cardiovasc Interv. 2022 Jun;15(6):e012074. doi: 10.1161/CIRCINTERVENTIONS.122.012074. Epub 2022 May 20.
Jozwiak JJ, Kasperczyk S, Tomasik T, Osadnik T, Windak A, Studzinski K, Mastej M, Catapano A, Ray KK, Mikhailidis DP, Toth PP, Howard G, Lip GYH, Tomaszewski M, Charchar FJ, Sattar N, Williams B, MacDonald TM, Krzemien P, Dobrakowski M, Kasperczyk A, Nowak D, Skowron L, Zak Z, Lewek J, Banach M Design and rationale of a nationwide screening analysis from the LIPIDOGRAM2015 and LIPIDOGEN2015 studies. Arch Med Sci. 2020 Jun 4;18(3):604-616. doi: 10.5114/aoms.2020.96052. eCollection 2022.
Karimi Galougahi K, Mohebi R, Chertow GM, Ali ZA Reply: Alterations in Practice Because of Contrast-Associated Acute Kidney Injury Following PCI: An Example of “Renalism”. JACC Cardiovasc Interv. 2022 May 23;15(10):1093-1094. doi: 10.1016/j.jcin.2022.04.020.
Udell JA, Jones WS, Petrie MC, Harrington J, Anker SD, Bhatt DL, Hernandez AF, Butler J Sodium Glucose Cotransporter-2 Inhibition for Acute Myocardial Infarction: JACC Review Topic of the Week. J Am Coll Cardiol. 2022 May 24;79(20):2058-2068. doi: 10.1016/j.jacc.2022.03.353.
Klok FA, Piazza G, Sharp ASP, Ni Ainle F, Jaff MR, Chauhan N, Patel B, Barco S, Goldhaber SZ, Kucher N, Lang IM, Schmidtmann I, Sterling KM, Becker D, Martin N, Rosenfield K, Konstantinides SV Ultrasound-facilitated, catheter-directed thrombolysis vs anticoagulation alone for acute intermediate-high-risk pulmonary embolism: Rationale and design of the HI-PEITHO study. Am Heart J. 2022 Sep;251:43-53. doi: 10.1016/j.ahj.2022.05.011. Epub 2022 May 16.
Cheng XS, Liu S, Han J, Stedman MR, Chertow GM, Tan JC, Fearon WF Trends in Coronary Artery Disease Screening before Kidney Transplantation. Kidney360. 2021 Dec 9;3(3):516-523. doi: 10.34067/KID.0005282021. eCollection 2022 Mar 31.
Usman MS, Van Spall HGC, Greene SJ, Pandey A, McGuire DK, Ali ZA, Mentz RJ, Fonarow GC, Spertus JA, Anker SD, Butler J, James SK, Khan MS The need for increased pragmatism in cardiovascular clinical trials. Nat Rev Cardiol. 2022 Nov;19(11):737-750. doi: 10.1038/s41569-022-00705-w. Epub 2022 May 17.
Parwani PJ, Van Spall HGC, Mamas M Representation of women in heart failure trials: does it matter? Heart. 2022 Sep 12;108(19):1508-1509. doi: 10.1136/heartjnl-2022-321094.
Valgimigli M, Smits PC, Frigoli E, Bongiovanni D, Tijssen J, Hovasse T, Mafragi A, Ruifrok WT, Karageorgiev D, Aminian A, Garducci S, Merkely B, Routledge H, Ando K, Diaz Fernandez JF, Cuisset T, Nesa Malik FT, Halabi M, Belle L, Din J, Beygui F, Abhyankar A, Reczuch K, Pedrazzini G, Heg D, Vranckx P, MASTER DAPT Investigators Duration of antiplatelet therapy after complex percutaneous coronary intervention in patients at high bleeding risk: a MASTER DAPT trial sub-analysis. Eur Heart J. 2022 Sep 1;43(33):3100-3114. doi: 10.1093/eurheartj/ehac284.
Zeitouni M, Marquis-Gravel G, Smilowitz NR, Zakroysky P, Wojdyla DM, Amit AP, Rao SV, Wang TY Prophylactic Mechanical Circulatory Support Use in Elective Percutaneous Coronary Intervention for Patients With Stable Coronary Artery Disease. Circ Cardiovasc Interv. 2022 May;15(5):e011534. doi: 10.1161/CIRCINTERVENTIONS.121.011534. Epub 2022 May 17.
Greenberg SM, Ziai WC, Cordonnier C, Dowlatshahi D, Francis B, Goldstein JN, Hemphill JC 3rd, Johnson R, Keigher KM, Mack WJ, Mocco J, Newton EJ, Ruff IM, Sansing LH, Schulman S, Selim MH, Sheth KN, Sprigg N, Sunnerhagen KS, American Heart Association/American Stroke Association 2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage: A Guideline From the American Heart Association/American Stroke Association. Stroke. 2022 Jul;53(7):e282-e361. doi: 10.1161/STR.0000000000000407. Epub 2022 May 17.
Angraal S, Hejjaji V, Tang Y, Gosch KL, Patel MR, Heyligers J, White CJ, Tutein Nolthenius R, Mena-Hurtado C, Aronow HD, Moneta GL, Fitridge R, Soukas PA, Abbott JD, Secemsky EA, Spertus JA, Smolderen KG One-Year Health Status Outcomes Following Early Invasive and Noninvasive Treatment in Symptomatic Peripheral Artery Disease. Circ Cardiovasc Interv. 2022 Jun;15(6):e011506. doi: 10.1161/CIRCINTERVENTIONS.121.011506. Epub 2022 May 17.
Marchina S, Trevino-Calderon JA, Hassani S, Massaro JM, Lioutas VA, Carvalho F, Selim M Perihematomal Edema and Clinical Outcome After Intracerebral Hemorrhage: A Systematic Review and Meta-Analysis. Neurocrit Care. 2022 Aug;37(1):351-362. doi: 10.1007/s12028-022-01512-4. Epub 2022 May 16.
Osibogun O, Ogunmoroti O, Kolade OB, Hays AG, Okunrintemi V, Minhas AS, Gulati M, Michos ED A Systematic Review and Meta-Analysis of the Association Between Polycystic Ovary Syndrome and Coronary Artery Calcification. J Womens Health (Larchmt). 2022 Jun;31(6):762-771. doi: 10.1089/jwh.2021.0608. Epub 2022 May 16.
Tse YK, Chandramouli C, Li HL, Yu SY, Wu MZ, Ren QW, Chen Y, Wong PF, Sit KY, Chan DT, Ho CK, Au WK, Li XL, Tse HF, Lam CSP, Yiu KH Concomitant Hepatorenal Dysfunction and Malnutrition in Valvular Heart Surgery: Long-Term Prognostic Implications for Death and Heart Failure. J Am Heart Assoc. 2022 May 17;11(10):e024060. doi: 10.1161/JAHA.121.024060. Epub 2022 May 16.
Mohebi R, van Kimmenade R, McCarthy C, Gaggin H, Mehran R, Dangas G, Januzzi JL Jr A Biomarker-Enhanced Model for Prediction of Acute Kidney Injury and Cardiovascular Risk Following Angiographic Procedures: CASABLANCA AKI Prediction Substudy. J Am Heart Assoc. 2022 May 17;11(10):e025729. doi: 10.1161/JAHA.122.025729. Epub 2022 May 16.
Butala NM, Tamez H, Secemsky EA, Grantham JA, Spertus JA, Cohen DJ, Jones P, Salisbury AC, Arnold SV, Harrell F, Lombardi W, Karmpaliotis D, Moses J, Sapontis J, Yeh RW Predicting Residual Angina After Chronic Total Occlusion Percutaneous Coronary Intervention: Insights from the OPEN-CTO Registry. J Am Heart Assoc. 2022 May 17;11(10):e024056. doi: 10.1161/JAHA.121.024056. Epub 2022 May 16.
Hsieh CY, Kao HM, Sung KL, Sposato LA, Sung SF, Lin SJ Validation of Risk Scores for Predicting Atrial Fibrillation Detected After Stroke Based on an Electronic Medical Record Algorithm: A Registry-Claims-Electronic Medical Record Linked Data Study. Front Cardiovasc Med. 2022 Apr 29;9:888240. doi: 10.3389/fcvm.2022.888240. eCollection 2022.
Al-Lamee R Reply: ORBITA-2 trial design and rationale: what causes angina after PCI? EuroIntervention. 2022 May 15;18(1):96. doi: 10.4244/EIJ-D-22-00264.
Rimbas RC, Balinisteanu A, Magda SL, Visoiu SI, Ciobanu AO, Beganu E, Nicula AI, Vinereanu D New Advanced Imaging Parameters and Biomarkers-A Step Forward in the Diagnosis and Prognosis of TTR Cardiomyopathy. J Clin Med. 2022 Apr 22;11(9):2360. doi: 10.3390/jcm11092360.
Kuo JY, Jin X, Sun JY, Chang SH, Chi PC, Sung KT, Mok GSP, Yun CH, Chang SC, Chung FP, Yu CH, Wu TH, Hung CL, Yeh HI, Lam CSP Insights on Distinct Left Atrial Remodeling Between Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction. Front Cardiovasc Med. 2022 Apr 26;9:857360. doi: 10.3389/fcvm.2022.857360. eCollection 2022.
Vijay A, Yancy CW Resident Physician Wellness Postpandemic: How Does Healing Occur? JAMA. 2022 Jun 7;327(21):2077-2078. doi: 10.1001/jama.2022.7424.
Vandenbriele C, Arachchillage DJ, Frederiks P, Giustino G, Gorog DA, Gramegna M, Janssens S, Meyns B, Polzin A, Scandroglio M, Schrage B, Stone GW, Tavazzi G, Vanassche T, Vranckx P, Westermann D, Price S, Chieffo A Anticoagulation for Percutaneous Ventricular Assist Device-Supported Cardiogenic Shock: JACC Review Topic of the Week. J Am Coll Cardiol. 2022 May 17;79(19):1949-1962. doi: 10.1016/j.jacc.2022.02.052.
Natesan S, Mosarla RC, Parikh SA, Rosenfield K, Suomi J, Chalyan D, Jaff M, Secemsky EA Intravascular ultrasound in peripheral venous and arterial interventions: A contemporary systematic review and grading of the quality of evidence. Vasc Med. 2022 Aug;27(4):392-400. doi: 10.1177/1358863X221092817. Epub 2022 May 12.
Murphy WA, Lin N, Damask A, Schwartz GG, Steg PG, Szarek M, Banerjee P, Fazio S, Manvelian G, Pordy R, Shuldiner AR, Paulding C Pharmacogenomic Study of Statin-Associated Muscle Symptoms in the ODYSSEY OUTCOMES Trial. Circ Genom Precis Med. 2022 Jun;15(3):e003503. doi: 10.1161/CIRCGEN.121.003503. Epub 2022 May 11.
Sylvester KW, Chen A, Lewin A, Fanikos J, Goldhaber SZ, Connors JM Optimization of DOAC management services in a centralized anticoagulation clinic. Res Pract Thromb Haemost. 2022 May 5;6(3):e12696. doi: 10.1002/rth2.12696. eCollection 2022 Mar.
Limonte CP, Hall YN, Trikudanathan S, Tuttle KR, Hirsch IB, de Boer IH, Zelnick LR Prevalence of SGLT2i and GLP1RA use among US adults with type 2 diabetes. J Diabetes Complications. 2022 Jun;36(6):108204. doi: 10.1016/j.jdiacomp.2022.108204. Epub 2022 Apr 30.
Bikdeli B, Piazza G, Jimenez D, Muriel A, Wang Y, Khairani CD, Rosovsky RP, Mehdipoor G, O’Donoghue ML, Spagnolo P, Dreyer RP, Bertoletti L, Lopez-Jimenez L, Nunez MJ, Blanco-Molina A, Bates SM, Gerhard-Herman M, Goldhaber SZ, Monreal M, Krumholz HM Sex Differences in PrEsentation, Risk Factors, Drug and Interventional Therapies, and OUtcomes of Elderly PatientS with Pulmonary Embolism: Rationale and design of the SERIOUS-PE study. Thromb Res. 2022 Jun;214:122-131. doi: 10.1016/j.thromres.2022.04.019. Epub 2022 May 4.
Chowdhury M, Secemsky EA Atherectomy vs Other Modalities for Treatment During Peripheral Vascular Intervention. Curr Cardiol Rep. 2022 Jul;24(7):869-877. doi: 10.1007/s11886-022-01709-1. Epub 2022 May 10.
Robert R, Cottin Y, Potard V, Mary-Krause M, Lang S, Teiger E, Collet JP, Chauvet-Droit M, Ederhy S, Soulat-Dufour L, Ancedy Y, Adavane-Scheuble S, Nhan P, Steg PG, Funck-Brentano C, Costagliola D, Cohen A, Boccara F, on behalf the PACS-HIV Investigators Coronary Angiographic Features and Major Adverse Cardiac or Cerebrovascular Events in People Living With Human Immunodeficiency Virus Presenting With Acute Coronary Syndrome. Circ Cardiovasc Interv. 2022 Jun;15(6):e011945. doi: 10.1161/CIRCINTERVENTIONS.122.011945. Epub 2022 May 10.
Cantor WJ, Tan M, Berwanger O, Lavi S, White HD, Nicolau JC, Dehghani P, Tajer CD, Lopes RD, Moia DDF, Nicholls SJ, Parkhomenko A, Averkov O, Brass N, Lutchmedial S, Malaga G, Damiani LP, Piegas LS, Granger CB, Goodman SG Morphine and clinical outcomes in patients with ST segment elevation myocardial infarction treated with fibrinolytic and antiplatelet therapy: Insights from the TREAT trial. Am Heart J. 2022 Sep;251:1-12. doi: 10.1016/j.ahj.2022.05.005. Epub 2022 May 6.
Aggarwal R, Bibbins-Domingo K, Yeh RW, Song Y, Chiu N, Wadhera RK, Shen C, Kazi DS Diabetes Screening by Race and Ethnicity in the United States: Equivalent Body Mass Index and Age Thresholds. Ann Intern Med. 2022 Jun;175(6):765-773. doi: 10.7326/M20-8079. Epub 2022 May 10.
Tummala R, Gupta M, Devanabanda AR, Bandyopadhyay D, Aronow WS, Ray KK, Mamas M, Ghosh RK Bempedoic acid and its role in contemporary management of hyperlipidemia in atherosclerosis. Ann Med. 2022 Dec;54(1):1287-1296. doi: 10.1080/07853890.2022.2059559.
Konstam MA, Mann DL, Udelson JJE, Ardell JL, De Ferrari GM, Cowie MR, Klein HU, Gregory DD, Massaro JM, Libbus I, DiCarlo LA, Butler J, Parker JD, Teerlink JR Advances in Our Clinical Understanding of Autonomic Regulation Therapy Using Vagal Nerve Stimulation in Patients Living With Heart Failure. Front Physiol. 2022 Apr 21;13:857538. doi: 10.3389/fphys.2022.857538. eCollection 2022.
Sung KT, Chandramouli C, Lo CI, Tsai JP, Lai YH, Hsiao CC, Tsai SY, Yun CH, Hung TC, Kuo JY, Lin JL, Hou CJ, Chen YJ, Su CH, Hung CL, Bulwer BE, Yeh HI, Lam CSP Association of Female Menopause With Atrioventricular Mechanics and Outcomes. Front Cardiovasc Med. 2022 Apr 21;9:804336. doi: 10.3389/fcvm.2022.804336. eCollection 2022.
Kalayci A, Gibson CM, Ridker PM, Wright SD, Kingwell BA, Korjian S, Chi G, Lee JJ, Tricoci P, Kazmi SH, Fitzgerald C, Shaunik A, Berman G, Duffy D, Libby P ApoA-I Infusion Therapies Following Acute Coronary Syndrome: Past, Present, and Future. Curr Atheroscler Rep. 2022 Jul;24(7):585-597. doi: 10.1007/s11883-022-01025-7. Epub 2022 May 7.
Beauchamp A, Talevski J, Nicholls SJ, Wong Shee A, Martin C, Van Gaal W, Oqueli E, Ananthapavan J, Sharma L, O’Neil A, Brennan-Olsen SL, Jessup RL Health literacy and long-term health outcomes following myocardial infarction: protocol for a multicentre, prospective cohort study (ENHEARTEN study). BMJ Open. 2022 May 6;12(5):e060480. doi: 10.1136/bmjopen-2021-060480.
Kuramatsu JB, Gerner ST, Ziai W, Bardutzky J, Sembill JA, Sprugel MI, Mrochen A, Kolbl K, Ram M, Avadhani R, Falcone GJ, Selim MH, Lioutas VA, Endres M, Zweynert S, Vajkoczy P, Ringleb PA, Purrucker JC, Volkmann J, Neugebauer H, Erbguth F, Schellinger PD, Knappe UJ, Fink GR, Dohmen C, Minnerup J, Reichmann H, Schneider H, Rother J, Reimann G, Schwarz M, Bazner H, Classen J, Michalski D, Witte OW, Gunther A, Hamann GF, Lucking H, Dorfler A, Ishfaq MF, Chang JJ, Testai FD, Woo D, Alexandrov AV, Staykov D, Goyal N, Tsivgoulis G, Sheth KN, Awad IA, Schwab S, Hanley DF, Huttner HB, Collaborators Association of Intraventricular Fibrinolysis With Clinical Outcomes in Intracerebral Hemorrhage: An Individual Participant Data Meta-Analysis. Stroke. 2022 Sep;53(9):2876-2886. doi: 10.1161/STROKEAHA.121.038455. Epub 2022 May 6.
Blankstein R, Shaw LJ, Gulati M, Atalay MK, Bax J, Calnon DA, Dyke CK, Ferencik M, Heitner JF, Henry TD, Hung J, Knuuti J, Lindner JR, Phillips LM, Raman SV, Rao SV, Rybicki FJ, Saraste A, Stainback RF, Thompson RC, Williamson E, Nieman K, Tremmel JA, Woodard PK, Di Carli MF, Chandrashekhar YS Implications of the 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Chest Pain Guideline for Cardiovascular Imaging: A Multisociety Viewpoint. JACC Cardiovasc Imaging. 2022 May;15(5):912-926. doi: 10.1016/j.jcmg.2022.02.021.
Lin A, Kolossvary M, Cadet S, McElhinney P, Goeller M, Han D, Yuvaraj J, Nerlekar N, Slomka PJ, Marwan M, Nicholls SJ, Achenbach S, Maurovich-Horvat P, Wong DTL, Dey D Radiomics-Based Precision Phenotyping Identifies Unstable Coronary Plaques From Computed Tomography Angiography. JACC Cardiovasc Imaging. 2022 May;15(5):859-871. doi: 10.1016/j.jcmg.2021.11.016. Epub 2022 Jan 12.
Greco A, Laudani C, Occhipinti G, Angiolillo DJ, Capodanno D Reply: Short Duration of DAPT vs De-Escalation After Percutaneous Coronary Intervention for Acute Coronary Syndromes. JACC Cardiovasc Interv. 2022 May 9;15(9):999-1000. doi: 10.1016/j.jcin.2022.03.030.
Yoon SH, Makar M, Kar S, Chakravarty T, Oakley L, Sekhon N, Koseki K, Enta Y, Nakamura M, Hamilton M, Patel JK, Singh S, Skaf S, Siegel RJ, Bax JJ, Makkar RR Prognostic Value of Increased Mitral Valve Gradient After Transcatheter Edge-to-Edge Repair for Primary Mitral Regurgitation. JACC Cardiovasc Interv. 2022 May 9;15(9):935-945. doi: 10.1016/j.jcin.2022.01.281. Epub 2022 Apr 13.
Kelsey MD, Nelson AJ, Green JB, Granger CB, Peterson ED, McGuire DK, Pagidipati NJ Guidelines for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes: JACC Guideline Comparison. J Am Coll Cardiol. 2022 May 10;79(18):1849-1857. doi: 10.1016/j.jacc.2022.02.046.
Furtado RHM, Raz I, Goodrich EL, Murphy SA, Bhatt DL, Leiter LA, McGuire DK, Wilding JPH, Aylward P, Dalby AJ, Dellborg M, Dimulescu D, Nicolau JC, Oude Ophuis AJM, Cahn A, Mosenzon O, Gause-Nilsson I, Langkilde AM, Sabatine MS, Wiviott SD Efficacy and Safety of Dapagliflozin in Type 2 Diabetes According to Baseline Blood Pressure: Observations From DECLARE-TIMI 58 Trial. Circulation. 2022 May 24;145(21):1581-1591. doi: 10.1161/CIRCULATIONAHA.121.058103. Epub 2022 May 5.
Vergaro G, Gentile F, Aimo A, Januzzi JL Jr, Richards AM, Lam CSP, de Boer RA, Meems LMG, Latini R, Staszewsky L, Anand IS, Cohn JN, Ueland T, Gullestad L, Aukrust P, Brunner-La Rocca HP, Bayes-Genis A, Lupon J, Yoshihisa A, Takeishi Y, Egstrup M, Gustafsson I, Gaggin HK, Eggers KM, Huber K, Gamble GD, Ling LH, Leong KTG, Yeo PSD, Ong HY, Jaufeerally F, Ng TP, Troughton R, Doughty RN, Devlin G, Lund M, Giannoni A, Passino C, Emdin M Circulating levels and prognostic cut-offs of sST2, hs-cTnT, and NT-proBNP in women vs. men with chronic heart failure. ESC Heart Fail. 2022 Aug;9(4):2084-2095. doi: 10.1002/ehf2.13883. Epub 2022 May 5.
White HD BMJ Rapid Recommendations on use of proprotein convertase subtilisin/kexin 9 inhibitors and ezetimibe to reduce cardiovascular risk. Heart. 2022 Jul 27;108(16):1250-1252. doi: 10.1136/heartjnl-2022-321063.
Rimbas RC, Visoiu IS, Magda SL, Mihaila-Baldea S, Luchian ML, Chitroceanu AM, Hayat M, Mihalcea DJ, Dragoi-Galrinho-Antunes-Guerra R, Stefan M, Velcea A, Andronic AA, Lungeanu-Juravle L, Nicula AI, Vinereanu D New insights into the potential utility of the left atrial function analysis in heart failure with preserved ejection fraction diagnosis. PLoS One. 2022 May 4;17(5):e0267962. doi: 10.1371/journal.pone.0267962. eCollection 2022.
Gonzalez-Pacheco H, Gopar-Nieto R, Torres-Machorro A, Perez-Pinetta PE, Arias-Mendoza A Acute Mesenteric Ischemia Prior to Emergency Cardiac Surgery for Infective Endocarditis: Can We Design a Strategy to Improve Outcomes? Cureus. 2022 Apr 27;14(4):e24532. doi: 10.7759/cureus.24532. eCollection 2022 Apr.
Kanwar MK, Pagani FD, Mehra MR, Estep JD, Pinney SP, Silvestry SC, Uriel N, Goldstein DJ, Long J, Cleveland JC Jr, Kormos RL, Wang A, Chuang J, Cowger JA Center Variability in Patient Outcomes Following HeartMate 3 Implantation: An Analysis of the MOMENTUM 3 Trial. J Card Fail. 2022 Jul;28(7):1158-1168. doi: 10.1016/j.cardfail.2022.04.006. Epub 2022 Apr 30.
Ono M, Onuma Y, Kawashima H, Hara H, Gao C, Wang R, O’Leary N, Benit E, Janssens L, Ferrario M, Zurakowski A, Dominici M, Huber K, Buszman P, Garg S, Wykrzykowska JJ, Piek JJ, Juni P, Hamm C, Windecker S, Vranckx P, Deliargyris EN, Bhatt DL, Storey RF, Valgimigli M, Serruys PW, GLOBAL LEADERS trial investigators Impact of proton pump inhibitors on efficacy of antiplatelet strategies with ticagrelor or aspirin after percutaneous coronary intervention: Insights from the GLOBAL LEADERS trial. Catheter Cardiovasc Interv. 2022 Jul;100(1):72-82. doi: 10.1002/ccd.30217. Epub 2022 May 2.
Jovin IS, Warsavage TJ, Plomondon ME, Grunwald GK, Waldo SW, Rao SV, Brilakis ES, Azzalini L Iso-osmolar versus low-osmolar contrast media and outcomes after percutaneous coronary intervention: Insights from the VA CART Program. Catheter Cardiovasc Interv. 2022 Jul;100(1):85-93. doi: 10.1002/ccd.30218. Epub 2022 May 2.
Vart P, Correa-Rotter R, Hou FF, Jongs N, Chertow GM, Langkilde AM, McMurray JJV, Rossing P, Sjostrom CD, Stefansson BV, Toto RD, Douthat W, Escudero E, Isidto R, Khullar D, Bajaj HS, Wheeler DC, Heerspink HJL Efficacy and Safety of Dapagliflozin in Patients With CKD Across Major Geographic Regions. Kidney Int Rep. 2022 Feb 2;7(4):699-707. doi: 10.1016/j.ekir.2022.01.1060. eCollection 2022 Apr.
Daaboul Y, Rowin EJ, Couper GS, Arkun K, Patel AR Congenital Left Ventricular Diverticulum Complicated by Cardioembolic Stroke. CASE (Phila). 2022 Jan 13;6(2):55-58. doi: 10.1016/j.case.2021.11.010. eCollection 2022 Apr.
Sposato LA, Field TS Atrial fibrillation detection after stroke: Is all created equal? Eur J Neurol. 2022 Jul;29(7):1869-1870. doi: 10.1111/ene.15375. Epub 2022 May 8.
Pahuja M, Leifer ES, Clarke JD, Ahmad T, Daubert MA, Mark DB, Cooper L, Desvigne-Nickens P, Fiuzat M, Adams K, Ezekowitz J, Whellan DJ, Januzzi JL, O’Connor CM, Felker GM, Pina IL Assessing race and ethnicity differences in outcomes based on GDMT and target NT-proBNP in patients with heart failure with reduced ejection fraction: An analysis of the GUIDE-IT study. Prog Cardiovasc Dis. 2022 Mar-Apr;71:79-85. doi: 10.1016/j.pcad.2022.04.010. Epub 2022 Apr 29.
Javaid MA, Selim M, Ortega-Gutierrez S, Lattanzi S, Zargar S, Alaouieh DA, Hong E, Divani AA Potential Application of Intranasal Insulin Delivery for Treatment of Intracerebral Hemorrhage: A Review of The Literature. J Stroke Cerebrovasc Dis. 2022 Jul;31(7):106489. doi: 10.1016/j.jstrokecerebrovasdis.2022.106489. Epub 2022 Apr 27.
Steg PG, Bhatt DL, James SK, Darlington O, Hoskin L, Simon T, Fox KM, Leiter LA, Mehta SR, Harrington RA, Himmelmann A, Ridderstrale W, Andersson M, Bueno H, De Luca L, Tank A, Mellstrom C, McEwan P Cost-effectiveness of ticagrelor in patients with type 2 diabetes and coronary artery disease: a European economic evaluation of the THEMIS trial. Eur Heart J Cardiovasc Pharmacother. 2022 Dec 2;8(8):777-785. doi: 10.1093/ehjcvp/pvac032.
Aimo A, Vergaro G, Gonzalez A, Barison A, Lupon J, Delgado V, Richards AM, de Boer RA, Thum T, Arfsten H, Hulsmann M, Falcao-Pires I, Diez J, Foo RSY, Chan MYY, Anene-Nzelu CG, Abdelhamid M, Adamopoulos S, Anker SD, Belenkov Y, Ben Gal T, Cohen-Solal A, Bohm M, Chioncel O, Jankowska EA, Gustafsson F, Hill L, Jaarsma T, Januzzi JL, Jhund P, Lopatin Y, Lund LH, Metra M, Milicic D, Moura B, Mueller C, Mullens W, Nunez J, Piepoli MF, Rakisheva A, Ristic AD, Rossignol P, Savarese G, Tocchetti CG, van Linthout S, Volterrani M, Seferovic P, Rosano G, Coats AJS, Emdin M, Bayes-Genis A Cardiac remodelling – Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2022 Jun;24(6):944-958. doi: 10.1002/ejhf.2522. Epub 2022 May 16.
Sekino N, Selim M, Shehadah A Sepsis-associated brain injury: underlying mechanisms and potential therapeutic strategies for acute and long-term cognitive impairments. J Neuroinflammation. 2022 Apr 29;19(1):101. doi: 10.1186/s12974-022-02464-4.
Strom JB, Secemsky EA Seeing the entire elephant: The challenges of frailty assessment for peripheral artery disease. Vasc Med. 2022 Jun;27(3):258-260. doi: 10.1177/1358863X221088860. Epub 2022 Apr 29.
Ballantyne CM, Banach M, Bays HE, Catapano AL, Laufs U, Stroes ESG, Robinson P, Lei L, Ray KK Long-Term Safety and Efficacy of Bempedoic Acid in Patients With Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia (from the CLEAR Harmony Open-Label Extension Study). Am J Cardiol. 2022 Jul 1;174:1-11. doi: 10.1016/j.amjcard.2022.03.020. Epub 2022 Apr 26.
Khan MS, DeVore AD, Felker GM, Butler J, Fonarow GC, Greene SJ Reply: Revisited Metformin Therapy in Heart Failure With Preserved Ejection Fraction. JACC Heart Fail. 2022 May;10(5):366-367. doi: 10.1016/j.jchf.2022.02.013.
Jain V, Minhas AMK, Khan SU, Greene SJ, Pandey A, Van Spall HGC, Fonarow GC, Mentz RJ, Butler J, Khan MS Trends in HF Hospitalizations Among Young Adults in the United States From 2004 to 2018. JACC Heart Fail. 2022 May;10(5):350-362. doi: 10.1016/j.jchf.2022.01.021.
Cikes M, Planinc I, Claggett B, Cunningham J, Milicic D, Sweitzer N, Senni M, Gori M, Linssen G, Shah SJ, Packer M, Pfeffer M, Zile MR, Anand I, Chiang LM, Lam CSP, Redfield M, Desai AS, McMurray JJV, Solomon SD Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Trial. JACC Heart Fail. 2022 May;10(5):336-346. doi: 10.1016/j.jchf.2022.01.018. Epub 2022 Apr 6.
Gaba P, Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, Juliano RA, Jiao L, Doyle RT Jr, Granowitz C, Tardif JC, Giugliano RP, Martens FMAC, Gibson CM, Ballantyne CM, REDUCE-IT Investigators Prevention of Cardiovascular Events and Mortality With Icosapent Ethyl in Patients With Prior Myocardial Infarction. J Am Coll Cardiol. 2022 May 3;79(17):1660-1671. doi: 10.1016/j.jacc.2022.02.035.
Tuttle KR Learnings from Throwing Paint at the Wall for COVID-19 with an SGLT2 Inhibitor. Clin J Am Soc Nephrol. 2022 May;17(5):628-630. doi: 10.2215/CJN.03250322. Epub 2022 Apr 28.
Reza N, Butler J Assessing health status after discharge for decompensated heart failure: a patient-centred priority. Eur J Heart Fail. 2022 Jun;24(6):1030-1032. doi: 10.1002/ejhf.2521. Epub 2022 May 13.
Rethy L, Vu TT, Shah NS, Carnethon MR, Lagu T, Huffman MD, Yancy CW, Lloyd-Jones DM, Khan SS Blood Pressure and Glycemic Control Among Ambulatory US Adults With Heart Failure: National Health and Nutrition Examination Survey 2001 to 2018. Circ Heart Fail. 2022 May;15(5):e009229. doi: 10.1161/CIRCHEARTFAILURE.121.009229. Epub 2022 Apr 28.
Yancy CW, Khan SS Who Is at Risk for Heart Failure? JAMA Cardiol. 2022 Jun 1;7(6):632. doi: 10.1001/jamacardio.2022.0689.
Jin X, Hung CL, Tay WT, Soon D, Sim D, Sung KT, Loh SY, Lee S, Jaufeerally F, Ling LH, Richards AM, van Melle JP, Voors AA, Lam CSP Epicardial adipose tissue related to left atrial and ventricular function in heart failure with preserved versus reduced and mildly reduced ejection fraction. Eur J Heart Fail. 2022 Aug;24(8):1346-1356. doi: 10.1002/ejhf.2513. Epub 2022 Jun 26.
Tuttle KR, Levin A, Nangaku M, Kadowaki T, Agarwal R, Hauske SJ, Elsasser A, Ritter I, Steubl D, Wanner C, Wheeler DC Safety of Empagliflozin in Patients With Type 2 Diabetes and Chronic Kidney Disease: Pooled Analysis of Placebo-Controlled Clinical Trials. Diabetes Care. 2022 Jun 2;45(6):1445-1452. doi: 10.2337/dc21-2034.
Natale A, Kar S, Holmes D Letter by Natale et al Regarding Article, “Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial”. Circulation. 2022 Apr 26;145(17):e847-e848. doi: 10.1161/CIRCULATIONAHA.121.057567. Epub 2022 Apr 25.
Price MJ, Gibson DN, Kar S Letter by Price et al Regarding the Article, “Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial”. Circulation. 2022 Apr 26;145(17):e849. doi: 10.1161/CIRCULATIONAHA.121.058485. Epub 2022 Apr 25.
Selim M Building the Case for Targeting the Secondary Injury After Intracerebral Hemorrhage: Slowly but Surely. Stroke. 2022 Jun;53(6):2036-2037. doi: 10.1161/STROKEAHA.122.038321. Epub 2022 Apr 25.
Granger BB, Kaltenbach LA, Fonarow GC, Allen LA, Lanfear DE, Albert NM, Al-Khalidi HR, Butler J, Cooper LB, Dewald T, Felker GM, Heidenreich P, Kottam A, Lewis EF, Pina IL, Yancy CW, Granger CB, Hernandez AF, Devore AD Health System-Level Performance in Prescribing Guideline-Directed Medical Therapy for Patients With Heart Failure With Reduced Ejection Fraction: Results From the CONNECT-HF Trial. J Card Fail. 2022 Aug;28(8):1355-1361. doi: 10.1016/j.cardfail.2022.03.356. Epub 2022 Apr 22.
Korjian S, Gibson CM Digital technologies and the democratization of clinical research: Social media, wearables, and artificial intelligence. Contemp Clin Trials. 2022 Jun;117:106767. doi: 10.1016/j.cct.2022.106767. Epub 2022 Apr 21.
Hernandez AF, Albert NM, Allen LA, Ahmed R, Averina V, Boehmer JP, Cowie MR, Chien CV, Galvao M, Klein L, Kwan B, Lam CSP, Ruble SB, Stolen CM, Stein K, MANAGE-HF Study Multiple cArdiac seNsors for mAnaGEment of Heart Failure (MANAGE-HF) – Phase I Evaluation of the Integration and Safety of the HeartLogic Multisensor Algorithm in Patients With Heart Failure. J Card Fail. 2022 Aug;28(8):1245-1254. doi: 10.1016/j.cardfail.2022.03.349. Epub 2022 Apr 21.
Al-Lamee R, Aubiniere-Robb L, Berry C The British Cardiovascular Society and clinical studies in ischaemic heart disease: from RITA to ORBITA, and beyond. Heart. 2022 May;108(10):800-806. doi: 10.1136/heartjnl-2021-320150.
Darabont RO, Visoiu IS, Magda SL, Stoicescu C, Vintila VD, Udroiu C, Vinereanu D Implications of Myocardial Bridge on Coronary Atherosclerosis and Survival. Diagnostics (Basel). 2022 Apr 10;12(4):948. doi: 10.3390/diagnostics12040948.
Pandey A, Khan MS, Garcia K, Simpson F, Bahnson J, Patel KV, Singh S, Vaduganathan M, Bertoni A, Kitzman D, Johnson K, Lewis CE, Espeland MA Association of Baseline and Longitudinal Changes in Frailty Burden and Risk of Heart Failure in Type 2 Diabetes-Findings from the Look AHEAD Trial. J Gerontol A Biol Sci Med Sci. 2022 Dec 29;77(12):2489-2497. doi: 10.1093/gerona/glac094.
Molina EJ, Cowger J, Lee S, Horstmanshof D, Cleveland JC Jr, Goldstein DJ, Mehra MR, Uriel N, Salerno CT, Bourque K, Chuang J, Naka Y Outcomes in Smaller Body Size Adults After HeartMate 3 Left Ventricular Assist Device Implantation. Ann Thorac Surg. 2022 Dec;114(6):2262-2269. doi: 10.1016/j.athoracsur.2022.03.071. Epub 2022 Apr 19.
Nakamura H, Kataoka Y, Nicholls SJ, Puri R, Kitahara S, Murai K, Sawada K, Matama H, Iwai T, Honda S, Fujino M, Takagi K, Yoneda S, Otsuka F, Nishihira K, Asaumi Y, Tsujita K, Noguchi T Elevated Lipoprotein(a) as a potential residual risk factor associated with lipid-rich coronary atheroma in patients with type 2 diabetes and coronary artery disease on statin treatment: Insights from the REASSURE-NIRS registry. Atherosclerosis. 2022 May;349:183-189. doi: 10.1016/j.atherosclerosis.2022.03.033. Epub 2022 Apr 10.
Laudani C, Greco A, Occhipinti G, Angiolillo DJ, Capodanno D Reply: Short Duration of DAPT vs De-Escalation After Percutaneous Coronary Intervention: Only These 2 Options? JACC Cardiovasc Interv. 2022 Apr 25;15(8):903-904. doi: 10.1016/j.jcin.2022.03.007.
Redfors B, Kirtane AJ, Liu M, Musikantow DR, Witzenbichler B, Rinaldi MJ, Metzger DC, Weisz G, Stuckey TD, Brodie BR, Ben-Yehuda O, Mehran R, Stone GW Dual Antiplatelet Therapy Discontinuation, Platelet Reactivity, and Adverse Outcomes After Successful Percutaneous Coronary Intervention. JACC Cardiovasc Interv. 2022 Apr 25;15(8):797-806. doi: 10.1016/j.jcin.2022.01.300.
Lau ES, Wang D, Roberts M, Taylor CN, Murugappan G, Shadyab AH, Schnatz PF, Farland LV, Wood MJ, Scott NS, Eaton CB, Ho JE Infertility and Risk of Heart Failure in the Women’s Health Initiative. J Am Coll Cardiol. 2022 Apr 26;79(16):1594-1603. doi: 10.1016/j.jacc.2022.02.020.
Araki M, Park SJ, Dauerman HL, Uemura S, Kim JS, Di Mario C, Johnson TW, Guagliumi G, Kastrati A, Joner M, Holm NR, Alfonso F, Wijns W, Adriaenssens T, Nef H, Rioufol G, Amabile N, Souteyrand G, Meneveau N, Gerbaud E, Opolski MP, Gonzalo N, Tearney GJ, Bouma B, Aguirre AD, Mintz GS, Stone GW, Bourantas CV, Raber L, Gili S, Mizuno K, Kimura S, Shinke T, Hong MK, Jang Y, Cho JM, Yan BP, Porto I, Niccoli G, Montone RA, Thondapu V, Papafaklis MI, Michalis LK, Reynolds H, Saw J, Libby P, Weisz G, Iannaccone M, Gori T, Toutouzas K, Yonetsu T, Minami Y, Takano M, Raffel OC, Kurihara O, Soeda T, Sugiyama T, Kim HO, Lee T, Higuma T, Nakajima A, Yamamoto E, Bryniarski KL, Di Vito L, Vergallo R, Fracassi F, Russo M, Seegers LM, McNulty I, Park S, Feldman M, Escaned J, Prati F, Arbustini E, Pinto FJ, Waksman R, Garcia-Garcia HM, Maehara A, Ali Z, Finn AV, Virmani R, Kini AS, Daemen J, Kume T, Hibi K, Tanaka A, Akasaka T, Kubo T, Yasuda S, Croce K, Granada JF, Lerman A, Prasad A, Regar E, Saito Y, Sankardas MA, Subban V, Weissman NJ, Chen Y, Yu B, Nicholls SJ, Barlis P, West NEJ, Arbab-Zadeh A, Ye JC, Dijkstra J, Lee H, Narula J, Crea F, Nakamura S, Kakuta T, Fujimoto J, Fuster V, Jang IK Optical coherence tomography in coronary atherosclerosis assessment and intervention. Nat Rev Cardiol. 2022 Oct;19(10):684-703. doi: 10.1038/s41569-022-00687-9. Epub 2022 Apr 21.
Gulati M, Burgess S SYNTAXES, biomarkers and survival in complex coronary artery disease: the intervention of secondary prevention. EuroIntervention. 2022 Apr 22;17(18):1460-1462. doi: 10.4244/EIJ-E-22-00008.
Goldfarb MJ, Bechtel C, Capers Q 4th, de Velasco A, Dodson JA, Jackson JL, Kitko L, Pina IL, Rayner-Hartley E, Wenger NK, Gulati M, American Heart Association Council on Clinical Cardiology; Council on, Cardiovascular and Stroke Nursing; Council on Lifelong Congenital Heart Disease, and Heart Health in the Young; Council on Cardiovascular Radiology and, Intervention; Council on Hypertension; Council on the Kidney in Cardiovascular, Disease; and Council on Lifestyle and Cardiometabolic Health Engaging Families in Adult Cardiovascular Care: A Scientific Statement From the American Heart Association. J Am Heart Assoc. 2022 May 17;11(10):e025859. doi: 10.1161/JAHA.122.025859. Epub 2022 Apr 21.
Waijer SW, Vart P, Cherney DZI, Chertow GM, Jongs N, Langkilde AM, Mann JFE, Mosenzon O, McMurray JJV, Rossing P, Correa-Rotter R, Stefansson BV, Toto RD, Wheeler DC, Heerspink HJL Effect of dapagliflozin on kidney and cardiovascular outcomes by baseline KDIGO risk categories: a post hoc analysis of the DAPA-CKD trial. Diabetologia. 2022 Jul;65(7):1085-1097. doi: 10.1007/s00125-022-05694-6. Epub 2022 Apr 21.
Crespo-Leiro MG, Costanzo MR, Gustafsson F, Khush KK, Macdonald PS, Potena L, Stehlik J, Zuckermann A, Mehra MR Heart transplantation: focus on donor recovery strategies, left ventricular assist devices, and novel therapies. Eur Heart J. 2022 Jun 14;43(23):2237-2246. doi: 10.1093/eurheartj/ehac204.
Secemsky EA, Parikh SA, Kohi M, Lichtenberg M, Meissner M, Varcoe R, Holden A, Jaff M, Chalyan D, Clair D, Hawkins B, Rosenfield K Intravascular ultrasound guidance for lower extremity arterial and venous interventions. EuroIntervention. 2022 Sep 20;18(7):598-608. doi: 10.4244/EIJ-D-21-00898.
Coughlan JJ, Maeng M, Raber L, Brugaletta S, Aytekin A, Okkels Jensen L, Bar S, Ortega-Paz L, Laugwitz KL, Madsen M, Heg D, Sabate M, Kufner S, Warnakula Olesen KK, Kastrati A, Windecker S, Cassese S Ten-year patterns of stent thrombosis after percutaneous coronary intervention with new- versus early-generation drug-eluting stents: insights from the DECADE cooperation. Rev Esp Cardiol (Engl Ed). 2022 Nov;75(11):894-902. doi: 10.1016/j.rec.2022.02.003. Epub 2022 Apr 15.
Garg A, Rout A, Farhan S, Waxman S, Giustino G, Tayal R, Abbott JD, Huber K, Angiolillo DJ, Rao SV Dual antiplatelet therapy duration after percutaneous coronary intervention using drug eluting stents in high bleeding risk patients: A systematic review and meta-analysis. Am Heart J. 2022 Aug;250:1-10. doi: 10.1016/j.ahj.2022.04.004. Epub 2022 Apr 15.
White HD Zooming in on the Enigmas of Type 2 Myocardial Infarction. Circulation. 2022 Apr 19;145(16):1201-1204. doi: 10.1161/CIRCULATIONAHA.122.059454. Epub 2022 Apr 18.
Raisi-Estabragh Z, Kobo O, Freeman P, Petersen SE, Kolman L, Miller RJH, Roguin A, Van Spall HGC, Vuong J, Yang EH, Mamas MA Temporal trends in disease-specific causes of cardiovascular mortality amongst patients with cancer in the USA between 1999 and 2019. Eur Heart J Qual Care Clin Outcomes. 2022 Dec 13;9(1):54-63. doi: 10.1093/ehjqcco/qcac016.
Fermann GJ, Schrock JW, Levy PD, Pang P, Butler J, Chang AM, Char D, Diercks D, Han JH, Hiestand B, Hogan C, Jenkins CA, Kampe C, Khan Y, Kumar VA, Lee S, Lindenfeld J, Liu D, Miller KF, Peacock WF, Reilly CM, Robichaux C, Rothman RL, Self WH, Singer AJ, Sterling SA, Storrow AB, Stubblefield WB, Walsh C, Wilburn J, Collins SP Troponin is unrelated to outcomes in heart failure patients discharged from the emergency department. J Am Coll Emerg Physicians Open. 2022 Apr 9;3(2):e12695. doi: 10.1002/emp2.12695. eCollection 2022 Apr.
Nicholls SJ, Kataoka Y, Nissen SE, Prati F, Windecker S, Puri R, Hucko T, Aradi D, Herrman JR, Hermanides RS, Wang B, Wang H, Butters J, Di Giovanni G, Jones S, Pompili G, Psaltis PJ Effect of Evolocumab on Coronary Plaque Phenotype and Burden in Statin-Treated Patients Following Myocardial Infarction. JACC Cardiovasc Imaging. 2022 Jul;15(7):1308-1321. doi: 10.1016/j.jcmg.2022.03.002. Epub 2022 Mar 16.
Thomas CD, Franchi F, Keeley EC, Rossi JS, Winget M, David Anderson R, Dempsey AL, Gong Y, Gower MN, Kerensky RA, Kulick N, Malave JG, McDonough CW, Mulrenin IR, Starostik P, Beitelshees AL, Johnson JA, Stouffer GA, Winterstein AG, Angiolillo DJ, Lee CR, Cavallari LH Impact of the ABCD-GENE Score on Clopidogrel Clinical Effectiveness after PCI: A Multi-Site, Real-World Investigation. Clin Pharmacol Ther. 2022 Jul;112(1):146-155. doi: 10.1002/cpt.2612. Epub 2022 May 2.
McNaughton CD, McConnachie A, Cleland JG, Spertus JA, Angermann CE, Duklas P, Tromp J, Lam CSP, Filippatos G, Dahlstrom U, Dickstein K, Schweizer A, Perrone SV, Hassanein M, Ertl G, Obergfell A, Ghadanfar M, Collins SP Quality of life assessed 6 months after hospitalisation for acute heart failure: an analysis from REPORT-HF (international REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure). Eur J Heart Fail. 2022 Jun;24(6):1020-1029. doi: 10.1002/ejhf.2508. Epub 2022 May 12.
Shahid I, Khan MS, Siddiqi TJ, Arshad MS, Saleem A, Van Spall HGC, Reza N, Greene SJ, Michos ED Trends in National Institutes of Health R01 Funding of Principal Investigators in Cardiology by Gender. J Am Coll Cardiol. 2022 Apr 19;79(15):1544-1546. doi: 10.1016/j.jacc.2022.02.014.
Khan SS, Beach LB, Yancy CW Sex-Based Differences in Heart Failure: JACC Focus Seminar 7/7. J Am Coll Cardiol. 2022 Apr 19;79(15):1530-1541. doi: 10.1016/j.jacc.2022.02.013.
Mentias A, Aminian A, Youssef D, Pandey A, Menon V, Cho L, Nissen SE, Desai MY Long-Term Cardiovascular Outcomes After Bariatric Surgery in the Medicare Population. J Am Coll Cardiol. 2022 Apr 19;79(15):1429-1437. doi: 10.1016/j.jacc.2022.01.047.
Mac Grory B, Yaghi S, Cordonnier C, Sposato LA, Romano JG, Chaturvedi S Advances in Recurrent Stroke Prevention: Focus on Antithrombotic Therapies. Circ Res. 2022 Apr 15;130(8):1075-1094. doi: 10.1161/CIRCRESAHA.121.319947. Epub 2022 Apr 14.
Girerd N, Mewton N, Tartiere JM, Guijarro D, Jourdain P, Damy T, Lamblin N, Bayes-Genis A, Pellicori P, Januzzi JL, Rossignol P, Roubille F, a panel of multidisciplinary experts and the Heart Failure Working Group of the, French Society of Cardiology Practical outpatient management of worsening chronic heart failure. Eur J Heart Fail. 2022 May;24(5):750-761. doi: 10.1002/ejhf.2503. Epub 2022 Apr 27.
Kalogeropoulos AP, Butler J Uptitrating versus adding heart failure with reduced ejection fraction medications: bring more players to the game. Eur J Heart Fail. 2022 May;24(5):885-886. doi: 10.1002/ejhf.2507. Epub 2022 Apr 21.
Sinha A, Yancy CW, Patel RB Tipping the scale toward a more accurate and equitable assessment of heart failure with reduced ejection fraction pharmacotherapy eligibility: a call to incorporate cystatin C in estimating glomerular filtration rate. Eur J Heart Fail. 2022 May;24(5):867-870. doi: 10.1002/ejhf.2505. Epub 2022 Apr 20.
Kingwell BA, Nicholls SJ, Velkoska E, Didichenko SA, Duffy D, Korjian S, Gibson CM Antiatherosclerotic Effects of CSL112 Mediated by Enhanced Cholesterol Efflux Capacity. J Am Heart Assoc. 2022 Apr 19;11(8):e024754. doi: 10.1161/JAHA.121.024754. Epub 2022 Apr 12.
Macedo AVS, de Barros E Silva PGM, de Paula TC, Moll-Bernardes RJ, Mendonca Dos Santos T, Mazza L, Feldman A, Arruda GDAS, de Albuquerque DC, de Sousa AS, de Souza OF, Gibson CM, Granger CB, Alexander JH, Lopes RD Discontinuing vs continuing ACEIs and ARBs in hospitalized patients with COVID-19 according to disease severity: Insights from the BRACE CORONA trial. Am Heart J. 2022 Jul;249:86-97. doi: 10.1016/j.ahj.2022.04.001. Epub 2022 Apr 8.
Neuen BL, Oshima M, Agarwal R, Arnott C, Cherney DZ, Edwards R, Langkilde AM, Mahaffey KW, McGuire DK, Neal B, Perkovic V, Pong A, Sabatine MS, Raz I, Toyama T, Wanner C, Wheeler DC, Wiviott SD, Zinman B, Heerspink HJL Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Hyperkalemia in People With Type 2 Diabetes: A Meta-Analysis of Individual Participant Data From Randomized, Controlled Trials. Circulation. 2022 May 10;145(19):1460-1470. doi: 10.1161/CIRCULATIONAHA.121.057736. Epub 2022 Apr 8.
Lahoud RN, Dauerman HL, Callas P, Henderson A, Martin JA, Solomon RJ Nitric oxide acute kidney injury (NO-AKI) pilot trial. J Thromb Thrombolysis. 2022 Jul;54(1):7-10. doi: 10.1007/s11239-022-02645-1. Epub 2022 Apr 8.
Tromp J, Ouwerkerk W, Teng TK, Cleland JGF, Bamadhaj S, Angermann CE, Dahlstrom U, Tay WT, Dickstein K, Ertl G, Hassanein M, Perrone SV, Ghadanfar M, Schweizer A, Obergfell A, Collins SP, Filippatos G, Lam CSP Global disparities in prescription of guideline-recommended drugs for heart failure with reduced ejection fraction. Eur Heart J. 2022 Jun 14;43(23):2224-2234. doi: 10.1093/eurheartj/ehac103.
Van Remoortel H, Scheers H, Lauwers K, Gillebeert J, Stroobants S, Vranckx P, De Buck E, Vandekerckhove P Mass gathering events: a retrospective analysis of the triage categories, type of injury or medical complaint and medical usage rates. Emerg Med J. 2022 Sep;39(9):708-711. doi: 10.1136/emermed-2021-211745. Epub 2022 Apr 7.
Cutlip DE, Mehran R, Spitzer E, Morice MC, Krucoff MW Device and Procedure Relatedness: Viewpoint From Members of the ARC Steering Group. JACC Cardiovasc Interv. 2022 Apr 11;15(7):783-788. doi: 10.1016/j.jcin.2022.01.021.
Tuttle MK, Kiaii B, Van Mieghem NM, Laham RJ, Deeb GM, Windecker S, Chetcuti S, Yakubov SJ, Chawla A, Hockmuth D, Teefy P, Li S, Reardon MJ Functional Status After Transcatheter and Surgical Aortic Valve Replacement: 2-Year Analysis From the SURTAVI Trial. JACC Cardiovasc Interv. 2022 Apr 11;15(7):728-738. doi: 10.1016/j.jcin.2022.01.284.
Gaudino M, Di Franco A, Cao D, Giustino G, Bairey Merz CN, Fremes SE, Kirtane AJ, Kunadian V, Lawton JS, Masterson Creber RM, Sandner S, Vogel B, Zwischenberger BA, Dangas GD, Mehran R Sex-Related Outcomes of Medical, Percutaneous, and Surgical Interventions for Coronary Artery Disease: JACC Focus Seminar 3/7. J Am Coll Cardiol. 2022 Apr 12;79(14):1407-1425. doi: 10.1016/j.jacc.2021.07.066.
McBride K, Nguyen J, Dowling A, Howard NJ, Franks C, Hillier S, Wade V, King V, Rigney J, Burton N, Mitchell JA, Nicholls SJ, Paquet C, Brown A A systematic review on assessment and management of preventive cardiovascular care in primary health for Aboriginal and Torres Strait Islander women and men. Aust J Prim Health. 2022 Jun;28(3):179-199. doi: 10.1071/PY21219.
Reynolds MR, Niileksela CR, Gignac GE, Sevillano CN Working memory capacity development through childhood: A longitudinal analysis. Dev Psychol. 2022 Jul;58(7):1254-1263. doi: 10.1037/dev0001360. Epub 2022 Apr 7.
Spyropoulos AC, Raskob GE, Cohen AT, Ageno W, Weitz JI, Spiro TE, Lu W, Lipardi C, Albers GW, Elliott CG, Halperin JL, Hiatt WR, Maynard G, Steg PG, Sugarmann C, Barnathan ES Association of Bleeding Severity With Mortality in Extended Thromboprophylaxis of Medically Ill Patients in the MAGELLAN and MARINER Trials. Circulation. 2022 May 10;145(19):1471-1479. doi: 10.1161/CIRCULATIONAHA.121.057847. Epub 2022 Apr 7.
Savarese G, Uijl A, Ouwerkerk W, Tromp J, Anker SD, Dickstein K, Hage C, Lam CSP, Lang CC, Metra M, Ng LL, Orsini N, Samani NJ, van Veldhuisen DJ, Cleland JGF, Voors AA, Lund LH Biomarker changes as surrogate endpoints in early-phase trials in heart failure with reduced ejection fraction. ESC Heart Fail. 2022 Aug;9(4):2107-2118. doi: 10.1002/ehf2.13917. Epub 2022 Apr 6.
Pacheco C, Mullen KA, Coutinho T, Jaffer S, Parry M, Van Spall HGC, Clavel MA, Edwards JD, Sedlak T, Norris CM, Dhukai A, Grewal J, Mulvagh SL The Canadian Women’s Heart Health Alliance Atlas on the Epidemiology, Diagnosis, and Management of Cardiovascular Disease in Women – Chapter 5: Sex- and Gender-Unique Manifestations of Cardiovascular Disease. CJC Open. 2021 Nov 23;4(3):243-262. doi: 10.1016/j.cjco.2021.11.006. eCollection 2022 Mar.
Le N, Rahman T, Kapralik JL, Ibrahim Q, Lear SA, Van Spall HGC The Hospital at Home Model vs Routine Hospitalization for Acute Heart Failure: A Survey of Patients’ Preferences. CJC Open. 2021 Oct 20;4(3):263-270. doi: 10.1016/j.cjco.2021.10.005. eCollection 2022 Mar.
Van Spall HGC, Fonarow GC, Mamas MA Underutilization of Guideline-Directed Medical Therapy in Heart Failure: Can Digital Health Technologies PROMPT Change? J Am Coll Cardiol. 2022 Jun 7;79(22):2214-2218. doi: 10.1016/j.jacc.2022.03.351. Epub 2022 Apr 3.
MacGowan GA, McDiarmid A, Jansen K, Coats L, Crossland D, Woods A, Kunadian V, Shah A, Schueler S, Parry G Gender differences in the assessment, decision-making and outcomes for ventricular assist devices and heart transplantation: An analysis from a UK transplant center. Clin Transplant. 2022 Jun;36(6):e14666. doi: 10.1111/ctr.14666. Epub 2022 Apr 18.
Eikelboom JW, Bosch J, Connolly SJ, Tyrwitt J, Fox KAA, Muehlhofer E, Neumann C, Tasto C, Bangdiwala SI, Diaz R, Alings M, Dagenais GR, Leong DP, Lonn EM, Avezum A, Piegas LS, Widimsky P, Parkhomenko AN, Bhatt DL, Branch KRH, Probstfield JL, Lopez-Jaramillo P, Ryden L, Pogosova N, Keltai K, Keltai M, Ertl G, Stoerk S, Dans AL, Lanas F, Liang Y, Zhu J, Torp-Pedersen C, Maggioni AP, Commerford PJ, Guzik TJ, Vanassche T, Verhamme P, O’Donnell M, Tonkin AM, Varigos JD, Vinereanu D, Felix C, Kim JH, Ibrahim KS, Lewis BS, Metsarinne KP, Aboyans V, Steg PG, Hori M, Kakkar A, Anand SS, Lamy A, Sharma M, Yusuf S Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open Label Extension of the COMPASS trial. Eur Heart J Cardiovasc Pharmacother. 2022 Dec 2;8(8):786-795. doi: 10.1093/ehjcvp/pvac023.
Abunimer AM, Lak AM, Calvachi P, Smith TR, Aglio LS, Almefty KK, Dunn IF, Bi WL, Goldhaber SZ, Al-Mefty O Early Detection and Management of Venous Thrombosis in Skull Base Surgery: Role of Routine Doppler Ultrasound Monitoring. Neurosurgery. 2022 Jul 1;91(1):115-122. doi: 10.1227/neu.0000000000001936. Epub 2022 Apr 7.
Gogia S, Edens M, Fall KN, Petrossian G, Horst J, Jas Garcia J, Ozdemir D, Karimi Galougahi K, Karmpaliotis D, Kirtane AJ, Ben-Yehuda O, Maehara A, Mintz GS, Ali ZA Temporal trends of invasive physiologic assessment of coronary artery stenosis severity: insights from a quaternary care center in the United States. Coron Artery Dis. 2022 Aug 1;33(5):424-426. doi: 10.1097/MCA.0000000000001137. Epub 2022 Apr 5.
Garcia P, Han J, Montez-Rath ME, Sun S, Shang T, Parsonnet J, Chertow GM, Anand S, Schiller B, Abra G SARS-CoV-2 Booster Vaccine Response among Patients Receiving Dialysis. Clin J Am Soc Nephrol. 2022 Jul;17(7):1036-1038. doi: 10.2215/CJN.00890122. Epub 2022 Apr 5.
Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, Fang JC, Fedson SE, Fonarow GC, Hayek SS, Hernandez AF, Khazanie P, Kittleson MM, Lee CS, Link MS, Milano CA, Nnacheta LC, Sandhu AT, Stevenson LW, Vardeny O, Vest AR, Yancy CW 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2022 May 3;79(17):1757-1780. doi: 10.1016/j.jacc.2021.12.011. Epub 2022 Apr 1.
Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, Fang JC, Fedson SE, Fonarow GC, Hayek SS, Hernandez AF, Khazanie P, Kittleson MM, Lee CS, Link MS, Milano CA, Nnacheta LC, Sandhu AT, Stevenson LW, Vardeny O, Vest AR, Yancy CW 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2022 May 3;79(17):e263-e421. doi: 10.1016/j.jacc.2021.12.012. Epub 2022 Apr 1.
Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, Fang JC, Fedson SE, Fonarow GC, Hayek SS, Hernandez AF, Khazanie P, Kittleson MM, Lee CS, Link MS, Milano CA, Nnacheta LC, Sandhu AT, Stevenson LW, Vardeny O, Vest AR, Yancy CW, WRITING COMMITTEE MEMBERS 2022 American College of Cardiology/American Heart Association/Heart Failure Society of America Guideline for the Management of Heart Failure: Executive Summary. J Card Fail. 2022 May;28(5):810-830. doi: 10.1016/j.cardfail.2022.02.009. Epub 2022 Apr 1.
Ostadal P, Steg PG, Poulouin Y, Bhatt DL, Bittner VA, Chua T, Diaz R, Goodman SG, Huo Y, Jukema JW, Karpov Y, Pordy R, Scemama M, Szarek M, White HD, Schwartz GG, ODYSSEY OUTCOMES Investigators Metabolic risk factors and effect of alirocumab on cardiovascular events after acute coronary syndrome: a post-hoc analysis of the ODYSSEY OUTCOMES randomised controlled trial. Lancet Diabetes Endocrinol. 2022 May;10(5):330-340. doi: 10.1016/S2213-8587(22)00043-2. Epub 2022 Apr 1.
Selvaraj S, Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Juliano RA, Jiao L, Tardif JC, Ballantyne CM, REDUCE-IT Investigators Impact of Icosapent Ethyl on Cardiovascular Risk Reduction in Patients With Heart Failure in REDUCE-IT. J Am Heart Assoc. 2022 Apr 5;11(7):e024999. doi: 10.1161/JAHA.121.024999. Epub 2022 Apr 4.
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M, Burri H, Butler J, Celutkiene J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Piepoli MF, Price S, Rosano GMC, Ruschitzka F, Skibelund AK, ESC Scientific Document Group [2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC]. G Ital Cardiol (Rome). 2022 Apr;23(4 Suppl 1):e1-e127. doi: 10.1714/3777.37630.
Devarajan P, Chertow GM, Susztak K, Levin A, Agarwal R, Stenvinkel P, Chapman AB, Warady BA Emerging Role of Clinical Genetics in CKD. Kidney Med. 2022 Feb 11;4(4):100435. doi: 10.1016/j.xkme.2022.100435. eCollection 2022 Apr.
Kumar P, Lim A, Poh SL, Hazirah SN, Chua CJH, Sutamam NB, Arkachaisri T, Yeo JG, Kofidis T, Sorokin V, Lam CSP, Richards AM, Albani S Pro-Inflammatory Derangement of the Immuno-Interactome in Heart Failure. Front Immunol. 2022 Mar 15;13:817514. doi: 10.3389/fimmu.2022.817514. eCollection 2022.
Hartwell M, Torgerson T, Essex R, Campbell B, Belardo D, Vassar M Public Awareness of a Plant-Based Diet Following the Release of “Game Changers” and “What The Health” Documentaries. Am J Lifestyle Med. 2021 Sep 24;16(2):190-196. doi: 10.1177/15598276211044106. eCollection 2022 Mar-Apr.
Hughes ZH, Ning H, Shah SJ, Yancy CW, Wilkins JT, Lloyd-Jones DM, Khan SS, Shah NS Distribution of 10- and 30-Year Predicted Risks for Heart Failure in the US Population: National Health and Nutrition Examination Surveys 2015 to 2018. Circ Heart Fail. 2022 May;15(5):e009351. doi: 10.1161/CIRCHEARTFAILURE.121.009351. Epub 2022 Apr 4.
Price MJ, Valderrabano M, Zimmerman S, Friedman DJ, Kar S, Curtis JP, Masoudi FA, Freeman JV Periprocedural Pericardial Effusion Complicating Transcatheter Left Atrial Appendage Occlusion: A Report From the NCDR LAAO Registry. Circ Cardiovasc Interv. 2022 May;15(5):e011718. doi: 10.1161/CIRCINTERVENTIONS.121.011718. Epub 2022 Apr 2.
Wang AX, Busque S, Kuo J, Singh U, Roeltgen K, Pinsky BA, Chertow GM, Scandling JD, Lenihan CR SARS-CoV-2 Neutralizing Monoclonal Antibodies for the Treatment of COVID-19 in Kidney Transplant Recipients. Kidney360. 2021 Oct 20;3(1):133-143. doi: 10.34067/KID.0005732021. eCollection 2022 Jan 27.
Nissen SE, Wolski K, Balog C, Swerdlow DI, Scrimgeour AC, Rambaran C, Wilson RJ, Boyce M, Ray KK, Cho L, Watts GF, Koren M, Turner T, Stroes ES, Melgaard C, Campion GV Single Ascending Dose Study of a Short Interfering RNA Targeting Lipoprotein(a) Production in Individuals With Elevated Plasma Lipoprotein(a) Levels. JAMA. 2022 May 3;327(17):1679-1687. doi: 10.1001/jama.2022.5050.
Simonato M, Vemulapalli S, Ben-Yehuda O, Wu C, Wood L, Popma J, Feldman T, Krohn C, Hardy KM, Guibone K, Christensen B, Alu MC, Chen S, Ng VG, Chau KH, Shahim B, Vincent F, MacMahon J, James S, Mack M, Leon MB, Thourani VH, Carroll J, Krucoff M Minimum Core Data Elements for Evaluation of TAVR: A Scientific Statement by PASSION CV, HVC, and TVT Registry. JACC Cardiovasc Interv. 2022 Apr 11;15(7):685-697. doi: 10.1016/j.jcin.2022.01.014.
Simonato M, Vemulapalli S, Ben-Yehuda O, Wu C, Wood L, Popma J, Feldman T, Krohn C, Hardy KM, Guibone K, Christensen B, Alu MC, Chen S, Ng VG, Chau KH, Shahim B, Vincent F, MacMahon J, James S, Mack M, Leon MB, Thourani VH, Carroll J, Krucoff M Minimum Core Data Elements for Evaluation of TAVR: A Scientific Statement by PASSION CV, HVC, and TVT Registry. Ann Thorac Surg. 2022 May;113(5):1730-1742. doi: 10.1016/j.athoracsur.2022.01.018. Epub 2022 Mar 30.
Sharma T, Tapales AJD, Ross CS, Malenka DJ, Flynn JM, Ferguson M, Young MN, Vasaiwala S, Kramer RS, Iribarne A, Dauerman HL Concordance of Guideline-Based Risk Stratification and Selection of Patients for Transcatheter Aortic Valve Implantation or Surgical Replacement. Am J Cardiol. 2022 Jun 15;173:94-99. doi: 10.1016/j.amjcard.2022.02.042. Epub 2022 Mar 30.
Rastogi T, Ho FK, Rossignol P, Merkling T, Butler J, Clark A, Collier T, Delles C, Jukema JW, Heymans S, Latini R, Mebazaa A, Pellicori P, Sever P, Staessen JA, Thijs L, Cleland JG, Sattar N, Zannad F, Girerd N Comparing and contrasting risk factors for heart failure in patients with and without history of myocardial infarction: data from HOMAGE and the UK Biobank. Eur J Heart Fail. 2022 Jun;24(6):976-984. doi: 10.1002/ejhf.2495. Epub 2022 Apr 18.
D’Souza SS, Kumar A, Weinfurter J, Park MA, Maufort J, Tao L, Kang H, Dettle ST, Golos T, Thomson JA, Reynolds MR, Slukvin I Generation of SIV-resistant T cells and macrophages from nonhuman primate induced pluripotent stem cells with edited CCR5 locus. Stem Cell Reports. 2022 Apr 12;17(4):953-963. doi: 10.1016/j.stemcr.2022.03.003. Epub 2022 Mar 31.
Morris AA, Butler J Updated Heart Failure Guidelines: Time for a Refresh. Circulation. 2022 May 3;145(18):1371-1373. doi: 10.1161/CIRCULATIONAHA.122.059104. Epub 2022 Apr 1.
Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, Fang JC, Fedson SE, Fonarow GC, Hayek SS, Hernandez AF, Khazanie P, Kittleson MM, Lee CS, Link MS, Milano CA, Nnacheta LC, Sandhu AT, Stevenson LW, Vardeny O, Vest AR, Yancy CW 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022 May 3;145(18):e876-e894. doi: 10.1161/CIR.0000000000001062. Epub 2022 Apr 1.
Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, Fang JC, Fedson SE, Fonarow GC, Hayek SS, Hernandez AF, Khazanie P, Kittleson MM, Lee CS, Link MS, Milano CA, Nnacheta LC, Sandhu AT, Stevenson LW, Vardeny O, Vest AR, Yancy CW, ACC/AHA Joint Committee Members 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022 May 3;145(18):e895-e1032. doi: 10.1161/CIR.0000000000001063. Epub 2022 Apr 1.
Mohebi R, Jackson L, McCarthy CP, Murtagh G, Murphy SP, Abboud A, Miksenas H, Gaggin HK, Januzzi JL Jr Relation of High-Sensitivity Cardiac Troponin I and Obstructive Coronary Artery Disease in Patients Without Acute Myocardial Infarction. Am J Cardiol. 2022 Jun 15;173:16-24. doi: 10.1016/j.amjcard.2022.03.001. Epub 2022 Mar 28.
Tromp J, Ouwerkerk W, Lam CSP, Voors AA Reply: A Systematic Review and Network Meta-Analysis of Pharmacological Treatment of HFrEF. JACC Heart Fail. 2022 Apr;10(4):293-294. doi: 10.1016/j.jchf.2022.01.016.
Khan MS, Segar MW, Usman MS, Singh S, Greene SJ, Fonarow GC, Anker SD, Felker GM, Januzzi JL Jr, Butler J, Pandey A Frailty, Guideline-Directed Medical Therapy, and Outcomes in HFrEF: From the GUIDE-IT Trial. JACC Heart Fail. 2022 Apr;10(4):266-275. doi: 10.1016/j.jchf.2021.12.004. Epub 2022 Mar 9.
Mihatov N, Mosarla RC, Kirtane AJ, Parikh SA, Rosenfield K, Chen S, Song Y, Yeh RW, Secemsky EA Outcomes Associated With Peripheral Artery Disease in Myocardial Infarction With Cardiogenic Shock. J Am Coll Cardiol. 2022 Apr 5;79(13):1223-1235. doi: 10.1016/j.jacc.2022.01.037.
Connors JM, Brooks MM, Sciurba FC, Fu Z, Ridker PM Clinical predictors of COVID-19 severity and bleeding in the ACTIV-4B COVID-19 outpatient thrombosis prevention trial. Am J Hematol. 2022 Jul;97(7):E235-E240. doi: 10.1002/ajh.26553. Epub 2022 Apr 11.
Angiolillo DJ, Galli M, Collet JP, Kastrati A, O’Donoghue ML Antiplatelet therapy after percutaneous coronary intervention. EuroIntervention. 2022 Apr 1;17(17):e1371-e1396. doi: 10.4244/EIJ-D-21-00904.
Borlaug BA, Blair J, Bergmann MW, Bugger H, Burkhoff D, Bruch L, Celermajer DS, Claggett B, Cleland JGF, Cutlip DE, Dauber I, Eicher JC, Gao Q, Gorter TM, Gustafsson F, Hayward C, van der Heyden J, Hasenfuss G, Hummel SL, Kaye DM, Komtebedde J, Massaro JM, Mazurek JA, McKenzie S, Mehta SR, Petrie MC, Post MC, Nair A, Rieth A, Silvestry FE, Solomon SD, Trochu JN, Van Veldhuisen DJ, Westenfeld R, Leon MB, Shah SJ, REDUCE LAP-HF-II Investigators Latent Pulmonary Vascular Disease May Alter the Response to Therapeutic Atrial Shunt Device in Heart Failure. Circulation. 2022 May 24;145(21):1592-1604. doi: 10.1161/CIRCULATIONAHA.122.059486. Epub 2022 Mar 31.
Galli M, Franchi F, Rollini F, Been L, Jaoude PA, Rivas A, Zhou X, Jia S, Maaliki N, Lee CH, Pineda AM, Suryadevara S, Soffer D, Zenni MM, Geisler T, Jennings LK, Bass TA, Angiolillo DJ Platelet P2Y12 inhibiting therapy in adjunct to vascular dose of rivaroxaban or aspirin: a pharmacodynamic study of dual pathway inhibition vs. dual antiplatelet therapy. Eur Heart J Cardiovasc Pharmacother. 2022 Sep 29;8(7):728-737. doi: 10.1093/ehjcvp/pvac022.
Maitra NS, Mahtta D, Navaneethan S, Vaughan EM, Kochar A, Gulati M, Levine GN, Petersen LA, Virani SS A Mistake Not to Be Repeated: What Can We Learn from the Underutilization of Statin Therapy for Efficient Dissemination of Cardioprotective Glucose Lowering Agents? Curr Cardiol Rep. 2022 Jun;24(6):689-698. doi: 10.1007/s11886-022-01694-5. Epub 2022 Mar 29.
Tamura N, Goto S, Yokota H, Goto S Contributing role of mitochondrial energy metabolism on platelet adhesion, activation and thrombus formation under blood flow conditions. Platelets. 2022 Oct 3;33(7):1083-1089. doi: 10.1080/09537104.2022.2046722. Epub 2022 Mar 29.
Laufs U, Ballantyne CM, Banach M, Bays H, Catapano AL, Duell PB, Goldberg AC, Gotto AM, Leiter LA, Ray KK, Bloedon LT, MacDougall D, Zhang Y, Mancini GBJ Efficacy and safety of bempedoic acid in patients not receiving statins in phase 3 clinical trials. J Clin Lipidol. 2022 May-Jun;16(3):286-297. doi: 10.1016/j.jacl.2022.03.001. Epub 2022 Mar 13.
Extramiana F, Steg PG Atrial Fibrillation Screening: The Tools Are Ready, But Should We Do It? Circulation. 2022 Mar 29;145(13):955-958. doi: 10.1161/CIRCULATIONAHA.121.058369. Epub 2022 Mar 28.
Xian Y, Xu H, Smith EE, Fonarow GC, Bhatt DL, Schwamm LH, Peterson ED Evaluation of Evidence-Based Dual Antiplatelet Therapy for Secondary Prevention in US Patients With Acute Ischemic Stroke. JAMA Intern Med. 2022 May 1;182(5):559-564. doi: 10.1001/jamainternmed.2022.0323.
Mendelson L, Sanchorawala V, Connors L, Joshi T, Doros G, Pogrebinsky A, Havasi A Correlation Between 24-Hour Urine Protein and Random Urine Protein-Creatinine Ratio in Amyloid Light-Chain Amyloidosis. Kidney Med. 2022 Feb 3;4(4):100427. doi: 10.1016/j.xkme.2022.100427. eCollection 2022 Apr.
Alpert JS, Jaffe AS, White HD, Thygesen KA Type 1, Type 2 Myocardial Infarction and Non-Ischemic Myocardial Injury-Opinion from the Front Lines. Am J Med. 2022 Aug;135(8):935-938. doi: 10.1016/j.amjmed.2022.03.004. Epub 2022 Mar 25.
Michelhaugh SA, Januzzi JL Jr Using Artificial Intelligence to Better Predict and Develop Biomarkers. Heart Fail Clin. 2022 Apr;18(2):275-285. doi: 10.1016/j.hfc.2021.11.004. Epub 2022 Mar 8.
Vengalasetti YV, Chertow GM, Popat R Dysgeusia and Dysosmia in Chronic Kidney Disease: NHANES 2011-2014. J Ren Nutr. 2022 Sep;32(5):537-541. doi: 10.1053/j.jrn.2021.11.003. Epub 2021 Nov 20.
Lin A, Manral N, McElhinney P, Killekar A, Matsumoto H, Kwiecinski J, Pieszko K, Razipour A, Grodecki K, Park C, Otaki Y, Doris M, Kwan AC, Han D, Kuronuma K, Flores Tomasino G, Tzolos E, Shanbhag A, Goeller M, Marwan M, Gransar H, Tamarappoo BK, Cadet S, Achenbach S, Nicholls SJ, Wong DT, Berman DS, Dweck M, Newby DE, Williams MC, Slomka PJ, Dey D Deep learning-enabled coronary CT angiography for plaque and stenosis quantification and cardiac risk prediction: an international multicentre study. Lancet Digit Health. 2022 Apr;4(4):e256-e265. doi: 10.1016/S2589-7500(22)00022-X.
Gonzalez A, Richards AM, de Boer RA, Thum T, Arfsten H, Hulsmann M, Falcao-Pires I, Diez J, Foo RSY, Chan MY, Aimo A, Anene-Nzelu CG, Abdelhamid M, Adamopoulos S, Anker SD, Belenkov Y, Ben Gal T, Cohen-Solal A, Bohm M, Chioncel O, Delgado V, Emdin M, Jankowska EA, Gustafsson F, Hill L, Jaarsma T, Januzzi JL, Jhund PS, Lopatin Y, Lund LH, Metra M, Milicic D, Moura B, Mueller C, Mullens W, Nunez J, Piepoli MF, Rakisheva A, Ristic AD, Rossignol P, Savarese G, Tocchetti CG, Van Linthout S, Volterrani M, Seferovic P, Rosano G, Coats AJS, Bayes-Genis A Cardiac remodelling – Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2022 Jun;24(6):927-943. doi: 10.1002/ejhf.2493. Epub 2022 Apr 21.
Anker SD, Ponikowski P, Khan MS, Friede T, Jankowska EA, Fabien V, Goehring UM, Metra M, Pina IL, Coats AJS, Rosano G, Dorigotti F, Comin-Colet J, Van Veldhuisen DJ, Filippatos GS, Butler J Responder analysis for improvement in 6-min walk test with ferric carboxymaltose in patients with heart failure with reduced ejection fraction and iron deficiency. Eur J Heart Fail. 2022 May;24(5):833-842. doi: 10.1002/ejhf.2491. Epub 2022 Apr 21.
Abramov D, Kobo O, Mohamed M, Roguin A, Osman M, Patel B, Parwani P, Alraies C, Sauer AJ, Van Spall HGC, Mamas MA Management and outcomes of acute myocardial infarction in patients with preexisting heart failure: an analysis of 2 million patients from the national inpatient sample. Expert Rev Cardiovasc Ther. 2022 Mar;20(3):233-240. doi: 10.1080/14779072.2022.2058931. Epub 2022 Mar 31.
Elgendy IY, Wegermann ZK, Li S, Mahtta D, Grau-Sepulveda M, Smilowitz NR, Gulati M, Garratt KN, Wang TY, Jneid H Sex Differences in Management and Outcomes of Acute Myocardial Infarction Patients Presenting With Cardiogenic Shock. JACC Cardiovasc Interv. 2022 Mar 28;15(6):642-652. doi: 10.1016/j.jcin.2021.12.033.
Rao SV RESPONSE: Navigating the Transition From Fellowship to Early Career: “Sink or Swim” to “Lifting All Boats”. J Am Coll Cardiol. 2022 Mar 29;79(12):1218-1219. doi: 10.1016/j.jacc.2021.08.080.
Ferreira JP, Butler J, Zannad F, Filippatos G, Schueler E, Steubl D, Zeller C, Januzzi JL, Pocock S, Packer M, Anker SD Mineralocorticoid Receptor Antagonists and Empagliflozin in Patients With Heart Failure and Preserved Ejection Fraction. J Am Coll Cardiol. 2022 Mar 29;79(12):1129-1137. doi: 10.1016/j.jacc.2022.01.029.
Johansen KL, Chertow GM, Gilbertson DT, Herzog CA, Ishani A, Israni AK, Ku E, Li S, Li S, Liu J, Obrador GT, O’Hare AM, Peng Y, Powe NR, Roetker NS, St Peter WL, Saeed F, Snyder J, Solid C, Weinhandl ED, Winkelmayer WC, Wetmore JB US Renal Data System 2021 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis. 2022 Apr;79(4 Suppl 1):A8-A12. doi: 10.1053/j.ajkd.2022.02.001.
Mulangala J, Akers EJ, Solly EL, Bamhare PM, Wilsdon LA, Wong NKP, Tan JTM, Bursill CA, Nicholls SJ, Di Bartolo BA Pro-Calcific Environment Impairs Ischaemia-Driven Angiogenesis. Int J Mol Sci. 2022 Mar 20;23(6):3363. doi: 10.3390/ijms23063363.
Ullah W, Zahid S, Sandhyavenu H, Faisaluddin M, Khalil F, Pasha AK, Alraies MC, Cuisset T, Rao SV, Sabouret P, Savage MP, Fischman DL Extended, standard, or De-escalation antiplatelet therapy for patients with coronary artery disease undergoing percutaneous coronary intervention? A trial-sequential, bivariate, influential, and network meta-analysis. Eur Heart J Cardiovasc Pharmacother. 2022 Sep 29;8(7):717-727. doi: 10.1093/ehjcvp/pvac020.
Dehghani P, Cao D, Baber U, Nicolas J, Sartori S, Pivato CA, Zhang Z, Dangas G, Angiolillo DJ, Briguori C, Cohen DJ, Collier T, Dudek D, Gibson M, Gil R, Huber K, Kaul U, Kornowski R, Krucoff MW, Kunadian V, Mehta S, Moliterno DJ, Ohman EM, Escaned J, Sardella G, Sharma SK, Shlofmitz R, Weisz G, Witzenbichler B, Pocock S, Mehran R Ticagrelor monotherapy after PCI in patients with concomitant diabetes mellitus and chronic kidney disease: TWILIGHT DM-CKD. Eur Heart J Cardiovasc Pharmacother. 2022 Sep 29;8(7):707-716. doi: 10.1093/ehjcvp/pvac016.
Bubb KJ, Nelson AJ, Nicholls SJ Targeting triglycerides to lower residual cardiovascular risk. Expert Rev Cardiovasc Ther. 2022 Mar;20(3):185-191. doi: 10.1080/14779072.2022.2058489. Epub 2022 Mar 28.
Ducrocq G, Bhatt DL, Lee JJ, Kui N, Fox KM, Harrington RA, Leiter LA, Mehta SR, Kiss RG, James S, Vinereanu D, Huber K, Andersson M, Himmelmann A, Simon T, Steg PG Balance of benefit and risk of ticagrelor in patients with diabetes and stable coronary artery disease according to bleeding risk assessment with the CRUSADE score: Data from THEMIS and THEMIS PCI. Am Heart J. 2022 Jul;249:23-33. doi: 10.1016/j.ahj.2022.03.008. Epub 2022 Mar 20.
DeFilippis EM, Echols M, Adamson PB, Batchelor WB, Cooper LB, Cooper LS, Desvigne-Nickens P, George RT, Ibrahim NE, Jessup M, Kitzman DW, Leifer ES, Mendoza M, Pina IL, Psotka M, Senatore FF, Stein KM, Teerlink JR, Yancy CW, Lindenfeld J, Fiuzat M, O’Connor CM, Vardeny O, Vaduganathan M Improving Enrollment of Underrepresented Racial and Ethnic Populations in Heart Failure Trials: A Call to Action From the Heart Failure Collaboratory. JAMA Cardiol. 2022 May 1;7(5):540-548. doi: 10.1001/jamacardio.2022.0161.
Januzzi JL, Garasic JM, Kasner SE, McDonald V, Petrie MC, Seltzer J, Mauro M, Croce K, Berman E, Deininger M, Hochhaus A, Pinilla-Ibarz J, Nicolini F, Kim DW, DeAngelo DJ, Kantarjian H, Xu J, Hall T, Srivastava S, Naranjo D, Cortes J Correction: Retrospective analysis of arterial occlusive events in the PACE trial by an independent adjudication committee. J Hematol Oncol. 2022 Mar 23;15(1):33. doi: 10.1186/s13045-022-01239-x.
Han Y, Claessen BE, Chen SL, Chunguang Q, Zhou Y, Xu Y, Hailong L, Chen J, Qiang W, Zhang R, Luo S, Li Y, Zhu J, Zhao X, Cheng X, Wang J, Su X, Tao J, Sun Y, Wang G, Li Y, Bian L, Goel R, Sartori S, Zhang Z, Angiolillo DJ, Cohen DJ, Gibson CM, Kastrati A, Krucoff M, Mehta SR, Ohman EM, Steg PG, Liu Y, Dangas G, Sharma S, Baber U, Mehran R Ticagrelor With or Without Aspirin in Chinese Patients Undergoing Percutaneous Coronary Intervention: A TWILIGHT China Substudy. Circ Cardiovasc Interv. 2022 Apr;15(4):e009495. doi: 10.1161/CIRCINTERVENTIONS.120.009495. Epub 2022 Mar 23.
Connors JM, Ridker PM Thromboinflammation and Antithrombotics in COVID-19: Accumulating Evidence and Current Status. JAMA. 2022 Apr 5;327(13):1234-1235. doi: 10.1001/jama.2022.2361.
Baerman EA, Kaplan J, Shen JI, Winkelmayer WC, Erickson KF Cost Barriers to More Widespread Use of Peritoneal Dialysis in the United States. J Am Soc Nephrol. 2022 Jun;33(6):1063-1072. doi: 10.1681/ASN.2021060854. Epub 2022 Mar 21.
Montez-Rath ME, Garcia P, Han J, Cadden L, Hunsader P, Morgan C, Kerschmann R, Beyer P, Dittrich M, Block GA, Anand S, Parsonnet J, Chertow GM SARS-CoV-2 infection during the Omicron surge among patients receiving dialysis: the role of circulating receptor-binding domain antibodies and vaccine doses. medRxiv [Preprint]. 2022 Mar 18:2022.03.15.22272426. doi: 10.1101/2022.03.15.22272426.
Douglas PS, Mack MJ, Acosta DA, Benjamin EJ, Biga C, Hayes SN, Ijioma NN, Jay-Fuchs L, Khandelwal AK, McPherson JA, Mieres JH, Roswell RO, Sengupta PP, Stokes N, Wade EA, Yancy CW, Writing Committee 2022 ACC Health Policy Statement on Building Respect, Civility, and Inclusion in the Cardiovascular Workplace: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2022 May 31;79(21):2153-2184. doi: 10.1016/j.jacc.2022.03.006. Epub 2022 Mar 17.
Raja A, Dicks A, Sardar P, Schermerhorn ML, Yeh RW, Secemsky EA Accuracy of Administrative Claims Codes for Identifying Devices Used in Endovascular Femoropopliteal Artery Revascularisation: A Retrospective Observational Study at Two Tertiary Centres in the United States. Eur J Vasc Endovasc Surg. 2022 May;63(5):769-770. doi: 10.1016/j.ejvs.2022.01.009. Epub 2022 Mar 17.
Gluckman TJ, Bhave NM, Allen LA, Chung EH, Spatz ES, Ammirati E, Baggish AL, Bozkurt B, Cornwell WK 3rd, Harmon KG, Kim JH, Lala A, Levine BD, Martinez MW, Onuma O, Phelan D, Puntmann VO, Rajpal S, Taub PR, Verma AK, Writing Committee 2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocarditis and Other Myocardial Involvement, Post-Acute Sequelae of SARS-CoV-2 Infection, and Return to Play: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2022 May 3;79(17):1717-1756. doi: 10.1016/j.jacc.2022.02.003. Epub 2022 Mar 16.
Foster L, Robinson L, Yeatts SD, Conwit RA, Shehadah A, Lioutas V, Selim M, i-DEF Investigators Effect of Deferoxamine on Trajectory of Recovery After Intracerebral Hemorrhage: A Post Hoc Analysis of the i-DEF Trial. Stroke. 2022 Jul;53(7):2204-2210. doi: 10.1161/STROKEAHA.121.037298. Epub 2022 Mar 21.
Genereux P, Chernin G, Assali AR, Peruga JZ, Robinson SD, Schampaert E, Bagur R, Mansour S, Rodes-Cabau J, McEntegart M, Gerber R, L’Allier P, de Silva R, Daneault B, Aggarwal SK, Dzavik V, Ozan MO, Ben-Yehuda O, Maehara A, Stone GW, Jonas M Double-blind, placebo-controlled evaluation of biorest liposomal alendronate in diabetic patients undergoing PCI: The BLADE-PCI trial. Am Heart J. 2022 Jul;249:45-56. doi: 10.1016/j.ahj.2022.03.004. Epub 2022 Mar 17.
Mohebi R, Karimi Galougahi K, Garcia JJ, Horst J, Ben-Yehuda O, Radhakrishnan J, Chertow GM, Jeremias A, Cohen DJ, Cohen DJ, Maehara A, Mintz GS, Chen S, Redfors B, Leon MB, Stuckey TD, Rinaldi MJ, Weisz G, Witzenbichler B, Kirtane AJ, Mehran R, Dangas GD, Stone GW, Ali ZA Long-Term Clinical Impact of Contrast-Associated Acute Kidney Injury Following PCI: An ADAPT-DES Substudy. JACC Cardiovasc Interv. 2022 Apr 11;15(7):753-766. doi: 10.1016/j.jcin.2021.11.026. Epub 2022 Mar 16.
Salah HM, Pandey A, Van Spall HGC, Michos ED, McGarrah RW, Fudim M Meta-Analysis of Nonalcoholic Fatty Liver Disease and Incident Heart Failure. Am J Cardiol. 2022 May 15;171:180-181. doi: 10.1016/j.amjcard.2022.02.012. Epub 2022 Mar 16.
Chow LS, Gerszten RE, Taylor JM, Pedersen BK, van Praag H, Trappe S, Febbraio MA, Galis ZS, Gao Y, Haus JM, Lanza IR, Lavie CJ, Lee CH, Lucia A, Moro C, Pandey A, Robbins JM, Stanford KI, Thackray AE, Villeda S, Watt MJ, Xia A, Zierath JR, Goodpaster BH, Snyder MP Exerkines in health, resilience and disease. Nat Rev Endocrinol. 2022 May;18(5):273-289. doi: 10.1038/s41574-022-00641-2. Epub 2022 Mar 18.
Huang Z, Rockhold FW, Jones WS, Hernandez AF, McCall D, DeMets DL, Hochman JS, Gersh BJ, Campos H, Jacobs AK, Yancy CW The challenges of data safety monitoring for a pragmatic study: Lessons from the ADAPTABLE study. Contemp Clin Trials. 2022 Apr;115:106732. doi: 10.1016/j.cct.2022.106732. Epub 2022 Mar 15.
Gulati M, Korn RM, Wood MJ, Sarma A, Douglas PS, Singh T, Merz NB, Lee J, Mehran R, Andrews OA, Williams JC Childbearing Among Women Cardiologists: The Interface of Experience, Impact, and the Law. J Am Coll Cardiol. 2022 Mar 22;79(11):1076-1087. doi: 10.1016/j.jacc.2021.12.034.
Cleland JGF, Butler J, Januzzi JL Jr, Pellicori P, McDonagh T Only people with increased plasma concentrations of natriuretic peptides should be included in outcome trials of diabetes, cardiovascular and kidney disease: implications for clinical practice. Eur J Heart Fail. 2022 Apr;24(4):678-680. doi: 10.1002/ejhf.2488. Epub 2022 Mar 31.
Spitzer E, Fanaroff AC, Gibson CM, Seltzer J, McFadden E, Ali M, Wilson M, Menon V, Mehran R, Held C, Mahaffey KW, Lopes RD Independence of clinical events committees: A consensus statement from clinical research organizations. Am Heart J. 2022 Jun;248:120-129. doi: 10.1016/j.ahj.2022.03.005. Epub 2022 Mar 13.
Lopes RD, Guimaraes PO, Schwartz GG, Bhatt DL, Bittner VA, Budaj A, Dalby AJ, Diaz R, Goodman SG, Harrington RA, Jukema JW, Kiss RG, Loy M, Pordy R, Poulouin Y, Szarek M, White HD, Steg PG, ODYSSEY OUTCOMES Investigators Effect of Alirocumab on Incidence of Atrial Fibrillation After Acute Coronary Syndromes: Insights from the ODYSSEY OUTCOMES Trial. Am J Med. 2022 Jul;135(7):915-918. doi: 10.1016/j.amjmed.2022.02.016. Epub 2022 Mar 14.
Alkhalil M, Dzavik V, Bhatt DL, Mehran R, Mehta SR Antiplatelet Therapy in Patients Undergoing Elective Percutaneous Coronary Intervention. Curr Cardiol Rep. 2022 Mar;24(3):277-293. doi: 10.1007/s11886-022-01645-0. Epub 2022 Mar 16.
DeVore AD, Hellkamp AS, Thomas L, Albert NM, Butler J, Patterson JH, Spertus JA, Williams FB, Shen X, Hernandez AF, Fonarow GC The association of improvement in left ventricular ejection fraction with outcomes in patients with heart failure with reduced ejection fraction: data from CHAMP-HF. Eur J Heart Fail. 2022 May;24(5):762-770. doi: 10.1002/ejhf.2486. Epub 2022 Mar 31.
Vaduganathan M, Piccini JP, Camm AJ, Crijns HJGM, Anker SD, Butler J, Stewart J, Braceras R, Albuquerque APA, Wieloch M, Hohnloser SH Dronedarone for the treatment of atrial fibrillation with concomitant heart failure with preserved and mildly reduced ejection fraction: a post-hoc analysis of the ATHENA trial. Eur J Heart Fail. 2022 Jun;24(6):1094-1101. doi: 10.1002/ejhf.2487. Epub 2022 Apr 10.
Vinson AJ, Singh S, Chadban S, Cherney D, Gaber O, Gill JS, Helgeson E, Herzog CA, Jardine M, Jha V, Kasiske BL, Mannon RB, Michos ED, Mottl AK, Newby K, Roy-Chaudhury P, Sawinski D, Sharif A, Sridhar VS, Tuttle KR, Vock DM, Matas A Premature Death in Kidney Transplant Recipients: The Time for Trials is Now. J Am Soc Nephrol. 2022 Apr;33(4):665-673. doi: 10.1681/ASN.2021111517. Epub 2022 Mar 15.
Salah HM, Verma S, Santos-Gallego CG, Bhatt AS, Vaduganathan M, Khan MS, Lopes RD, Al’Aref SJ, McGuire DK, Fudim M Sodium-Glucose Cotransporter 2 Inhibitors and Cardiac Remodeling. J Cardiovasc Transl Res. 2022 Oct;15(5):944-956. doi: 10.1007/s12265-022-10220-5. Epub 2022 Mar 15.
Vranckx P, Morrow D, Verbrugge F Appointment as patient advocacy associate editor. Eur Heart J Acute Cardiovasc Care. 2022 Jun 7;11(4):275. doi: 10.1093/ehjacc/zuac027.
Keshvani N, Mehta A, Alger HM, Rutan C, Williams J, Zhang S, Young R, Alhanti B, Chiswell K, Greene SJ, DeVore AD, Yancy CW, Fonarow GC, Pandey A Heart failure quality of care and in-hospital outcomes during the COVID-19 pandemic: findings from the Get With The Guidelines-Heart Failure registry. Eur J Heart Fail. 2022 Jun;24(6):1117-1128. doi: 10.1002/ejhf.2484. Epub 2022 Apr 6.
Genereux P, Kirtane AJ, Kandzari DE, Armstrong EJ, Krucoff MW, Redfors B, Ben-Yehuda O, Lerew DR, Ali ZA, Maehara A, O’Neill WW, Stone GW Randomized evaluation of vessel preparation with orbital atherectomy prior to drug-eluting stent implantation in severely calcified coronary artery lesions: Design and rationale of the ECLIPSE trial. Am Heart J. 2022 Jul;249:1-11. doi: 10.1016/j.ahj.2022.03.003. Epub 2022 Mar 12.
Kandzari DE, Mahfoud F, Weber MA, Townsend R, Parati G, Fisher NDL, Lobo MD, Bloch M, Bohm M, Sharp ASP, Schmieder RE, Azizi M, Schlaich MP, Papademetriou V, Kirtane AJ, Daemen J, Pathak A, Ukena C, Lurz P, Grassi G, Myers M, Finn AV, Morice MC, Mehran R, Juni P, Stone GW, Krucoff MW, Whelton PK, Tsioufis K, Cutlip DE, Spitzer E Clinical Trial Design Principles and Outcomes Definitions for Device-Based Therapies for Hypertension: A Consensus Document From the Hypertension Academic Research Consortium. Circulation. 2022 Mar 15;145(11):847-863. doi: 10.1161/CIRCULATIONAHA.121.057687. Epub 2022 Mar 14.
Assimon MM, Pun PH, Al-Khatib SM, Brookhart MA, Gaynes BN, Winkelmayer WC, Flythe JE Proton pump inhibitors may enhance the risk of citalopram- and escitalopram-associated sudden cardiac death among patients receiving hemodialysis. Pharmacoepidemiol Drug Saf. 2022 Jun;31(6):670-679. doi: 10.1002/pds.5428. Epub 2022 Mar 24.
Belardo D, Michos ED, Blankstein R, Blumenthal RS, Ferdinand KC, Hall K, Klatt K, Natajaran P, Ostfeld RJ, Reddy K, Rodriguez R, Sriram U, Tobias DK, Gulati M Practical, Evidence-Based Approaches to Nutritional Modifications to Reduce Atherosclerotic Cardiovascular Disease: An American Society For Preventive Cardiology Clinical Practice Statement. Am J Prev Cardiol. 2022 Mar 2;10:100323. doi: 10.1016/j.ajpc.2022.100323. eCollection 2022 Jun.
Rafiudeen R, Barlis P, White HD, van Gaal W Type 2 MI and Myocardial Injury in the Era of High-sensitivity Troponin. Eur Cardiol. 2022 Feb 17;17:e03. doi: 10.15420/ecr.2021.42. eCollection 2022 Feb.
Yuvaraj J, Cameron W, Andrews J, Lin A, Nerlekar N, Nicholls SJ, Hamilton GS, Wong DTL Coronary computed tomography angiography-based assessment of vascular inflammation in patients with obstructive sleep apnoea and coronary artery disease. Cardiovasc Diagn Ther. 2022 Feb;12(1):123-134. doi: 10.21037/cdt-21-338.
Kataoka Y, Nicholls SJ, Andrews J, Uno K, Kapadia SR, Tuzcu EM, Nissen SE, Puri R Plaque microstructures during metformin therapy in type 2 diabetic subjects with coronary artery disease: optical coherence tomography analysis. Cardiovasc Diagn Ther. 2022 Feb;12(1):77-87. doi: 10.21037/cdt-21-346.
Mensink FB, Ten Cate TJF, Damen SAJ, Roes K, Di Mario C, Singh V, Ali ZA, Skinner W, Artis A, Torguson R, Zhang C, Doros G, Garcia-Garcia HM, Mintz GS, Geuns RV, Waksman R Near-infrared spectroscopy predicts events in men and women: Results from the Lipid Rich Plaque study. Int J Cardiol Heart Vasc. 2022 Mar 8;39:100985. doi: 10.1016/j.ijcha.2022.100985. eCollection 2022 Apr.
Butler J, Khan MS, Friede T, Jankowska EA, Fabien V, Goehring UM, Dorigotti F, Metra M, Pina IL, Coats AJS, Rosano G, Comin-Colet J, Van Veldhuisen DJ, Filippatos GS, Anker SD, Ponikowski P Health status improvement with ferric carboxymaltose in heart failure with reduced ejection fraction and iron deficiency. Eur J Heart Fail. 2022 May;24(5):821-832. doi: 10.1002/ejhf.2478. Epub 2022 Mar 29.
McGrail D, Sehgal S, Tuttle MK, Laham R, Belani K The Many Faces of the Interatrial Septum: A Diagnostic Dilemma and Considerations for Defect Closure Device Selection. J Cardiothorac Vasc Anesth. 2022 Aug;36(8 Pt B):3156-3162. doi: 10.1053/j.jvca.2022.01.034. Epub 2022 Jan 31.
Kislitsina ON, D Rich J, Wilcox JE, E Vorovich E, Wu T, Churyla A, S Harap R, Andrei AC, McCarthy PM, Yancy CW, Pham DT Propensity Score-Matched Comparison of Right Ventricular Strain in Women and Men Before and After Left Ventricular Assist Device Implantation. Innovations (Phila). 2022 Mar-Apr;17(2):102-110. doi: 10.1177/15569845221081937. Epub 2022 Mar 11.
Butler J, Spertus JA, Bamber L, Khan MS, Roessig L, Vlajnic V, Norquist JM, Anstrom KJ, Blaustein RO, Lam CSP, Armstrong PW, VITALITY-HFpEF Study Group Defining changes in physical limitation from the patient perspective: insights from the VITALITY-HFpEF randomized trial. Eur J Heart Fail. 2022 May;24(5):843-850. doi: 10.1002/ejhf.2481. Epub 2022 Apr 3.
Doll JA, Beaver K, Naranjo D, Waldo SW, Maynard C, Helfrich CD, Rao SV Trends in Arterial Access Site Selection and Bleeding Outcomes Following Coronary Procedures, 2011-2018. Circ Cardiovasc Qual Outcomes. 2022 May;15(5):e008359. doi: 10.1161/CIRCOUTCOMES.121.008359. Epub 2022 Mar 11.
Cheng XS, Han J, Braggs-Gresham JL, Held PJ, Busque S, Roberts JP, Tan JC, Scandling JD, Chertow GM, Dor A Trends in Cost Attributable to Kidney Transplantation Evaluation and Waiting List Management in the United States, 2012-2017. JAMA Netw Open. 2022 Mar 1;5(3):e221847. doi: 10.1001/jamanetworkopen.2022.1847.
Zile MR, Desai AS, Costanzo MR, Ducharme A, Maisel A, Mehra MR, Paul S, Sears SF, Smart F, Chien C, Guha A, Guichard JL, Hall S, Jonsson O, Johnson N, Sood P, Henderson J, Adamson PB, Lindenfeld J The GUIDE-HF trial of pulmonary artery pressure monitoring in heart failure: impact of the COVID-19 pandemic. Eur Heart J. 2022 Jul 14;43(27):2603-2618. doi: 10.1093/eurheartj/ehac114.
Sposato LA, Andrade J Prolonged Cardiac Monitoring for Atrial Fibrillation Detection After Stroke: In Search of the Elusive Sweet Spot. Neurology. 2022 May 10;98(19):781-783. doi: 10.1212/WNL.0000000000200333. Epub 2022 Mar 9.
Sajiki Y, Konnai S, Okagawa T, Maekawa N, Goto S, Kohara J, Nitanai A, Takahashi H, Kubota K, Takeda H, Murata S, Ohashi K Estradiol-induced immune suppression via prostaglandin E2 during parturition in bovine leukemia virus-infected cattle. PLoS One. 2022 Mar 9;17(3):e0263660. doi: 10.1371/journal.pone.0263660. eCollection 2022.
Briguori C, Mathew RO, Huang Z, Mavromatis K, Hickson LJ, Lau WL, Mathew A, Mahajan S, Wheeler DC, Claes KJ, Chen G, Nolasco FEB, Stone GW, Fleg JL, Sidhu MS, Rockhold FW, Chertow GM, Hochman JS, Maron DJ, Bangalore S Dialysis Initiation in Patients With Chronic Coronary Disease and Advanced Chronic Kidney Disease in ISCHEMIA-CKD. J Am Heart Assoc. 2022 Mar 15;11(6):e022003. doi: 10.1161/JAHA.121.022003. Epub 2022 Mar 9.
Peterson BE, Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, Juliano RA, Jiao L, Doyle RT Jr, Granowitz C, Gibson CM, Pinto D, Giugliano RP, Budoff MJ, Tardif JC, Verma S, Ballantyne CM, REDUCE-IT Investigators Treatment With Icosapent Ethyl to Reduce Ischemic Events in Patients With Prior Percutaneous Coronary Intervention: Insights From REDUCE-IT PCI. J Am Heart Assoc. 2022 Mar 15;11(6):e022937. doi: 10.1161/JAHA.121.022937. Epub 2022 Mar 9.
Pellegrini VD Jr, Eikelboom JW, Evarts CM, Franklin PD, Garvin KL, Goldhaber SZ, Iorio R, Lambourne CA, Magaziner J, Magder L, Steering Committee of the PEPPER Trial and the PEPPER Trial Investigators, funded, by PCORI Randomised comparative effectiveness trial of Pulmonary Embolism Prevention after hiP and kneE Replacement (PEPPER): the PEPPER trial protocol. BMJ Open. 2022 Mar 8;12(3):e060000. doi: 10.1136/bmjopen-2021-060000.
Ono M, Hara H, Kawashima H, Gao C, Wang R, Wykrzykowska JJ, Piek JJ, Garg S, Hamm C, Steg PG, Valgimigli M, Windecker S, Vranckx P, Onuma Y, Serruys PW Ticagrelor monotherapy versus aspirin monotherapy at 12 months after percutaneous coronary intervention: a landmark analysis of the GLOBAL LEADERS trial. EuroIntervention. 2022 Aug 5;18(5):e377-e388. doi: 10.4244/EIJ-D-21-00870.
Mohebi R, McCarthy CP, Magaret CA, Barnes G, Rhyne RF, Peters C, Gaggin HK, Januzzi JL Performance of a protein biomarker panel for prediction of cardiovascular events in patients with diabetes mellitus. Eur J Prev Cardiol. 2022 May 27;29(8):e270-e271. doi: 10.1093/eurjpc/zwac050.
Bainey KR, Bastiany A, Cohen E, Eckstein J, Elbarouni B, Graham MM, Kidwai B, Andrea Lavoie, Liu S, Mansour S, Matteau A, O’Neill B, Sathananthan J, Sibbald M, Welsh RC, Madan M 2022 CCS/CAIC Guidelines for Training and Retraining in Adult Interventional Cardiology. Can J Cardiol. 2022 Aug;38(8):1307-1311. doi: 10.1016/j.cjca.2022.02.027. Epub 2022 Mar 4.
Li HL, Tromp J, Teramoto K, Tse YK, Yu SY, Lam LY, Li KY, Wu MZ, Ren QW, Wong PF, Cheung CL, To KK, Tse HF, Lam CSP, Yiu KH Temporal trends and patterns of infective endocarditis in a Chinese population: A territory-wide study in Hong Kong (2002-2019). Lancet Reg Health West Pac. 2022 Mar 4;22:100417. doi: 10.1016/j.lanwpc.2022.100417. eCollection 2022 May.
Winkelmayer WC, Walther CP Retraction notice to “Roxadustat for CKD Anemia – Starting the Jigsaw Puzzle, What Will the Finished Picture Show?” Kidney Int Rep. 2021;6:559-561. Kidney Int Rep. 2022 Feb 5;7(3):665. doi: 10.1016/j.ekir.2022.01.1070. eCollection 2022 Mar.
Hodlmoser S, Carrero JJ, Kurnikowski A, Fu EL, Swartling O, Winkelmayer WC, Schernhammer ES, Hecking M Kidney Function, Kidney Replacement Therapy, and Mortality in Men and Women. Kidney Int Rep. 2021 Dec 27;7(3):444-454. doi: 10.1016/j.ekir.2021.12.024. eCollection 2022 Mar.
Provenzano M, Jongs N, Vart P, Stefansson BV, Chertow GM, Langkilde AM, McMurray JJV, Correa-Rotter R, Rossing P, Sjostrom CD, Toto RD, Wheeler DC, Heerspink HJL, DAPA-CKD Trial Committees and Investigators The Kidney Protective Effects of the Sodium-Glucose Cotransporter-2 Inhibitor, Dapagliflozin, Are Present in Patients With CKD Treated With Mineralocorticoid Receptor Antagonists. Kidney Int Rep. 2021 Dec 14;7(3):436-443. doi: 10.1016/j.ekir.2021.12.013. eCollection 2022 Mar.
Wang MC, Dolan B, Freed BH, Vega L, Markoski N, Wainright AE, Kane B, Seegmiller LE, Harrington K, Lewis AA, Shah SJ, Yancy CW, Neeland IJ, Ning H, Lloyd-Jones DM, Khan SS Corrigendum: Rationale and Design of a Pharmacist-led Intervention for the Risk-Based Prevention of Heart Failure: The FIT-HF Pilot Study. Front Cardiovasc Med. 2022 Feb 18;9:844270. doi: 10.3389/fcvm.2022.844270. eCollection 2022.
Solomon SD, Vaduganathan M, Claggett BL, de Boer RA, DeMets D, Hernandez AF, Inzucchi SE, Kosiborod MN, Lam CSP, Martinez F, Shah SJ, Belohlavek J, Chiang CE, Willem Borleffs CJ, Comin-Colet J, Dobreanu D, Drozdz J, Fang JC, Alcocer Gamba MA, Al Habeeb W, Han Y, Cabrera Honorio JW, Janssens SP, Katova T, Kitakaze M, Merkely B, O’Meara E, Kerr Saraiva JF, Tereschenko SN, Thierer J, Vardeny O, Verma S, Vinh PN, Wilderang U, Zaozerska N, Lindholm D, Petersson M, McMurray JJV Baseline Characteristics of Patients With HF With Mildly Reduced and Preserved Ejection Fraction: DELIVER Trial. JACC Heart Fail. 2022 Mar;10(3):184-197. doi: 10.1016/j.jchf.2021.11.006.
Farkouh ME, Stone GW, Lala A, Bagiella E, Moreno PR, Nadkarni GN, Ben-Yehuda O, Granada JF, Dressler O, Tinuoye EO, Granada C, Bustamante J, Peyra C, Godoy LC, Palacios IF, Fuster V Anticoagulation in Patients With COVID-19: JACC Review Topic of the Week. J Am Coll Cardiol. 2022 Mar 8;79(9):917-928. doi: 10.1016/j.jacc.2021.12.023.
Januzzi JL Jr, Ohman EM Underdiagnosis of Ischemic Heart Disease in New-Onset Heart Failure: A Call to Action. J Am Coll Cardiol. 2022 Mar 8;79(9):861-863. doi: 10.1016/j.jacc.2022.01.003.
Saldarriaga C, Atar D, Stebbins A, Lewis BS, Abidin IZ, Blaustein RO, Butler J, Ezekowitz JA, Hernandez AF, Lam CSP, O’Connor CM, Pieske B, Ponikowski P, Roessig L, Voors AA, Anstrom KJ, Armstrong PW, VICTORIA Study Group Vericiguat in patients with coronary artery disease and heart failure with reduced ejection fraction. Eur J Heart Fail. 2022 May;24(5):782-790. doi: 10.1002/ejhf.2468. Epub 2022 Mar 20.
Cherney DZI, Charbonnel B, Cosentino F, Dagogo-Jack S, McGuire DK, Pratley R, Shih WJ, Frederich R, Maldonado M, Pong A, Cannon CP, VERTIS CV Investigators Ertugliflozin, renoprotection and potential confounding by muscle wasting. Reply to Groothof D, Post A, Gans ROB et al [letter]. Diabetologia. 2022 May;65(5):908-911. doi: 10.1007/s00125-021-05623-z. Epub 2022 Mar 3.
Verso M, Agnelli G, Munoz A, Connors JM, Sanchez O, Huisman M, Brenner B, Gussoni G, Cohen AT, Becattini C Recurrent venous thromboembolism and major bleeding in patients with localised, locally advanced or metastatic cancer: an analysis of the Caravaggio study. Eur J Cancer. 2022 Apr;165:136-145. doi: 10.1016/j.ejca.2022.01.023. Epub 2022 Feb 27.
Devereaux PJ, Lamy A, Chan MTV, Allard RV, Lomivorotov VV, Landoni G, Zheng H, Paparella D, McGillion MH, Belley-Cote EP, Parlow JL, Underwood MJ, Wang CY, Dvirnik N, Abubakirov M, Fominskiy E, Choi S, Fremes S, Monaco F, Urrutia G, Maestre M, Hajjar LA, Hillis GS, Mills NL, Margari V, Mills JD, Billing JS, Methangkool E, Polanczyk CA, Sant’Anna R, Shukevich D, Conen D, Kavsak PA, McQueen MJ, Brady K, Spence J, Le Manach Y, Mian R, Lee SF, Bangdiwala SI, Hussain S, Borges FK, Pettit S, Vincent J, Guyatt GH, Yusuf S, Alpert JS, White HD, Whitlock RP, VISION Cardiac Surgery Investigators High-Sensitivity Troponin I after Cardiac Surgery and 30-Day Mortality. N Engl J Med. 2022 Mar 3;386(9):827-836. doi: 10.1056/NEJMoa2000803.
Goldsweig AM, Baron SJ Prosthetic valve endocarditis: Literally a growing concern following transcatheter aortic valve replacement. Catheter Cardiovasc Interv. 2022 Feb;99(3):904-905. doi: 10.1002/ccd.30126.
Rangaswami J, Bhalla V, Chertow GM, Harrington RA, Staruschenko A, Tuttle K, Braunwald E Changing the Trajectory of Heart Failure and Kidney Disease: A Call for Action. Clin J Am Soc Nephrol. 2022 May;17(5):742-745. doi: 10.2215/CJN.00470122. Epub 2022 Mar 1.
Marquis-Gravel G, Robert-Halabi M, Bainey KR, Tanguay JF, Mehta SR The Evolution of Antiplatelet Therapy After Percutaneous Coronary Interventions: A 40-Year Journey. Can J Cardiol. 2022 Oct;38(10 Suppl1):S79-S88. doi: 10.1016/j.cjca.2022.02.022. Epub 2022 Feb 26.
Samsky MD, Rao SV Review of Cardiogenic Shock After Acute Myocardial Infarction-Reply. JAMA. 2022 Mar 1;327(9):879. doi: 10.1001/jama.2021.25178.
Xu H, Granger BB, Drake CD, Peterson ED, Dupre ME Effectiveness of Telemedicine Visits in Reducing 30-Day Readmissions Among Patients With Heart Failure During the COVID-19 Pandemic. J Am Heart Assoc. 2022 Apr 5;11(7):e023935. doi: 10.1161/JAHA.121.023935. Epub 2022 Mar 1.
Gragnano F, Zwahlen M, Vranckx P, Heg D, Schmidlin K, Hamm C, Steg PG, Gargiulo G, McFadden EP, Onuma Y, Chichareon P, Benit E, Mollmann H, Janssens L, Leonardi S, Zurakowski A, Arrivi A, Van Geuns RJ, Huber K, Slagboom T, Calabro P, Serruys PW, Juni P, Valgimigli M, Windecker S, GLOBAL LEADERS Investigators [Link] Ticagrelor Monotherapy or Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation: Per-Protocol Analysis of the GLOBAL LEADERS Trial. J Am Heart Assoc. 2022 May 17;11(10):e024291. doi: 10.1161/JAHA.121.024291. Epub 2022 Mar 1.
Li J, Thiele S, Kirk RW, Quirk BC, Hoogendoorn A, Chen YC, Peter K, Nicholls SJ, Verjans JW, Psaltis PJ, Bursill C, Herkommer AM, Giessen H, McLaughlin RA 3D-Printed Micro Lens-in-Lens for In Vivo Multimodal Microendoscopy. Small. 2022 Apr;18(17):e2107032. doi: 10.1002/smll.202107032. Epub 2022 Mar 1.
Spertus JA, Birmingham MC, Nassif M, Damaraju CV, Abbate A, Butler J, Lanfear DE, Lingvay I, Kosiborod MN, Januzzi JL The SGLT2 inhibitor canagliflozin in heart failure: the CHIEF-HF remote, patient-centered randomized trial. Nat Med. 2022 Apr;28(4):809-813. doi: 10.1038/s41591-022-01703-8. Epub 2022 Feb 28.
Gandhi M, Tan RS, Lim SL, Rand K, Lam CSP, Luo N, Cheung YB Investigating 5-Level EQ-5D (EQ-5D-5L) Values Based on Preferences of Patients With Heart Disease. Value Health. 2022 Mar;25(3):451-460. doi: 10.1016/j.jval.2021.09.010. Epub 2021 Nov 25.
Ormiston CK, Rosander A, Taub PR Heart-Healthy Diets and the Cardiometabolic Jackpot. Med Clin North Am. 2022 Mar;106(2):235-247. doi: 10.1016/j.mcna.2021.11.001.
Beldhuis IE, Lam CSP, Testani JM, Voors AA, Van Spall HGC, Ter Maaten JM, Damman K Evidence-Based Medical Therapy in Patients With Heart Failure With Reduced Ejection Fraction and Chronic Kidney Disease. Circulation. 2022 Mar;145(9):693-712. doi: 10.1161/CIRCULATIONAHA.121.052792. Epub 2022 Feb 28.
Ortega-Paz L, Brugaletta S, Gomez-Lara J, Alfonso F, Cequier A, Romani S, Bordes P, Serra A, Iniguez A, Salinas P, Garcia Del Blanco B, Goicolea J, Hernandez-Antolin R, Cuesta J, Gomez-Hospital JA, Sabate M Magnesium-based resorbable scaffold vs permanent metallic sirolimus-eluting stent in patients with ST-segment elevation myocardial infarction: 3-year results of the MAGSTEMI randomised controlled trial. EuroIntervention. 2022 Aug 5;18(5):e389-e396. doi: 10.4244/EIJ-D-21-00651.
Senman B, Rao SV Heart Team Without Borders: Taking the Heart Team Beyond the Institution. J Am Heart Assoc. 2022 Mar;11(5):e025080. doi: 10.1161/JAHA.122.025080. Epub 2022 Feb 28.
Secemsky EA, Kochar A Illuminating the Path for Novel Peripheral Drug-Eluting Stents. JACC Cardiovasc Interv. 2022 Mar 28;15(6):627-629. doi: 10.1016/j.jcin.2022.01.022. Epub 2022 Feb 23.
Batra G, Renlund H, Kunadian V, James SK, Storey RF, Steg PG, Katus HA, Harrington RA, Gibson CM, Budaj A, Siegbahn A, Wallentin L Effects of early myocardial reperfusion and perfusion on myocardial necrosis/dysfunction and inflammation in patients with ST-segment and non-ST-segment elevation acute coronary syndrome: results from the PLATelet inhibition and patients Outcomes (PLATO) trial. Eur Heart J Acute Cardiovasc Care. 2022 Jun 7;11(4):336-349. doi: 10.1093/ehjacc/zuac020.
Branch-Elliman W, Ferguson R, Doros G, Woods P, Leatherman S, Strymish J, Datta R, Goswami R, Jankowich MD, Shah NR, Taylor TH, Page ST, Schiller SJ, Shannon C, Hau C, Flynn M, Holmberg E, Visnaw K, Dhond R, Brophy M, Monach PA Subcutaneous sarilumab for the treatment of hospitalized patients with moderate to severe COVID19 disease: A pragmatic, embedded randomized clinical trial. PLoS One. 2022 Feb 25;17(2):e0263591. doi: 10.1371/journal.pone.0263591. eCollection 2022.
Haouzi A, Tuttle M, Eyal A, Tandon K, Tung P, Zimetbaum PJ, Kramer DB Clinical management of conduction abnormalities following transcatheter aortic valve replacement: prospective evaluation of a standardized management pathway. J Interv Card Electrophysiol. 2022 Jun;64(1):195-202. doi: 10.1007/s10840-022-01156-6. Epub 2022 Feb 25.
Sattar N, McGuire DK, Pavo I, Weerakkody GJ, Nishiyama H, Wiese RJ, Zoungas S Tirzepatide cardiovascular event risk assessment: a pre-specified meta-analysis. Nat Med. 2022 Mar;28(3):591-598. doi: 10.1038/s41591-022-01707-4. Epub 2022 Feb 24.
Kosmala W, Negishi T, Thavendiranathan P, Penicka M, De Blois J, Murbraech K, Miyazaki S, Shirazi M, Santoro C, Vinereanu D, Cho GY, Hristova K, Popescu BA, Kurosawa K, Izumo M, Negishi K, Przewlocka-Kosmala M, Marwick TH Incremental Value of Myocardial Work over Global Longitudinal Strain in the Surveillance for Cancer-Treatment-Related Cardiac Dysfunction: A Case-Control Study. J Clin Med. 2022 Feb 9;11(4):912. doi: 10.3390/jcm11040912.
Bikdeli B, Khairani CD, Barns BM, Rosovsky RP, Jimenez D, Monreal M, Sylvester KW, Middeldorp S, Bates SM, Krumholz HM, Goldhaber SZ, Hunt BJ, Piazza G Women’s representation in venous thromboembolism randomized trials and registries: The illustrative example of direct oral anticoagulants for acute treatment. Contemp Clin Trials. 2022 Apr;115:106714. doi: 10.1016/j.cct.2022.106714. Epub 2022 Feb 21.
Moledina SM, Kontopantelis E, Wijeysundera HC, Banerjee S, Van Spall HGC, Gale CP, Shah BN, Mohamed MO, Weston C, Shoaib A, Mamas MA Ethnicity-dependent performance of the Global Registry of Acute Coronary Events risk score for prediction of non-ST-segment elevation myocardial infarction in-hospital mortality: nationwide cohort study. Eur Heart J. 2022 Jun 21;43(24):2289-2299. doi: 10.1093/eurheartj/ehac052.
Han JK, Belardo D, Ibrahim NE, Capers Q 4th, Grines CL, Smith SC Jr, Walsh MN, Gulati M A Look Back, A Path Forward: Moving Toward Diversity and Inclusion in Cardiovascular Society Presidents. JACC Case Rep. 2022 Feb 16;4(4):247-253. doi: 10.1016/j.jaccas.2021.12.022. eCollection 2022 Feb 16.
Peterson BE, Harrington RA, Stone GW, Steg PG, Gibson CM, Hamm CW, Price MJ, Lopes RD, Leonardi S, Prats J, Deliargyris EN, Mahaffey KW, White HD, Bhatt DL Effect of Platelet Inhibition by Cangrelor Among Obese Patients Undergoing Coronary Stenting: Insights From CHAMPION. Circ Cardiovasc Interv. 2022 Mar;15(3):e011069. doi: 10.1161/CIRCINTERVENTIONS.121.011069. Epub 2022 Feb 24.
Baron SJ, Ryan MP, Moore KA, Clancy SJ, Gunnarsson CL Contemporary Costs Associated With Transcatheter Versus Surgical Aortic Valve Replacement in Medicare Beneficiaries. Circ Cardiovasc Interv. 2022 Mar;15(3):e011295. doi: 10.1161/CIRCINTERVENTIONS.121.011295. Epub 2022 Feb 23.
Ferreira JP, Packer M, Butler J, Zannad F Reconsidering the ejection fraction centric view of pharmacologic treatment for heart failure. Eur J Heart Fail. 2022 Jul;24(7):1148-1153. doi: 10.1002/ejhf.2457. Epub 2022 Mar 7.
Rai D, Kumar A, Waheed SH, Pandey R, Guerriero M, Kapoor A, Tahir MW, Zahid S, Hajra A, Balmer-Swain M, Castelletti S, Maas AHEM, Grapsa J, Mulvagh S, Zieroth S, Kalra A, Michos ED, Gulati M Gender Differences in International Cardiology Guideline Authorship: A Comparison of the US, Canadian, and European Cardiology Guidelines From 2006 to 2020. J Am Heart Assoc. 2022 Mar;11(5):e024249. doi: 10.1161/JAHA.121.024249. Epub 2022 Feb 22.
Raber I, Palmeri NO, Tahir UA, Zimetbaum PJ A Pacemaker Red Herring and a Hypertrophic Cardiomyopathy Copycat. Circulation. 2022 Feb 22;145(8):622-625. doi: 10.1161/CIRCULATIONAHA.121.058658. Epub 2022 Feb 21.
Opstal TSJ, van Broekhoven A, Fiolet ATL, Mosterd A, Eikelboom JW, Nidorf SM, Thompson PL, Budgeon CA, Bartels L, de Nooijer R, Bax WA, Tijssen JGP, El Messaoudi S, Cornel JH Long-Term Efficacy of Colchicine in Patients With Chronic Coronary Disease: Insights From LoDoCo2. Circulation. 2022 Feb 22;145(8):626-628. doi: 10.1161/CIRCULATIONAHA.121.058233. Epub 2022 Feb 21.
Liu X, Kim C, Han Z, Lim P, Roychoudhury S, Fava M, Doros G Assessing treatment benefit in the presence of placebo response using the sequential parallel comparison design. Stat Med. 2022 May 30;41(12):2166-2190. doi: 10.1002/sim.9349. Epub 2022 Feb 20.
Kianoush S, Al Rifai M, Patel J, George J, Gulati M, Taub P, Moran T, Shapiro MD, Agarwala A, Ullah W, Lavie CJ, Bittner V, Ballantyne CM, Virani SS Association of participation in Cardiac Rehabilitation with Social Vulnerability Index: The behavioral risk factor surveillance system. Prog Cardiovasc Dis. 2022 Mar-Apr;71:86-91. doi: 10.1016/j.pcad.2022.02.003. Epub 2022 Feb 16.
West M, Kirby A, Stewart RA, Blankenberg S, Sullivan D, White HD, Hunt D, Marschner I, Janus E, Kritharides L, Watts GF, Simes J, Tonkin AM, LIPID Study Group * Circulating Cystatin C Is an Independent Risk Marker for Cardiovascular Outcomes, Development of Renal Impairment, and Long-Term Mortality in Patients With Stable Coronary Heart Disease: The LIPID Study. J Am Heart Assoc. 2022 Mar;11(5):e020745. doi: 10.1161/JAHA.121.020745. Epub 2022 Feb 18.
Kunadian V, Raharjo DE Breaking down the barriers in the management of INOCA: how can we do better in the diagnosis of coronary vasomotor disorders? EuroIntervention. 2022 Feb 18;17(15):1201-1203. doi: 10.4244/EIJ-E-21-00008.
DeFilippis EM, Beale A, Martyn T, Agarwal A, Elkayam U, Lam CSP, Hsich E Heart Failure Subtypes and Cardiomyopathies in Women. Circ Res. 2022 Feb 18;130(4):436-454. doi: 10.1161/CIRCRESAHA.121.319900. Epub 2022 Feb 17.
Ray KK, Dhalwani N, Sibartie M, Bridges I, Ebenbichler C, Perrone-Filardi P, Villa G, Vogt A, Bruckert E Low-density lipoprotein cholesterol levels exceed the recommended European threshold for PCSK9i initiation: lessons from the HEYMANS study. Eur Heart J Qual Care Clin Outcomes. 2022 Jun 6;8(4):447-460. doi: 10.1093/ehjqcco/qcac009.
Nelson AJ, O’Brien EC, Kaltenbach LA, Green JB, Lopes RD, Morse CG, Al-Khalidi HR, Aroda VR, Cavender MA, Gaynor T, Kirk JK, Lingvay I, Magwire ML, McGuire DK, Pak J, Pop-Busui R, Richardson CR, Senyucel C, Kelsey MD, Pagidipati NJ, Granger CB Use of Lipid-, Blood Pressure-, and Glucose-Lowering Pharmacotherapy in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease. JAMA Netw Open. 2022 Feb 1;5(2):e2148030. doi: 10.1001/jamanetworkopen.2021.48030.
Beleigoli A, Nicholls SJ, Brown A, Chew DP, Beltrame J, Maeder A, Maher C, Versace VL, Hendriks JM, Tideman P, Kaambwa B, Zeitz C, Prichard IJ, Tavella R, Tirimacco R, Keech W, Astley C, Govin K, Nesbitt K, Du H, Champion S, Pinero de Plaza MA, Lynch I, Poulsen V, Ludlow M, Wanguhu K, Meyer H, Krollig A, Gebremichael L, Green C, Clark RA, CHAP Project Team Implementation and prospective evaluation of the Country Heart Attack Prevention model of care to improve attendance and completion of cardiac rehabilitation for patients with cardiovascular diseases living in rural Australia: a study protocol. BMJ Open. 2022 Feb 16;12(2):e054558. doi: 10.1136/bmjopen-2021-054558.
Welsh RC, Dehghani P, Lopes R, Wojdyla DM, Aronson R, Granger CB, Windecker S, Vora AN, Vinereanu D, Halvorsen S, Parkhomenko A, Mehran R, Alexander JH, Goodman S Impact of prior oral anticoagulant use and outcomes on patients from secondary analysis in the AUGUSTUS trial. Open Heart. 2022 Feb;9(1):e001892. doi: 10.1136/openhrt-2021-001892.
Varshney AS, Butler J, Vaduganathan M The Enabling Potential of Device Therapy for Heart Failure. J Card Fail. 2022 Jul;28(7):1227-1229. doi: 10.1016/j.cardfail.2022.02.005. Epub 2022 Feb 14.
Stevens CJ, Shaffer JA, Edwards KS, Masters KS, Leon KK, Wood MJ, Pittman Wagers T Younger Age Impacts Perceptions of Care Received in the Emergency Department Among Women with Spontaneous Coronary Artery Dissection. J Womens Health (Larchmt). 2022 Aug;31(8):1165-1172. doi: 10.1089/jwh.2021.0162. Epub 2022 Feb 16.
Nissenson AR, Chertow GM, Conway PT Breaking the Barriers to Innovation in Kidney Care: The Time is Now. Clin J Am Soc Nephrol. 2022 Apr;17(4):591-593. doi: 10.2215/CJN.15721221. Epub 2022 Feb 15.
Kontopantelis E, Mamas MA, Webb RT, Castro A, Rutter MK, Gale CP, Ashcroft DM, Pierce M, Abel KM, Price G, Faivre-Finn C, Van Spall HGC, Graham MM, Morciano M, Martin GP, Sutton M, Doran T Excess years of life lost to COVID-19 and other causes of death by sex, neighbourhood deprivation, and region in England and Wales during 2020: A registry-based study. PLoS Med. 2022 Feb 15;19(2):e1003904. doi: 10.1371/journal.pmed.1003904. eCollection 2022 Feb.
Walther CP, Winkelmayer WC, Navaneethan SD Updated US Prevalence Estimates for Chronic Kidney Disease Stage and Complications Using the New Race-Free Equation to Estimate Glomerular Filtration Rate. JAMA Netw Open. 2022 Feb 1;5(2):e220460. doi: 10.1001/jamanetworkopen.2022.0460.
Bavishi A, Colangelo LA, Rasmussen-Torvik LJ, Lima JAC, Nannini DR, Vaduganathan M, Pandey A, Lloyd-Jones DM, Shah SJ, Patel RB Genetic variation in sodium glucose co-transporter 1 and cardiac structure and function at middle age. ESC Heart Fail. 2022 Apr;9(2):1496-1501. doi: 10.1002/ehf2.13841. Epub 2022 Feb 15.
Hageman SHJ, McKay AJ, Ueda P, Gunn LH, Jernberg T, Hagstrom E, Bhatt DL, Steg PG, Lall K, Magi R, Gynnild MN, Ellekjaer H, Saltvedt I, Tunon J, Mahillo I, Acena A, Kaminski K, Chlabicz M, Sawicka E, Tillman T, McEvoy JW, Di Angelantonio E, Graham I, De Bacquer D, Ray KK, Dorresteijn JAN, Visseren FLJ Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm. Eur Heart J. 2022 May 7;43(18):1715-1727. doi: 10.1093/eurheartj/ehac056.
Lam CSP How to Incorporate Sex and Gender Into the Design of Cardiovascular Clinical Trials. Circulation. 2022 Feb 15;145(7):499-501. doi: 10.1161/CIRCULATIONAHA.121.058771. Epub 2022 Feb 14.
Weintraub WS, Bhatt DL, Zhang Z, Dolman S, Boden WE, Bress AP, King JB, Bellows BK, Tajeu GS, Derington CG, Johnson J, Andrade K, Steg PG, Miller M, Brinton EA, Jacobson TA, Tardif JC, Ballantyne CM, Kolm P Cost-effectiveness of Icosapent Ethyl for High-risk Patients With Hypertriglyceridemia Despite Statin Treatment. JAMA Netw Open. 2022 Feb 1;5(2):e2148172. doi: 10.1001/jamanetworkopen.2021.48172.
Nowbar AN, Rajkumar C, Foley M, Ahmed-Jushuf F, Howard JP, Seligman H, Petraco R, Sen S, Nijjer SS, Shun-Shin MJ, Keeble TR, Sohaib A, Collier D, McVeigh P, Harrell FE, Francis DP, Al-Lamee RK A double-blind randomised placebo-controlled trial of percutaneous coronary intervention for the relief of stable angina without antianginal medications: design and rationale of the ORBITA-2 trial. EuroIntervention. 2022 Apr 22;17(18):1490-1497. doi: 10.4244/EIJ-D-21-00649.
Beitelshees AL, Thomas CD, Empey PE, Stouffer GA, Angiolillo DJ, Franchi F, Tuteja S, Limdi NA, Lee JC, Duarte JD, Kreutz RP, Skaar TC, Coons JC, Giri J, McDonough CW, Rowland R, Stevenson JM, Thai T, Vesely MR, Wellen JT, Johnson JA, Winterstein AG, Cavallari LH, Lee CR, Implementing Genomics in Practice (IGNITE) Network Pharmacogenetics Working Group CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention in Diverse Clinical Settings. J Am Heart Assoc. 2022 Feb 15;11(4):e024159. doi: 10.1161/JAHA.121.024159. Epub 2022 Feb 12.
Koplan BA, Winkelmayer WC, Costea AI, Roy-Chaudhury P, Tumlin JA, Kher V, Williamson DE, Pokhariyal S, Charytan DM, Monitoring in Dialysis (MiD) Investigators and Committees Implantable Loop Recorder Monitoring and the Incidence of Previously Unrecognized Atrial Fibrillation in Patients on Hemodialysis. Kidney Int Rep. 2021 Oct 16;7(2):189-199. doi: 10.1016/j.ekir.2021.10.001. eCollection 2022 Feb.
D’Angelo RN, Khanna R, Wong C, Yeh RW, Goldstein L, Marcello S, Tung P, D’Avila A, Zimetbaum PJ Very early versus early referral for ablation in young patients with newly diagnosed paroxysmal atrial fibrillation. Pacing Clin Electrophysiol. 2022 Mar;45(3):348-356. doi: 10.1111/pace.14459. Epub 2022 Feb 23.
Sidhu MS, Alexander KP, Huang Z, O’Brien SM, Chaitman BR, Stone GW, Newman JD, Boden WE, Maggioni AP, Steg PG, Ferguson TB, Demkow M, Peteiro J, Wander GS, Phaneuf DC, De Belder MA, Doerr R, Alexanderson-Rosas E, Polanczyk CA, Henriksen PA, Conway DSG, Miro V, Sharir T, Lopes RD, Min JK, Berman DS, Rockhold FW, Balter S, Borrego D, Rosenberg YD, Bangalore S, Reynolds HR, Hochman JS, Maron DJ, ISCHEMIA Research Group Causes of cardiovascular and noncardiovascular death in the ISCHEMIA trial. Am Heart J. 2022 Jun;248:72-83. doi: 10.1016/j.ahj.2022.01.017. Epub 2022 Feb 9.
Dawwas GK, Cuker A, Connors JM, Barnes GD Apixaban has superior effectiveness and safety compared to rivaroxaban in patients with commercial healthcare coverage: A population-based analysis in response to CVS 2022 formulary changes. Am J Hematol. 2022 May;97(5):E173-E176. doi: 10.1002/ajh.26494. Epub 2022 Feb 24.
McCarthy CP, Januzzi JL Multiple biomarkers for rapid rule-out of myocardial infarction: worth the added stress? Eur Heart J Acute Cardiovasc Care. 2022 Mar 16;11(3):213-214. doi: 10.1093/ehjacc/zuac019.
Mottl AK, Alicic R, Argyropoulos C, Brosius FC, Mauer M, Molitch M, Nelson RG, Perreault L, Nicholas SB KDOQI US Commentary on the KDIGO 2020 Clinical Practice Guideline for Diabetes Management in CKD. Am J Kidney Dis. 2022 Apr;79(4):457-479. doi: 10.1053/j.ajkd.2021.09.010. Epub 2022 Feb 7.
Kereiakes DJ, Yeh RW DES and DAPT in Evolution: Will Clinical Guidelines Follow? JACC Cardiovasc Interv. 2022 Feb 14;15(3):278-281. doi: 10.1016/j.jcin.2021.12.014.
Laudani C, Greco A, Occhipinti G, Ingala S, Calderone D, Scalia L, Agnello F, Legnazzi M, Mauro MS, Rochira C, Buccheri S, Mehran R, James S, Angiolillo DJ, Capodanno D Short Duration of DAPT Versus De-Escalation After Percutaneous Coronary Intervention for Acute Coronary Syndromes. JACC Cardiovasc Interv. 2022 Feb 14;15(3):268-277. doi: 10.1016/j.jcin.2021.11.028.
McCarthy CP, Januzzi JL Jr Periprocedural MI as an Endpoint in Clinical Trials: A Proposed Path Forward. J Am Coll Cardiol. 2022 Feb 15;79(6):527-529. doi: 10.1016/j.jacc.2021.11.046.
Kam W, Holmes DN, Hernandez AF, Saver JL, Fonarow GC, Smith EE, Bhatt DL, Schwamm LH, Reeves MJ, Matsouaka RA, Khan YM, Unverdorben M, Birmingham MC, Lyden PD, Asimos AW, Altschul D, Schoonover TL, Jumaa MA, Nomura JT, Suri MFK, Moore SA, Lafranchise EF, Olson D, Peterson ED, Xian Y Association of Recent Use of Non-Vitamin K Antagonist Oral Anticoagulants With Intracranial Hemorrhage Among Patients With Acute Ischemic Stroke Treated With Alteplase. JAMA. 2022 Feb 22;327(8):760-771. doi: 10.1001/jama.2022.0948.
Mayhew CR, Gallagher A, Bensimhon A, Dauerman HL, Tsai MH, Martin JA Cost-effectiveness analysis of a resource-intensive approach versus minimally invasive strategy for high-risk transcatheter aortic valve replacement patients. J Comp Eff Res. 2022 Mar;11(4):217-227. doi: 10.2217/cer-2021-0210. Epub 2022 Feb 10.
Tisdale RL, Cusick MM, Aluri KZ, Handley TJ, Joyner AKC, Salomon JA, Chertow GM, Goldhaber-Fiebert JD, Owens DK Cost-Effectiveness of Dapagliflozin for Non-diabetic Chronic Kidney Disease. J Gen Intern Med. 2022 Oct;37(13):3380-3387. doi: 10.1007/s11606-021-07311-5. Epub 2022 Feb 8.
Almarzooq ZI, Kazi DS, Wang Y, Chung M, Tian W, Strom JB, Baron SJ, Yeh RW Outcomes of stroke events during transcatheter aortic valve implantation. EuroIntervention. 2022 Jul 22;18(4):e335-e344. doi: 10.4244/EIJ-D-21-00951.
Beohar N, Ailawadi G, Kotinkaduwa LN, Redfors B, Simonato M, Zhang Z, Morgan LG, Escolar E, Kar S, Lim DS, Mishell JM, Whisenant BK, Abraham WT, Lindenfeld J, Mack MJ, Stone GW Impact of baseline renal dysfunction on cardiac outcomes and end-stage renal disease in heart failure patients with mitral regurgitation: the COAPT trial. Eur Heart J. 2022 May 1;43(17):1639-1648. doi: 10.1093/eurheartj/ehac026.
Shapiro SD, Alkayyali M, Reynolds A, Reilly K, Selim M, Dangayach N, Mocco J, Kellner CP, Liang JW Stereotactic IntraCerebral Underwater Blood Aspiration (SCUBA) Improves Survival Following Intracerebral Hemorrhage as Compared with Predicted Mortality. World Neurosurg. 2022 May;161:e289-e294. doi: 10.1016/j.wneu.2022.01.123. Epub 2022 Feb 5.
Aggarwal M, Ros E, Allen K, Sikand G, Agarwala A, Aspry K, Kris-Etherton P, Devries S, Reddy K, Singh T, Litwin SE, Keefe JO, Miller M, Andrus B, Blankstein R, Batiste C, Belardo D, Wenger C, Batts T, Barnard ND, White BA, Ornish D, Williams KA, Ostfeld RJ, Freeman AM Controversial Dietary Patterns: A High Yield Primer for Clinicians. Am J Med. 2022 Jun;135(6):680-687. doi: 10.1016/j.amjmed.2022.01.028. Epub 2022 Feb 5.
Capodanno D, Angiolillo DJ, Lennon RJ, Goodman SG, Kim SW, O’Cochlain F, So DY, Sweeney J, Rihal CS, Farkouh M, Pereira NL ABCD-GENE Score and Clinical Outcomes Following Percutaneous Coronary Intervention: Insights from the TAILOR-PCI Trial. J Am Heart Assoc. 2022 Feb 15;11(4):e024156. doi: 10.1161/JAHA.121.024156. Epub 2022 Feb 8.
Elbadawi A, Tan BE, Sammour Y, Saad M, Omer M, Baron SJ, Sharaf B, Abbott JD, Gordon PC Sex-related differences in the trends and outcomes of trans-septal transcatheter mitral valve replacement: Insights from the National Readmissions Database. Catheter Cardiovasc Interv. 2022 Apr;99(5):1636-1644. doi: 10.1002/ccd.30072. Epub 2022 Feb 7.
Comella A, Chan J, Thakkar HV, Kim J, Michail M, Nicholls SJ, Gooley R, Ko B, Cameron JD, Brown AJ Agreement Between iFR and Other Non-Hyperaemic Pressure Ratios in Severe Aortic Stenosis. Cardiovasc Revasc Med. 2022 Aug;41:47-52. doi: 10.1016/j.carrev.2022.01.011. Epub 2022 Jan 19.
Gonzalez-Juanatey JR, Lemesle G, Puymirat E, Ducrocq G, Cachanado M, Arnaiz JA, Martinez-Selles M, Silvain J, Ariza-Sole A, Ferrari E, Calvo G, Danchin N, Avendano-Sola C, Rousseau A, Vicaut E, Gonzalez-Ferrero T, Steg PG, Simon T, REALITY Investigators One-Year Major Cardiovascular Events After Restrictive Versus Liberal Blood Transfusion Strategy in Patients With Acute Myocardial Infarction and Anemia: The REALITY Randomized Trial. Circulation. 2022 Feb 8;145(6):486-488. doi: 10.1161/CIRCULATIONAHA.121.057909. Epub 2022 Feb 7.
Iba T, Connors JM, Levi M, Levy JH Heatstroke-induced coagulopathy: Biomarkers, mechanistic insights, and patient management. EClinicalMedicine. 2022 Jan 22;44:101276. doi: 10.1016/j.eclinm.2022.101276. eCollection 2022 Feb.
Krzemien P, Kasperczyk S, Banach M, Kasperczyk A, Dobrakowski M, Tomasik T, Windak A, Mastej M, Catapano A, Ray KK, Mikhailidis DP, Toth PP, Howard G, Lip GY, Tomaszewski M, Charchar FJ, Sattar N, Williams B, MacDonald TM, Penson PE, Jozwiak JJ Relationship Between Anti-DFS70 Autoantibodies and Oxidative Stress. Biomark Insights. 2022 Jan 30;17:11772719211066791. doi: 10.1177/11772719211066791. eCollection 2022.
Salah HM, Al’Aref SJ, Khan MS, Al-Hawwas M, Vallurupalli S, Mehta JL, Mounsey JP, Greene SJ, McGuire DK, Lopes RD, Fudim M Efficacy and safety of sodium-glucose cotransporter 2 inhibitors initiation in patients with acute heart failure, with and without type 2 diabetes: a systematic review and meta-analysis. Cardiovasc Diabetol. 2022 Feb 5;21(1):20. doi: 10.1186/s12933-022-01455-2.
Salisbury AC, Kirtane AJ, Ali ZA, Grantham JA, Lombardi WL, Yeh RW, Genereux P, Allen KB, Brown WM, Nugent K, Gosch KL, Karmpaliotis D, Spertus JA, Kandzari DE, OPTIMUM Study Investigators The Outcomes of Percutaneous RevascularizaTIon for Management of SUrgically Ineligible Patients With Multivessel or Left Main Coronary Artery Disease (OPTIMUM) Registry: Rationale and Design. Cardiovasc Revasc Med. 2022 Aug;41:83-91. doi: 10.1016/j.carrev.2022.01.008. Epub 2022 Jan 31.
Shah SJ, Borlaug BA, Chung ES, Cutlip DE, Debonnaire P, Fail PS, Gao Q, Hasenfuss G, Kahwash R, Kaye DM, Litwin SE, Lurz P, Massaro JM, Mohan RC, Ricciardi MJ, Solomon SD, Sverdlov AL, Swarup V, van Veldhuisen DJ, Winkler S, Leon MB, REDUCE LAP-HF II investigators Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial. Lancet. 2022 Mar 19;399(10330):1130-1140. doi: 10.1016/S0140-6736(22)00016-2. Epub 2022 Feb 1.
Oikonomou EK, Suchard MA, McGuire DK, Khera R Phenomapping-Derived Tool to Individualize the Effect of Canagliflozin on Cardiovascular Risk in Type 2 Diabetes. Diabetes Care. 2022 Apr 1;45(4):965-974. doi: 10.2337/dc21-1765.
Rhee JJ, Han J, Montez-Rath ME, Kim SH, Cullen MR, Stafford RS, Winkelmayer WC, Chertow GM Cardiovascular outcomes associated with prescription of sodium-glucose co-transporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in patients with diabetes and chronic kidney disease. Diabetes Obes Metab. 2022 May;24(5):928-937. doi: 10.1111/dom.14657. Epub 2022 Feb 16.
Naidu SS, Baran DA, Jentzer JC, Hollenberg SM, van Diepen S, Basir MB, Grines CL, Diercks DB, Hall S, Kapur NK, Kent W, Rao SV, Samsky MD, Thiele H, Truesdell AG, Henry TD SCAI SHOCK Stage Classification Expert Consensus Update: A Review and Incorporation of Validation Studies: This statement was endorsed by the American College of Cardiology (ACC), American College of Emergency Physicians (ACEP), American Heart Association (AHA), European Society of Cardiology (ESC) Association for Acute Cardiovascular Care (ACVC), International Society for Heart and Lung Transplantation (ISHLT), Society of Critical Care Medicine (SCCM), and Society of Thoracic Surgeons (STS) in December 2021. J Am Coll Cardiol. 2022 Mar 8;79(9):933-946. doi: 10.1016/j.jacc.2022.01.018. Epub 2022 Jan 31.
Fiuzat M, Hamo CE, Butler J, Abraham WT, DeFilippis EM, Fonarow GC, Lindenfeld J, Mentz RJ, Psotka MA, Solomon SD, Teerlink JR, Vaduganathan M, Vardeny O, McMurray JJV, O’Connor CM Optimal Background Pharmacological Therapy for Heart Failure Patients in Clinical Trials: JACC Review Topic of the Week. J Am Coll Cardiol. 2022 Feb 8;79(5):504-510. doi: 10.1016/j.jacc.2021.11.033.
Vaduganathan M, Sattar N, Xu J, Butler J, Mahaffey KW, Neal B, Shaw W, Rosenthal N, Pfeifer M, Hansen MK, Januzzi JL Jr Stress Cardiac Biomarkers, Cardiovascular and Renal Outcomes, and Response to Canagliflozin. J Am Coll Cardiol. 2022 Feb 8;79(5):432-444. doi: 10.1016/j.jacc.2021.11.027.
Vranckx P, Angiolillo DJ, Valgimigli M Patients With Atrial Fibrillation and PCI or ACS: Does Predicted Risk Matter? J Am Coll Cardiol. 2022 Feb 8;79(5):428-431. doi: 10.1016/j.jacc.2021.11.034.
Coniglio AC, Segar MW, Loungani RS, Savla JJ, Grodin JL, Fox ER, Garg S, de Lemos JA, Berry JD, Drazner MH, Shah S, Hall ME, Shah A, Khan SS, Mentz RJ, Pandey A Transthyretin V142I Genetic Variant and Cardiac Remodeling, Injury, and Heart Failure Risk in Black Adults. JACC Heart Fail. 2022 Feb;10(2):129-138. doi: 10.1016/j.jchf.2021.09.006. Epub 2021 Dec 8.
Myhre PL, Prescott MF, Murphy SP, Fang JC, Mitchell GF, Ward JH, Claggett B, Desai AS, Solomon SD, Januzzi JL Early B-Type Natriuretic Peptide Change in HFrEF Patients Treated With Sacubitril/Valsartan: A Pooled Analysis of EVALUATE-HF and PROVE-HF. JACC Heart Fail. 2022 Feb;10(2):119-128. doi: 10.1016/j.jchf.2021.09.007. Epub 2022 Jan 12.
Echouffo-Tcheugui JB, Ogunmoroti O, Golden SH, Bertoni AG, Mongraw-Chaffin M, Pandey A, Ndumele CE, Michos ED Glycemic Markers and Heart Failure Subtypes: The Multi-Ethnic Study of Atherosclerosis (MESA). J Card Fail. 2022 Nov;28(11):1593-1603. doi: 10.1016/j.cardfail.2022.01.011. Epub 2022 Jan 31.
Rao S, Jamal Siddiqi T, Khan MS, Michos ED, Navar AM, Wang TJ, Greene SJ, Prabhakaran D, Khera A, Pandey A Association of polypill therapy with cardiovascular outcomes, mortality, and adherence: A systematic review and meta-analysis of randomized controlled trials. Prog Cardiovasc Dis. 2022 Jul-Aug;73:48-55. doi: 10.1016/j.pcad.2022.01.005. Epub 2022 Feb 1.
Karim AM, Li J, Panhwar MS, Arshad S, Shalabi S, Mena-Hurtado C, Aronow HD, Secemsky EA, Shishehbor MH Impact of malnutrition and frailty on mortality and major amputation in patients with CLTI. Catheter Cardiovasc Interv. 2022 Mar;99(4):1300-1309. doi: 10.1002/ccd.30113. Epub 2022 Feb 3.
Pollock C, James G, Garcia Sanchez JJ, Arnold M, Carrero JJ, Lam CSP, Chen H, Nolan S, Pecoits-Filho R Cost of End-of-Life Inpatient Encounters in Patients with Chronic Kidney Disease in the United States: A Report from the DISCOVER CKD Retrospective Cohort. Adv Ther. 2022 Mar;39(3):1432-1445. doi: 10.1007/s12325-021-02010-3. Epub 2022 Feb 3.
Dykun I, Bayturan O, Carlo J, Nissen SE, Kapadia SR, Tuzcu EM, Nicholls SJ, Puri R HbA1c, Coronary atheroma progression and cardiovascular outcomes. Am J Prev Cardiol. 2022 Jan 18;9:100317. doi: 10.1016/j.ajpc.2022.100317. eCollection 2022 Mar.
Ortega-Paz L, Galli M, Angiolillo DJ Updated meta-analysis of randomized controlled trials on the safety and efficacy of different prophylactic anticoagulation dosing regimens in non-critically ill hospitalized patients with COVID-19. Eur Heart J Cardiovasc Pharmacother. 2022 May 5;8(3):E15-E17. doi: 10.1093/ehjcvp/pvac010.
Simonato M, Ben-Yehuda O, Vincent F, Zhang Z, Redfors B Consequences of Inaccurate Assumptions in Coronary Stent Noninferiority Trials: A Systematic Review and Meta-analysis. JAMA Cardiol. 2022 Mar 1;7(3):320-327. doi: 10.1001/jamacardio.2021.5724.
Tromp TR, Hartgers ML, Hovingh GK, Vallejo-Vaz AJ, Ray KK, Soran H, Freiberger T, Bertolini S, Harada-Shiba M, Blom DJ, Raal FJ, Cuchel M, Homozygous Familial Hypercholesterolaemia International Clinical Collaborators Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study. Lancet. 2022 Feb 19;399(10326):719-728. doi: 10.1016/S0140-6736(21)02001-8. Epub 2022 Jan 28.
Carpenter HJ, Ghayesh MH, Zander AC, Ottaway JL, Di Giovanni G, Nicholls SJ, Psaltis PJ Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression. J Vis Exp. 2022 Jan 15;(179). doi: 10.3791/62933.
Hira RS, Gosch KL, Kazi DS, Yeh RW, Kataruka A, Maddox TM, Shah T, Jneid H, Bhatt DL, Virani SS Potential Impact of the 2019 ACC/AHA Guidelines on the Primary Prevention of Cardiovascular Disease Recommendations on the Inappropriate Routine Use of Aspirin and Aspirin Use Without a Recommended Indication for Primary Prevention of Cardiovascular Disease in Cardiology Practices: Insights From the NCDR PINNACLE Registry. Circ Cardiovasc Qual Outcomes. 2022 Mar;15(3):e007979. doi: 10.1161/CIRCOUTCOMES.121.007979. Epub 2022 Jan 31.
Salah HM, Minhas AMK, Khan MS, Khan SU, Ambrosy AP, Blumer V, Vaduganathan M, Greene SJ, Pandey A, Fudim M Trends and characteristics of hospitalizations for heart failure in the United States from 2004 to 2018. ESC Heart Fail. 2022 Apr;9(2):947-952. doi: 10.1002/ehf2.13823. Epub 2022 Jan 30.
Song C, Madhavan MV, Lindenfeld J, Abraham WT, Kar S, Lim DS, Grayburn PA, Kapadia SR, Kotinkaduwa LN, Mack MJ, Stone GW Age-Related Outcomes After Transcatheter Mitral Valve Repair in Patients With Heart Failure: Analysis From COAPT. JACC Cardiovasc Interv. 2022 Feb 28;15(4):397-407. doi: 10.1016/j.jcin.2021.11.037. Epub 2022 Jan 31.
Kalayci A, Gibson CM, Hernandez AF, Hull RD, Cohen AT, Fitzgerald C, Hussain SD, Chi G, Alkhalfan F, Harrington RA, Goldhaber SZ Inverse relationship between body mass index and risk of venous thromboembolism among medically ill hospitalized patients: Observations from the APEX trial. Thromb Res. 2022 Mar;211:63-69. doi: 10.1016/j.thromres.2022.01.016. Epub 2022 Jan 20.
Alsayed N, Almahmeed W, Alnouri F, Al-Waili K, Sabbour H, Sulaiman K, Zubaid M, Ray KK, Al-Rasadi K Consensus clinical recommendations for the management of plasma lipid disorders in the Middle East: 2021 update. Atherosclerosis. 2022 Feb;343:28-50. doi: 10.1016/j.atherosclerosis.2021.11.022. Epub 2021 Dec 10.
Parcha V, Heindl B, Kalra R, Bress A, Rao S, Pandey A, Gower B, Irvin MR, McDonald MN, Li P, Arora G, Arora P Genetic European Ancestry and Incident Diabetes in Black Individuals: Insights From the SPRINT Trial. Circ Genom Precis Med. 2022 Feb;15(1):e003468. doi: 10.1161/CIRCGEN.121.003468. Epub 2022 Jan 28.
Graham CA, Tan MK, Chew DP, Gale CP, Fox KAA, Bagai A, Henderson MA, Quraishi AUR, Dery JP, Cheema AN, Fisher H, Brieger D, Lutchmedial SR, Lavi S, Wong BYL, Cieza T, Mehta SR, Brass N, Goodman SG, Yan AT Use and outcomes of dual antiplatelet therapy for acute coronary syndrome in patients with chronic kidney disease: insights from the Canadian Observational Antiplatelet Study (COAPT). Heart Vessels. 2022 Aug;37(8):1291-1298. doi: 10.1007/s00380-022-02029-8. Epub 2022 Jan 28.
Hasegawa K, Lewis BS Are SGLT2 inhibitors effective against ‘all’ heart failure with preserved ejection fraction? Eur Heart J Cardiovasc Pharmacother. 2022 May 5;8(3):E10. doi: 10.1093/ehjcvp/pvac004.
Costanzo MR, Januzzi JL Jr 21st Century CE: The New Iron Age? J Am Coll Cardiol. 2022 Feb 1;79(4):352-354. doi: 10.1016/j.jacc.2021.11.026.
Siddiqi OK, Mints YY, Berk JL, Connors L, Doros G, Gopal DM, Kataria S, Lohrmann G, Pipilas AR, Ruberg FL Diflunisal treatment is associated with improved survival for patients with early stage wild-type transthyretin (ATTR) amyloid cardiomyopathy: the Boston University Amyloidosis Center experience. Amyloid. 2022 Jun;29(2):71-78. doi: 10.1080/13506129.2021.2000388. Epub 2022 Jan 27.
Piepoli MF, Adamo M, Barison A, Bestetti RB, Biegus J, Bohm M, Butler J, Carapetis J, Ceconi C, Chioncel O, Coats A, Crespo-Leiro MG, de Simone G, Drexel H, Emdin M, Farmakis D, Halle M, Heymans S, Jaarsma T, Jankowska E, Lainscak M, Lam CSP, Lochen ML, Lopatin Y, Maggioni A, Matrone B, Metra M, Noonan K, Pina I, Prescott E, Rosano G, Seferovic PM, Sliwa K, Stewart S, Uijl A, Vaartjes I, Vermeulen R, Monique Verschuren WM, Volterrani M, von Heahling S, Hoes A Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology. Eur J Heart Fail. 2022 Jan;24(1):143-168. doi: 10.1002/ejhf.2351.
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M, Burri H, Butler J, Celutkiene J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A, Authors/Task Force Members:, ESC Scientific Document Group 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2022 Jan;24(1):4-131. doi: 10.1002/ejhf.2333.
Piepoli MF, Adamo M, Barison A, Bestetti RB, Biegus J, Bohm M, Butler J, Carapetis J, Ceconi C, Chioncel O, Coats A, Crespo-Leiro MG, de Simone G, Drexel H, Emdin M, Farmakis D, Halle M, Heymans S, Jaarsma T, Jankowska E, Lainscak M, Lam CSP, Lochen ML, Lopatin Y, Maggioni A, Matrone B, Metra M, Noonan K, Pina I, Prescott E, Rosano G, Seferovic PM, Sliwa K, Stewart S, Uijl A, Vaartjes I, Vermeulen R, Verschuren WM, Volterrani M, Von Haehling S, Hoes A Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology. Eur J Prev Cardiol. 2022 Feb 19;29(1):275-300. doi: 10.1093/eurjpc/zwab147.
Dmytriw AA, Dibas M, Phan K, Efendizade A, Ospel J, Schirmer C, Settecase F, Heran MKS, Kuhn AL, Puri AS, Menon BK, Sivakumar S, Mowla A, Vela-Duarte D, Linfante I, Dabus GC, Regenhardt RW, D’Amato S, Rosenthal JA, Zha A, Talukder N, Sheth SA, Hassan AE, Cooke DL, Leung LY, Malek AM, Voetsch B, Sehgal S, Wakhloo AK, Goyal M, Wu H, Cohen J, Ghozy S, Turkel-Parella D, Farooq Z, Vranic JE, Rabinov JD, Stapleton CJ, Minhas R, Velayudhan V, Chaudhry ZA, Xavier A, Bullrich MB, Pandey S, Sposato LA, Johnson SA, Gupta G, Khandelwal P, Ali L, Liebeskind DS, Farooqui M, Ortega-Gutierrez S, Nahab F, Jillella DV, Chen K, Aziz-Sultan MA, Abdalkader M, Kaliaev A, Nguyen TN, Haussen DC, Nogueira RG, Haq IU, Zaidat OO, Sanborn E, Leslie-Mazwi TM, Patel AB, Siegler JE, Tiwari A, North American Neurovascular COVID-19 (NAN-C) Consortium & Society of Vascular, and Interventional Neurology (SVIN) Investigators Acute ischaemic stroke associated with SARS-CoV-2 infection in North America. J Neurol Neurosurg Psychiatry. 2022 Apr;93(4):360-368. doi: 10.1136/jnnp-2021-328354. Epub 2022 Jan 25.
Scheers H, Van Remoortel H, Lauwers K, Gillebeert J, Stroobants S, Vranckx P, De Buck E, Vandekerckhove P Predicting medical usage rate at mass gathering events in Belgium: development and validation of a nonlinear multivariable regression model. BMC Public Health. 2022 Jan 25;22(1):173. doi: 10.1186/s12889-022-12580-8.
Goto S, Goto S A Patient-Level Meta-Analysis: The End of the Era of Direct Oral Anticoagulant Developmental Trials in Patients With Atrial Fibrillation? Circulation. 2022 Jan 25;145(4):256-258. doi: 10.1161/CIRCULATIONAHA.121.058159. Epub 2022 Jan 24.
Rashid HN, Michail M, Ihdayhid AR, Khav N, Tan S, Nasis A, Nicholls SJ, Cameron JD, Gooley RP Prosthesis Geometrical Predictors of Leaflet Thrombosis Following Transcatheter Aortic Valve Replacement With Intra-Annular Prostheses. Heart Lung Circ. 2022 May;31(5):678-684. doi: 10.1016/j.hlc.2021.11.013. Epub 2022 Jan 20.
Tromp J, Beusekamp JC, Ouwerkerk W, van der Meer P, Cleland JGF, Angermann CE, Dahlstrom U, Ertl G, Hassanein M, Perrone SV, Ghadanfar M, Schweizer A, Obergfell A, Filippatos G, Dickstein K, Collins SP, Lam CSP Regional differences in precipitating factors of hospitalization for acute heart failure: insights from the REPORT-HF registry. Eur J Heart Fail. 2022 Apr;24(4):645-652. doi: 10.1002/ejhf.2431. Epub 2022 Feb 17.
Jackson J, Alkhalil M, Ratcovich H, Wilkinson C, Mehran R, Kunadian V Evidence base for the management of women with non-ST elevation acute coronary syndrome. Heart. 2022 Oct 13;108(21):1682-1689. doi: 10.1136/heartjnl-2021-320533.
Held C, Hadziosmanovic N, Aylward PE, Hagstrom E, Hochman JS, Stewart RAH, White HD, Wallentin L Body Mass Index and Association With Cardiovascular Outcomes in Patients With Stable Coronary Heart Disease – A STABILITY Substudy. J Am Heart Assoc. 2022 Feb;11(3):e023667. doi: 10.1161/JAHA.121.023667. Epub 2022 Jan 21.
Chandramouli C, Ting TW, Tromp J, Agarwal A, Svedlund S, Saraste A, Hage C, Tan RS, Beussink-Nelson L, Lagerstrom Fermer M, Gan LM, Lund L, Shah SJ, Lam CSP Sex differences in proteomic correlates of coronary microvascular dysfunction among patients with heart failure and preserved ejection fraction. Eur J Heart Fail. 2022 Apr;24(4):681-684. doi: 10.1002/ejhf.2435. Epub 2022 Jan 31.
Angiolillo DJ, Prats J, Deliargyris EN, Schneider DJ, Scheiman J, Kimmelstiel C, Steg PG, Alberts M, Rosengart T, Mehran R, Bhatt DL Pharmacokinetic and Pharmacodynamic Profile of a Novel Phospholipid Aspirin Formulation. Clin Pharmacokinet. 2022 Apr;61(4):465-479. doi: 10.1007/s40262-021-01090-2. Epub 2022 Jan 20.
Franchi F, Rollini F, Angiolillo DJ Reply: The Effects of Cangrelor on Platelet Aggregation in STEMI Patients: Methodological or Pharmacological Issues? JACC Cardiovasc Interv. 2022 Jan 24;15(2):230-231. doi: 10.1016/j.jcin.2021.12.002.
Loccoh EC, Joynt Maddox KE, Wang Y, Kazi DS, Yeh RW, Wadhera RK Rural-Urban Disparities in Outcomes of Myocardial Infarction, Heart Failure, and Stroke in the United States. J Am Coll Cardiol. 2022 Jan 25;79(3):267-279. doi: 10.1016/j.jacc.2021.10.045.
Fitzsimons S, Poppe KK, Choi Y, Devlin G, Lund M, Lam CSP, Troughton R, Richards AM, Doughty RN Relationship Between Soluble Transferrin Receptor and Clinical Outcomes in Patients With Heart Failure According to Ejection Fraction Phenotype: The New Zealand PEOPLE Study. J Card Fail. 2022 Aug;28(8):1255-1263. doi: 10.1016/j.cardfail.2021.12.018. Epub 2022 Jan 17.
Mehra MR Cardiac Xenotransplantation: Rebirth Amidst an Uncertain Future. J Card Fail. 2022 May;28(5):873-874. doi: 10.1016/j.cardfail.2022.01.006. Epub 2022 Jan 17.
Tan S, White HD, Layland J Heparin use in acute coronary syndromes and cardiovascular interventions: habit or evidence based? Eur Heart J. 2022 Mar 7;43(10):1008-1011. doi: 10.1093/eurheartj/ehab896.
Cutlip DE, Jauhar R, Meraj P, Garratt KN, Novack V, Novack L, Maillard L, Erglis A, Stoler R, Barakat M, Silber S, PzF SHIELD Trial Investigators Five-Year Clinical Outcomes of the COBRA Polyzene F NanoCoated Coronary Stent System. Cardiovasc Revasc Med. 2022 Aug;41:76-80. doi: 10.1016/j.carrev.2021.12.030. Epub 2022 Jan 3.
Mihatov N, Secemsky EA, Kereiakes DJ, Steg PG, Cutlip DE, Kirtane AJ, Mehran R, Zhao B, Song Y, Gibson CM, Yeh RW Individualizing Dual Antiplatelet Therapy (DAPT) Duration Based on Bleeding Risk, Ischemic Risk, or Both: An Analysis From the DAPT Study. Cardiovasc Revasc Med. 2022 Aug;41:105-112. doi: 10.1016/j.carrev.2022.01.006. Epub 2022 Jan 12.
Vernon ST, Kott KA, Hansen T, Finemore M, Baumgart KW, Bhindi R, Yang J, Hansen PS, Nicholls SJ, Celermajer DS, Ward MR, van Nunen SA, Grieve SM, Figtree GA Immunoglobulin E Sensitization to Mammalian Oligosaccharide Galactose-alpha-1,3 (alpha-Gal) Is Associated With Noncalcified Plaque, Obstructive Coronary Artery Disease, and ST-Segment-Elevated Myocardial Infarction. Arterioscler Thromb Vasc Biol. 2022 Mar;42(3):352-361. doi: 10.1161/ATVBAHA.121.316878. Epub 2022 Jan 20.
Rivas A, Lauw MN, Schnabel RB, Crowther M, Van Spall HGC Stroke and Thromboembolism in Patients with Heart Failure and Sinus Rhythm: A Matter of Risk Stratification? Thromb Haemost. 2022 Jun;122(6):871-878. doi: 10.1055/a-1745-2083. Epub 2022 Apr 21.
Chunawala ZS, Qamar A, Arora S, Pandey A, Fudim M, Vaduganathan M, Bhatt DL, Mentz RJ, Caughey MC Prevalence and Prognostic Significance of Polyvascular Disease in Patients Hospitalized With Acute Decompensated Heart Failure: The ARIC Study. J Card Fail. 2022 Aug;28(8):1267-1277. doi: 10.1016/j.cardfail.2022.01.002. Epub 2022 Jan 16.
Jiang GY, Wasfy JH Insurance Expansion as a Policy Tool to Reduce Pregnancy-Related Maternal Cardiovascular Mortality. Circ Cardiovasc Qual Outcomes. 2022 Jan;15(1):e008578. doi: 10.1161/CIRCOUTCOMES.121.008578. Epub 2022 Jan 18.
Maulion C, Januzzi JL Risk Prediction Scores in Cardiovascular Disease: Useful Tool or “Model of the Week”? J Card Fail. 2022 Apr;28(4):551-553. doi: 10.1016/j.cardfail.2021.11.019. Epub 2022 Jan 14.
Greene SJ, Fonarow GC, Butler J Web Exclusive. Annals for Hospitalists Inpatient Notes – Clinical Pearls-Stopping, Starting, and Optimizing Guideline-Directed Medical Therapy in Patients Hospitalized for Heart Failure With Reduced Ejection Fraction. Ann Intern Med. 2022 Jan;175(1):HO2-HO3. doi: 10.7326/M21-4558.
Sinha S, Gould LJ, Nigwekar SU, Serena TE, Brandenburg V, Moe SM, Aronoff G, Chatoth DK, Hymes JL, Miller S, Padgett C, Carroll KJ, Perello J, Gold A, Chertow GM The CALCIPHYX study: a randomized, double-blind, placebo-controlled, Phase 3 clinical trial of SNF472 for the treatment of calciphylaxis. Clin Kidney J. 2021 Jul 6;15(1):136-144. doi: 10.1093/ckj/sfab117. eCollection 2022 Jan.
Chiarito M, Baber U, Cao D, Sharma SK, Dangas G, Angiolillo DJ, Briguori C, Cohen DJ, Dudek D, Dzavik V, Escaned J, Gil R, Hamm CW, Henry T, Huber K, Kastrati A, Kaul U, Kornowski R, Krucoff M, Kunadian V, Mehta SR, Moliterno D, Ohman EM, Oldroyd K, Sardella G, Zhongjie Z, Sartori S, Stefanini G, Shlofmitz R, Steg PG, Weisz G, Witzenbichler B, Han YL, Pocock S, Gibson CM, Mehran R Ticagrelor Monotherapy After PCI in High-Risk Patients With Prior MI: A Prespecified TWILIGHT Substudy. JACC Cardiovasc Interv. 2022 Feb 14;15(3):282-293. doi: 10.1016/j.jcin.2021.11.005. Epub 2022 Jan 12.
Boden WE, Kaski JC, Al-Lamee R, Weintraub WS What constitutes an appropriate empirical trial of antianginal therapy in patients with stable angina before referral for revascularisation? Lancet. 2022 Feb 12;399(10325):691-694. doi: 10.1016/S0140-6736(21)02045-6. Epub 2022 Jan 13.
Fernando S, Salagaras T, Schwarz N, Sandeman L, Tan JTM, Xie J, Zareh J, Jensen K, Williamson A, Dimasi C, Chhay P, Toledo-Flores D, Long A, Manavis J, Worthington M, Fitridge R, Di Bartolo BA, Bursill CA, Nicholls SJ, Proud CG, Psaltis PJ Eukaryotic elongation factor 2 kinase regulates foam cell formation via translation of CD36. FASEB J. 2022 Feb;36(2):e22154. doi: 10.1096/fj.202101034R.
Wang A, Ferro EG, Song Y, Xu J, Sun T, Yeh RW, Strom JB, Kramer DB Frailty in patients undergoing percutaneous left atrial appendage closure. Heart Rhythm. 2022 May;19(5):814-821. doi: 10.1016/j.hrthm.2022.01.007. Epub 2022 Jan 11.
Usman MS, Khan MS, Fonarow GC, Greene SJ, Friede T, Vaduganathan M, Filippatos G, Coats AJS, Anker SD, Butler J Robustness of outcomes in trials evaluating sodium-glucose co-transporter 2 inhibitors for heart failure. ESC Heart Fail. 2022 Apr;9(2):885-893. doi: 10.1002/ehf2.13785. Epub 2022 Jan 13.
Drame I, Gibson CM, Nonyel NP, Addo-Atuah J, Butler L, Riley A, Kebodeaux C, Henson B, Borja-Hart N Strategies for Incorporating Health Disparities and Cultural Competency Training into the Pharmacy Curriculum and Co-curriculum. Am J Pharm Educ. 2022 Mar;86(3):8631. doi: 10.5688/ajpe8631. Epub 2022 Jan 13.
Singh N, Bhatt DL, Miller M, Steg PG, Brinton EA, Jacobson TA, Jiao L, Tardif JC, Mason RP, Ballantyne CM, REDUCE-IT Investigators Consistency of Benefit of Icosapent Ethyl by Background Statin Type in REDUCE-IT. J Am Coll Cardiol. 2022 Jan 18;79(2):220-222. doi: 10.1016/j.jacc.2021.11.005.
Mentias A, Keshvani N, Desai MY, Kumbhani DJ, Sarrazin MV, Gao Y, Kapadia S, Peterson ED, Mack M, Girotra S, Pandey A Risk-Adjusted, 30-Day Home Time After Transcatheter Aortic Valve Replacement as a Hospital-Level Performance Metric. J Am Coll Cardiol. 2022 Jan 18;79(2):132-144. doi: 10.1016/j.jacc.2021.10.038.
Schmidt B, Velaer KN, Thomas IC, Ganesan C, Song S, Pao AC, Thong AE, Liao JC, Chertow GM, Skinner EC, Leppert JT Renal Morbidity Following Radical Cystectomy in Patients with Bladder Cancer. Eur Urol Open Sci. 2022 Jan 3;35:29-36. doi: 10.1016/j.euros.2021.11.001. eCollection 2022 Jan.
Mak KH, Vidal-Petiot E, Young R, Sorbets E, Greenlaw N, Ford I, Tendera M, Ferrari R, Tardif JC, Udell JA, Escobedo J, Fox KM, Steg PG, CLARIFY Investigators Prevalence of diabetes and impact on cardiovascular events and mortality in patients with chronic coronary syndromes, across multiple geographical regions and ethnicities. Eur J Prev Cardiol. 2022 Jan 11;28(16):1795-1806. doi: 10.1093/eurjpc/zwab011.
Gevaert AB, Kataria R, Zannad F, Sauer AJ, Damman K, Sharma K, Shah SJ, Van Spall HGC Heart failure with preserved ejection fraction: recent concepts in diagnosis, mechanisms and management. Heart. 2022 Aug 11;108(17):1342-1350. doi: 10.1136/heartjnl-2021-319605.
Kolkailah AA, Wiviott SD, Raz I, Murphy SA, Mosenzon O, Bhatt DL, Leiter LA, Wilding JPH, Gause-Nilsson I, Sabatine MS, McGuire DK Effect of Dapagliflozin on Hematocrit in Patients With Type 2 Diabetes at High Cardiovascular Risk: Observations From DECLARE-TIMI 58. Diabetes Care. 2022 Feb 1;45(2):e27-e29. doi: 10.2337/dc21-1668.
Chi G, Lee JJ, Kazmi SHA, Fitzgerald C, Memar Montazerin S, Kalayci A, Korjian S, Heise M, Deckelbaum LI, Libby P, Bhatt DL, Gibson CM Early and late recurrent cardiovascular events among high-risk patients with an acute coronary syndrome: Meta-analysis of phase III studies and implications on trial design. Clin Cardiol. 2022 Mar;45(3):299-307. doi: 10.1002/clc.23773. Epub 2022 Jan 12.
Arevalos V, Ortega-Paz L, Brugaletta S Mid-term effects of SARS-CoV-2 infection on cardiovascular outcomes. Med Clin (Engl Ed). 2022 Jan 7;158(1):41-42. doi: 10.1016/j.medcle.2021.05.008.
Mansour SG, Bhatraju PK, Coca SG, Obeid W, Wilson FP, Stanaway IB, Jia Y, Thiessen-Philbrook H, Go AS, Ikizler TA, Siew ED, Chinchilli VM, Hsu CY, Garg AX, Reeves WB, Liu KD, Kimmel PL, Kaufman JS, Wurfel MM, Himmelfarb J, Parikh SM, Parikh CR, for the ASSESS-AKI Consortium Angiopoietins as Prognostic Markers for Future Kidney Disease and Heart Failure Events after Acute Kidney Injury. J Am Soc Nephrol. 2022 Mar;33(3):613-627. doi: 10.1681/ASN.2021060757. Epub 2022 Jan 11.
Cahn A, Wiviott SD, Mosenzon O, Goodrich EL, Murphy SA, Yanuv I, Rozenberg A, Bhatt DL, Leiter LA, McGuire DK, Wilding JPH, Gause-Nilsson IAM, Langkilde AM, Sabatine MS, Raz I Association of Baseline HbA1c With Cardiovascular and Renal Outcomes: Analyses From DECLARE-TIMI 58. Diabetes Care. 2022 Apr 1;45(4):938-946. doi: 10.2337/dc21-1744.
Goldenberg NA, Kittelson JM, Abshire TC, Bonaca M, Casella JF, Dale RA, Halperin JL, Hamblin F, Kessler CM, Manco-Johnson MJ, Sidonio RF, Spyropoulos AC, Steg PG, Turpie AGG, Schulman S, Kids-DOTT Trial Investigators and the ATLAS Group Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism: The Kids-DOTT Randomized Clinical Trial. JAMA. 2022 Jan 11;327(2):129-137. doi: 10.1001/jama.2021.23182.
Sharma G, Grandhi GR, Acquah I, Mszar R, Mahajan S, Khan SU, Javed Z, Mehta LS, Gulati M, Cainzos-Achirica M, Blumenthal RS, Nasir K Social Determinants of Suboptimal Cardiovascular Health Among Pregnant Women in the United States. J Am Heart Assoc. 2022 Jan 18;11(2):e022837. doi: 10.1161/JAHA.121.022837. Epub 2022 Jan 11.
Suresh K, Holtrop JS, Dickinson LM, Willems E, Smith PC, Gritz RM, Perreault L PATHWEIGH, pragmatic weight management in adult patients in primary care in Colorado, USA: study protocol for a stepped wedge cluster randomized trial. Trials. 2022 Jan 10;23(1):26. doi: 10.1186/s13063-021-05954-7.
de Lemos JA, McGuire DK, Hill JA Celebrating The Next Generation of Cardiovascular Investigators. Circulation. 2022 Jan 11;145(2):91-93. doi: 10.1161/CIRCULATIONAHA.121.058678. Epub 2022 Jan 10.
Wu P, Mamas MA, Gulati M Health Care Professional’s Knowledge of Pregnancy Complications and Women’s Cardiovascular Health: An International Study Utilizing Social Media. J Womens Health (Larchmt). 2022 Aug;31(8):1197-1207. doi: 10.1089/jwh.2021.0298. Epub 2022 Jan 7.
Allen LA, Teerlink JR, Gottlieb SS, Ahmad T, Lam CSP, Psotka MA Heart Failure Spending Function: An Investment Framework for Sequencing and Intensification of Guideline-Directed Medical Therapies. Circ Heart Fail. 2022 Apr;15(4):e008594. doi: 10.1161/CIRCHEARTFAILURE.121.008594. Epub 2022 Jan 10.
Fox KAA, Virdone S, Bassand JP, Camm AJ, Goto S, Goldhaber SZ, Haas S, Kayani G, Koretsune Y, Misselwitz F, Oh S, Piccini JP, Parkhomenko A, Sawhney JPS, Stepinska J, Turpie AGG, Verheugt FWA, Kakkar AK, GARFIELD-AF investigators* Do baseline characteristics and treatments account for geographical disparities in the outcomes of patients with newly diagnosed atrial fibrillation? The prospective GARFIELD-AF registry. BMJ Open. 2022 Jan 7;12(1):e049933. doi: 10.1136/bmjopen-2021-049933.
Arora S, Qamar A, Gupta P, Hendrickson M, Singh A, Vaduganathan M, Pandey A, Bansal A, Batra V, Mukhopadhyay S, Yusuf J, Tyagi S, Girish MP, Kaul P, Bhatt DL, Gupta M Guideline based eligibility for primary prevention statin therapy – Insights from the North India ST-elevation myocardial infarction registry (NORIN-STEMI). J Clin Lipidol. 2022 Mar-Apr;16(2):227-236. doi: 10.1016/j.jacl.2021.12.001. Epub 2021 Dec 22.
Blankstein R, Gulati M, Jaber WA, Bullock-Palmer RP, Bhatt DL, Shaw LJ The 2021 Chest Pain Guideline: A Revolutionary New Paradigm for Cardiac Testing. JACC Cardiovasc Imaging. 2022 Jan;15(1):140-144. doi: 10.1016/j.jcmg.2021.10.005. Epub 2021 Oct 28.
Dawson LP, Lum M, Nerleker N, Nicholls SJ, Layland J Coronary Atherosclerotic Plaque Regression: JACC State-of-the-Art Review. J Am Coll Cardiol. 2022 Jan 4;79(1):66-82. doi: 10.1016/j.jacc.2021.10.035.
Januzzi JL, Garasic JM, Kasner SE, McDonald V, Petrie MC, Seltzer J, Mauro M, Croce K, Berman E, Deininger M, Hochhaus A, Pinilla-Ibarz J, Nicolini F, Kim DW, DeAngelo DJ, Kantarjian H, Xu J, Hall T, Srivastava S, Naranjo D, Cortes J Retrospective analysis of arterial occlusive events in the PACE trial by an independent adjudication committee. J Hematol Oncol. 2022 Jan 6;15(1):1. doi: 10.1186/s13045-021-01221-z.
Butler J, Siddiqi TJ, Filippatos G, Ferreira JP, Pocock SJ, Zannad F, Anker SD Early benefit with empagliflozin in heart failure with preserved ejection fraction: insights from the EMPEROR-Preserved trial. Eur J Heart Fail. 2022 Feb;24(2):245-248. doi: 10.1002/ejhf.2420. Epub 2022 Jan 18.
Shah A, Mentz RJ, Sun JL, Rao VN, Alhanti B, Blumer V, Starling R, Butler J, Greene SJ Emergency Department Visits Versus Hospital Readmissions Among Patients Hospitalized for Heart Failure. J Card Fail. 2022 Jun;28(6):916-923. doi: 10.1016/j.cardfail.2021.11.025. Epub 2022 Jan 3.
Sposato LA, Chaturvedi S, Hsieh CY, Morillo CA, Kamel H Atrial Fibrillation Detected After Stroke and Transient Ischemic Attack: A Novel Clinical Concept Challenging Current Views. Stroke. 2022 Mar;53(3):e94-e103. doi: 10.1161/STROKEAHA.121.034777. Epub 2022 Jan 5.
Khan MS, Bakris GL, Shahid I, Weir MR, Butler J Potential Role and Limitations of Estimated Glomerular Filtration Rate Slope Assessment in Cardiovascular Trials: A Review. JAMA Cardiol. 2022 May 1;7(5):549-555. doi: 10.1001/jamacardio.2021.5151.
Chertow GM, Vart P, Jongs N, Langkilde AM, McMurray JJV, Correa-Rotter R, Rossing P, Sjostrom CD, Stefansson BV, Toto RD, Wheeler DC, Heerspink HJL Quetelet (body mass) index and effects of dapagliflozin in chronic kidney disease. Diabetes Obes Metab. 2022 May;24(5):827-837. doi: 10.1111/dom.14641. Epub 2022 Feb 16.
Galli M, Franchi F, Rollini F, Been L, Jaoude PA, Rivas A, Zhou X, Jia S, Maaliki N, Lee CH, Pineda AM, Suryadevara S, Soffer D, Zenni MM, Geisler T, Jennings LK, Bass TA, Angiolillo DJ Pharmacodynamic Profiles of Dual-Pathway Inhibition with or without Clopidogrel versus Dual Antiplatelet Therapy in Patients with Atherosclerotic Disease. Thromb Haemost. 2022 Aug;122(8):1341-1351. doi: 10.1055/a-1730-8725. Epub 2022 Jan 4.
Borovac JA, Mohamed MO, Kontopantelis E, Alkhouli M, Alraies MC, Cheng RK, Elgendy IY, Velagapudi P, Paul TK, Van Spall HGC, Mamas MA Frailty Among Patients With Acute ST-Elevation Myocardial Infarction in the United States: The Impact of the Primary Percutaneous Coronary Intervention on In-Hospital Outcomes. J Invasive Cardiol. 2022 Jan;34(1):E55-E64. doi: 10.25270/jic/21.00069.
Noubiap JJ, Agbaedeng TA, Nyaga UF, Lau DH, Worthley MI, Nicholls SJ, Sanders P Atrial fibrillation incidence, prevalence, predictors, and adverse outcomes in acute coronary syndromes: A pooled analysis of data from 8 million patients. J Cardiovasc Electrophysiol. 2022 Mar;33(3):414-422. doi: 10.1111/jce.15351. Epub 2022 Jan 17.
Leiter LA, Banach M, Catapano AL, Duell PB, Gotto AM Jr, Laufs U, Mancini GBJ, Ray KK, Hanselman JC, Ye Z, Bays HE Bempedoic acid in patients with type 2 diabetes mellitus, prediabetes, and normoglycaemia: A post hoc analysis of efficacy and glycaemic control using pooled data from phase 3 clinical trials. Diabetes Obes Metab. 2022 May;24(5):868-880. doi: 10.1111/dom.14645. Epub 2022 Feb 3.
Ahmed AI, Han Y, Ahmed AM, Faza NN, Michos ED, Gulati M, Zoghbi WA, Al-Mallah MH Association of Twitter Metrics and Cardiology and Heart Surgery National Hospital Rankings. Mayo Clin Proc Innov Qual Outcomes. 2021 Dec 20;6(1):16-18. doi: 10.1016/j.mayocpiqo.2021.11.001. eCollection 2022 Feb.
Sharma A, Mahaffey KW, Gibson CM, Hicks KA, Alexander KP, Ali M, Chaitman BR, Held C, Hlatky M, Jones WS, Mehran R, Menon V, Rockhold FW, Seltzer J, Spitzer E, Wilson M, Lopes RD Clinical events classification (CEC) in clinical trials: Report on the current landscape and future directions – proceedings from the CEC Summit 2018. Am Heart J. 2022 Apr;246:93-104. doi: 10.1016/j.ahj.2021.12.012. Epub 2021 Dec 31.
Patel KV, Keshvani N, Pandey A, Vaduganathan M, Holmes DN, Matsouaka RA, DeVore AD, Allen LA, Yancy CW, Fonarow GC Association of readmission penalty amount with subsequent 30-day risk standardized readmission and mortality rates among patients hospitalized with heart failure: An analysis of get with the guidelines – heart failure participating centers. Am Heart J. 2022 Apr;246:1-11. doi: 10.1016/j.ahj.2021.12.014. Epub 2021 Dec 30.
Ostrominski JW, Hirji S, Bhatt AS, Butler J, Fiuzat M, Fonarow GC, Heidenreich PA, Januzzi JL Jr, Lam CSP, Maddox TM, O’Connor CM, Vaduganathan M Cost and Value in Contemporary Heart Failure Clinical Guidance Documents. JACC Heart Fail. 2022 Jan;10(1):1-11. doi: 10.1016/j.jchf.2021.08.002. Epub 2021 Nov 10.
Mishra NK, Engel J Jr, Liebeskind DS, Sharma VK, Hirsch LJ, Kasner SE, French JA, Devinsky O, Friedman A, Dawson J, Quinn TJ, Selim M, de Havenon A, Yasuda CL, Cendes F, Benninger F, Zaveri HP, Burneo JG, Srivastava P, Bhushan Singh M, Bhatia R, Vishnu VY, Bentes C, Ferro J, Weiss S, Sivaraju A, Kim JA, Galovic M, Gilmore EJ, Pitkanen A, Davis K, Sansing LH, Sheth KN, Paz JT, Singh A, Sheth S, Worrall BB, Grotta JC, Casillas-Espinos PM, Chen Z, Nicolo JP, Yan B, Kwan P, for International Post Stroke Epilepsy Research Consortium (IPSERC) International Post Stroke Epilepsy Research Consortium (IPSERC): A consortium to accelerate discoveries in preventing epileptogenesis after stroke. Epilepsy Behav. 2022 Feb;127:108502. doi: 10.1016/j.yebeh.2021.108502. Epub 2021 Dec 27.
Khan MS, Bakris GL, Packer M, Shahid I, Anker SD, Fonarow GC, Wanner C, Weir MR, Zannad F, Butler J Kidney function assessment and endpoint ascertainment in clinical trials. Eur Heart J. 2022 Apr 6;43(14):1379-1400. doi: 10.1093/eurheartj/ehab832.
Cerasuolo JO, Mandzia J, Cipriano LE, Kapral MK, Fang J, Hachinski V, Sposato LA Intravenous Thrombolysis After First-Ever Ischemic Stroke and Reduced Incident Dementia Rate. Stroke. 2022 Apr;53(4):1170-1177. doi: 10.1161/STROKEAHA.121.034969. Epub 2021 Dec 30.
Blake K, Yancy CW Change the Name of the Blalock-Taussig Shunt to Blalock-Thomas-Taussig Shunt. JAMA Surg. 2022 Apr 1;157(4):287-288. doi: 10.1001/jamasurg.2021.5611.
Amarenco P, Kim JS, Labreuche J, Charles H, Giroud M, Lavallee PC, Lee BC, Mahagne MH, Meseguer E, Nighoghossian N, Steg PG, Vicaut E, Bruckert E, Treat Stroke to Target Investigators* Intracranial Hemorrhage in the TST Trial. Stroke. 2022 Feb;53(2):457-462. doi: 10.1161/STROKEAHA.121.035846. Epub 2021 Dec 29.
Lahu S, Behnes M, Ndrepepa G, Neumann FJ, Sibbing D, Bernlochner I, Menichelli M, Mayer K, Richardt G, Gewalt S, Angiolillo DJ, Coughlan JJ, Aytekin A, Witzenbichler B, Hochholzer W, Cassese S, Kufner S, Xhepa E, Sager HB, Joner M, Fusaro M, Laugwitz KL, Schunkert H, Schupke S, Kastrati A, Akin I Body mass index and efficacy and safety of ticagrelor versus prasugrel in patients with acute coronary syndromes. Rev Esp Cardiol (Engl Ed). 2022 Sep;75(9):747-755. doi: 10.1016/j.rec.2021.11.007. Epub 2021 Dec 24.
Connors JM, Moll M, Levy JH Interpreting recent clinical studies for COVID-19: A continual process with more new data. Anaesth Crit Care Pain Med. 2022 Feb;41(1):101016. doi: 10.1016/j.accpm.2021.101016. Epub 2021 Dec 24.
Ferreira JP, Anker SD, Butler J, Filippatos G, Iwata T, Salsali A, Zeller C, Pocock SJ, Zannad F, Packer M Impact of anaemia and the effect of empagliflozin in heart failure with reduced ejection fraction: findings from EMPEROR-Reduced. Eur J Heart Fail. 2022 Apr;24(4):708-715. doi: 10.1002/ejhf.2409. Epub 2022 Jan 9.
Gulati M, Levy PD, Mukherjee D, Amsterdam E, Bhatt DL, Birtcher KK, Blankstein R, Boyd J, Bullock-Palmer RP, Conejo T, Diercks DB, Gentile F, Greenwood JP, Hess EP, Hollenberg SM, Jaber WA, Jneid H, Joglar JA, Morrow DA, O’Connor RE, Ross MA, Shaw LJ, Writing Committee Members 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Cardiovasc Comput Tomogr. 2022 Jan-Feb;16(1):54-122. doi: 10.1016/j.jcct.2021.11.009. Epub 2021 Dec 1.
Arora S, Brown ZD, Sivaraj K, Hendrickson MJ, Mazzella AJ, Chang PP, Vaduganathan M, Qamar A, Gehi AK, Pandey A, Vavalle JP The Relationship Between Atrial Fibrillation, Mitral Regurgitation, and Heart Failure Subtype: The ARIC Study. J Card Fail. 2022 Jun;28(6):883-892. doi: 10.1016/j.cardfail.2021.10.015. Epub 2021 Dec 23.
Carroll BJ, Beyer SE, Shanafelt C, Kabrhel C, Rali P, Rivera-Lebron B, Rosovsky R, Ross CB, Pinto DS, Secemsky EA Interhospital Transfer for the Management of Acute Pulmonary Embolism. Am J Med. 2022 Apr;135(4):531-535. doi: 10.1016/j.amjmed.2021.11.015. Epub 2021 Dec 24.
Nanna MG, Vemulapalli S, Fordyce CB, Mark DB, Patel MR, Al-Khalidi HR, Kelsey M, Martinez B, Yow E, Mullen S, Stone GW, Ben-Yehuda O, Udelson JE, Rogers C, Douglas PS The prospective randomized trial of the optimal evaluation of cardiac symptoms and revascularization: Rationale and design of the PRECISE trial. Am Heart J. 2022 Mar;245:136-148. doi: 10.1016/j.ahj.2021.12.004. Epub 2021 Dec 23.
Cutlip DE ROSES – Avoiding the Thorns. Cardiovasc Revasc Med. 2022 Mar;36:71-72. doi: 10.1016/j.carrev.2021.12.014. Epub 2021 Dec 16.
Matetic A, Mohamed MO, Roberts DJ, Rana JS, Alraies MC, Patel B, Sauer AJ, Diaz-Arocutipa C, Sattar Y, Van Spall HGC, Mamas MA Real-world management and outcomes of 7 million patients with acute coronary syndrome according to clinical research trial enrolment status: a propensity matched analysis. Eur Heart J Qual Care Clin Outcomes. 2022 Jun 6;8(4):409-419. doi: 10.1093/ehjqcco/qcab098.
Furtado JD, Ruotolo G, Nicholls SJ, Dullea R, Carvajal-Gonzalez S, Sacks FM Pharmacological Inhibition of CETP (Cholesteryl Ester Transfer Protein) Increases HDL (High-Density Lipoprotein) That Contains ApoC3 and Other HDL Subspecies Associated With Higher Risk of Coronary Heart Disease. Arterioscler Thromb Vasc Biol. 2022 Feb;42(2):227-237. doi: 10.1161/ATVBAHA.121.317181. Epub 2021 Dec 23.
Gong J, Castro RRT, Caron JP, Bay CP, Hainer J, Opotowsky AR, Mehra MR, Maron BA, Di Carli MF, Groarke JD, Nohria A Usefulness of ventilatory inefficiency in predicting prognosis across the heart failure spectrum. ESC Heart Fail. 2022 Feb;9(1):293-302. doi: 10.1002/ehf2.13761. Epub 2021 Dec 21.
McGuire DK, de Lemos JA, Hill JA, Circulation Editors Team Recognized Outstanding Reviewers for Circulation in 2021. Circulation. 2022 Jan 4;145(1):4. doi: 10.1161/CIRCULATIONAHA.121.058519. Epub 2021 Dec 20.
Nicholls SJ, Shaw LJ Shining Light on the Impact of Air Pollution. JACC Cardiovasc Imaging. 2022 Feb;15(2):343-344. doi: 10.1016/j.jcmg.2021.11.001. Epub 2021 Dec 15.
Honda S, Puri R, Anderson T, Kastelein JJP, Brennan DM, Kassahun H, Somaratne R, Wasserman SM, Nissen SE, Nicholls SJ Determinants of Plaque Progression Despite Very Low Low-Density Lipoprotein-Cholesterol Levels With the PCSK9 Inhibitor, Evolocumab. JACC Cardiovasc Imaging. 2022 Apr;15(4):709-711. doi: 10.1016/j.jcmg.2021.11.014. Epub 2021 Dec 15.
Lim HS, Shaw S, Carter AW, Jayawardana S, Mossialos E, Mehra MR A clinical and cost-effectiveness analysis of the HeartMate 3 left ventricular assist device for transplant-ineligible patients: A United Kingdom perspective. J Heart Lung Transplant. 2022 Feb;41(2):174-186. doi: 10.1016/j.healun.2021.11.014. Epub 2021 Nov 24.
Handelsman Y, Anderson JE, Bakris GL, Ballantyne CM, Beckman JA, Bhatt DL, Bloomgarden ZT, Bozkurt B, Budoff MJ, Butler J, Dagogo-Jack S, de Boer IH, DeFronzo RA, Eckel RH, Einhorn D, Fonseca VA, Green JB, Grunberger G, Guerin C, Inzucchi SE, Jellinger PS, Kosiborod MN, Kushner P, Lepor N, Mende CW, Michos ED, Plutzky J, Taub PR, Umpierrez GE, Vaduganathan M, Weir MR DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases. J Diabetes Complications. 2022 Feb;36(2):108101. doi: 10.1016/j.jdiacomp.2021.108101. Epub 2021 Dec 7.
White HD, Schwartz GG, Szarek M, Bhatt DL, Bittner VA, Chiang CE, Diaz R, Goodman SG, Jukema JW, Loy M, Pagidipati N, Pordy R, Ristic AD, Zeiher AM, Wojdyla DM, Steg PG, ODYSSEY OUTCOMES Investigators Alirocumab after acute coronary syndrome in patients with a history of heart failure. Eur Heart J. 2022 Apr 19;43(16):1554-1565. doi: 10.1093/eurheartj/ehab804.
Angchaisuksiri P, Goto S, Farjat AE, Fryk H, Bang SM, Chiang CE, Jing ZC, Kondo K, Sathar J, Tse E, Phusanti S, Kayani G, Weitz JI, Ageno W, Goldhaber SZ, Kakkar AK Corrigendum to “Venous thromboembolism in Asia and worldwide: Emerging insights from GARFIELD-VTE” [Thromb. Res. 2021 May;201:63-72]. Thromb Res. 2022 Jan;209:105. doi: 10.1016/j.thromres.2021.11.022. Epub 2021 Dec 15.
Jackson AM, Rorth R, Liu J, Kristensen SL, Anand IS, Claggett BL, Cleland JGF, Chopra VK, Desai AS, Ge J, Gong J, Lam CSP, Lefkowitz MP, Maggioni AP, Martinez F, Packer M, Pfeffer MA, Pieske B, Redfield MM, Rizkala AR, Rouleau JL, Seferovic PM, Tromp J, Van Veldhuisen DJ, Yilmaz MB, Zannad F, Zile MR, Kober L, Petrie MC, Jhund PS, Solomon SD, McMurray JJV, PARAGON-HF Committees and Investigators Diabetes and pre-diabetes in patients with heart failure and preserved ejection fraction. Eur J Heart Fail. 2022 Mar;24(3):497-509. doi: 10.1002/ejhf.2403. Epub 2022 Jan 4.
Januzzi JL, Tan X, Yang L, Brady JE, Yang M, Banka P, Lautsch D N-terminal pro-B-type natriuretic peptide testing patterns in patients with heart failure with reduced ejection fraction. ESC Heart Fail. 2022 Feb;9(1):87-99. doi: 10.1002/ehf2.13749. Epub 2021 Dec 16.
Galli M, Benenati S, Franchi F, Rollini F, Capodanno D, Biondi-Zoccai G, Vescovo GM, Cavallari LH, Bikdeli B, Ten Berg J, Mehran R, Gibson CM, Crea F, Pereira NL, Sibbing D, Angiolillo DJ Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials. Eur Heart J. 2022 Mar 7;43(10):959-967. doi: 10.1093/eurheartj/ehab836.
Cavender MA, Harrington RA, Stone GW, Steg PG, Gibson CM, Hamm CW, Price MJ, Lopes RD, Leonardi S, Deliargyris EN, Prats J, Mahaffey KW, White HD, Bhatt DL, CHAMPION PHOENIX Investigators* Ischemic Events Occur Early in Patients Undergoing Percutaneous Coronary Intervention and Are Reduced With Cangrelor: Findings From CHAMPION PHOENIX. Circ Cardiovasc Interv. 2022 Jan;15(1):e010390. doi: 10.1161/CIRCINTERVENTIONS.120.010390. Epub 2021 Dec 17.
Norris T, Razieh C, Zaccardi F, Yates T, Islam N, Gillies CL, Chudasama YV, Rowlands AV, Davies MJ, McCann GP, Banerjee A, Lam CSP, Docherty AB, Openshaw PJ, Baillie JK, Semple MG, Lawson CA, Khunti K, ISARIC4C investigators Impact of cardiometabolic multimorbidity and ethnicity on cardiovascular/renal complications in patients with COVID-19. Heart. 2022 Jul 13;108(15):1200-1208. doi: 10.1136/heartjnl-2021-320047.
Wei S, Le N, Zhu JW, Breathett K, Greene SJ, Mamas MA, Zannad F, Van Spall HGC Factors Associated With Racial and Ethnic Diversity Among Heart Failure Trial Participants: A Systematic Bibliometric Review. Circ Heart Fail. 2022 Mar;15(3):e008685. doi: 10.1161/CIRCHEARTFAILURE.121.008685. Epub 2021 Dec 16.
Caramori ML, Tuttle KR, Tandon N, Tunnicliffe DJ, de Boer IH, Rossing P, Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group The authors reply. Kidney Int. 2022 Feb;101(2):420-421. doi: 10.1016/j.kint.2021.11.019. Epub 2021 Dec 11.
Anand S, Montez-Rath ME, Han J, Garcia P, Cadden L, Hunsader P, Morgan C, Kerschmann R, Beyer P, Dittrich M, Block GA, Chertow GM, Parsonnet J SARS-CoV-2 Vaccine Antibody Response and Breakthrough Infection in Patients Receiving Dialysis. Ann Intern Med. 2022 Mar;175(3):371-378. doi: 10.7326/M21-4176. Epub 2021 Dec 14.
Almarzooq ZI, Yeh RW ‘State of the Art’ PCI: bridging the implementation gap. Eur Heart J. 2022 Mar 31;43(13):1317-1319. doi: 10.1093/eurheartj/ehab855.
Zhu JW, Reed JL, Van Spall HGC The underrepresentation of female athletes in sports research: considerations for cardiovascular health. Eur Heart J. 2022 May 1;43(17):1609-1611. doi: 10.1093/eurheartj/ehab846.
Shah NP, Clare RM, Chiswell K, Navar AM, Shah BR, Peterson ED Trends of blood pressure control in the U.S. during the COVID-19 pandemic. Am Heart J. 2022 May;247:15-23. doi: 10.1016/j.ahj.2021.11.017. Epub 2021 Dec 10.
Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, Bischoff JM, Bittl JA, Cohen MG, DiMaio JM, Don CW, Fremes SE, Gaudino MF, Goldberger ZD, Grant MC, Jaswal JB, Kurlansky PA, Mehran R, Metkus TS Jr, Nnacheta LC, Rao SV, Sellke FW, Sharma G, Yong CM, Zwischenberger BA, Writing Committee Members 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2022 Jan 18;79(2):197-215. doi: 10.1016/j.jacc.2021.09.005. Epub 2021 Dec 9.
Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, Bischoff JM, Bittl JA, Cohen MG, DiMaio JM, Don CW, Fremes SE, Gaudino MF, Goldberger ZD, Grant MC, Jaswal JB, Kurlansky PA, Mehran R, Metkus TS Jr, Nnacheta LC, Rao SV, Sellke FW, Sharma G, Yong CM, Zwischenberger BA, Writing Committee Members 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2022 Jan 18;79(2):e21-e129. doi: 10.1016/j.jacc.2021.09.006. Epub 2021 Dec 9.
Khan MS, Solomon N, DeVore AD, Sharma A, Felker GM, Hernandez AF, Heidenreich PA, Matsouaka RA, Green JB, Butler J, Yancy CW, Peterson PN, Fonarow GC, Greene SJ Clinical Outcomes With Metformin and Sulfonylurea Therapies Among Patients With Heart Failure and Diabetes. JACC Heart Fail. 2022 Mar;10(3):198-210. doi: 10.1016/j.jchf.2021.11.001. Epub 2021 Dec 8.
Tromp J, Ouwerkerk W, van Veldhuisen DJ, Hillege HL, Richards AM, van der Meer P, Anand IS, Lam CSP, Voors AA A Systematic Review and Network Meta-Analysis of Pharmacological Treatment of Heart Failure With Reduced Ejection Fraction. JACC Heart Fail. 2022 Feb;10(2):73-84. doi: 10.1016/j.jchf.2021.09.004. Epub 2021 Dec 8.
Tomasoni D, Fonarow GC, Adamo M, Anker SD, Butler J, Coats AJS, Filippatos G, Greene SJ, McDonagh TA, Ponikowski P, Rosano G, Seferovic P, Vaduganathan M, Voors AA, Metra M Sodium-glucose co-transporter 2 inhibitors as an early, first-line therapy in patients with heart failure and reduced ejection fraction. Eur J Heart Fail. 2022 Mar;24(3):431-441. doi: 10.1002/ejhf.2397. Epub 2022 Jan 17.
Pagnesi M, Butler J, Metra M Ejection fraction in heart failure: just become Emperor’s new clothes? Eur J Heart Fail. 2022 Feb;24(2):351-352. doi: 10.1002/ejhf.2399. Epub 2022 Jan 10.
Khan SS, Ning H, Allen NB, Carnethon MR, Yancy CW, Shah SJ, Wilkins JT, Tian L, Lloyd-Jones DM Development and Validation of a Long-Term Incident Heart Failure Risk Model. Circ Res. 2022 Jan 21;130(2):200-209. doi: 10.1161/CIRCRESAHA.121.319595. Epub 2021 Dec 10.
Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, Bischoff JM, Bittl JA, Cohen MG, DiMaio JM, Don CW, Fremes SE, Gaudino MF, Goldberger ZD, Grant MC, Jaswal JB, Kurlansky PA, Mehran R, Metkus TS Jr, Nnacheta LC, Rao SV, Sellke FW, Sharma G, Yong CM, Zwischenberger BA 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022 Jan 18;145(3):e4-e17. doi: 10.1161/CIR.0000000000001039. Epub 2021 Dec 9.
Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, Bischoff JM, Bittl JA, Cohen MG, DiMaio JM, Don CW, Fremes SE, Gaudino MF, Goldberger ZD, Grant MC, Jaswal JB, Kurlansky PA, Mehran R, Metkus TS Jr, Nnacheta LC, Rao SV, Sellke FW, Sharma G, Yong CM, Zwischenberger BA 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022 Jan 18;145(3):e18-e114. doi: 10.1161/CIR.0000000000001038. Epub 2021 Dec 9.
Dangas G, Baber U, Sharma S, Giustino G, Sartori S, Nicolas J, Goel R, Mehta S, Cohen D, Angiolillo DJ, Zhang Z, Camaj A, Cao D, Briguori C, Dudek D, Escaned J, Huber K, Collier T, Kornowski R, Kunadian V, Moliterno DJ, Ohman EM, Weisz G, Gil R, Krucoff MW, Kaul U, Oldroyd KG, Sardella G, Shlofmitz R, Witzenbichler B, Kastrati A, Han YL, Steg PG, Pocock S, Gibson CM, Mehran R Safety and efficacy of ticagrelor monotherapy according to drug-eluting stent type: the TWILIGHT-STENT study. EuroIntervention. 2022 Mar 18;17(16):1330-1339. doi: 10.4244/EIJ-D-21-00721.
Luyckx VA, Rule AD, Tuttle KR, Delanaye P, Liapis H, Gandjour A, Romagnani P, Anders HJ Nephron overload as a therapeutic target to maximize kidney lifespan. Nat Rev Nephrol. 2022 Mar;18(3):171-183. doi: 10.1038/s41581-021-00510-7. Epub 2021 Dec 8.
Butler J, Packer M, Filippatos G, Ferreira JP, Zeller C, Schnee J, Brueckmann M, Pocock SJ, Zannad F, Anker SD Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction. Eur Heart J. 2022 Feb 3;43(5):416-426. doi: 10.1093/eurheartj/ehab798.
Butler CR, Appelbaum PS, Ascani H, Aulisio M, Campbell CE, de Boer IH, Dighe AL, Hall DE, Himmelfarb J, Knight R, Mehl K, Murugan R, Rosas SE, Sedor JR, O’Toole JF, Tuttle KR, Waikar SS, Freeman M, Kidney Precision Medicine Project A Participant-Centered Approach to Understanding Risks and Benefits of Participation in Research Informed by the Kidney Precision Medicine Project. Am J Kidney Dis. 2022 Jul;80(1):132-138. doi: 10.1053/j.ajkd.2021.10.006. Epub 2021 Dec 4.
Siostrzonek P, Brath H, Zweiker R, Drexel H, Hoelzl R, Hemetsberger M, Ray KK Lipid lowering therapy in primary and secondary prevention in Austria: are LDL-C goals achieved? : Results from the DA VINCI study. Wien Klin Wochenschr. 2022 Apr;134(7-8):294-301. doi: 10.1007/s00508-021-01978-w. Epub 2021 Dec 6.
Tromp J, Seekings PJ, Hung CL, Iversen MB, Frost MJ, Ouwerkerk W, Jiang Z, Eisenhaber F, Goh RSM, Zhao H, Huang W, Ling LH, Sim D, Cozzone P, Richards AM, Lee HK, Solomon SD, Lam CSP, Ezekowitz JA Automated interpretation of systolic and diastolic function on the echocardiogram: a multicohort study. Lancet Digit Health. 2022 Jan;4(1):e46-e54. doi: 10.1016/S2589-7500(21)00235-1. Epub 2021 Dec 1.
Bounameaux H, Haas S, Farjat AE, Ageno W, Weitz JI, Goldhaber SZ, Turpie AGG, Goto S, Angchaisuksiri P, Nielsen JD, Kayani G, Schellong S, Mantovani LG, Prandoni P, Kakkar AK Corrigendum to “Comparative effectiveness of oral anticoagulants in venous thromboembolism: GARFIELD-VTE” [Thromb. Res. 2020 Jul; 191:103-112]. Thromb Res. 2022 Aug;216:129. doi: 10.1016/j.thromres.2021.11.023. Epub 2021 Dec 2.
Catapano AL, Ray KK, Tokgozoglu L Prevention guidelines and EAS/ESC guidelines for the treatment of dyslipidaemias: A look to the future. Atherosclerosis. 2022 Jan;340:51-52. doi: 10.1016/j.atherosclerosis.2021.11.021. Epub 2021 Nov 26.
Mohamed MO, Van Spall HGC, Morillo C, Wilton SB, Kontopantelis E, Rashid M, Wu P, Patwala A, Mamas MA The Impact of Charlson Comorbidity Index on De Novo Cardiac Implantable Electronic Device Procedural Outcomes in the United States. Mayo Clin Proc. 2022 Jan;97(1):88-100. doi: 10.1016/j.mayocp.2021.06.029. Epub 2021 Dec 1.
Verma S, Dhingra NK, Butler J, Anker SD, Ferreira JP, Filippatos G, Januzzi JL, Lam CSP, Sattar N, Peil B, Nordaby M, Brueckmann M, Pocock SJ, Zannad F, Packer M, EMPEROR-Reduced trial committees and investigators Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial. Lancet Diabetes Endocrinol. 2022 Jan;10(1):35-45. doi: 10.1016/S2213-8587(21)00292-8. Epub 2021 Nov 30.
Patel KV, Segar MW, Lavie CJ, Kondamudi N, Neeland IJ, Almandoz JP, Martin CK, Carbone S, Butler J, Powell-Wiley TM, Pandey A Diabetes Status Modifies the Association Between Different Measures of Obesity and Heart Failure Risk Among Older Adults: A Pooled Analysis of Community-Based NHLBI Cohorts. Circulation. 2022 Jan 25;145(4):268-278. doi: 10.1161/CIRCULATIONAHA.121.055830. Epub 2021 Dec 3.
Rossing P, Inzucchi SE, Vart P, Jongs N, Docherty KF, Jhund PS, Kober L, Kosiborod MN, Martinez FA, Ponikowski P, Sabatine MS, Solomon SD, DeMets DL, Bengtsson O, Lindberg M, Langkilde AM, Sjostrand M, Stefansson BV, Karlsson C, Chertow GM, Hou FF, Correa-Rotter R, Toto RD, Wheeler DC, McMurray JJV, Heerspink HJL, DAPA-CKD and DAPA-HF Trial Committees and Investigators Dapagliflozin and new-onset type 2 diabetes in patients with chronic kidney disease or heart failure: pooled analysis of the DAPA-CKD and DAPA-HF trials. Lancet Diabetes Endocrinol. 2022 Jan;10(1):24-34. doi: 10.1016/S2213-8587(21)00295-3. Epub 2021 Nov 29.
Rashid HN, Michail M, Ramnarain J, Nasis A, Nicholls SJ, Cameron JD, Gooley RP The impact of hypo-attenuated leaflet thickening on haemodynamic valve deterioration following transcatheter aortic valve replacement. J Cardiovasc Comput Tomogr. 2022 Mar-Apr;16(2):168-173. doi: 10.1016/j.jcct.2021.11.013. Epub 2021 Nov 26.
Wheeler DC, Jongs N, Stefansson BV, Chertow GM, Greene T, Hou FF, Langkilde AM, McMurray JJV, Rossing P, Nowicki M, Wittmann I, Correa-Rotter R, Sjostrom CD, Toto RD, Heerspink HJL, DAPA-CKD Trial Committees and Investigators Safety and efficacy of dapagliflozin in patients with focal segmental glomerulosclerosis: a prespecified analysis of the dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial. Nephrol Dial Transplant. 2022 Aug 22;37(9):1647-1656. doi: 10.1093/ndt/gfab335.
Kelshiker MA, Seligman H, Howard JP, Rahman H, Foley M, Nowbar AN, Rajkumar CA, Shun-Shin MJ, Ahmad Y, Sen S, Al-Lamee R, Petraco R, Coronary Flow Outcomes Reviewing Committee Coronary flow reserve and cardiovascular outcomes: a systematic review and meta-analysis. Eur Heart J. 2022 Apr 19;43(16):1582-1593. doi: 10.1093/eurheartj/ehab775.
Strom JB, Zhao Y, Shen C, Wasfy JH, Xu J, Yucel E, Tanguturi V, Hyland PM, Markson LJ, Kazi DS, Cui J, Hung J, Yeh RW, Manning WJ Development and validation of an echocardiographic algorithm to predict long-term mitral and tricuspid regurgitation progression. Eur Heart J Cardiovasc Imaging. 2022 Nov 17;23(12):1606-1616. doi: 10.1093/ehjci/jeab254.
Doll JA, Nelson AJ, Kaltenbach LA, Wojdyla D, Waldo SW, Rao SV, Wang TY Percutaneous Coronary Intervention Operator Profiles and Associations With In-Hospital Mortality. Circ Cardiovasc Interv. 2022 Jan;15(1):e010909. doi: 10.1161/CIRCINTERVENTIONS.121.010909. Epub 2021 Dec 1.
You S, Masutani EM, Alley MT, Vasanawala SS, Taub PR, Liau J, Roberts AC, Hsiao A Deep Learning Automated Background Phase Error Correction for Abdominopelvic 4D Flow MRI. Radiology. 2022 Mar;302(3):584-592. doi: 10.1148/radiol.2021211270. Epub 2021 Nov 30.
Fridman S, Jimenez-Ruiz A, Vargas-Gonzalez JC, Sposato LA Differences between Atrial Fibrillation Detected before and after Stroke and TIA: A Systematic Review and Meta-Analysis. Cerebrovasc Dis. 2022;51(2):152-157. doi: 10.1159/000520101. Epub 2021 Nov 29.
Jaramillo-Morales J, Korucu B, Pike MM, Lipworth L, Stewart T, Headley SAE, Germain M, Begue G, Roshanravan B, Tuttle KR, Himmelfarb J, Robinson-Cohen C, Ikizler TA, Gamboa JL Effects of caloric restriction and aerobic exercise on circulating cell-free mitochondrial DNA in patients with moderate to severe chronic kidney disease. Am J Physiol Renal Physiol. 2022 Jan 1;322(1):F68-F75. doi: 10.1152/ajprenal.00270.2021. Epub 2021 Nov 29.
Vergaro G, Aimo A, Januzzi JL Jr, Richards AM, Lam CSP, Latini R, Staszewsky L, Anand IS, Ueland T, Rocca HB, Bayes-Genis A, Lupon J, de Boer RA, Yoshihisa A, Takeishi Y, Gustafsson I, Eggers KM, Huber K, Gamble GD, Leong KTG, Yeo PSD, Ong HY, Jaufeerally F, Ng TP, Troughton R, Doughty RN, Emdin M, Passino C Cardiac biomarkers retain prognostic significance in patients with heart failure and chronic obstructive pulmonary disease. J Cardiovasc Med (Hagerstown). 2022 Jan 1;23(1):28-36. doi: 10.2459/JCM.0000000000001281.
Ivey-Miranda JB, Wetterling F, Gaul R, Sheridan S, Asher JL, Rao VS, Maulion C, Mahoney D, Mebazaa A, Gray AP, Burkhoff D, Cowie MR, Cox ZL, Butler J, Fudim M, McDonald K, Damman K, Borlaug BA, Testani JM Changes in inferior vena cava area represent a more sensitive metric than changes in filling pressures during experimental manipulation of intravascular volume and tone. Eur J Heart Fail. 2022 Mar;24(3):455-462. doi: 10.1002/ejhf.2395. Epub 2022 Jan 11.
Levy JH, Faraoni D, Almond CS, Baumann-Kreuziger L, Bembea MM, Connors JM, Dalton HJ, Davies R, Dumont LJ, Griselli M, Karkouti K, Massicotte MP, Teruya J, Thiagarajan RR, Spinella PC, Steiner ME Consensus Statement: Hemostasis Trial Outcomes in Cardiac Surgery and Mechanical Support. Ann Thorac Surg. 2022 Mar;113(3):1026-1035. doi: 10.1016/j.athoracsur.2021.09.080. Epub 2021 Nov 24.
Hendren NS, Segar MW, Zhong L, Michelis KC, Drazner MH, Young JB, Tang WHW, Pandey A, Grodin JL Phenomapping a Novel Classification System for Patients With Destination Therapy Left Ventricular Assist Devices. Am J Cardiol. 2022 Feb 1;164:93-99. doi: 10.1016/j.amjcard.2021.10.028. Epub 2021 Nov 20.
Breathett KK, Xu H, Sweitzer NK, Calhoun E, Matsouaka RA, Yancy CW, Fonarow GC, DeVore AD, Bhatt DL, Peterson PN Is the affordable care act medicaid expansion associated with receipt of heart failure guideline-directed medical therapy by race and ethnicity? Am Heart J. 2022 Feb;244:135-148. doi: 10.1016/j.ahj.2021.11.011. Epub 2021 Nov 20.
Mujaj B, Zhang ZY, Yang WY, Thijs L, Wei FF, Verhamme P, Delles C, Butler J, Sever P, Latini R, Gf Cleland J, Zannad F, Staessen JA, Heart Omics in Ageing Investigators Aspirin use is associated with increased risk for incident heart failure: a patient-level pooled analysis. ESC Heart Fail. 2022 Feb;9(1):685-694. doi: 10.1002/ehf2.13688. Epub 2021 Nov 22.
Gutierrez JA, Christian RT, Aday AW, Gu L, Schulteis RD, Shihai L, Petrini M, Sun AY, Swaminathan RV, Katzenberger DR, Banerjee S, Rao SV Electronic alerts to initiate anticoagulation dialogue in patients with atrial fibrillation. Am Heart J. 2022 Mar;245:29-40. doi: 10.1016/j.ahj.2021.11.008. Epub 2021 Nov 19.
Xian Y, Xu H, Smith EE, Saver JL, Reeves MJ, Bhatt DL, Hernandez AF, Peterson ED, Schwamm LH, Fonarow GC Achieving More Rapid Door-to-Needle Times and Improved Outcomes in Acute Ischemic Stroke in a Nationwide Quality Improvement Intervention. Stroke. 2022 Apr;53(4):1328-1338. doi: 10.1161/STROKEAHA.121.035853. Epub 2021 Nov 22.
Gibson CM, Mehta S, Ceschim MRS, Frauenfelder A, Vieira D, Botelho R, Fernandez F, Villagran C, Niklitschek S, Matheus CI, Pinto G, Vallenilla I, Lopez C, Acosta MI, Munguia A, Fitzgerald C, Mazzini J, Pisana L, Quintero S Evolution of single-lead ECG for STEMI detection using a deep learning approach. Int J Cardiol. 2022 Jan 1;346:47-52. doi: 10.1016/j.ijcard.2021.11.039. Epub 2021 Nov 18.
Shlofmitz E, Mintz GS, Torguson R, Zhang C, Shea C, Shah P, Doros G, Ali ZA, Artis A, Singh V, Skinner W, Cate TT, Di Mario C, Garcia-Garcia HM, Waksman R Longitudinal Distribution of Lipid-Rich Plaque in Nonculprit Lesions: A Lipid Rich Plaque Study Subanalysis. JACC Cardiovasc Imaging. 2022 Jan;15(1):168-170. doi: 10.1016/j.jcmg.2021.07.019. Epub 2021 Nov 17.
Butler J, Anker SD, Siddiqi TJ, Coats AJS, Dorigotti F, Filippatos G, Friede T, Gohring UM, Kosiborod MN, Lund LH, Metra M, Moreno Quinn C, Pina IL, Pinto FJ, Rossignol P, Szecsody P, Van Der Meer P, Weir M, Pitt B Patiromer for the management of hyperkalaemia in patients receiving renin-angiotensin-aldosterone system inhibitors for heart failure: design and rationale of the DIAMOND trial. Eur J Heart Fail. 2022 Jan;24(1):230-238. doi: 10.1002/ejhf.2386. Epub 2021 Dec 9.
Pfeffer MA, Claggett B, Lewis EF, Granger CB, Kober L, Maggioni AP, Mann DL, McMurray JJV, Rouleau JL, Solomon SD, Steg PG, Berwanger O, Cikes M, De Pasquale CG, Fernandez A, Filippatos G, Jering K, Landmesser U, Menon V, Merkely B, Petrie MC, Petrov I, Schou M, Senni M, Sim D, van der Meer P, Lefkowitz M, Zhou Y, Wang Y, Braunwald E Impact of Sacubitril/Valsartan Versus Ramipril on Total Heart Failure Events in the PARADISE-MI Trial. Circulation. 2022 Jan 4;145(1):87-89. doi: 10.1161/CIRCULATIONAHA.121.057429. Epub 2021 Nov 19.
Greene SJ, Butler J, Hellkamp AS, Spertus JA, Vaduganathan M, Devore AD, Albert NM, Patterson JH, Thomas L, Williams FB, Hernandez AF, Fonarow GC Comparative Effectiveness of Dosing of Medical Therapy for Heart Failure: From the CHAMP-HF Registry. J Card Fail. 2022 Mar;28(3):370-384. doi: 10.1016/j.cardfail.2021.08.023. Epub 2021 Nov 15.
Akl E, Pinilla-Echeverri N, Garcia-Garcia HM, Mehta SR, Dan K, Kuku KO, Courtney BK, Sheth T First in-human evaluation of a novel intravascular ultrasound and optical coherence tomography system for intracoronary imaging. Catheter Cardiovasc Interv. 2022 Feb;99(3):686-698. doi: 10.1002/ccd.30001. Epub 2021 Nov 18.
DeVore AD, Hill CL, Thomas LE, Albert NM, Butler J, Patterson JH, Hernandez AF, Williams FB, Shen X, Spertus JA, Fonarow GC Identifying patients at increased risk for poor outcomes from heart failure with reduced ejection fraction: the PROMPT-HF risk model. ESC Heart Fail. 2022 Feb;9(1):178-185. doi: 10.1002/ehf2.13709. Epub 2021 Nov 17.
Reid CM, Patel A, Nicholls SJ, Briffa T Strengthening cardiovascular trials across Australia and New Zealand-the Alliance for Cardiovascular Trials (ANZACT) Network. Eur Heart J. 2022 May 1;43(17):1612-1614. doi: 10.1093/eurheartj/ehab753.
Vranckx P, Morrow D, Verbrugge F The European Heart Journal Acute Cardiovascular Care (EHJ ACVC) 2022: message from the editorial board. Eur Heart J Acute Cardiovasc Care. 2022 Jan 12;11(1):1. doi: 10.1093/ehjacc/zuab101.
Wei C, Wang J, Foster LD, Yeatts SD, Moy C, Mocco J, Selim M, i-DEF Investigators Effect of Deferoxamine on Outcome According to Baseline Hematoma Volume: A Post Hoc Analysis of the i-DEF Trial. Stroke. 2022 Apr;53(4):1149-1156. doi: 10.1161/STROKEAHA.121.035421. Epub 2021 Nov 18.
Marquina C, Lacaze P, Tiller J, Riaz M, Sturm AC, Nelson MR, Ference BA, Pang J, Watts GF, Nicholls SJ, Zoungas S, Liew D, McNeil J, Ademi Z Population genomic screening of young adults for familial hypercholesterolaemia: a cost-effectiveness analysis. Eur Heart J. 2022 Sep 7;43(34):3243-3254. doi: 10.1093/eurheartj/ehab770.
Katz IR, Rogers MP, Lew R, Thwin SS, Doros G, Ahearn E, Ostacher MJ, DeLisi LE, Smith EG, Ringer RJ, Ferguson R, Hoffman B, Kaufman JS, Paik JM, Conrad CH, Holmberg EF, Boney TY, Huang GD, Liang MH, Li+ plus Investigators Lithium Treatment in the Prevention of Repeat Suicide-Related Outcomes in Veterans With Major Depression or Bipolar Disorder: A Randomized Clinical Trial. JAMA Psychiatry. 2022 Jan 1;79(1):24-32. doi: 10.1001/jamapsychiatry.2021.3170.
Yancy CW, Kirtane A Race Bias in Transcatheter Aortic Valve Replacement: Are We Sure? JAMA Cardiol. 2022 Feb 1;7(2):158. doi: 10.1001/jamacardio.2021.4647.
Nathan AS, Yang L, Yang N, Eberly LA, Khatana SAM, Dayoub EJ, Vemulapalli S, Julien H, Cohen DJ, Nallamothu BK, Baron SJ, Desai ND, Szeto WY, Herrmann HC, Groeneveld PW, Giri J, Fanaroff AC Racial, Ethnic, and Socioeconomic Disparities in Access to Transcatheter Aortic Valve Replacement Within Major Metropolitan Areas. JAMA Cardiol. 2022 Feb 1;7(2):150-157. doi: 10.1001/jamacardio.2021.4641.
Vaduganathan M, Greene SJ, Zhang S, Solomon N, Chiswell K, Devore AD, Butler J, Heidenreich PA, Huang JC, Kittleson MM, Joynt Maddox KE, Mcdermott JJ, Owens AT, Peterson PN, Solomon SD, Vardeny O, Yancy CW, Fonarow GC Projected Clinical Benefits of Implementation of SGLT-2 Inhibitors Among Medicare Beneficiaries Hospitalized for Heart Failure. J Card Fail. 2022 Apr;28(4):554-563. doi: 10.1016/j.cardfail.2021.11.010. Epub 2021 Nov 14.
Mohebi R, Januzzi JL Cardiovascular benefit of SGLT2 inhibitors. Crit Rev Clin Lab Sci. 2022 May;59(3):142-155. doi: 10.1080/10408363.2021.1993439. Epub 2021 Nov 17.
Ezekowitz JA, Alemayehu W, Rathwell S, Grant AD, Fiuzat M, Whellan DJ, Ahmad T, Adams K, Pina IL, Cooper LS, Januzzi JL, Leifer ES, Mark D, O’Connor CM, Felker GM The influence of comorbidities on achieving an N-terminal pro-b-type natriuretic peptide target: a secondary analysis of the GUIDE-IT trial. ESC Heart Fail. 2022 Feb;9(1):77-86. doi: 10.1002/ehf2.13692. Epub 2021 Nov 16.
Butler J, Filippatos G, Jamal Siddiqi T, Brueckmann M, Bohm M, Chopra VK, Pedro Ferreira J, Januzzi JL, Kaul S, Pina IL, Ponikowski P, Shah SJ, Senni M, Vedin O, Verma S, Peil B, Pocock SJ, Zannad F, Packer M, Anker SD Empagliflozin, Health Status, and Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial. Circulation. 2022 Jan 18;145(3):184-193. doi: 10.1161/CIRCULATIONAHA.121.057812. Epub 2021 Nov 15.
Banovic M, Putnik S, Penicka M, Doros G, Deja MA, Kockova R, Kotrc M, Glaveckaite S, Gasparovic H, Pavlovic N, Velicki L, Salizzoni S, Wojakowski W, Van Camp G, Nikolic SD, Iung B, Bartunek J, AVATAR Trial Investigators* Aortic Valve Replacement Versus Conservative Treatment in Asymptomatic Severe Aortic Stenosis: The AVATAR Trial. Circulation. 2022 Mar;145(9):648-658. doi: 10.1161/CIRCULATIONAHA.121.057639. Epub 2021 Nov 13.
Greene SJ, Butler J, Fonarow GC In-hospital initiation of quadruple medical therapy for heart failure: making the post-discharge vulnerable phase far less vulnerable. Eur J Heart Fail. 2022 Jan;24(1):227-229. doi: 10.1002/ejhf.2382. Epub 2021 Nov 23.
Nikolakopoulos I, Vemmou E, Xenogiannis I, Karacsonyi J, Rao SV, Romagnoli E, Tsigkas G, Milkas A, Velagapudi P, Alaswad K, Rangan BV, Garcia S, Burke MN, Brilakis ES Radial versus femoral access in patients with coronary artery bypass surgery: Frequentist and Bayesian meta-analysis. Catheter Cardiovasc Interv. 2022 Feb;99(2):462-471. doi: 10.1002/ccd.30010. Epub 2021 Nov 14.
Lam CSP, Ramasundarahettige C, Branch KRH, Sattar N, Rosenstock J, Pratley R, Del Prato S, Lopes RD, Niemoeller E, Khurmi NS, Baek S, Gerstein HC Efpeglenatide and Clinical Outcomes With and Without Concomitant Sodium-Glucose Cotransporter-2 Inhibition Use in Type 2 Diabetes: Exploratory Analysis of the AMPLITUDE-O Trial. Circulation. 2022 Feb 22;145(8):565-574. doi: 10.1161/CIRCULATIONAHA.121.057934. Epub 2021 Nov 14.
Lala A, Tayal U, Hamo CE, Youmans Q, Al-Khatib SM, Bozkurt B, Davis MB, Januzzi J, Mentz R, Sauer A, Walsh MN, Yancy C, Gulati M Sex Differences in Heart Failure. J Card Fail. 2022 Mar;28(3):477-498. doi: 10.1016/j.cardfail.2021.10.006. Epub 2021 Nov 10.
Haimovich JS, Cui J, Yeh RW, Ferris TG, Hsu J, Wasfy JH Expansion of Insurance Under the Affordable Care Act and Invasive Management of Acute Myocardial Infarction. Cardiovasc Revasc Med. 2022 Jun;39:90-96. doi: 10.1016/j.carrev.2021.10.003. Epub 2021 Oct 9.
Krzemien P, Kasperczyk S, Banach M, Kasperczyk A, Dobrakowski M, Tomasik T, Windak A, Mastej M, Catapano A, Ray KK, Mikhailidis DP, Toth PP, Howard G, Lip GYH, Tomaszewski M, Charchar FJ, Sattar N, Williams B, MacDonald TM, Penson PE, Jozwiak JJ, LIPIDOGRAM2015 Investigators Analysis of the impact of sex and age on the variation in the prevalence of antinuclear autoantibodies in Polish population: a nationwide observational, cross-sectional study. Rheumatol Int. 2022 Feb;42(2):261-271. doi: 10.1007/s00296-021-05033-9. Epub 2021 Nov 10.
Rhee CM, Kalantar-Zadeh K, Tuttle KR Novel approaches to hypoglycemia and burnt-out diabetes in chronic kidney disease. Curr Opin Nephrol Hypertens. 2022 Jan 1;31(1):72-81. doi: 10.1097/MNH.0000000000000756.
Durstenfeld MS, Sun K, Ma Y, Rodriguez F, Secemsky EA, Parikh RV, Hsue PY Association of HIV infection with outcomes among adults hospitalized with COVID-19. AIDS. 2022 Mar 1;36(3):391-398. doi: 10.1097/QAD.0000000000003129.
Galea R, De Marco F, Meneveau N, Aminian A, Anselme F, Grani C, Huber AT, Teiger E, Iriart X, Babongo Bosombo F, Heg D, Franzone A, Vranckx P, Fischer U, Pedrazzini G, Bedogni F, Raber L, Valgimigli M Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: Primary Results of the SWISS-APERO Randomized Clinical Trial. Circulation. 2022 Mar 8;145(10):724-738. doi: 10.1161/CIRCULATIONAHA.121.057859. Epub 2021 Nov 6.
Mentias A, Desai MY, Vaughan-Sarrazin MS, Rao S, Morris AA, Hall JL, Menon V, Hockenberry J, Sims M, Fonarow GC, Girotra S, Pandey A Community-Level Economic Distress, Race, and Risk of Adverse Outcomes After Heart Failure Hospitalization Among Medicare Beneficiaries. Circulation. 2022 Jan 11;145(2):110-121. doi: 10.1161/CIRCULATIONAHA.121.057756. Epub 2021 Nov 8.
Butala NM, Faridi KF, Tamez H, Strom JB, Song Y, Shen C, Secemsky EA, Mauri L, Kereiakes DJ, Curtis JP, Gibson CM, Yeh RW Estimation of DAPT Study Treatment Effects in Contemporary Clinical Practice: Findings From the EXTEND-DAPT Study. Circulation. 2022 Jan 11;145(2):97-106. doi: 10.1161/CIRCULATIONAHA.121.056878. Epub 2021 Nov 8.
Sofi F, Dinu M, Reboldi G, Stracci F, Pedretti RFE, Valente S, Gensini G, Gibson CM, Ambrosio G Worldwide differences of hospitalization for ST-segment elevation myocardial infarction during COVID-19: A systematic review and meta-analysis. Int J Cardiol. 2022 Jan 15;347:89-96. doi: 10.1016/j.ijcard.2021.10.156. Epub 2021 Nov 2.
Gibson CM, Mack MJ, Lee VT, Schneider DJ, Sellke FW, Ohman EM, Thourani VH, Doros G, Kroger H, Cutlip DE, Deliargyris EN Rationale and design of the safe and timely antithrombotic removal – ticagrelor (STAR-T) trial: A prospective, multi-center, double-blind, randomized controlled trial evaluating reductions in postoperative bleeding with intraoperative removal of ticagrelor by the drugsorb-ATR device in patients undergoing cardiothoracic surgery within 48 hours from last ticagrelor dose. Am Heart J. 2022 Mar;245:19-28. doi: 10.1016/j.ahj.2021.10.188. Epub 2021 Nov 1.
Xenogiannis I, Rangan BV, Uyeda L, Banerjee S, Edson R, Bhatt DL, Goldman S, Holmes DR Jr, Rao SV, Shunk K, Mavromatis K, Ramanathan K, Bavry AA, McFalls EO, Garcia S, Thai H, Uretsky BF, Latif F, Armstrong E, Ortiz J, Jneid H, Liu J, Aggrawal K, Conner TA, Wagner T, Karacsonyi J, Ventura B, Alsleben A, Lu Y, Shih MC, Brilakis ES In-Stent Restenosis in Saphenous Vein Grafts (from the DIVA Trial). Am J Cardiol. 2022 Jan 1;162:24-30. doi: 10.1016/j.amjcard.2021.09.024. Epub 2021 Nov 1.
Segar MW, Khan MS, Patel KV, Vaduganathan M, Kannan V, Willett D, Peterson E, Tang WHW, Butler J, Everett BM, Fonarow GC, Wang TJ, McGuire DK, Pandey A Incorporation of natriuretic peptides with clinical risk scores to predict heart failure among individuals with dysglycaemia. Eur J Heart Fail. 2022 Jan;24(1):169-180. doi: 10.1002/ejhf.2375. Epub 2021 Nov 23.
Anand S, Chertow GM, Beddhu S Obesity and Incident Kidney Disease: Busting the Myth of Metabolically Healthy Obesity. Am J Kidney Dis. 2022 Jan;79(1):7-8. doi: 10.1053/j.ajkd.2021.08.008. Epub 2021 Oct 30.
Sharma A, Zheng Y, Ezekowitz JA, Westerhout CM, Udell JA, Goodman SG, Armstrong PW, Buse JB, Green JB, Josse RG, Kaufman KD, McGuire DK, Ambrosio G, Chuang LM, Lopes RD, Peterson ED, Holman RR Cluster Analysis of Cardiovascular Phenotypes in Patients With Type 2 Diabetes and Established Atherosclerotic Cardiovascular Disease: A Potential Approach to Precision Medicine. Diabetes Care. 2022 Jan 1;45(1):204-212. doi: 10.2337/dc20-2806.
Katsanos AH, Selim MH, Shoamanesh A Authors’ reply to “Statin treatment and cerebral microbleeds: A risk assessment”. J Neurol Sci. 2022 Jan 15;432:120037. doi: 10.1016/j.jns.2021.120037. Epub 2021 Oct 21.
Cohen O, Ageno W, Farjat AE, Turpie AGG, Weitz JI, Haas S, Goto S, Goldhaber SZ, Angchaisuksiri P, Gibbs H, MacCallum P, Kayani G, Schellong S, Bounameaux H, Mantovani LG, Prandoni P, Kakkar AK, GARFIELD-VTE investigators Management strategies and clinical outcomes in patients with inferior vena cava thrombosis: Data from GARFIELD-VTE. J Thromb Haemost. 2022 Feb;20(2):366-374. doi: 10.1111/jth.15574. Epub 2021 Nov 8.
Jowell AR, Sarma AA, Gulati M, Michos ED, Vaught AJ, Natarajan P, Powe CE, Honigberg MC Interventions to Mitigate Risk of Cardiovascular Disease After Adverse Pregnancy Outcomes: A Review. JAMA Cardiol. 2022 Mar 1;7(3):346-355. doi: 10.1001/jamacardio.2021.4391.
Beyer SE, Shanafelt C, Pinto DS, Weinstein JL, Giri J, Sista AK, Yeh RW, Secemsky EA, Carroll BJ National trends in utilization of thrombolytic therapy for acute pulmonary embolism. Vasc Med. 2022 Feb;27(1):75-76. doi: 10.1177/1358863X211048544. Epub 2021 Oct 26.
Tamura N, Shimizu K, Shiozaki S, Sugiyama K, Nakayama M, Goto S, Takagi S, Goto S Important Regulatory Roles of Erythrocytes in Platelet Adhesion to the von Willebrand Factor on the Wall under Blood Flow Conditions. Thromb Haemost. 2022 Jun;122(6):974-983. doi: 10.1055/a-1677-9499. Epub 2021 Dec 29.
Song S, Thomas IC, Ganesan C, Velaer KN, Chertow GM, Pao AC, Leppert JT Twenty-four-hour Urine Testing and Urinary Stone Disease Recurrence in Veterans. Urology. 2022 Jan;159:33-40. doi: 10.1016/j.urology.2021.10.005. Epub 2021 Oct 22.
Santema BT, Arita VA, Sama IE, Kloosterman M, van den Berg MP, Nienhuis HLA, Van Gelder IC, van der Meer P, Zannad F, Metra M, Ter Maaten JM, Cleland JG, Ng LL, Anker SD, Lang CC, Samani NJ, Dickstein K, Filippatos G, van Veldhuisen DJ, Lam CSP, Rienstra M, Voors AA Pathophysiological pathways in patients with heart failure and atrial fibrillation. Cardiovasc Res. 2022 Aug 24;118(11):2478-2487. doi: 10.1093/cvr/cvab331.
Assimon MM, Pun PH, Wang LC, Al-Khatib SM, Brookhart MA, Weber DJ, Winkelmayer WC, Flythe JE Analysis of Respiratory Fluoroquinolones and the Risk of Sudden Cardiac Death Among Patients Receiving Hemodialysis. JAMA Cardiol. 2022 Jan 1;7(1):75-83. doi: 10.1001/jamacardio.2021.4234.
Chung M, Faridi KF, Kazi DS, Almarzooq ZI, Song Y, Baron SJ, Yeh RW Days at Home After Transcatheter vs Surgical Aortic Valve Replacement in Intermediate-Risk Patients. JAMA Cardiol. 2022 Jan 1;7(1):110-112. doi: 10.1001/jamacardio.2021.4036.
Mihailidou AS, Gulati M Impact of hypertensive disorders of pregnancy: lessons from CONCEPTION. Eur Heart J. 2022 Sep 14;43(35):3362-3364. doi: 10.1093/eurheartj/ehab666.
Thorsness R, Raines NH, White EM, Santostefano CM, Parikh SM, Riester MR, Feifer RA, Mor V, Zullo AR Association of Kidney Function With 30-Day Mortality Following SARS-CoV-2 Infection in Nursing Home Residents: A Retrospective Cohort Study. Am J Kidney Dis. 2022 Feb;79(2):305-307. doi: 10.1053/j.ajkd.2021.09.009. Epub 2021 Oct 14.
Garcia P, Anand S, Han J, Montez-Rath ME, Sun S, Shang T, Parsonnet J, Chertow GM, Schiller B, Abra G COVID-19 Vaccine Type and Humoral Immune Response in Patients Receiving Dialysis. J Am Soc Nephrol. 2022 Jan;33(1):33-37. doi: 10.1681/ASN.2021070936. Epub 2021 Oct 13.
Yancy CW, Hernandez AF, Fonarow GC Identifying Treatments for Stage C2 Heart Failure. JAMA Cardiol. 2022 Jan 1;7(1):34-35. doi: 10.1001/jamacardio.2021.4024.
Ray KK, Reeskamp LF, Laufs U, Banach M, Mach F, Tokgozoglu LS, Connolly DL, Gerrits AJ, Stroes ESG, Masana L, Kastelein JJP Combination lipid-lowering therapy as first-line strategy in very high-risk patients. Eur Heart J. 2022 Feb 22;43(8):830-833. doi: 10.1093/eurheartj/ehab718.
Kozlitina J, Garg S, Drazner MH, Matulevicius SA, Ayers C, Overton J, Reid J, Baras A, Rao K, Pandey A, Berry J, de Lemos JA, Grodin JL Clinical Implications of the Amyloidogenic V122I Transthyretin Variant in the General Population. J Card Fail. 2022 Mar;28(3):403-414. doi: 10.1016/j.cardfail.2021.09.015. Epub 2021 Oct 9.
Abboud A, Kui N, Gaggin HK, Ibrahim NE, Chen-Tournoux AA, Christenson RH, Hollander JE, Levy PD, Nagurney JT, Nowak RM, Pang PS, Peacock WF, Walters EL, Januzzi JL Multiple Cardiac Biomarker Testing Among Patients With Acute Dyspnea From the ICON-RELOADED Study. J Card Fail. 2022 Feb;28(2):226-233. doi: 10.1016/j.cardfail.2021.08.025. Epub 2021 Oct 9.
Millenaar D, Dillmann M, Fehlmann T, Flohr A, Mehran R, Al-Lamee R, Lauder L, Ukena C, Bohm M, Keller A, Mahfoud F Sex Differences in Cardiovascular Research: A Scientometric Analysis. J Am Heart Assoc. 2022 Mar 15;11(6):e021522. doi: 10.1161/JAHA.121.021522. Epub 2021 Oct 11.
Kochar A, Doll JA, Liang L, Curran J, Peterson ED Temporal Trends in Post Myocardial Infarction Heart Failure and Outcomes Among Older Adults. J Card Fail. 2022 Apr;28(4):531-539. doi: 10.1016/j.cardfail.2021.09.001. Epub 2021 Oct 5.
Sattar N, Anker SD, Butler J, Verma S Obesity, heart failure, and SGLT2 inhibition: DECLARE-TIMI 58 provides insights. Eur Heart J. 2022 Aug 14;43(31):2968-2970. doi: 10.1093/eurheartj/ehab709.
Pichert MD, Smolderen KG, Castro-Dominguez Y, Jelani QU, Nagpal S, Provance JB, Huang J, Malik AO, Secemsky EA, Derbas LA, Mena-Hurtado CI Trends in drug-coated device use for peripheral artery disease: Insights from the Vascular Quality Initiative (VQI). Vasc Med. 2022 Feb;27(1):73-74. doi: 10.1177/1358863X211043567. Epub 2021 Oct 5.
Belcher JM, Parada XV, Simonetto DA, Juncos LA, Karakala N, Wadei HM, Sharma P, Regner KR, Nadim MK, Garcia-Tsao G, Velez JCQ, Parikh SM, Chung RT, Allegretti AS, HRS-HARMONY Study Investigators Terlipressin and the Treatment of Hepatorenal Syndrome: How the CONFIRM Trial Moves the Story Forward. Am J Kidney Dis. 2022 May;79(5):737-745. doi: 10.1053/j.ajkd.2021.08.016. Epub 2021 Oct 2.
Goto S, McGuire DK, Goto S The Future Role of High-Performance Computing in Cardiovascular Medicine and Science -Impact of Multi-Dimensional Data Analysis. J Atheroscler Thromb. 2022 May 1;29(5):559-562. doi: 10.5551/jat.RV17062. Epub 2021 Oct 2.
Diamond JE, McIlvaine S, Korjian S, Cruden P, Dechen T, Piatkowski G, Kazi DS, Gavin M Patterns of Recovery in Cardiovascular Care after the COVID-19 Pandemic Surge. Am J Med Sci. 2022 Apr;363(4):305-310. doi: 10.1016/j.amjms.2021.09.005. Epub 2021 Sep 28.
Cainzos-Achirica M, Anugula D, Mszar R, Grandhi G, Patel KV, Bittencourt MS, Blankstein R, Blaha MJ, Blumenthal RS, Ray KK, Bhatt DL, Nasir K Rationale and pathways forward in the implementation of coronary artery calcium-based enrichment of randomized trials. Am Heart J. 2022 Jan;243:54-65. doi: 10.1016/j.ahj.2021.09.006. Epub 2021 Sep 26.
Ross C, Kumar R, Pelland-Marcotte MC, Mehta S, Kleinman ME, Thiagarajan RR, Ghbeis MB, VanderPluym CJ, Friedman KG, Porras D, Fynn-Thompson F, Goldhaber SZ, Brandao LR Acute Management of High-Risk and Intermediate-Risk Pulmonary Embolism in Children: A Review. Chest. 2022 Mar;161(3):791-802. doi: 10.1016/j.chest.2021.09.019. Epub 2021 Sep 26.
Salah HM, Minhas AMK, Khan MS, Khan SU, Ambrosy AP, Blumer V, Vaduganathan M, Greene SJ, Pandey A, Fudim M Trends in hospitalizations for heart failure, acute myocardial infarction, and stroke in the United States from 2004 to 2018. Am Heart J. 2022 Jan;243:103-109. doi: 10.1016/j.ahj.2021.09.009. Epub 2021 Sep 25.
Bainey KR, Fleg JL, Hochman JS, Kunichoff DF, Anthopolos R, Chernyavskiy AM, Demkow M, Lopez-Quijano JM, Escobedo J, Poh KK, Ramos RB, Lima EG, Schuchlenz H, Ali ZA, Stone GW, Maron DJ, O’Brien SM, Spertus JA, Bangalore S Predictors of outcome in the ISCHEMIA-CKD trial: Anatomy versus ischemia. Am Heart J. 2022 Jan;243:187-200. doi: 10.1016/j.ahj.2021.09.008. Epub 2021 Sep 25.
Velaer K, Thomas IC, Yang J, Kapphahn K, Metzner TJ, Golla A, Hoerner CR, Fan AC, Master V, Chertow GM, Brooks JD, Patel CJ, Desai M, Leppert JT Clinical laboratory tests associated with survival in patients with metastatic renal cell carcinoma: A Laboratory Wide Association Study (LWAS). Urol Oncol. 2022 Jan;40(1):12.e23-12.e30. doi: 10.1016/j.urolonc.2021.08.011. Epub 2021 Sep 24.
Redfors B, Simonato M, Chen S, Vincent F, Zhang Z, Thiele H, Eitel I, Patel MR, Ohman EM, Maehara A, Ben-Yehuda O, Stone GW Ambient temperature and infarct size, microvascular obstruction, left ventricular function and clinical outcomes after ST-segment elevation myocardial infarction. Coron Artery Dis. 2022 Mar 1;33(2):81-90. doi: 10.1097/MCA.0000000000001099.
Demola P, Di Mario C, Torguson R, Ten Cate T, Bambagioni G, Ali Z, Skinner W, Artis A, Zhang C, Garcia-Garcia HM, Doros G, Mintz GS, Waksman R Greater plaque burden and cholesterol content may explain an increased incidence of non-culprit events in diabetic patients: a Lipid-Rich Plaque substudy. Eur Heart J Cardiovasc Imaging. 2022 Jul 21;23(8):1098-1107. doi: 10.1093/ehjci/jeab161.
Oshunbade AA, Lirette ST, Windham BG, Shafi T, Hamid A, Gbadamosi SO, Tin A, Yimer WK, Tibuakuu M, Clark D 3rd, Kamimura D, Lutz EA, Mentz RJ, Fox ER, Butler J, Butler KR, Garovic VD, Turner ST, Mosley TH Jr, Hall ME Hypertensive Diseases in Pregnancy and Kidney Function Later in Life: The Genetic Epidemiology Network of Arteriopathy (GENOA) Study. Mayo Clin Proc. 2022 Jan;97(1):78-87. doi: 10.1016/j.mayocp.2021.07.018. Epub 2021 Sep 24.
Alfonso F, de la Torre Hernandez JM, Ibanez B, Sabate M, Pan M, Gulati R, Saw J, Angiolillo DJ, Adlam D, Sanchez-Madrid F Rationale and design of the BA-SCAD (Beta-blockers and Antiplatelet agents in patients with Spontaneous Coronary Artery Dissection) randomized clinical trial. Rev Esp Cardiol (Engl Ed). 2022 Jun;75(6):515-522. doi: 10.1016/j.rec.2021.08.003. Epub 2021 Sep 22.
Heerspink HJL, Cherney D, Postmus D, Stefansson BV, Chertow GM, Dwyer JP, Greene T, Kosiborod M, Langkilde AM, McMurray JJV, Correa-Rotter R, Rossing P, Sjostrom CD, Toto RD, Wheeler DC, DAPA-CKD Trial Committees and Investigators A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function. Kidney Int. 2022 Jan;101(1):174-184. doi: 10.1016/j.kint.2021.09.005. Epub 2021 Sep 22.
Seltzer J, Senatore F, Faulkner K, Stein KM, Browning LS, Voloshko P, Papadopoulos EJ The COVID-19 pandemic and cardiovascular issues in clinical trials: Practical and regulatory issues in remote monitoring of cardiac safety. Am Heart J. 2022 Jan;243:122-126. doi: 10.1016/j.ahj.2021.09.005. Epub 2021 Sep 20.
Manoogian ENC, Chow LS, Taub PR, Laferrere B, Panda S Time-restricted Eating for the Prevention and Management of Metabolic Diseases. Endocr Rev. 2022 Mar 9;43(2):405-436. doi: 10.1210/endrev/bnab027.
Amin AP, Frogge N, Kulkarni H, Ridolfi G, Ewald G, Miller R, Hall B, Rogers S, Gluckman T, Curtis J, Masoudi FA, Rao SV The bleeding risk treatment paradox at the physician and hospital level: Implications for reducing bleeding in patients undergoing percutaneous coronary intervention. Am Heart J. 2022 Jan;243:221-231. doi: 10.1016/j.ahj.2021.08.021. Epub 2021 Sep 20.
Agnelli G, Munoz A, Franco L, Mahe I, Brenner B, Connors JM, Gussoni G, Hamulyak EN, Lambert C, Suero MR, Bauersachs R, Torbicki A, Becattini C Apixaban and Dalteparin for the Treatment of Venous Thromboembolism in Patients with Different Sites of Cancer. Thromb Haemost. 2022 May;122(5):796-807. doi: 10.1055/s-0041-1735194. Epub 2021 Sep 16.
Bikdeli B, Hogan H, Morrison RB, Fanikos J, Campia U, Barns BM, Pfeferman MB, Snyder JE, Khairani CD, Goldhaber SZ, Piazza G Extended-Duration Low-Intensity Apixaban to Prevent Recurrence in Patients with Provoked Venous Thromboembolism and Enduring Risk Factors: Rationale and Design of the HI-PRO Trial. Thromb Haemost. 2022 Jun;122(6):1061-1070. doi: 10.1055/a-1646-2244. Epub 2021 Oct 31.
Butala NM, Song Y, Shen C, Cohen DJ, Yeh RW Effect of intensive versus limited monitoring on clinical trial conduct and outcomes: A randomized trial. Am Heart J. 2022 Jan;243:77-86. doi: 10.1016/j.ahj.2021.09.002. Epub 2021 Sep 14.
Ortega-Paz L, Galli M, Capodanno D, Franchi F, Rollini F, Bikdeli B, Mehran R, Montalescot G, Gibson CM, Lopes RD, Andreotti F, Angiolillo DJ Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials. Eur Heart J Cardiovasc Pharmacother. 2022 Sep 29;8(7):677-686. doi: 10.1093/ehjcvp/pvab070.
Lopez-Sendon JL, Cyr DD, Mark DB, Bangalore S, Huang Z, White HD, Alexander KP, Li J, Nair RG, Demkow M, Peteiro J, Wander GS, Demchenko EA, Gamma R, Gadkari M, Poh KK, Nageh T, Stone PH, Keltai M, Sidhu M, Newman JD, Boden WE, Reynolds HR, Chaitman BR, Hochman JS, Maron DJ, O’Brien SM Effects of initial invasive vs. initial conservative treatment strategies on recurrent and total cardiovascular events in the ISCHEMIA trial. Eur Heart J. 2022 Jan 13;43(2):148-149. doi: 10.1093/eurheartj/ehab509.
Aggarwal M, Freeman AM, Ros E, Allen K, Sikand G, Aspry K, Kris-Etherton P, Devries S, Reddy K, Singh T, Litwin SE, O’Keefe J, Miller M, Andrus B, Blankstein R, Batiste C, Belardo D, Wenger C, Batts T, Barnard ND, White BA, Ornish D, Williams KA, Ostfeld RJ Trending Nutrition Controversies #3: Top Controversies in 2021. Am J Med. 2022 Feb;135(2):146-156. doi: 10.1016/j.amjmed.2021.07.046. Epub 2021 Sep 9.
Hermes Z, Joynt Maddox KE, Yeh RW, Zhao Y, Shen C, Wadhera RK Neighborhood Socioeconomic Disadvantage and Mortality Among Medicare Beneficiaries Hospitalized for Acute Myocardial Infarction, Heart Failure, and Pneumonia. J Gen Intern Med. 2022 Jun;37(8):1894-1901. doi: 10.1007/s11606-021-07090-z. Epub 2021 Sep 10.
Rajkumar CA, Ganesananthan S, Ahmad Y, Seligman H, Thornton GD, Foley M, Nowbar AN, Howard JP, Francis DP, Keeble TR, Grunwald IQ, Al-Lamee RK, Malik I, Shun-Shin MJ Mechanical thrombectomy with retrievable stents and aspiration catheters for acute ischaemic stroke: a meta-analysis of randomised controlled trials. EuroIntervention. 2022 Apr 1;17(17):e1425-e1434. doi: 10.4244/EIJ-D-21-00343.
Galindo RJ, Pasquel FJ, Vellanki P, Alicic R, Lam DW, Fayfman M, Migdal AL, Davis GM, Cardona S, Urrutia MA, Perez-Guzman C, Zamudio-Coronado KW, Peng L, Tuttle KR, Umpierrez GE Degludec hospital trial: A randomized controlled trial comparing insulin degludec U100 and glargine U100 for the inpatient management of patients with type 2 diabetes. Diabetes Obes Metab. 2022 Jan;24(1):42-49. doi: 10.1111/dom.14544. Epub 2021 Sep 24.
Sarafidis P, Martens S, Saratzis A, Kadian-Dodov D, Murray PT, Shanahan CM, Hamdan AD, Engelman DT, Teichgraber U, Herzog CA, Cheung M, Jadoul M, Winkelmayer WC, Reinecke H, Johansen K, for Conference Participants Diseases of the Aorta and Kidney Disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Cardiovasc Res. 2022 Sep 20;118(12):2582-2595. doi: 10.1093/cvr/cvab287.
Magavern EF, Kaski JC, Turner RM, Drexel H, Janmohamed A, Scourfield A, Burrage D, Floyd CN, Adeyeye E, Tamargo J, Lewis BS, Kjeldsen KP, Niessner A, Wassmann S, Sulzgruber P, Borry P, Agewall S, Semb AG, Savarese G, Pirmohamed M, Caulfield MJ Challenges in cardiovascular pharmacogenomics implementation: a viewpoint from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy. Eur Heart J Cardiovasc Pharmacother. 2022 Jan 5;8(1):100-103. doi: 10.1093/ehjcvp/pvab063.
Maffeis C, Inciardi RM, Khan MS, Tafciu E, Bergamini C, Benfari G, Setti M, Ribichini FL, Cicoira M, Butler J, Rossi A Determinants of exercise intolerance symptoms considered non-specific for heart failure in patients with stage A and B: role of the left atrium in the transition phase to overt heart failure. Int J Cardiovasc Imaging. 2022 Jan;38(1):103-112. doi: 10.1007/s10554-021-02375-0. Epub 2021 Aug 30.
Tavenier AH, Mehran R, Chiarito M, Cao D, Pivato CA, Nicolas J, Beerkens F, Nardin M, Sartori S, Baber U, Angiolillo DJ, Capodanno D, Valgimigli M, Hermanides RS, van ‘t Hof AWJ, Ten Berg JM, Chang K, Kini AS, Sharma SK, Dangas G Guided and unguided de-escalation from potent P2Y12 inhibitors among patients with acute coronary syndrome: a meta-analysis. Eur Heart J Cardiovasc Pharmacother. 2022 Aug 11;8(5):492-502. doi: 10.1093/ehjcvp/pvab068.
Glikson M, Nielsen JC, Kronborg MB, Michowitz Y, Auricchio A, Barbash IM, Barrabes JA, Boriani G, Braunschweig F, Brignole M, Burri H, Coats AJS, Deharo JC, Delgado V, Diller GP, Israel CW, Keren A, Knops RE, Kotecha D, Leclercq C, Merkely B, Starck C, Thylen I, Tolosana JM, Leyva F, Linde C, Abdelhamid M, Aboyans V, Arbelo E, Asteggiano R, Baron-Esquivias G, Bauersachs J, Biffi M, Birgersdotter-Green U, Bongiorni MG, Borger MA, Celutkiene J, Cikes M, Daubert JC, Drossart I, Ellenbogen K, Elliott PM, Fabritz L, Falk V, Fauchier L, Fernandez-Aviles F, Foldager D, Gadler F, De Vinuesa PGG, Gorenek B, Guerra JM, Hermann Haugaa K, Hendriks J, Kahan T, Katus HA, Konradi A, Koskinas KC, Law H, Lewis BS, Linker NJ, Lochen ML, Lumens J, Mascherbauer J, Mullens W, Nagy KV, Prescott E, Raatikainen P, Rakisheva A, Reichlin T, Ricci RP, Shlyakhto E, Sitges M, Sousa-Uva M, Sutton R, Suwalski P, Svendsen JH, Touyz RM, Van Gelder IC, Vernooy K, Waltenberger J, Whinnett Z, Witte KK 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Europace. 2022 Jan 4;24(1):71-164. doi: 10.1093/europace/euab232.
Goldhaber SZ, Ageno W, Casella IB, Chee KH, Schellong S, Singer DE, Voccia I, Tang W, Schulman S Safety and effectiveness of dabigatran in routine clinical practice: the RE-COVERY DVT/PE study. J Thromb Thrombolysis. 2022 Feb;53(2):399-409. doi: 10.1007/s11239-021-02463-x. Epub 2021 Aug 28.
Montarello NJ, Singh K, Sinhal A, Wong DTL, Alcock R, Rajendran S, Dautov R, Barlis P, Patel S, Nidorf SM, Thompson PL, Salagaras T, Butters J, Nerlekar N, Di Giovanni G, Ottaway JL, Nicholls SJ, Psaltis PJ Assessing the Impact of Colchicine on Coronary Plaque Phenotype After Myocardial Infarction with Optical Coherence Tomography: Rationale and Design of the COCOMO-ACS Study. Cardiovasc Drugs Ther. 2022 Dec;36(6):1175-1186. doi: 10.1007/s10557-021-07240-9. Epub 2021 Aug 25.
Vaduganathan M, Fonarow GC, Greene SJ, Devore AD, Albert NM, Duffy CI, Hill CL, Patterson JH, Spertus JA, Thomas LE, Williams FB, Hernandez AF, Butler J Treatment Persistence of Renin-Angiotensin-Aldosterone-System Inhibitors Over Time in Heart Failure with Reduced Ejection Fraction. J Card Fail. 2022 Feb;28(2):191-201. doi: 10.1016/j.cardfail.2021.08.008. Epub 2021 Aug 21.
Zhu JW, Le N, Wei S, Zuhlke L, Lopes RD, Zannad F, Van Spall HGC Global representation of heart failure clinical trial leaders, collaborators, and enrolled participants: a bibliometric review 2000-20. Eur Heart J Qual Care Clin Outcomes. 2022 Sep 5;8(6):659-669. doi: 10.1093/ehjqcco/qcab058.
Rocha J, Castillo-Lavergne CM, Byrd MJ, Carnethon MR, Miller R, Lin M, Marsh EE, Jackson JK, Yancy CW Reimagining educational equity through strategic alliance partnerships in response to the USA STEM-M diversity gap. Health Promot Int. 2022 Apr 29;37(2):daab094. doi: 10.1093/heapro/daab094.
Oyama K, Raz I, Cahn A, Kuder J, Murphy SA, Bhatt DL, Leiter LA, McGuire DK, Wilding JPH, Park KS, Goudev A, Diaz R, Spinar J, Gause-Nilsson IAM, Mosenzon O, Sabatine MS, Wiviott SD Obesity and effects of dapagliflozin on cardiovascular and renal outcomes in patients with type 2 diabetes mellitus in the DECLARE-TIMI 58 trial. Eur Heart J. 2022 Aug 14;43(31):2958-2967. doi: 10.1093/eurheartj/ehab530.
Capodanno D, Bhatt DL, Gibson CM, James S, Kimura T, Mehran R, Rao SV, Steg PG, Urban P, Valgimigli M, Windecker S, Angiolillo DJ Bleeding avoidance strategies in percutaneous coronary intervention. Nat Rev Cardiol. 2022 Feb;19(2):117-132. doi: 10.1038/s41569-021-00598-1. Epub 2021 Aug 23.
Nowbar AN, Francis DP, Al-Lamee RK Quality of Life Assessment in Trials of Revascularization for Chronic Stable Angina: Insights from ORBITA and the Implications of Blinding. Cardiovasc Drugs Ther. 2022 Oct;36(5):1011-1018. doi: 10.1007/s10557-021-07198-8. Epub 2021 Aug 21.
Bainey KR, Zheng Y, Coulden R, Sonnex E, Thompson R, Mei J, Bastiany A, Welsh R Remote ischaemic conditioning in ST elevation myocardial infarction: a registry-based randomised trial. Heart. 2022 May;108(9):703-709. doi: 10.1136/heartjnl-2021-319455. Epub 2021 Aug 20.
Robinson PC, Terkeltaub R, Pillinger MH, Shah B, Karalis V, Karatza E, Liew D, Imazio M, Cornel JH, Thompson PL, Nidorf M Consensus Statement Regarding the Efficacy and Safety of Long-Term Low-Dose Colchicine in Gout and Cardiovascular Disease. Am J Med. 2022 Jan;135(1):32-38. doi: 10.1016/j.amjmed.2021.07.025. Epub 2021 Aug 18.
Kuku KO, Garcia-Garcia HM, Doros G, Mintz GS, Ali ZA, Skinner WH, Artis AK, Ten Cate T, Powers E, Wong SC, Wykrzykowska J, Dube S, Kazziha S, van der Ent M, Shah P, Sum S, Torguson R, Di Mario C, Waksman R Predicting future left anterior descending artery events from non-culprit lesions: insights from the Lipid-Rich Plaque study. Eur Heart J Cardiovasc Imaging. 2022 Sep 10;23(10):1365-1372. doi: 10.1093/ehjci/jeab160.
Savarese G, Butler J, Lund LH, Bhatt DL, Anker SD Cardiovascular effects of non-insulin glucose-lowering agents: a comprehensive review of trial evidence and potential cardioprotective mechanisms. Cardiovasc Res. 2022 Jul 27;118(10):2231-2252. doi: 10.1093/cvr/cvab271.
Law AC, Stevens JP, Choi E, Shen C, Mehta AB, Yeh RW, Walkey AJ Days out of Institution after Tracheostomy and Gastrostomy Placement in Critically Ill Older Adults. Ann Am Thorac Soc. 2022 Mar;19(3):424-432. doi: 10.1513/AnnalsATS.202106-649OC.
Becattini C, Bauersachs R, Maraziti G, Bertoletti L, Cohen A, Connors JM, Manfellotto D, Sanchez A, Brenner B, Agnelli G Renal function and clinical outcome of patients with cancer-associated venous thromboembolism randomized to receive apixaban or dalteparin. Results from the Caravaggio trial. Haematologica. 2022 Jul 1;107(7):1567-1576. doi: 10.3324/haematol.2021.279072.
Capodanno D, Angiolillo DJ Oral antithrombotic therapy for the prevention of recurrent cerebrovascular events. Eur Heart J Cardiovasc Pharmacother. 2022 Jun 8;8(4):383-391. doi: 10.1093/ehjcvp/pvab062.
Fishbane S, Charytan DM, Chertow GM, Ford M, Kovesdy CP, Pergola PE, Pollock C, Spinowitz B Consensus-Based Recommendations for the Management of Hyperkalemia in the Hemodialysis Setting. J Ren Nutr. 2022 Jul;32(4):e1-e14. doi: 10.1053/j.jrn.2021.06.003. Epub 2021 Aug 5.
Seligman H, Nijjer SS, van de Hoef TP, de Waard GA, Mejia-Renteria H, Echavarria-Pinto M, Shun-Shin MJ, Howard JP, Cook CM, Warisawa T, Ahmad Y, Androshchuk V, Rajkumar C, Nowbar A, Kelshiker MA, van Lavieren MA, Meuwissen M, Danad I, Knaapen P, Sen S, Al-Lamee R, Mayet J, Escaned J, Piek JJ, van Royen N, Davies JE, Francis DP, Petraco R Phasic flow patterns of right versus left coronary arteries in patients undergoing clinical physiological assessment. EuroIntervention. 2022 Feb 18;17(15):1260-1270. doi: 10.4244/EIJ-D-21-00189.
Jensen IS, Wu E, Cyr PL, Claussen M, Winkler T, Salahuddin K, Prats J, Mahaffey KW, Gibson CM, Steg PG, Stone GW, Bhatt DL Cost-Consequence Analysis of Using Cangrelor in High Angiographic Risk Percutaneous Coronary Intervention Patients: A US Hospital Perspective. Am J Cardiovasc Drugs. 2022 Jan;22(1):93-104. doi: 10.1007/s40256-021-00491-9. Epub 2021 Jul 31.
Bikdeli B, Yanamandala M, Wang X, Campia U, Gravereaux EC, Padera RF, Gerhard-Herman M, Piazza G, Goldhaber SZ Images in Vascular Medicine: Pulmonary embolism and acute aortic syndromes – Double trouble when vascular medicine emergencies meet. Vasc Med. 2022 Feb;27(1):97-99. doi: 10.1177/1358863X211029695. Epub 2021 Jul 20.
Essien UR, McCabe ME, Kershaw KN, Youmans QR, Fine MJ, Yancy CW, Khan SS Association Between Neighborhood-Level Poverty and Incident Atrial Fibrillation: a Retrospective Cohort Study. J Gen Intern Med. 2022 May;37(6):1436-1443. doi: 10.1007/s11606-021-06976-2. Epub 2021 Jul 8.
Reilly CM, Higgins M, Butler J, Esiashvili N, Fei B, Flynn T, Dormer JD, Schreibmann E The Contribution of Thoracic Radiation Dose Volumes to Subsequent Development of Cardiovascular Disease in Cancer Survivors. J Cardiovasc Nurs. 2022 Sep-Oct 01;37(5):E129-E138. doi: 10.1097/JCN.0000000000000834.
Rodriguez-Arias JJ, Gomez-Lara J, Caballero-Borrego J, Ortega-Paz L, Arevalos V, Teruel L, Gil-Jimenez T, Oyarzabal L, Romaguera R, Moreno-Terribas G, Gomez-Hospital JA, Sabate M, Brugaletta S Long-Term Vascular Function in CTO Recanalization: A Randomized Clinical Trial of Ticagrelor vs. Clopidogrel. Cardiovasc Revasc Med. 2022 Apr;37:61-67. doi: 10.1016/j.carrev.2021.06.129. Epub 2021 Jul 1.
Neumiller JJ, Shubrook JH, Manley T, Alicic RZ, Tuttle KR Optimizing use of SGLT2 inhibitors and other evidence-based therapies to improve outcomes in patients with type 2 diabetes and chronic kidney disease: An opportunity for pharmacists. Am J Health Syst Pharm. 2022 Jan 1;79(1):e65-e70. doi: 10.1093/ajhp/zxab271.
Drexel H, Pocock SJ, Lewis BS, Saely CH, Kaski JC, Rosano GMC, Tautermann G, Huber K, Dopheide JF, Mader A, Niessner A, Savarese G, Schmidt TA, Semb AG, Tamargo J, Wassmann S, Clodi M, Kjeldsen KP, Agewall S Subgroup analyses in randomized clinical trials: value and limitations. Review #3 on important aspects of randomized clinical trials in cardiovascular pharmacotherapy. Eur Heart J Cardiovasc Pharmacother. 2022 May 5;8(3):302-310. doi: 10.1093/ehjcvp/pvab048.
McKay AJ, Gunn LH, Ference BA, Dorresteijn JAN, Berkelmans GFN, Visseren FLJ, Ray KK Is the SMART risk prediction model ready for real-world implementation? A validation study in a routine care setting of approximately 380 000 individuals. Eur J Prev Cardiol. 2022 Mar 30;29(4):654-663. doi: 10.1093/eurjpc/zwab093.
Arevalos V, Ortega-Paz L, Brugaletta S Mid-term effects of SARS-CoV-2 infection on cardiovascular outcomes. Med Clin (Barc). 2022 Jan 7;158(1):41-42. doi: 10.1016/j.medcli.2021.05.006. Epub 2021 May 28.
Galli M, Capodanno D, Benenati S, D’Amario D, Crea F, Andreotti F, Angiolillo DJ Efficacy and safety of dual-pathway inhibition in patients with cardiovascular disease: a meta-analysis of 49 802 patients from 7 randomized trials. Eur Heart J Cardiovasc Pharmacother. 2022 Aug 11;8(5):519-528. doi: 10.1093/ehjcvp/pvab043.
Tsoi M, Tandon K, Zimetbaum PJ, Frishman WH Conduction Disturbances and Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement: Predictors and Prevention. Cardiol Rev. 2022 Jul-Aug 01;30(4):179-187. doi: 10.1097/CRD.0000000000000398. Epub 2021 Jun 14.
Ferreira JP, Cleland JG, Lam CSP, Anker SD, Mehra MR, van Veldhuisen DJ, Byra WM, LaPolice DA, Greenberg B, Zannad F New-onset atrial fibrillation in patients with worsening heart failure and coronary artery disease: an analysis from the COMMANDER-HF trial. Clin Res Cardiol. 2022 Jan;111(1):50-59. doi: 10.1007/s00392-021-01891-2. Epub 2021 Jun 14.
Franchi F, Rollini F, Been L, Maaliki N, Abou Jaoude P, Rivas A, Zhou X, Jia S, Briceno M, Lee CH, Pineda AM, Suryadevara S, Soffer D, Zenni MM, Bass TA, Angiolillo DJ Impact of chronic kidney disease on the pharmacodynamic and pharmacokinetic effects of ticagrelor in patients with diabetes mellitus and coronary artery disease. Eur Heart J Cardiovasc Pharmacother. 2022 Aug 11;8(5):452-461. doi: 10.1093/ehjcvp/pvab042.
Correale M, Petroni R, Coiro S, Antohi EL, Monitillo F, Leone M, Triggiani M, Ishihara S, Dungen HD, Sarwar CMS, Memo M, Sabbah HN, Metra M, Butler J, Nodari S Paradigm shift in heart failure treatment: are cardiologists ready to use gliflozins? Heart Fail Rev. 2022 Jul;27(4):1147-1163. doi: 10.1007/s10741-021-10107-8. Epub 2021 Jun 7.
Faz GT, Angiolillo DJ Septal perforating artery originating from the ramus intermedius artery. Coron Artery Dis. 2022 Jan 1;31(1):e13-e14. doi: 10.1097/MCA.0000000000001059.
Nader R, Zhen A, Angel-Korman A, Pavlovich SS, Pogrebinsky A, Doros G, Menn-Josephy H, Stern L, Sanchorawala V, Havasi A Predictors and outcomes of acute kidney injury during autologous stem cell transplantation in AL amyloidosis. Nephrol Dial Transplant. 2022 Jun 23;37(7):1281-1288. doi: 10.1093/ndt/gfab189.
Li J, Montarello NJ, Hoogendoorn A, Verjans JW, Bursill CA, Peter K, Nicholls SJ, McLaughlin RA, Psaltis PJ Multimodality Intravascular Imaging of High-Risk Coronary Plaque. JACC Cardiovasc Imaging. 2022 Jan;15(1):145-159. doi: 10.1016/j.jcmg.2021.03.028. Epub 2021 May 19.
Chen S, Redfors B, Serruys PW, Pieter Kappetein A, Crowley A, Ben-Yehuda O, Srdanovic I, Lembo NJ, Brown WM 3rd, Sabik JF 3rd, Stone GW Impact of renin-angiotensin system inhibitors after revascularization of patients with left main coronary artery disease. Coron Artery Dis. 2022 Jan 1;31(1):37-44. doi: 10.1097/MCA.0000000000001053.
Claessen BE, Ben-Yehuda O, Mehran R, Sorrentino S, Guedeney P, Chen S, Dressler O, Kini AS, Sharma SK, Mansour S, Noiseux N, Li D, Kappetein AP, Sabik JF 3rd, Serruys PW, Stone GW White blood cell count and clinical outcomes after left main coronary artery revascularization: insights from the EXCEL trial. Coron Artery Dis. 2022 Jan 1;31(1):45-51. doi: 10.1097/MCA.0000000000001052.
Beska B, Coakley D, MacGowan G, Adams-Hall J, Wilkinson C, Kunadian V Frailty and quality of life after invasive management for non-ST elevation acute coronary syndrome. Heart. 2022 Feb;108(3):203-211. doi: 10.1136/heartjnl-2021-319064. Epub 2021 May 14.
Moledina SM, Shoaib A, Graham MM, Biondi-Zoccai G, Van Spall HGC, Kontopantelis E, Rashid M, Aktaa S, Gale CP, Weston C, Mamas MA Association of admitting physician specialty and care quality and outcomes in non-ST-segment elevation myocardial infarction (NSTEMI): insights from a national registry. Eur Heart J Qual Care Clin Outcomes. 2022 Aug 17;8(5):557-567. doi: 10.1093/ehjqcco/qcab038.
Gallone G, Baldetti L, Angelini F, Saglietto A, Bellettini M, Beneduce A, Ranotti V, Chiarito M, Leone PP, Pagnesi M, De Filippo O, Landra F, Bruno F, Marengo G, Collino M, Ferrante G, Stefanini GG, Colombo A, Al-Lamee R, Francis DP, Jolicoeur ME, Henry TD, Giannini F, D’Ascenzo F, De Ferrari GM The Placebo Effect on Symptoms, Quality of Life, and Functional Outcomes in Patients With Angina Pectoris: A Meta-analysis of Randomized Placebo-Controlled Trials. Can J Cardiol. 2022 Jan;38(1):113-122. doi: 10.1016/j.cjca.2021.04.022. Epub 2021 May 8.
Schellong S, Ageno W, Casella IB, Chee KH, Schulman S, Singer DE, Desch M, Tang W, Voccia I, Zint K, Goldhaber SZ Profile of Patients with Isolated Distal Deep Vein Thrombosis versus Proximal Deep Vein Thrombosis or Pulmonary Embolism: RE-COVERY DVT/PE Study. Semin Thromb Hemost. 2022 Jun;48(4):446-458. doi: 10.1055/s-0041-1729169. Epub 2021 May 10.
Moledina SM, Shoaib A, Weston C, Aktaa S, Van Spall HGC, Kassam A, Kontopantelis E, Banerjee S, Rashid M, Gale CP, Mamas MA Ethnic disparities in care and outcomes of non-ST-segment elevation myocardial infarction: a nationwide cohort study. Eur Heart J Qual Care Clin Outcomes. 2022 Aug 17;8(5):518-528. doi: 10.1093/ehjqcco/qcab030.
Fox KAA, Virdone S, Pieper KS, Bassand JP, Camm AJ, Fitzmaurice DA, Goldhaber SZ, Goto S, Haas S, Kayani G, Oto A, Misselwitz F, Piccini JP, Dalgaard F, Turpie AGG, Verheugt FWA, Kakkar AK, GARFIELD-AF Investigators GARFIELD-AF risk score for mortality, stroke, and bleeding within 2 years in patients with atrial fibrillation. Eur Heart J Qual Care Clin Outcomes. 2022 Mar 2;8(2):214-227. doi: 10.1093/ehjqcco/qcab028.
Bikdeli B, Talasaz AH, Rashidi F, Bakhshandeh H, Rafiee F, Rezaeifar P, Baghizadeh E, Matin S, Jamalkhani S, Tahamtan O, Sharif-Kashani B, Beigmohammadi MT, Farrokhpour M, Sezavar SH, Payandemehr P, Dabbagh A, Moghadam KG, Khalili H, Yadollahzadeh M, Riahi T, Abedini A, Lookzadeh S, Rahmani H, Zoghi E, Mohammadi K, Sadeghipour P, Abri H, Tabrizi S, Mousavian SM, Shahmirzaei S, Amin A, Mohebbi B, Parhizgar SE, Aliannejad R, Eslami V, Kashefizadeh A, Dobesh PP, Kakavand H, Hosseini SH, Shafaghi S, Ghazi SF, Najafi A, Jimenez D, Gupta A, Madhavan MV, Sethi SS, Parikh SA, Monreal M, Hadavand N, Hajighasemi A, Maleki M, Sadeghian S, Piazza G, Kirtane AJ, Van Tassell BW, Stone GW, Lip GYH, Krumholz HM, Goldhaber SZ, Sadeghipour P Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit: 90-Day Results from the INSPIRATION Randomized Trial. Thromb Haemost. 2022 Jan;122(1):131-141. doi: 10.1055/a-1485-2372. Epub 2021 Jun 6.
Vilson FL, Schmidt B, White L, Soerensen SJC, Ganesan C, Pao AC, Enemchukwu E, Chertow GM, Leppert JT Removing Race from eGFR calculations: Implications for Urologic Care. Urology. 2022 Apr;162:42-48. doi: 10.1016/j.urology.2021.03.018. Epub 2021 Mar 30.
Iqbal MB, Moore PT, Nadra IJ, Robinson SD, Fretz E, Ding L, Fung A, Aymong E, Chan AW, Hodge S, Webb J, Sheth T, Jolly SS, Mehta SR, Sathananthan J, Wood DA, Della Siega A, British Columbia Cardiac Registry Investigators Complete revascularization in stable multivessel coronary artery disease: A real world analysis from the British Columbia Cardiac Registry. Catheter Cardiovasc Interv. 2022 Feb;99(3):627-638. doi: 10.1002/ccd.29564. Epub 2021 Mar 4.
Suleiman T, Scott A, Tong D, Khanna V, Kunadian V Contemporary device management of cardiogenic shock following acute myocardial infarction. Heart Fail Rev. 2022 May;27(3):915-925. doi: 10.1007/s10741-021-10088-8. Epub 2021 Mar 3.
Magavern EF, Kaski JC, Turner RM, Drexel H, Janmohamed A, Scourfield A, Burrage D, Floyd CN, Adeyeye E, Tamargo J, Lewis BS, Kjeldsen KP, Niessner A, Wassmann S, Sulzgruber P, Borry P, Agewall S, Semb AG, Savarese G, Pirmohamed M, Caulfield MJ The role of pharmacogenomics in contemporary cardiovascular therapy: a position statement from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy. Eur Heart J Cardiovasc Pharmacother. 2022 Jan 5;8(1):85-99. doi: 10.1093/ehjcvp/pvab018.
Gautier A, Ducrocq G, Elbez Y, Fox KM, Ferrari R, Ford I, Tardif JC, Tendera M, Feldman LJ, Steg PG Cardiovascular risk of chronic coronary syndrome patients according to vascular phenotype, diabetes, and smoking. Eur J Prev Cardiol. 2022 Feb 19;29(1):e35-e37. doi: 10.1093/eurjpc/zwaa137.
Figtree GA, Vernon ST, Nicholls SJ Taking the next steps to implement polygenic risk scoring for improved risk stratification and primary prevention of coronary artery disease. Eur J Prev Cardiol. 2022 Mar 30;29(4):580-587. doi: 10.1093/eurjpc/zwaa030.
Khan SU, Yedlapati SH, Lone AN, Khan MS, Wenger NK, Watson KE, Gulati M, Hays AG, Michos ED A comparative analysis of premature heart disease- and cancer-related mortality in women in the USA, 1999-2018. Eur Heart J Qual Care Clin Outcomes. 2022 May 5;8(3):315-323. doi: 10.1093/ehjqcco/qcaa099.
Ahmad Y, Kane C, Arnold AD, Cook CM, Keene D, Shun-Shin M, Cole G, Al-Lamee R, Francis DP, Howard JP Randomized Blinded Placebo-Controlled Trials of Renal Sympathetic Denervation for Hypertension: A Meta-Analysis. Cardiovasc Revasc Med. 2022 Jan;34:112-118. doi: 10.1016/j.carrev.2021.01.031. Epub 2021 Jan 30.
Greene SJ, Tan X, Yeh YC, Bernauer M, Zaidi O, Yang M, Butler J Factors associated with non-use and sub-target dosing of medical therapy for heart failure with reduced ejection fraction. Heart Fail Rev. 2022 May;27(3):741-753. doi: 10.1007/s10741-021-10077-x. Epub 2021 Jan 20.
Yehya A, Shah KS, Mitter SS, Ibrahim NE, Sperry B, Shah M, Chaudhry SP, Rajagopalan N, Hernandez-Montfort J, Mohan R, Alexander KM, Sinha S, Butler J, Kittleson MM Challenges and the innovations in the care of advanced heart failure patients during COVID-19. Heart Fail Rev. 2022 Jan;27(1):235-238. doi: 10.1007/s10741-021-10074-0. Epub 2021 Jan 12.
Shen L, Qiu L, Liu D, Wang L, Huang H, Ge H, Xiao Y, Liu Y, Jin J, Liu X, Wang DW, Peterson ED, He B, Zhou N The Association of Low Molecular Weight Heparin Use and In-hospital Mortality Among Patients Hospitalized with COVID-19. Cardiovasc Drugs Ther. 2022 Feb;36(1):113-120. doi: 10.1007/s10557-020-07133-3. Epub 2021 Jan 4.
De Caterina R, Patti G, Westerbergh J, Horowitz J, Ezekowitz JA, Lewis BS, Lopes RD, McMurray JJV, Atar D, Bahit MC, Keltai M, Lopez-Sendon JL, Ruzyllo W, Granger CB, Alexander JH, Wallentin L Heterogeneity of diabetes as a risk factor for major adverse cardiovascular events in anticoagulated patients with atrial fibrillation: an analysis of the ARISTOTLE trial. Eur Heart J Cardiovasc Pharmacother. 2022 May 5;8(3):227-235. doi: 10.1093/ehjcvp/pvaa140.
Costa F, Valgimigli M, Steg PG, Bhatt DL, Hohnloser SH, Ten Berg JM, Miede C, Nordaby M, Lip GYH, Oldgren J, Cannon CP Antithrombotic therapy according to baseline bleeding risk in patients with atrial fibrillation undergoing percutaneous coronary intervention: applying the PRECISE-DAPT score in RE-DUAL PCI. Eur Heart J Cardiovasc Pharmacother. 2022 May 5;8(3):216-226. doi: 10.1093/ehjcvp/pvaa135.
Montarello NJ, Nguyen MT, Wong DTL, Nicholls SJ, Psaltis PJ Inflammation in Coronary Atherosclerosis and Its Therapeutic Implications. Cardiovasc Drugs Ther. 2022 Apr;36(2):347-362. doi: 10.1007/s10557-020-07106-6. Epub 2020 Nov 10.
Ono M, Tomaniak M, Koenig W, Khamis R, de Silva R, Chichareon P, Kawashima H, Hara H, Gao C, Wang R, Huber K, Vrolix M, Jasionowicz P, Wykrzykowska JJ, Piek JJ, Juni P, Hamm C, Steg PG, Windecker S, Onuma Y, Storey RF, Serruys PW Impact of white blood cell count on clinical outcomes in patients treated with aspirin-free ticagrelor monotherapy after percutaneous coronary intervention: insights from the GLOBAL LEADERS trial. Eur Heart J Cardiovasc Pharmacother. 2022 Jan 5;8(1):39-47. doi: 10.1093/ehjcvp/pvaa110.
Gragnano F, Heg D, Franzone A, McFadden EP, Leonardi S, Piccolo R, Vranckx P, Branca M, Serruys PW, Benit E, Liebetrau C, Janssens L, Ferrario M, Zurakowski A, Diletti R, Dominici M, Huber K, Slagboom T, Buszman P, Bolognese L, Tumscitz C, Bryniarski K, Aminian A, Vrolix M, Petrov I, Garg S, Naber C, Prokopczuk J, Hamm C, Steg PG, Juni P, Windecker S, Valgimigli M PRECISE-DAPT score for bleeding risk prediction in patients on dual or single antiplatelet regimens: insights from the GLOBAL LEADERS and GLASSY. Eur Heart J Cardiovasc Pharmacother. 2022 Jan 5;8(1):28-38. doi: 10.1093/ehjcvp/pvaa106.
El Hadidi S, Rosano G, Tamargo J, Agewall S, Drexel H, Kaski JC, Niessner A, Lewis BS, Coats AJS, Savarese G Potentially inappropriate prescriptions in heart failure with reduced ejection fraction: ESC position statement on heart failure with reduced ejection fraction-specific inappropriate prescribing. Eur Heart J Cardiovasc Pharmacother. 2022 Feb 16;8(2):187-210. doi: 10.1093/ehjcvp/pvaa108.
Tavenier AH, Hermanides RS, Ottervanger JP, Tolsma R, van Beurden A, Slingerland RJ, Ter Horst PGJ, Gosselink ATM, Dambrink JE, van Leeuwen MAH, Roolvink V, Kedhi E, Klungel OH, Belitser SV, Angiolillo DJ, Pustjens T, Rasoul S, Gho B, Stein M, Ruiters L, van ‘t Hof AWJ Impact of opioids on P2Y12 receptor inhibition in patients with ST-elevation myocardial infarction who are pre-treated with crushed ticagrelor: Opioids aNd crushed Ticagrelor In Myocardial infarction Evaluation (ON-TIME 3) trial. Eur Heart J Cardiovasc Pharmacother. 2022 Jan 5;8(1):4-12. doi: 10.1093/ehjcvp/pvaa095.
Triposkiadis F, Xanthopoulos A, Parissis J, Butler J, Farmakis D Pathogenesis of chronic heart failure: cardiovascular aging, risk factors, comorbidities, and disease modifiers. Heart Fail Rev. 2022 Jan;27(1):337-344. doi: 10.1007/s10741-020-09987-z.
Hohlfelder B, Kelly D, Hoang M, Anger KE, Sylvester KW, Kaufman RM, Connors JM Activated Clotting Times Demonstrate Weak Correlation With Heparin Dosing in Adult Extracorporeal Membrane Oxygenation. Am J Ther. 2022 Jul 1;29(4):e385-e393. doi: 10.1097/MJT.0000000000001113.

Publications – 2022

NEWS

ABOUT US

CAREERS

CONTACT US

SERVICES

CENTERS OF EXCELLENCE

CLINICAL RESEARCH